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Abstract
The Cdx homeobox transcription factor family are expressed during 
development regulating axial skeletal development. Later, Cdxl and Cdx2 expression 
is restricted to the crypt-villus axis in the differentiating intestinal epithelium. 
However, the regulatory mechanisms governing Cdxl are not completly understood. 
In this study, the Cdx genes of Fugu rubripes were identified and characterized. 
Consistently, the Fugu Cdx family contains the same gene structure and tissue 
distribution as their mammalian orthologs. To investigate the regulatory mechanisms 
controlling the Cdxl expression reporter mouse Cdxl LacZ and Fugu Cdxl GFP 
constructs were assayed in intestinal cells. Cis-regulatory elements located upstream 
of the mouse and Fugu Cdxl were able, and even enhanced, the expression of the 
reporter in the cells.
Subsequently, functional expression assays in the zebrafish embryo, revealed 
that the Fugu Cdxl upstream region directs the expression of the transgene during 
gastrulation, and at 14-somite stage, in the posterior region of the embryo. Further 
comparative analysis of the Fugu, mouse and human 5’ flanking regions showed 
conserved transcription factor binding sites across species.
The Adenomatous Polyposis Coli (Ape) multifunctional protein is involved in 
cell adhesion, cell migration and cell proliferation. In tissues like the intestine, Ape is 
involved in the regulation of p-catenin in the Wnt signalling pathway. When p- 
catenin translocates into the nucleus, it forms a complex with the Tcf/Lef transcription 
factors to activate genes involved in proliferation and differentiation of the cells (e.g. 
Cdxl). When the Wnt pathway is activated, an inhibitory complex formed by Axin, 
GSK3P and Ape down-regulates p-catenin; transcriptional activation of genes does 
not take place. Ape regulates indirectly the proliferation and differentiation changes in 
the intestinal cells.
To investigate Apcl regulation and its potential interaction with the Cdx 
proteins, comparative studies to look for conserved regulatory regions and 
transcription factors binding sites were performed using the Fugu rubripes genome.
We identified and characterized the Fugu Apcl and Apc2 genes. Comparative studies 
showed a good level of conservation of the genomic, gene and amino acid structures 
of the Ape genes between mouse, human and Fugu. RT-PCR analyses revealed that 
the Fugu Ape genes are expressed, in the same variety of tissues and during 
development as the mouse orthologs.
Comparative analyses of the mouse and Fugu Apcl upstream sequences 
showed that, even though their sequences have diverged during evolution, 
transcription factor binding sites (e.g. Cdx, GATA and HNF) remain conserved 
between the species. Transfection and transactivation assays using the mouse Apcl 
upstream sequence and the Cdxl and Cdx2 cDNA, suggest an antagonistic role of the 
Caudal proteins in the regulation of mApcl in intestinal cells.
The expression distribution of the Fugu Apcl gene, and the presence of 
conserved transcription factor binding sites between mouse and Fugu upstream 
regions, suggest that the regulatory mechanism of the Apcl in the intestinal tissue are 
conserved between species.
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1.1 Anterior posterior axis formation
1.1.1 Formation of the embryo
The development of the embryo is a very well conserved process. The first 
stage of development occurs after the fertilized egg has undergone 4 cell divisions, at 
the 16 cell stage, the embryo is called morula, which consists of a group of inner cells 
surrounded by larger cells. The cells derived from the external cells will form the 
trophoblast cells. At this stage, the first two cell lineages of the embryo have 
originated, the trophectoderm and the inner cell mass. The trophectoderm gives rise to 
extraembryonic structures.
The trophoblast cells, also known as trophectoderm, do not contribute to the 
embryo proper. The trophectoderm will give rise to the extra embryonic structures 
(e.g. placenta) and the inner cell mass (ICM) will develop into the embryo proper. By 
the time of implantation, the embryo has developed to a vesicular structure called the 
blastocyst (32 cell stage). The blastocyst contains an external cell layer that begins to 
expand as fluid fills the internal cavity. The inner cell mass is attached to the internal 
side of the vesicle.
The inner cell mass divides into two, the primitive ectoderm and the primitive 
endoderm or epiblast. The primitive endoderm will contribute to the formation of the 
extra embryonic membranes such as the parietal endoderm and the visceral endoderm. 
The primitive ectoderm also contributes to the embryo and also some extra embryonic 
membranes.
After this stage, the embryo begins to acquire a cup shaped appearance and at
6.5 days after fertilization, the future axis of the embryo becomes visible with the 
onset of gastrulation and the formation of the primitive streak. The start of the 
primitive streak marks the posterior of the embryo. These processes are tightly 
regulated at the genetic level (Figure 1.1).
2
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Figure. 1.1. Early development of the mouse embryo. A. After cleavage, the 
blastocyst forms the trophectoderm and the ICM. The ICM divides into the
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primitive ectoderm or epiblast and the primitive endoderm. B. The polar 
trophectoderm in contact with the epiblast forms the extraembryonic tissues, the 
ectoplacental cone and mural trophectoderm. The epiblast elongates and forms a 
cup-shape structure. C. The epiblast and extraembryonic tissue form a cylindrical 
structure known as the egg cylinder. D. The primitive streak starts at the 
posterior of the epiblast (P) and extends interiorly (A), The epiblast cells 
migrating through the streak will become mesoderm and endoderm. E. The 
primitive streak continues its extension; the extraembryonic mesoderm develops 
at the posterior of the primitive streak. The visceral yolk sac, the allantois and 
chorion will be part of the placenta. F. At the end of gastrulation, organogenesis 
takes place with the appearance of heart, cranial neural folds and somites 
(Wolpert et al. 2002)
During gastrulation the cell sheets rearrange, occupy new positions and find 
new neighbours to generate the three main germ layers -ectoderm, mesoderm and 
endoderm- that will rise to all the tissues of the body. At the end of gastrulation, the 
heart, liver and gut have acquired their respective positions in the embryo; the head 
becomes distinct and the forelimb buds start to develop. Organogenesis follows and 
culminates in development of the adult with the creation of specific tissues and organs 
(Gilbert 2000; Wolpert et al. 2002).
1.1.2 Anterior posterior axis formation
The anterior posterior axis of the organism is established at a very early stage 
of development. As mentioned earlier, gastrulation marks the establisment of the 
anterior posterior axis (A- P axis) in the embryo. At 6.5 days the cells of the epiblast, 
a group of cells that will give rise to the embryo proper, start to form the primitive 
streak. The site of formation of the streak marks the posterior end of the embryo, and 
the cells from this region move towards the anterior part forming the primitive streak. 
In the anterior region some cells establish a signaling node, the organizer. Goosecoid, 
Nodal, Lim-1 and HNF3/3 are genes expressed in the node and are involved in the 
initiation and maintenance of the primitive streak as well as in the formation of the 
most anterior regions of the embryo like the head.
4
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Once the A- P axis has been established, the patterning and identity of the 
structures is specified by the Hox genes. These homeobox genes provide the cells with 
positional information to migrate and locate in the proper position to generate future 
structures. The Hox genes are expressed in mesodermal cells present in the primitive 
streak. The paraxial mesoderm then becomes segmented into somites that give rise to 
the muscles, skin and axial skeleton (Marshall et a l 1996).
Studies using different model systems (Conion 1995; Gellon and McGinnis 
1998) have shown the contribution of the Hox genes to the establishment and 
formation of the A- P axis in the developing embryo. These studies demonstrated that 
a shift or ablation of specific Hox genes produce alterations in somites and vertebral 
transformation.
However, specification of the A-P axis does not depend on the expression of 
the Hox genes. Studies have shown that the murine Cdx genes as well as its homolog 
Caudal in Drosophila are essential for the A-P axis formation during early 
development. Cdxl has been shown to bind to the Hoxa-7 promoter, a gene involved 
is somitogenesis (Subramanian et a l 1995). The Hoxb-8a gene expressed in the 
central nervous system during development is also regulated by Cdx proteins, and 
ectopic expression of Cdx anteriorizes the expression of Hoxb-8 in the embryo 
(Charite et a l 1998). The Hoxc-8 is expressed in the embryonic tissues where Cdx2 is 
also expressed, two specific Cdx2 binding sites identified in the Hoxc-8 upstream 
regulatory region have been shown to drive the expression of the gene; furthermore, 
these Cdx2 binding sites were able to activate heterologous promoters when placed in 
an enhancer position (Taylor et al 1997).
1.1.3 Role of the Cdx in anterior-posterior axis formation
The Caudal related homeodomain transcription factors, Cdxl, Cdx2 and Cdx4, 
are known to be expressed early during development and contribute to the A-P axis 
formation in the mouse embryo.
During development, Cdxl is expressed during late gastrulation at 7.5 dpc. 
Cdxl shows a gradient of expression, being the posterior end of the primitive streak 
more active in Cdxl expression than the anterior end. Paraxial mesoderm and 
neuroectoderm also show expression at this stage. By 8.5 dpc expression is found in
5
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the neuroectoderm and in the mesoderm of the developing somites. Between 8.25 and 
8.75dpc the most anterior expression of Cdxl is at the base of the hindbrain. This 
expression boundary then moves to the spinal cord limit. After the formation of the 
somites, the anterior boundary of expression is at the spinal cord and the dorsal region 
of the somites. At 9.0 dpc, the mesoderm begins to form the forelimb bud between the 
seventh and tenth somites. By 9.5 dpc Cdxl expression is located in the dorsal region 
of the anterior somites and in the mesodermal cells of the forelimb buds. After this 
stage, expression of the transcript decreases markedly, although the Cdxl protein is 
still found until 12 dpc in the somites (Meyer and Gruss 1993).
In contrast to Cdxl, Cdx2 is expressed much earlier at 3.5 dpc in the 
trophectoderm of the blastocyst. From 4.0 to 6.5 dpc, Cdx2 expression is detected in 
extraembryonic ectoderm. At 7.5 dpc, expression is present in the chorion, the most 
external extraembryonic membranes involved in respiratory exchange; the mesoderm 
of the developing allantoic bud, the allantoids is a set of extraembryonic membranes 
where blood is carried in and out of the placenta; the ectoplacental cone, which is 
derived from the extraembryonic ectoderm and attaches to the uterine wall and 
posterior primitive streak.
At 8.5 dpc, Cdx2 expression is seen in all three germ layers in the posterior 
region of the embryo; the anterior expression is found in the neural tube, neural plate 
and notochord, a mesodermal derived structure beneath the future central nervous 
system. The paraxial mesoderm is also positive in expression. By 9.5 dpc, the tail bud, 
neural tube, notochord posterior and gut endoderm of the embryo remains positive, 
although no more expression is seen anteriorly to the foregut/midgut junction. At this 
stage, there is a gradual decrease of expression in the notochord and neural plate.
At 12.5 dpc, expression is restricted to the gut endoderm; gut epithelium 
shows strong expression in the foregut/midgut boundary, and the expression decreases 
towards the posterior part of the hindgut. The epithelium is negative in expression in 
the rectum and urogenital sinus. At this stage, the cytotrophoblast, a structure derived 
from the trophectoderm is also positive for Cdx2 expression (Beck et al. 1995).
The third Caudal related homebox factor, Cdx4, is also expressed during early 
stages in the posterior region of the developing embryo. The allantois and the 
posterior end of the primitive streak are positive for Cdx4 expression at 7.0-7.5 dpc.
6
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By 8.5 dpc, Cdx4 is highly expressed in the posterior neural tube, presomitic 
mesoderm and hindgut endoderm. At this stage there is a gradual expression of the 
gene being the posterior part of the embryo the strongest in expression. The anterior 
limit of expression lies posterior to the youngest somite.
At 9.5 dpc, Cdx4 expression is still present in the tail bud of the embryo, 
neural tube, early mesoderm and the epithelium of the hindgut are positive in 
expression, while no expression is found in any anterior structure. No expression has 
been detected after 10.5 dpc (Gamer and Wright 1993).
1.2 Intestinal crypt villus axis
1.2.1 Structure and histology of the intestine
In mammals including mouse, the formation of the gut begins after 
gastrulation when the endoderm invaginates to create the anterior and posterior 
intestinal portals. These ends elongate inwards and finally fuse to create a primitive 
intestinal tube surrounded by mesodermal tissue. This process happens at 8.5 dpc 
when the embryo turns its body. As development proceeds, three main regions start to 
differentiate in the gut tube: the foregut, from which will originate the pharynx, 
oesophagus and stomach; the midgut that will give rise to the small intestine; and the 
hindgut that gives rise to the large intestine. After birth, ingestion and primary 
digestion occur in the foregut; the completion of digestion and absorption of nutrients 
take place in the small intestine; and water and salt reabsortion as well as ejection of 
waste are performed in the large intestine (Kaufman et a l 1997).
The anatomy of the intestine is similar in the midgut and hindgut; both organs 
consist of epithelium, surrounded by connective tissue. These two tissues are 
surrounded by concentric layers of smooth tissue innervated by enteric nerves. The 
function of the enteric nerves is to allow contractions of the intestine during digestion 
(Kedinger et al 1998).
The intestinal epithelium is a renewing tissue where proliferation, 
differentiation and migration of cells occur through the life of the individual in a 
tightly regulated process. There are two axes of differentiation in the intestine, the 
anterior posterior axis (A-P) and the crypt-villus axis (C-V). The crypt (also known as
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crypts of Lieberkiihn) is a proliferative compartment located at the bottom of the CV 
axis, where a reservoir of stem cells is located. The villus is the top compartment 
where differentiated cells migrate to take their place.
Bjerknes et al. (1999) proposed that two populations of cells are derived from 
each stem cell, a population that will give rise to the absorptive enterocytes and a 
population that will produce the different secretory cells (goblet, enteroendocrine and 
paneth). The Paneth cells are the only differentiated cell types that stay at the bottom 
of the crypt. The other three types, goblet cells, enteroendocrine cells and absorptive 
enterocytes differentiate as they migrate to the villus (Potten and Loeffler 1990; 
Stappenbeck et al 2002).
1.2.2 Role of the Cdx in intestinal epithelial differentiation
The Caudal family, specifically Cdxl and Cdx2 whose second phase of 
expression is restricted to the developing intestine and maintained through adulthood, 
are early players in the specification of the intestine (Duprey et al. 1988; James and 
Kazenwadel 1991; Beck e ta l  1995; Subramanian et a l 1998)
As the intestine develops and matures, the A-P axis is distinguished during the 
epithelial differentiation along the cephalo-caudal regions, resulting in morphological 
and biochemical differences between the small and large intestine (16-17dpc). Once 
the cells are specified as gut primordia, a regional patterning marks the foregut, 
midgut and hindgut development derived from endoderm tissue. At this stage, 
expression of Cdxl and Cdx2 is restricted to the intestinal epithelium. Cdx2 is 
especially important for hindgut development (Freund et a l 2003). The Cdx genes 
may influence the A-P patterning through regulation of the Hox genes 
(Chawengsaksophak et a l 1997; Charite et a l 1998).
At 14.5 dpc, a weak expression of Cdxl reappears in the small and large 
intestine epithelium. At 17.5 dpc, the expression becomes stronger in both tissues 
(Duprey et a l 1988; Subramanian et a l 1998). The increase of this expression obeys 
to the developmental transition of the gut. Then, expression is restricted to the base of 
the primitive villi. Twenty days after birth, the finger-like villi separated by the crypts 
are a characteristic feature of the small intestine. In contrast, crypts are the main 
feature in the colon. Cdxl expression is located at the base of the crypts. Expression 
in the anterior posterior axis goes from the duodenum to the colon (Figure 1.2), the
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expression being stronger in the colon and decreasing gradually in the anterior region 
(James and Kazenwadel 1991; Subramanian et al. 1998).
From 12.5 dpc onwards Cdx2 is expressed in the epithelium of the gut; there is 
an anterior posterior pattern in expression. In the proximal colon transcripts are more 
abundant than in the distal colon. The expression of Cdx2 in the proximal colon is 
stronger in undifferentiated cells at the base of the crypt than in differentiated cells at 
the top of the crypt. In contrast, in the distal colon expression is stronger in 
differentiated cells (Figure 1.2) situated in the top half of the crypt. (James et al. 1994; 
Silberg et al. 2000).
By 15 dpc, Cdx2 is expressed in the endoderm intestinal epithelium (Figure 
1.2), the expression continues in the adult intestinal epithelium, in the villus of the 
small intestine and in the crypts of the colon (James et al. 1994). Due to the 
expression pattern shown by Cdxl and Cdx2 in the crypt-villus axis, Cdxl is essential 
in maintaining the population of cells that come from the stem cell niche, and cells 
that undergo differentiation. In contrast, the role of Cdx2 in this axis seems connected 
with maturation and differentiation of cells situated outside of the crypt.
Cdx2 is expressed in the differentiated enterocytes and regulates the 
expression of enterocytic genes. Reports have shown that Cdx2 is involved in the 
regulation of specific intestinal genes such as those encoding sucrase isomaltase, 
carbonic anhydrase 1, apoliprotein B, among others (Suh et al. 1994; Drummond et 
al. 1996; Lee et al. 1996).
The Cdx2 binding sites have to be located in an enhancer context in order to 
show specific cell type activation (Taylor et al. 1997), suggesting the involvement of 
a co- activator factor to mediate the binding of Cdx2 in its binding site. For example, 
Cdx2 forms a transcriptional complex with HNF-la  and GATA4 to activate the 
sucrose isomaltase (SI) gene in the epithelial cells in the villus (Boudreau et al. 2002).
Cdxl has been found to activate the pancreatitis associated protein I promoter, 
a gene involved in cell proliferation in the crypts (Moucadel et al. 2001). Lynch et al 
(2000) reported that Cdxl is able to inhibit growth of intestinal epithelial cells by 
disrupting the G1 phase of the cell cycle. This inhibition appears to be due to a 
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Figure 1.2. Expression of mCdxl and mCdx2 in the intestinal epithelium. Stomach (S), duodenum (D), jejunum (J) ileum (I), proximal colon 
(PC), distal colon (DC), caecum (C). Red arrow and red bar indicate the expression of Cdxl in the anterior posterior axis and in the crypt 
villi axis. Blue arrows indicate Cdx2 expression along both axes. Enteroendocrine cells (EE), transit amplifying cells (TAC), stem cell (SC), 
paneth cell (P), goblet cell (G) and epithelium (E). (a) Cdxl expression in small and large intestine day 16, (b) Cdxl expression in small 
and large intestine day 17, (c) Cdxl expression in colon day 17 and (d) Cdx2 expression in small and large intestine. Photographs of Cdxl 
and Cdx2 expression in the adult and in developing intestine from Subramanian et. al. (1998).
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1.2.3 Genes involved in the intestinal epithelial formation and 
differentiation
Signaling cascades and transcription factors are required for the generation of 
distinct tissues and organs during development. The cascades are initiated and 
mediated by soluble factors like the Wnt pathway. In addition, development of tissues 
depends on the expression and activity of a number of transcription factors associated 
with these signal transduction pathways. Studies in the specification, regulation and 
proliferation of intestinal epithelium in the mouse have shown that several genes are 
involved in these complex processes. Many transcription factors, including the 
homeobox factors are involved in tumorigenesis in the intestinal epithelium 
(Clatworthy and Subramanian 2001).
Along with the expression of the Cdxl and Cdx2, other genes have been 
identified in maintaining the structure and function of the intestinal epithelium. The 
Tcf4 factor, a member of the TCF/LEF family, is expressed in the proliferative region 
in the small intestine (Korinek et a l 1998). The Cdxl transcription factor as 
mentioned before, has an early expression in the proliferating epithelium; its 
expression is later restricted to the proliferative regions in the crypts (Duprey et al 
1988; Subramanian et a l 1998). Studies have shown that Cdxl stimulates cell 
proliferation and induces cell differentiation from the stem cells to the proliferating 
and transit cells. In contrast, Cdx2 has been proved to decrease the levels of 
proliferating cells and enhance differentiation (Suh and G. 1996; Lorentz et a l 1997; 
Mallo et al 1998; Soubeyran et a l 1999)
The Fkh6 gene is expressed in the layer adjacent to the epithelium, the 
mesenchyme (Kaestner et a l 1997). HFH11 and HNF3/3, which belong to the 
forkhead family, are expressed in the crypts in the adult; however, HFH11 is also 
expressed in epithelium and mesenchyme in early stages of the intestine development 
(Ye et a l 1997). And Cdx2, the other member of the Caudal family, is expressed in 
the villus (James and Kazenwadel 1991).
The generation of the gut involves the interaction of epithelium and 
mesenchyme. The basement membrane acts as a barrier between these two layers. 
This basement membrane is involved in cell adhesion and cytoskeletal organization. It 
also influences differentiation and proliferation of cells (Clatworthy and Subramanian 
2001).
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The Wnt signalling pathway is required for the organization of the intestinal 
epithelium. When the Wnt pathway is activated, p-catenin is stabilized and 
translocated into the nucleus. Interaction with the TCF/LEF transcription factor 
complex leads to the activation of genes involved in the maintenance of the gut 
epithelium (Brantjes et al. 2002). Pownall et al. (1996) and Isaacs et al. (1998) have 
shown that Xcad3 is an intermediate early target of the FGF signaling pathway in 
Xenopus development, that normal expression of posterior Hox genes is dependent on 
FGF signalling, and that this regulation is probably mediated by the activation of 
Xcad3.
1.3 The Drosophila Caudal gene, expression and function
1.3.1 Anterior- posterior axis in Drosophila
Pattern formation and specification in the early development of Drosophila is 
initiated by a group of homeobox transcription factors expressed either maternally or 
zygotically in the embryo. One of these homeobox factors is Caudal (cad) that is 
expressed during the formation of the unfecunded egg (oogenesis) as a maternal 
transcript and later in development is expressed zygotically in the embryo. By the 
stage that the nuclei migrate to the periphery of the zygote, cad concentrates in the 
posterior end of the zygote forming an anterior posterior gradient. By stage 13, both 
maternal and zygotic cad maintain the antero-posterior gradient. Before the 
cellularisation stage, the maternal cad decreases and zygotic cad emerges to form first 
an anterior posterior gradient, that later becomes restricted to a stripe of expression 
located in the middle of the embryo, where the abdominal segments will be formed. 
This process is controlled by hunchback (hb), a gene also expressed maternally and 
zygotically in the embryo. The zygotic hb gradient regulates positively the zygotic 
cad expression in the abdominal zone of the embryo, where cad becomes a stripe of 
expression in the posterior end of hb gradient.
The first gradient showed by cad is due to the presence of Bicoid (bed), which 
forms an anterior posterior gradient where the highest concentration is located in the 
anterior pole of the embryo, the same gradient showed by hb, and prevents translation 
of cad. The way in which bed represses the expression of cad is via interaction with 
cis- elements located in the 3’ untranslated region (UTR) of cad mRNA (Niessing et
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al. 2002). As a result, cad concentrates in the posterior end of the embryo where bed 
is not present and can not be translated. Figure 2 illustrates the distribution and 
gradient formed by bed and cad during the early development of Drosophila. The cad 
maternal messenger is present evenly all throughout the egg (Figure 1.3a); after 
fertilization, cad mRNA locates in the posterior of the embryo (Figure 1.3b); the bed 
maternal messenger forms an anterior gradient in the embryo (Figure 1.3c); which 
will create an opposite gradient to cad, establishing the positional identity of the 
anterior posterior axis en the embryo (Figure 1.3d).
A
a) MatemaJ Cad mRNA distribution
b) Expression of Cad
c) Expression o f Bed mRNA d) Bed gradient and Cad gradient
Figure 1.3. Cad gradient formation in the Drosophila developing embryo, a) Maternal 
cad mRNA distribution (white bar), b) Expression of cad mRNA in wild type 
embryo (grey bar), c) Expression of bed mRNA (red bar) and d) bed gradient 
overlapping the cad gradient, (red and grey bars). Adapted from Rivera-Pomar 
et. al. (1996).
1.3.2 Caudal mutations
Studies performed with Drosophila mutants suggest that Cad is also involved 
during gastrulation in the Drosophila embryo. Absence of maternal and zygotic cad 
causes defects in the development of the hindgut. When only maternal cad is present, 
there is formation of the hindgut. However, when only the zygotic cad is present, the
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hindgut is malformed. In the absence of both, there is no formation of hindgut in the 
embryo. There is a redundancy in activity between the maternal and zygotic product, 
since the absence of one of the products can be compensated by the other (Struhl and 
White 1985).
The expression of other genes has been studied in cad mutants. Expression of 
wg, a segment polarity gene involved in the establishment of parasegment boundaries, 
is affected. The fkh  gene, required for the normal development of the hindgut 
primordium, is also affected as well as fog , a gene required in the spermatogenesis 
process (Wu and Lengyel 1998).
1.3.3 The Caudal homologs: expression and function
Since the identification of the Drosophila cad gene, many cad homologs have 
been isolated in different species. In situ hybridization and immunostaining 
experiments have showed the distribution and expression pattern of the Cdx genes at 
different developmental stages in different organisms. These data illustrate an 
overlapping pattern of Cdx expression along the A-P axis of the embryo, from the 
gastrulation stage to the tail bud stage of the embryo. The expression patterns of the 
Cdx members in different stages of development in mouse, zebrafish, and Xenopus are 
described in this section and in figure 3.
Cdxl is expressed at day 7.5 dpc. in the late primitive streak in the mouse 
embryo (Figure 1.4, panel A), in ectodermal and mesodermal cells, in visceral 
ectoderm but not expression is present in the definitive endoderm (Meyer and Gruss
1993). By 8.5 dpc, expression of Cdxl is present in the neural tube, somites 
mesoderm and limb buds (Figure 1.4, panel B). By 9.5 dpc expression is found in the 
dorsal region of the tail bud (Figure 1.4, panel C); at 10.5 dpc (Figure 1.4 panel D), 
Cdxl is present in the posterior tail bud, forelimb bud and anterior somites (Duprey et 
al 1988).
Cdx2 is first expressed at preimplantation stages, in trophoectodermal cells 
and extraembryonic ectoderm during the implantation stage and in placenta. In later 
stages, at 7.5 dpc is present in the posterior primitive streak (Figure 1.4, panel A). By 
the day 8.5 p.c., Cdx2 is expressed in ectoderm, mesoderm and endoderm of the 
embryonic tail bud; expression is also present in the neural plate, neural tube and
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notochord (Figure 1.4, panel B). At 9.5 dpc, the tail bud is positive for expression 
(Figure 1.4, panel C) and at 12.5 dpc (Figure 1.4 panel D), expression is detected in 
the gut epithelium (Beck et a l 1995).
Expression of Cdx4 is present at 7.5 dpc in the primitive streak (Figure 1.4, 
panel A); at 8.5 dpc expression is found in the hindgut endoderm (Figure 1.4, panel B) 
and by 9.0 to 9.5 dpc (Figure 1.4, panel C), the tail bud is positive for expression 
(Gamer and Wright 1993).
The presence and expression of Cdx has also been studied in Danio rerio 
(zebrafish). ZfCdx is first detected at 50% epiboly, the early stage of gastrulation in 
zebrafish. Expression is present in the blastoderm margin, with more restricted 
expression in the epiblast (Figure 1.4, panel A). At 70% epiboly, also known as the 
shield stage, expression is detected in the vegetal epiblast. By the end of gastrulation 
(90% epiboly), expression is restricted to the vegetal epiblast with a weaker 
expression in the hypoblast. The vegetal epiblast will constitute the future posterior 
part of the embryo; cells from the hypoblast will give rise to the endoderm and 
mesoderm tissues. During the 1 somite stage (lOhrs), just after epiboly, expression is 
detected in ventral mesenchyme, posterior neural plate, segmental plate and the 
posterior tail (Figure 1.4, panel B). During mid somitogenesis at the stage of 14 
somites (16 hrs), zfCdx is present in posterior spinal cord, notochord, ventral 
mesenchyme and tail bud (Figure 1.4, panel C). By the late somitogenesis stage 
(22hrs), expression is located in the neurectodermal cells, spinal cord, and tail bud; 
the mesoderm remains negative for expression. At 30hrs, also known as the 
pharyngula stage, expression of zfCdx is just detectable in the posterior spinal cord 
(Figure 1.4, panel D). After 48hrs, expression of zfCdx is undetectable in the 
developing embryo (Joly et a l 1992).
Xenopus studies have shown that Cdx genes are also expressed during the 
early development to specify the anterior posterior axis, and later in the developing 
gut. As in the case of the mouse, all three Xcad genes are expressed during the 
gastrulation period; Xcadl and Xcad2 are expressed in the dorsal lip during mid 
gastrulation (stage 11); the expression of Xcad3 at this stage is expressed in the 
marginal zone (Figure 1.4, panel A), although this expression becomes a broader band 
around the blastopore. The blastopore is a circular invagination in the ventral side of 
the embryo where mesoderm and endoderm converge during gastrulation. At stage 13
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once the blastopore closes, expression of Xcadl and Xcad2 is located in the posterior 
part of the embryo; Xcad3 shows a weaker expression also in the posterior end 
(Figure 1.4, panel B).
During neurulation (stage 17), the three Xcad genes are expressed in the 
posterior part, in the developing neural tube although the anterior expression varies 
for each gene at this point (Figure 1.4, panel C). Nevertheless, the anterior boundaries 
for each gene are visible at the 15 somite stage (24 stage), Xcadl extends its 
expression to the 5th to 6th somite, Xcad2 to 7th- 8th somite and Xcad3 shows its 
anterior expression in the 2nd to 3rd somite. In the posterior end, the three genes show 
an overlapping expression. By stage 31, expression is almost undetectable Xcadl 
shows a faint expression in the posterior spinal cord (Figure 1.4, panel D). By the 41- 
stage expression of Xcadl and Xcad2 can be detected in the gut endoderm (Pillemer et 
al 1998).
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Figure 1.4. Expression of Cdx genes at different stages of the embryo development. 
Expression of the mouse Cdxl (mCdxl), Cdx2 (mCdx2), Cdx4 (mCdx4), 
zebrafish Cadi (Zfcad), Xenopus caudal 1 {Xcadl), Xenopus caudal (Xcad2) and 
Xenopus caudal (Xcad3) A. Represents the Cdx expression of mCdxl, mCdx2 
and mCdx4 at 7.5 p.c., Zfcad at 50% epiboly, Xcadl, Xcad2 and Xcad3 at 11 
stage in embryo. B. Shows the Cdx expression of mCdxl, mCdx2 and mCdx4 at
8.5 p.c., Zfcad at 1 somite stage, Xcadl, Xcad2 and Xcad3 at 13 stage in embryo. 
C. Shows the Cdx expression of mCdxl, mCdx4 at 9.0 p.c., mCdx2 at 9.5 p.c., 
Zfcad at 14 somites stage, Xcadl, Xcad2 and Xcad3 at 17 stage in embryo. D. 
Cdx expression of mCdxl at 10.5, Zfcad at segmentation/ pharyngula stage, 
Xcadl, Xcad2 and Xcad3 at 31 stage in embryo. Photographs taken from: Meyer 
and Gruss (1993); Beck F, et. al. (1995); Gamer and Wright (1993); James, et. al. 
(1994); Joly, et. al. (1992) and Pillemer, et. al. (1998).
1.4 The phenotype o f C d xl and Cdx2 knockout mice
1.4.1 The Cdxl ‘A, effects on axial identities
In accordance with the expression of the Cdx genes during the establishment 
of the anterior posterior axis and their regulation of Hox genes, the Cdxl homozygous 
mutant shows skeletal abnormalities; the 1-7 cervical vertebrae and the first thoracic 
vertebrae suffer an anterior transformation in the mutant mice, the Cdxl'A also shows 
that the Hox genes undergo posterior shifts in their expression domains. This 
phenotype is similar to those shown by the disruption of the Hox genes. The Hoxd-3 
mutant mice show fusion of the basioccipital bone with the first vertebrae. This is, the 
anterior arch of the atlas transformed into the bassioccipital bone. The axis (the 
second vertebrae) shows atlas characteristics. Other vertebrae are also affected either 
because some of the vertebrae parts are deleted or because they are transformed to an 
anterior part (Condie and Capecchi 1993). Furthermore, the homeotic anterior 
transformations described for the Hox mutants are located in specific region whereas 
in Cdxl, the transformations occur in a wider area. These findings confirm that Cdxl 
is necessary to delimit the expression boundaries of the Hox genes in the primitive 
streak (Subramanian et al. 1995).
18
Chapter One: Introduction J.L. Juarez-Morales 2005
1.4.2 The Cdx2 '/+ mice, intestinal tumour formation
The Cdx2 null mutant mouse was generated by homologous recombination 
(Chawengsaksophak et a l 1997); the homozygote null mutant dies during the 
implantation stage between 3.5 and 5.5 dpc. However, the Cdx2 heterozygote mutants 
are viable and display a variable phenotype. At early stages, the mutant mice exhibit 
skeletal abnormalities; homeotic transformations are observed from the sixth cervical 
vertebrae to the eight thoracic vertebrae. The mutant mice are also characterized by a 
short tail; these axial abnormalities are linked to alterations in the Hox genes 
expression boundaries. In the first three months of development, a high percentage of 
the heterozygote mice develop multiple polyp-like lesions in the gut; the highest 
frequency of polyps are located in the proximal colon, in the area where Cdx2 is 
usually expressed. No polyp-like lesions are observed in regions where Cdx2 is not 
expressed. These polyps consist of normal gastric mucosa with villi and Paneth cells 
of intestinal tissue. The neoplastic cells present in the transformed intestinal 
epithelium do not express Cdx2.
1.4.3 Overlapping function of the Cdxl ^ Cdx2 genes
The Cdx2+/7 Cdxl'A double mutants also show skeletal abnormalities in the 
vertebral column. In this case, the homeotic transformations are more severe than the 
single mutant phenotypes and the posterior shift in the expression of the Hox genes is 
more affected, suggesting that the Cdx genes have an overlapping role in the anterior 
posterior patterning via regulation of Hox gene expression (van den Akker et a l 
2002).
As mentioned before, the second Cdx expression phase is in the developing 
and adult intestinal epithelium. In Cdx2+/-, the intestine acquires a forestomach 
epithelium in the midgut; this ectopic tissue is able to differentiate into all the tissues 
of the stomach but is unable to produce small intestinal tissue, indicating that Cdx2 is 
required for the maintenance of the intestinal epithelium (Beck et al 2003).
Studies have related Cdxl and Cdx2 to colorectal tumors. Cdx2 decreases with 
the advance of the tumor and Cdxl is upregulated in the early stages of the tumor 
development. Further studies have argued that Cdxl has oncogenic properties. Firstly
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ectopic expression of Cdxl is present in stomach, liver and oesophagus adenomas; 
furthermore, Cdxl is upregulated by the oncogenic Ras and the Wnt/p- catenin 
signaling pathways. However Cdxl is down regulated in colorectal tumors (Mallo et 
a l 1998;Lorentz et a l 1999).
Along with the Cdx genes, several genes are also expressed in the gut with 
characteristic expression patterns in the normal colon and during tumor progression. 
p53, a gene expressed in the base of the crypts, has been shown to downregulate Cdxl 
in IEC-6 cells. p53 expression is lost during tumor progression, which might allow an 
increase in Cdxl expression in the colon. Assays performed in IEC-6 and SW480 
cells show that Cdxl also stimulates the Bcl-2 gene, another factor expressed in the 
stem cell reservoir of the crypt (Moucadel et a l 2002). The same study shows that 
p21, a gene expressed at the top of the crypt and involved in cell arrest and 
differentiation, is downregulated by Cdxl, suggesting that Cdxl might prevent the 
differentiation process in the intestine.
Sox9, a gene that is expressed at the bottom of the crypt in small intestine and 
colon and depends on the Wnt/(3- catenin pathway, is able to repress Cdx2 expression 
in colon carcinoma cells (Blache et a l 2004).
1.5 Role of Cdx in haematopoietic differentiation
1.5.1 Role of Cdx4 in specifying blood progenitors in zebrafish
Apart from their role in the A-P axis formation and maintenance of the 
intestinal epithelium, the Caudal family, mainly Cdx2 and Cdx4, have been 
implicated in haematopoietic lineages. Two recent studies have identified Cdx4 as a 
regulator of the haematopoietic stem cells via regulation of the Hox genes (Davidson 
et a l 2003), and Cdx2 as a precursor of leukemia (Rawat et a l 2004).
One of these studies (Davidson et a l 2003) states that Cdx4 is involved in 
inducing blood formation in the kggtv205 mutant in zebra fish. The kgg mutant, who 
carries an autosomal recessive mutation, was first identified to produce tail defects in 
the zebrafish embryo. Anaemia is also present from the first day of development;
t V ithese mutants survive until the 10 day of development.
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Expression of scl, gatal, and runxl genes in the Kgg mutant was shown to be 
altered, producing haematopoietic abnormalities. Genes involved in the formation of 
kidney, such as Pax2.1 and Cxcr4b, showed shortened expression in these mutants. 
Further analysis showed that expression of wtl is extended from somite one to somite 
six, suggesting an expansion of anterior kidney fates. Structures like head, notochord 
and somites appear normal although the embryo is shorter in length (Davidson et al
2003).
Sequence analysis showed that the Cdx4 gene in the kgg*1240 mutants contains 
a nucleotide transversion (T to A), which produces a change in the amino acid 
sequence (F170L). This mutation disrupts the protein binding to the CdW-binding 
site. Cdx4 expression is not present in the nascent blood islands but its expression 
partially overlaps with the Scl in mesodermal cells. Overexpression of Cdx4 showed 
ectopic expression of Scl, Gatal and Jli genes near to the endogenous blood 
precursors at 5- 12 somite stage. Injection of Cdx4 mRNA partially rescued the 
population of Gatal and Scl expressing cells in the Kgg mutant (Davidson et al
2003).
Expression of Hoxb4, HoxbSa, Hoxb6b, Hoxb7a, Hoxb8a, Hoxb8b and 
Uoxa9a showed an altered expression pattern in the kgg*205 mutants. The stripe of 
haematopoietic vascular precursors is affected by changes in the anterior posterior 
patterning. There is loss of Gatal+ haematopoietic cells from the posterior stripe. 
Expression of Hoxb6b, Hoxb7a and Hoxa9a was also reduced. Over-expression of 
Cdx4 was able to rescue Hoxb6b, Hoxb7a and Hoxa9a in Cdx4 morphants (Davidson 
et al 2003).
To investigate if Cdx4 enhances the self-renewal or proliferation in stem cells, 
retroviral expression of Cdx4 was assayed in the mutant. Cdx4 induced multilineage 
haematopoietic progenitors, colony forming unit granulocyte 
erythroid/macrophage/megakarocytes colonies. Cdx4 was also able to induce 
expression of HoxB3, HoxB8 and HoxA9, genes that have been implicated in 
haematopoietic stem cell and immature expansion. These experiments indicate that 
disruption of Cdx4 expression causes perturbation of Hox expression, causing a 
reduction of erythroid cells (Davidson et a l 2003).
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1.5.2 Cdx2 and its relevance in acute myeloid leukaemia (AML)
A study performed by Rawat et. al. (2004) relates the ectopic expression of 
Cdx2 to the development of acute myeloid leukemia using a mouse model. The acute 
myeloid leukemia is produced by a gene fusion mechanism. The oncogenic potential 
of fusion genes is characteristic of the ETV6 gene.
There are mainly two different types of translocation related to the ETV6 
gene, 1) fusion to phosphotyrosine kinases and 2) fusion to transcription factors. The 
transcription factors involved in these translocations are AML1 and Cdx2. In the 
ETV6-AML1 fusion, no bone marrow transformation has been seen. In the ETV6-Cdx2 
fusion gene, ectopic expression of Cdx2 induces AML. However, ETV6- Cdx2 was 
unable to produce leukemia.
Irradiated mice transplanted with bone marrow cells expressing Cdx2, became 
moribund after post transplantation. These mice showed hematopoietic abnormalities 
and developed AML with formation of blast colonies in bone marrow, peripherial 
blood and spleen. Wild type mice injected with bone marrow cells of diseased Cdx2 
animals died within 24hrs after injection (Rawat et a l 2004). Conversely, irradiated 
mice transplanted with bone marrow cells expressing ETV6-Cdx2 fusion, showed an 
increment in their hematopoietic cell populations. None of the animals suffered from 
anemia or blast colony formation in peripheral blood (Rawat et a l 2004).
This study also showed that the N-terminal and the homeodomain of the Cdx2 
protein have to be intact in order to produce leukemia. Mutations produced in the 
PBX1 binding motif (W167A- Cdx2) of Cdx2 or the simple expression of Cdx2, 
showed blast formation in bone marrow cells. Mice transplanted with these cells 
developed leukemia. Cells expressing the ETV6-Cdx2 fusion, or an inactive form 
where the N-terminal of the Cdx2 (AN-Cdx2) was removed or a form with a mutated 
Cdx2 homeodomain (N515-Cdx2), did not form blast cell populations (Rawat et al
2004).
Analysis of the Cdx2 and ETV6-Cdx2 transplanted mice showed that Cdx2 did 
not increase expression of the leukemogenic homeobox genes HoxA9 and Meisl. 
Constitutive expression of Cdx2 is highly leukenogenic when it is ectopically
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expressed in hematopoietic progenitor cells. Ectopic expression of Cdx2 might 
activate genes that are not expressed in blood development. The mechanism of 
transcriptional activation of ETV6- Cdx2 is still to be identified; ETV6 
promotor/enhancer might be involved in the activation of Cdx2 in AML.
1.6 Regulation of the mouse Cdxl
1.6.1 Regulation of the mouse Cdxl by the Wnt signalling pathway
Due to its role in proliferation of the cell population in the intestinal 
epithelium, and its link with the development of tumors in the colon, Cdxl has been a 
gene of interest in the study and understanding of structure and maintenance of the 
intestine as well as in the study of the beginning of intestinal cancer. Recent studies 
have aimed to understand the regulation of the Cdxl gene by attempting to identify 
the regulatory elements involved in its regulation. Most of the work has been done 
using the murine Cdxl non-coding regions to test for enhancer regulatory regions 
either in cell lines or producing transgenic mice. This section describes the work and 
the understanding that we have to date in the regulation of this gene.
The importance of the Wnt pathway in diverse developmental processes has 
been demonstrated in a variety of organisms. Lickert et al. (2000) showed that the 
mouse Cdxl is a direct target of the Wnt/(3- catenin signalling pathway. The first 
findings of the regulation of Cdxl by Wnt were achieved using ES cells co-cultured 
on 3T3 cells expressing Wnt. Wntl, Wnt3a, Wnt7a stimulated the expression of Cdxl; 
however the strongest induction was given by Wnt4.
Deletion promoter analysis showed that the -3.6Kb non-coding sequence of 
the Cdxl gene was able to drive the expression of the gene in HEK293 cells. Four 
TBE (Tcf binding elements) were found to be contained in this 3.6Kb sequence, two 
of these sites located in the first -350bp.
Mutations of these four TBE motifs and combination of these mutations 
showed that the elements situated in the first 350 bp were relevant for the expression 
of the reporter. Electromobility shift assays proved that the P-catenin/Ze/7 complex 
was able to bind to the two TBE sites present in the Cdxl upstream region.
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Expression of Cdxl was observed in the co-cultures of small intestinal 
endoderm from rat embryos and 3T3 cells expressing Wnt, suggesting that Wntl can 
induce the expression of Cdxl in embryonic endoderm.
Analysis of Tcf4-/- embryos, which lack proliferative cells in the crypt region 
of the small intestine, showed a reduced staining with the anti- Cdxl antibody at 15.5 
dpc; by 17.0 dpc, no Cdxl expression was visible in the crypt region of the small 
intestine, although Cdxl expression was positive in the colon epithelium of the Tcf4-/- 
embryos.
1.6.2 Regulation of mCdxl by TBE and RARE sites
Once the regulation of Cdxl was established via the Wnt/(3-catenin pathway, 
the candidate regulators for the Cdxl transcription were the Tcf factors; reporter 
constructs carrying different lengths of the Cdxl upstream region were used to create 
transgenic mice. Analyses of the regions that showed expression of the reporter were 
analyzed for transcription factor binding sites; the TBE and retinoic acid response 
elements (RARE) were identified as responsible of the regulation of Cdxl.
Transgenic mice carrying the -3.6Kb non-coding region of Cdxl were found 
to express the transgene in mesodermal and ectodermal cells of the primitive streak at
7.5 dpc. By 8.7 dpc, expression in mesoderm and ectoderm was detected. Neural tube, 
somites and tail bud mesoderm also showed expression of the reporter. At 9.5 dpc, 
expression in the anterior region was present in the migrating neural crest cells, and 
dorsal root ganglia. In the posterior region, expression of the transgene was in the 
neural plate and tail bud mesoderm. No expression was seen in the hindgut endoderm. 
By 14.5 dpc, no reporter expression was detected in the embryonic intestine (Lickert 
and Kemler 2002).
Furthermore, the 0.7Kb upstream of the Cdxl gene was able to drive the 
expression of the transgene in a similar fashion to the one seen in the -3.6Kb 
construct at 7.5 dpc. By 8.5 dpc, expression was present in the neural tube, the border 
of the hindbrain, somites and paraxial mesoderm. By 9.5 dpc, expression was 
detectable in neural tube, somites and paraxial mesoderm; however, no expression 
was present in the hindgut ectoderm. Mutation of the TBE and RARE sites
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demonstrated that when the RARE site was mutated and the TBE sites were left 
intact, expression was observed in the primitive streak with enhanced expression in 
the base of the allantoids at 7.5 dpc. By 7.75 dpc, expression was seen in the ectoderm 
and posterior region of the embryo. By 8.5 dpc, expression was just present in the 
base of the allantoids, low expression was observed in the ectoderm and neural plate, 
and no expression was seen in the mesoderm. When the 2TBE and the RARE were 
mutated, no expression was present in the embryo (7.5 to 8.5 dpc).
The -0.7Kb promoter element seems to contain all the necessary cis- 
regulatory elements for the expression and regulation of the mouse Cdxl in the early 
stages of development. The TBE sites are important for the Cdxl expression at 7.5 
dpc and the RARE site is essential for initiation of expression in the primitive streak 
mesoderm and for the maintenance of expression in the primitive streak ectoderm.
1.6.3 The CdxA regulation, the conserved TBE and RARE elements
Gaunt et al. (2003) used the chick Cdxl {CdxA) to produce transgenic mouse 
embryos. A reporter construct containing 1.4Kb upstream region, 1st exon and 2.1Kb 
of the first intron was able to drive the expression of the LacZ gene from the adjacent 
region of the neural tube to the first somites at 8.5 dpc. By 8.7 dpc, strong expression 
is seen in the neural tube, whereas a weak staining is detected in the paraxial 
mesoderm. However, an extra construct containing 6Kb upstream region, part of the 
first exon and the 2nd intron of the [3-globin, showed no reporter expression for the 
eight transgenic lines produced.
An analysis of the CdxA sequence showed the presence of one RARE and a 
Tcf/p-catenin sites present in the 1st intron of the gene. Mutation of sites proved that 
when the RARE site is destroyed expression is seen in the neural tube at 8.7 dpc; 
however the boundary of expression is posterior to the somite 5. When the Tcf/fi- 
catenin is mutated, expression is seen in few cells in the posterior neuroectoderm, and 
the boundary of expression is until the somite 13. No expression is seen in the 
mesoderm at 8.7dpc.
To establish if the expression pattern showed by the CdxA element is similar 
to the one produced by the Cdxl, a reporter construct containing 5.7Kb mouse DNA
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(3.3Kb upstream region, 1st exon, and 1.8Kb of the 1st exon approx.) was used to 
produce transgenic mice. Expression in the mesoderm and neuroectoderm was 
observed at 8 dpc. By 8.7 dpc, a gradual expression was seen in these tissues; 
expression was also present in the anterior boundaries at the level of the first somite in 
the neuroectoderm and in the somitic mesoderm at the level of the fifth somite. Neural 
tube and lateral plate mesoderm were positive for the expression. At this stage, weak 
expression was seen at the level of the fith somite, due to a time- gradient expression.
In contrast with the work presented by Lickert and Kelmer (2002), Gaunt and 
collaborators showed that the cis regulatory regions involved in the regulation of 
CdxA are contained in the first intronic region instead of the upstream region of the 
Cdxl. However, the RARE and Tcf/p-catenin motifs seem to play a crucial role in the 
early expression and regulation of the gene.
1.6.4 Regulation of the human Cdxl
More recent studies have shown that the upstream region of the human CDX1 
contains the necessary elements to regulate the expression of the gene (Rankin et al
2004). Reporter constructs carrying the LacZ gene were used to generate transgenic 
mice. A -327 to + 68 bp element drove reporter expression in the base of the crypts in 
the small intestine and a scattered expression in the colon. However, different founder 
lines showed different patterns in expression or no detectable expression at all. These 
indicate that this heterogeneous expression is due to the site insertion of the transgene.
The region contained between -5667 and +68bp of the hCDXl gene was able 
to drive the expression in the serosa of the small intestine and colon, submucosa 
muscle layer, stomach, squamous cells of the kidney and granular cells of the 
cerebellum. Furthermore, the -15601 to +68bp region showed strong expression in 
intestinal epithelial cells, ileum and colon; no expression was detected in any other 
tissue. These suggest that the expression of this construct is insertion independent. By 
10.5dpc, this construct was expressed in the somites, neural tube, limb bud, tail bud, 
caudal region and embryonic intestine. By the 12.5 dpc a gradual decrease in 
expression was observed in the ectoderm and mesoderm. By E l3.5, strong expression 
was seen in the intestinal epithelium and by 14.5 dpc strong expression in the midgut
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(jejunum and ileum), foregut and hindgut showed a weak expression and the stomach 
was negative for the staining.
In conclusion, the -5667 and +68bp region seems to be responsible of the 
hCDXl expression during the early (mesoderm and ectoderm) and later (endoderm) 
stages of development. In addition, DNase I hypersensitive assays revealed two 
putative intestinal enhancer positioned at -5.8 and -6.8Kb upstream of the gene.
1.6.5 Regulation of mCdxl by Retinoic Acid
Studies have shown that hormone receptors mediate the effects of hormones 
on several genes. Retinoic Acid (RA) acting through the RA receptors (RARs) and 
Wnts have been implicated in vertebral patterning (Kessel and Gruss 1991). It is well 
established that RA and RAR play important roles in differentiation, growth, and 
homeostasis of epithelial cells in various tissues (Kastner et al 1995; Mangelsdorf et 
al. 1995). RAR belongs to a large steroid/non steroid nuclear hormone receptor 
superfamily that consists of three receptor isotypes a , p, y, each encoded by distinct 
genes. RAR forms a heterodimer with Retinoic X Receptors (RXRs) to bind to the 
RARE on the target genes. On its own, RAR DNA binding activity is weak, but it is 
enhanced by RAR/RXR dimerization (Yang et a l 1991). RAR consists of a DNA- 
binding domain that contains various functional domains. RAR interacts with other 
transcription factors such as CBP, p300 and nuclear receptor activators, which 
participate in DNA remodelling.
RA has been implicated in the regulation of Cdxl. Embryos treated with 
retinoic acid showed an increased of Cdxl expression in the posterior regions (Houle 
et a l 2000). The same up regulation is seen in embryo cultures and embryonal 
carcinoma cells. In embryos treated with RA, Cdxl expression is induced in the 
complete region of the primitive streak at 7.5 dpc. At 9.5 dpc, treated embryos 
showed an increase of expression in the fore limb buds, mesenchyme and presumptive 
dermamyotome.
The RARal '/_ mice when treated with retinoic acid, showed an induction of 
the Cdxl transcript at 8.5 dpc; however, in the treated RARal/y mutant, that 
induction in expression was compromised. Analysis of the -2Kb mCdxl fragment
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containing the internal ATG and the 5’UTR of the gene was able to drive the 
expression of the reporter in F9 carcinoma cells. The same activity was seen when the 
ATG and 5’UTR were removed. Stable cell lines carrying the remaining region were 
capable to respond to small doses of retinoic acid, which resembles the response to 
RA in vivo.
Analysis of this sequence showed the presence of a RARE element between -  
694 and -185 relative to the transcription start site. By EMSAs, this element was 
shown to be target for RAR and RXR factors. Mutation of the RARE site reduced the 
expression of the reporter in F9 cells. In agreement with the role of RA regulating 
Cdxl and the data obtained with the RARal/y mutant, it is suggested that the role of 
retinoic acid in the control of Cdxl expression is as an initiation factor, and the 
presence of other factor (s) may be the target in the maintenance of gene expression in 
later stages.
1.6.6 RARE regulates the expression of mCdxl in early 
development
Further studies by Houle et al. (2000; 2003) gave more insights in to the 
interaction of RA and the Cdxl regulatory region. Reporter assays using F9 cells 
proved that RA induced the expression of the RAREWt whereas no expression was 
induced in the RAREMut.
The RARE in the 2Kb upstream of the Cdxl was inactivated using a floxed 
neomycin selection cassette and the mutated RARE. The mice carrying the RAREMut 
showed a reduced presence of the Cdxl transcript. A weak expression was evident in 
the early somites stages with almost null expression in later stages. Although the Cdxl 
expression is reduced in the neuroectoderm at 8.0 dpc, no effect was seen in the 
rostral boundary expression, suggesting that the RARE site is necessary for the early 
and later stages of expression (Houle et a l 2003).
To investigate if the RAREMut responds to RA in vivo, pregnant mice were 
treated with RA. The wild type embryo exhibited an increase of the transcript in the 
primitive streak at 7.0 dpc whereas the RARE mutants showed the same level of 
expression at the same stage. From 7.5 to 8.5 dpc, RAREWt and RAREMut reflected
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the same level of induction suggesting that the regulation of Cdxl is via another RA 
pathway, where RARE is not involved in the regulation of Cdxl (Houle et al 2003).
1.6.7 Regulation of genes by RA and RAR
Retinoic acid, a derivative form of vitamin A, has been implicated in the 
regulation of the Hox genes. Studies have shown that RA can induce normal sequence 
of expression of the Hox genes (Boncinelli et a l 1991). Further studies demonstrated 
that a dose of exogenous RA provokes anteriorization of the Hox genes expression in 
mouse embryo that resembles posterior homeotic transformations (Kessel and Gruss 
1991).
The mode of RA action is by binding to its receptors RARa, RAR(3 and 
RARy; these nuclear receptors regulate the expression of genes by forming 
heterodimers with the retinoic X receptors. These heterodimers bind to the RAREs 
present in the promoter of genes which are inducible by RA (Mangelsdorf et a l 1995; 
Chambon 1996). The RARE motif is a repeat sequence of PuG(G/T)TCA however, 
this sequence has revealed to be highly polymorphic.
Studies have described the RAREs as a common element in the activation of 
Hox promoters, demonstrating that these genes are direct targets of RA. Expression of 
Hox genes with a RARE element has been described in the hindbrain, neuroectoderm 
and paraxial mesoderm and also in mesoderm like in the case of the Hoxd4 gene 
(Zhang et al 1997).
RA is not only involved at the level of Hox gene expression, its activity sets 
out earlier than the activation of Hox genes. The Cdxl_/' mouse displays homeotic 
transformations of the axial skeleton, which are very close to the RARa/y- null 
phenotype and a RARE regulates expression of Cdxl in tissue culture (Lohnes et a l 
1994; Subramanian et al 1995; Houle et a l 2000; Allan et al 2001). This work has 
proved that RA is a regulator of Cdxl in the early development.
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1.7 The Adenomatous Polyposis Coll (APC) gene
1.7.1 Expression and regulation of the Ape gene
Alteration of cell proliferation and differentiation is thought to be a major 
event in the initiation and progression of cancer. Colorectal cancer is a multi-step 
process linked to the inactivation or loss of expression of tumor suppressor genes. In 
general, an intestinal cell needs to comply with two essential requirements to develop 
into a cancer: it must acquire a) a selective advantage to allow for the initial clonal 
expansion, and b) genetic stability to allow for multiple hits at other genes responsible 
for malignant transformation (Fodde 2002).
Colorectal tumors are known to arise through a gradual series of histological 
changes, the so-called adenoma carcinoma sequence. Each change is accompanied by 
a genetic alteration in a specific oncogene or tumor suppressor gene. Loss of Ape 
function triggers this chain of molecular and histological changes. Extracolonic 
manifestations, including gastric and duodenal polyps, osteomas, desmoids, 
epidermoid cysts and retinal lesions, are commonly observed in patients with familial 
adenomatous polyps (Santoro and Groden 1997).
The Adenomatous polyposis coli (APC) protein is one of the key players in 
the (Wnt) pathway and regulation of /3- catenin. The Wnt signaling pathway is a very 
well conserved process across species that regulates proliferation and differentiation 
of cells. The role of APC in this signaling pathway is to regulate the p-catenin levels 
in the cytoplasm. In the absence of Wnt molecules, APC forms a complex with Axin, 
PP2A and GSK3P; the role of Axin, or its homologue Conductin, is to form the 
scaffold in this multiprotein complex, GSK3P phosphorylates p-catenin in its N- 
terminal region leading to the ubiquitination of P-catenin by the p-transducin repeat- 
containing protein (P-TRCP) and subsequent degradation by the proteosome pathway 
(Polakis 2000).
In the presence of Wnt signal, Frizzled, a transmembrane protein, activates 
Dishevelled (Dsh). Although it is not known how Dsh is activated and its secondary 
steps, it interacts with casein kinases like CK1, CK2 and GBP/Fratl, inhibitors of p- 
catenin. Dsh binds to Axin resulting in the disruption of the multimeric complex and 
accumulation of p- catenin in the cytoplasm (Figure 1.5, panel B). P- catenin
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translocates into the nucleus to bind to the TCF/Lef complex. TCF and Lef 
transcription factors are members of the lymphoid high mobility group (HMG). This 
results in the activation of genes involved in cell cycle, proliferation and 
differentiation of cells such as c-myc, Cyclin D l, TCF1, conexin 43, 
metalloproteinase matrylsin and Cdxl (van der Heyden et al. 1997; He et al 1998; 
Crawford et a l 1999; Shtutman et a l 1999). The Wnt pathway also regulates the 
expression of the Eph/ Ephrin surface molecules, which specify the position of each 
epithelial cell along the crypt villus axis (Batlle et a l 2002).
In the absence of Wnt signal and p-catenin, the TCF/Lef complex is inhibited 
by transcriptional co- repressors like the TLE/Groucho family or C-terminal binding 
protein CtBP (Brannon et al. 1999). Disruption of the Wnt signaling pathway can lead 
to an increase in proliferation and loss of differentiation (Figure 1.5, panel A). Thus, 
deregulation of APC produces inappropriate transcription, cell adhesion and 
disruption of the pathway. Mutations in the components of the Wnt pathway, such as 
the Ape or p-catenin, result in a continous translocation of p-catenin in to the nucleus, 
which in turn produces a constitutive expression of genes commonly found in colon 
cancers (Morin et a l 1997).
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Figure. 1.5. The Wnt-signaling pathway. A. In the absence of a Wnt signal, p-catenin 
is phosphorylated by the GSK3p/APC/Axin complex resulting in degradation of 
p-catenin.Transcription of genes is blocked due to the absence of Tcf/p- catenin 
complex in the nucleus (A). In the presence of a Wnt signal, Dishevelled (Dsh) 
inactivates Axin and GSK3p. The Axin/APC/ GSK3p is inhibited and p- catenin 
translocates into the nucleus to for a complex with Tcf factors to activate genes 
involved in proliferation and differentiation (B). Figure adapted from (Willert et 
al. 1997).
1.7.2 Role of APC in colon cancer
Inactivation of APC or direct inactivation of P- catenin by mutations in its 
APC binding site provoke accumulation of p- catenin in the cytoplasm. Studies have 
shown that introduction of wild type APC into cells with mutated APC protein 
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Colon cancer is the product of mutations that cause a continuous proliferation 
signal in the cells. Mutations in APC have been linked to Familial Adenomatous 
Polyposis patients (FAP). FAP is an autosomal dominant condition, which produces 
adenomatous polyps in the rectum and colon and in some cases, the polyps develop 
into tumors. The colonic cancer epithelial cells from FAP patients express only 
truncated forms of APC, lacking the central region of the protein, essential for the 
downregulation of p-catenin. Recently, mutations in Axinl or Conductin, components 
of the destruction complex have been found in hepatocellular carcinomas and in 
colorectal cancer (Hart et a l 1998).
Outside of the Wnt pathway, APC has a role in cell migration and intercellular 
adhesion. Studies performed in mice carrying a mutated APC version of the protein 
showed that enterocytes accumulate in the crypt villus boundary. These cells 
contained an increased level of P- catenin, indicating that normal APC locates in this 
boundary allowing the cells to migrate from the crypt to the villus (Wong et a l 1996).
1.7.3 Role of APC in cell migration
One of the main characteristics of tumour tissues is the loss of tissue structure 
and architecture; cell migration and cell adhesion are affected in these type of cells. 
APC has been found to regulate cell migration by regulating the microtubule function. 
Microtubules are cytoskeletal polymers of a/p  tubulin subunits, which are involved in 
cell migration. They serve as a track for motor proteins such as dyneins and kinesins, 
direct vesicle transport, locate organelles in their position and locate the microtubules 
themselves. APC binds to the microtubules that do not belong to the actin network 
and localizes at the edges of the cells (Smith et a l 1993; Neufeld and White 1997). 
Overexpression of the APC C- terminus shows its microtubule binding capacities; in 
vitro studies showed that the carboxy-terminal region of the APC protein binds to 
cytoplasmic microtubules, this region is usually deleted in cancers (Munemitsu et al
1994).
Mahmoud et al (1997) demonstrated that APC contributes to the migration of 
intestinal cells in the crypt-villus axis. A truncated APC protein affects the cell 
migration in the Min/+ mouse; no enterocyte migration, proliferation, apoptosis, or p- 
catenin levels are affected in these mice. Overexpression of APC results in an altered
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migration of intestinal cells. APC is also able to bind to the Rac specific guanidine 
nucleotide exchange factor (Asef), a small G protein involved in cell migration via 
interaction with actin cytoskeleton (Kawasaki et al. 2000).
1.8 Use o f the zebrafish in developmental biology
Teleosts, such as the zebrafish (Danio rerid), the pufferfisn (Fugu rubripes) 
and the medakafish or medaka (Oryzias latipes), are increasingly being used as 
vertebrate model systems in developmental biology and comparative and functional 
genomics. There are two main reasons why the teleosts are used as vertebrate models 
in these fields: firstly, their relative ease of application in genetics and secondly, their 
relatively small genome size. The compact genome of the zebrafish has facilitated 
molecular studies of human genes because most human genes that originated early in 
vertebrate evolution exist in the teleost genomes. In the zebrafish in particular, large- 
scale mutagenesis has been achieved, which has made it highly attractive as a 
vertebrate model for developmental genetics (Driever et a l 1996; Haffter et al. 1996).
A major advantage of the zebrafish is that it is an optically clear embryo, 
which allows observation of temporal and spatial changes in gene expression during 
the development of the living embryo. Further advantages are the easy accessibility of 
embryos and the number of embryos that can be collected and manipulated in a 
relatively short period of time.
Many zebrafish promoters have been isolated and characterized using the 
green fluorescence protein (GFP) or the red fluorescence protein (RFP); some of these 
promoters are specific for the gut, like the intestinal type fatty acid- binding protein 
(I-FABP). Reporter analyses revealed that the proximal 192-bp region of the I-FABP 
promoter is sufficient to direct intestine-specific expression during zebrafish 
development. Transgenic lines have been made to use the I- FABP gene as a marker 
for intestinal development in the zebrafish (Her et al. 2004).
Similar studies have used this transient-transgenic approach to screen 
conserved regulatory elements for enhancer activity in the zebrafish embryo (Woolfe 
et al. 2005). Whichever is the final output, whether in the use of developmental
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biology or functional genomics, the zebrafish has proved to be a very quick and useful 
model for in vivo developmental studies.
1.9 Use o f the Fugu in comparative genomics
The Japanese pufferfish genome has been used for a variety of studies in the 
field of comparative genomics. Firstly, the Fugu genome was used to address the 
location and structure of genes in human and higher organisms due to their highly 
similar repertoire of genes. In particular, the Fugu genome has been useful for 
addressing conserved non-coding regions that harbor regulatory elements in their 
sequence. The large evolutionary distance between Fugu and human offers a filter for 
the searching of these conserved non-coding elements. Such analyses would be 
impossible to do between human and rodent due to the high evolutionary conservation 
between their genomes.
Fugu has a small genome (390Mb), 8 times smaller than mammalian 
genomes. Due to its small genome size, Fugu has a very high gene density, small 
introns and low percentage of repetitive sequences (Brenner et al. 1993).
The conserved linkage between Fugu and human genes has been an advantage 
for positional cloning of human genes, finding new coding sequences and locating the 
intron/exon structures of the genes. Thus, essential regulatory elements may also be 
conserved, although these regulatory elements may be located much closer to the 
genes they regulate than the ones in mammalian genomes due to the small genome 
size in Fugu (Aparicio et al 1995; Elgar et a l 1996; Venkatesh et a l 1997; Gellner 
and Brenner 1999).
Several studies made use of this comparative tool to look for regulatory 
elements of developmental genes. The homeobox gene Hoxb-1, expressed during 
development in the spinal cord and hindbrain, was found to contain a conserved 
enhancer that directs the expression of the reporter during the early development. 
Similar results were found with Hoxb-4 where three conserved non-coding regions 
can drive the expression of the transgene in mouse embryos. Two important points are 
to be considered from this work; that the conserved non- coding regions tested were 
tissue specific, and that some of the conserved elements used to prepare the
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transgenics were Fugu DNA, which was able to replicate to some extent the 
expression of the homologous gene in the mouse embryo (Marshall et a l 1994; 
Aparicio et al. 1995).
Other examples have shown that the conserved elements are distributed not 
only upstream of the gene they regulate. The Wnt-1 gene, that is expressed during 
development in the midbrain and anterior region of the hindbrain, possesses a 110 bp 
conserved region located in the 3’ end of the Fugu Wnt-1, sufficient to drive the 
expression in the hindbrain (Rowitch et al 1998).
The Otx2 gene is essential for rostral head formation during development; a 
comparative and functional analysis of Fugu Otx2 revealed seven conserved elements 
located over 60 Kb in the Fugu Otx2 loci; the conserved elements were found to be 
independent in the regulation of expression when tested in zebrafish and mouse 
embryos (Kimura-Yoshida et a l 2004). These studies illustrate the use of comparative 
genomics, in specific the use of Fugu, in the searching of potential regulatory regions 
across species.
1.10 Objectives
The aims of this study are first; to understand how the mCdxl homeobox 
factor is regulated during development. Specifically, the objective was to locate the 
regulatory regions responsible for the early expression of the mCdxl and the elements 
involved in the late expression of the gene in the intestinal epithelium. Despite other 
studies on the regulation of Cdxl factor, the complete understanding of its regulation 
is still unknown.
A second aim is to understand the function of the Cdx factors in the regulation 
of other genes involved in the crypt villus axis differentiation. Based on the 
expression of the Cdxl and Cdx2 factors in the ciypt villus axis of the intestinal 
epithelium, and the expression pattern showed by the Ape in the intestine, our aim was 
to study if the Cdx factors are involved in the regulation of Ape. The hypothesis is that 
Cdxl, a gene expressed in the crypt involved in proliferation, would regulate in a 
negative manner the expression of Ape, in order to allow P-catenin to enter into the 
nucleus and activate Cdxl. Second, Cdx2, which is expressed in the villus and is
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involved in differentiation of cells, may regulate Ape in a positive way; by activating 
Ape, P-catenin would be degradated, and as a consequence the cells would undergo 
differentiation.
Finding the mechanisms by which these genes are regulated will increase our 
understanding of the regulation of genes that play a key role during development and 
adult stages. Although this work aims to characterize two specific genes, the results 
will also add new knowledge to the role and function of conserved non- coding 




Chapter Two: Materials and Methods J.L. Juarez-Morales 2005
2.1 Materials
2.1.1 Chemicals
Standard chemicals were obtained from Sigma (Dorset, UK) or BDH (Oxford, 
UK). Analytical grade Bacto agar, tryptone and yeast extract were obtained from 
Difco (Oxford, UK).
2.1.2 Enzymes
The Klenow enzyme, restriction enzymes, T4 DNA ligase and calf intestinal 
phosphatase (CIP) came from Boehringer Mannheim (Ingelheim, Germany), 
Amersham (Buckinghamshire UK), Cambio (Cambs, UK) or Pharmacia (New York, 
USA). Restriction enzymes were used at a concentration of 1 unit per pg of DNA in 
the buffer as recommend by the manufacturer.
2.1.3 Agarose gels
Restriction digests of DNA were resolved on a 0.8-2.0% agarose gel in Tris 
borate EDTA (10X TBE- 108 g Tris base, 55g boric acid, 40ml 0.5M EDTA per litre) 
buffer. Fragments prepared for ligations in Tris-acetate EDTA (50X TAE-242 g Tris 
base, 57.1 ml glacial acetic acid, 100ml 0.5M EDTA per litre) buffer (Sambrook et al. 
1989).
DNA markers used were BstEII digested lambda DNA (700bp-8Kb), or Hpall 
digested Blue Script DNA (lOObp- 700bp), 10X Ficoll loading buffer (25% Ficoll 
400, 0.25% bromophenol blue, 0.25% xylene cyanol FF).
2.1.4 Bacterial strains
The following strain of E coli was used for cloning and expression studies. 
Strain: DH5a Genotype: supE44A\ac\J\69 (4>80 /acZAM15) hsdR\7 recAl end A l 
gyrA96 thi-1 relAl.
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2.2 Methods
2.2.1 Preparation of DNA fragments for ligation
DNA fragments for cloning were prepared from plasmids digested with excess 
of enzyme. The digests were electrophoresed on 0.8% agarose gels in IX Tris- 
Acetate EDTA buffer (TAE). The fragment of interest was isolated by excising the 
band from the gel. The fragment of gel was placed in 300 pi of TAE in a dialysis 
membrane. The DNA was electroeluted into the buffer; the DNA was collected and 
extracted with phenol chloroform, and precipitated with 1/10 volume of 4M LiCl and
2.5 volumes of ethanol. The DNA pellet was dissolved in Milli Q water.
Fragments with 5’ overhangs were filled in by Klenow in a volume of lOpl 
containing DNA, lpl Klenow, lpl 10X Klenow buffer and 0.2mM dNTPs and were 
incubated at 37 °C for 30min.
2.2.2 Dephosphorylation of vectors
The vector ends were dephosphorylated with Calf Intestinal Phosphatase (CIP) 
in a volume of 15 pi, containing 1 pi CIP, 1.5pl 10X CIP buffer. For 
dephosphorylation of blunt ended fragments, a second incubation of 30min. was 
performed after the addition of lpl CIP. The CIP was heat inactivated at 75°C for 
5min.
2.2.3 Ligations
Both blunt and sticky ended ligations were carried out for 16 hrs. at 16°C. 
Ligations were performed in a volume of lOpl containing vector and insert, lpl T4 
DNA ligase, lpl 10X ligation buffer.
2.2.4 Competent cells
Competent E. coli cells (DH5a) for transformations were prepared using TSS 
(10% Polyethylene glycol (PEG) 6,000, 5% Dimethyl sulphoxide (DMSO), 25mM 
MgCk). 2ml of an overnight culture was inoculated into 100ml LB media (Luria 
Bertani medium: 1% tryptone, 1% NaCl, 0.5% yeast extract) and incubated at 37°C 
with shaking until OD600 reached 0.3-0.4. The cells were centrifuged in pre-cooled 
50ml polypropylene tubes at 3, 500 rpm for lOmin. at 4°C. The pellet was
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resuspended at one-tenth the original volume in ice cold TSS, and stored frozen at - 
70°C. (Chung et al. 1989).
2.2.5 Transformations
Frozen competent cells were thawed, and then left on ice for ten minutes. 
Aliquots (lOOul for a lOul ligation) were dispensed into pre-cooled Eppendorf tubes, 
DNA was added, and incubated on ice for 30min. The cells were heated and shocked 
at 42°C for 90s, returned to ice for one minute after the addition of 2-3 volumes of LB 
media. The transformed cells were incubated at 37°C with shaking for 45 min., and 
then pelleted at 13,000 rpm for 5 min. (microfuge) and re-suspended in 50pl of LB. 
The suspension was plated on agar plates (60pg/ml ampicillin) and incubated 
overnight at 37°C.
2.2.6 Plasmid mini- preps
Single colonies of transformants were inoculated into 3ml of LB media 
(70pg/ml ampicillin), and grown overnight at 37 °C with shaking. Cells (1.5ml) were 
pelleted at 13,000 rpm for one minute in Eppendorf tubes, and resuspended in 50|ul 
Tris and Sodium buffer EDTA (TNE) (lOmM Tris HC1 pH8, lOOmM NaCl, ImM 
EDTA). 50pl phenol/chloroform isoamyl alcohol (25:24:1) was added, and mixed 
thoroughly. This was centrifuged at 13,000 rpm for 5 min. 50pl of the aqueous phase 
was transferred to a new tube and the DNA precipitated by adding 25jul 5M 
ammonium acetate and 170pl ethanol and incubated at 20°C for 15min. The DNA 
was collected at 13,000-rpm for lOmin. This was washed in 70% ethanol, briefly 
dried and dissolved in 20pl Tris- EDTA (TE) (lOmM Tris HC1, pH 7.5 and ImM 
EDTA, pH 8.0)
2.2.6 Large scale plasmid prep
Single colonies were inoculated into 2ml of LB media (70pl/ml ampicillin) 
and grown overnight at 37°C. This was used to inoculate 500ml of LB media (70pl/ml 
ampicillin) and grown overnight at 37°C with shaking. Cells were pelleted (GSA 
rotor) at 5,000 rpm for 15min. at 4°C. The supernatant was drained and the pellet was 
re-suspended in 9ml solution 1 (50mM glucose, 25mM Tris, lOmM EDTA pH 7.), 
then incubated on ice for 5min., followed by the addition of 18ml of solution 2 (0.2 N 
NaOH, 1% SDS) and incubation for lOmin. on ice. To the cell lysate 9ml of solution
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3 (3M potassium and 5M acetate) was added and mixed by gentle swirling and a head 
over heels motion. Cell debris was pelleted at 8,000 rpm for 20min. at 4°C. To the 
supernatant containing the DNA, 0.6 volumes of isopropyl alcohol was added, and the 
DNA pelleted at 10,000 rpm for 20min. at 4°C. This was washed with 70% ethanol 
and dried briefly.
The DNA was either a) dissolved in 2ml of TE + lOOpg/ml RNase and left for 
Vz hr at 37°C, extracted with phenol/chloroform and precipitated by the addition of 2.5 
volumes of ethanol, or b) dissolved in 5ml of TE and 0.5ml of ethidium bromide 
(lOmg/ml) with 5.5g CsCl and centrifuged at 60,000 rpm for 20hr in a heat sealed 
polymer tube (Beckman L5-65 ultracentrifuge and Ti70.1 rotor). The supercoiled 
DNA was collected, and the ethidium bromide removed by repeated extraction with 
water plus salt-saturated n-butanol. The DNA was diluted 1:1 with TE and 
precipitated with 2.5 volumes of ethanol. The latter method was used when pure 
plasmid DNA was required for transfections of cells.
2.2.8 Restriction digestion
DNA from plasmid mini preps (0.5-1 pg) was digested with the appropriate 
restriction enzyme in a total volume of 20pl (2pl 10X buffer, lpl enzyme- 8 to lOu 
and 16pl water) with the first enzyme. After 3 hours the second enzyme was added if 
required and volume was made up to 40pl (4pl 10X buffer, 2pl enzyme- 8 to lOu and 
24 pi water). After 3 hours of digestion with the second enzyme, lpl (20pg) of RNAse 
was added and samples were checked on agarose gels. Digestions were incubated at 
37°C.
2.2.9 Preparation of DNA for sequencing
Double strand DNA for sequencing was purified on a caesium chloride 
gradient as described. Further purification was performed using a Micro Spin S-300 
column (Amersham). The column was vortexed to re-suspend the resin and 
centrifuged at 3rpm for 2min. 50pl of the sample was loaded into the column and 
centrifuged at 3rpm for 2min. An aliquot of the eluent containing the pure DNA was 
checked on a 0.8% agarose gel and quantified. 300-500ng of template DNA with 5- 
10 pmol of primer in a total volume of 6pl were used for sequencing.
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2.2.10 DNA sequencing
Sequencing was performed by automated cycle sequencing ABI sequencer. 
Nucleic acid sequence homology searches were performed using the FASTA 
programs of the GCG sequence analysis package and the GeneBank™/EMBL 
database (www.ebi.ac.uk/embl/index.html).
2.2.11 Polymerase Chain Reaction
PCR mixtures contained 200pM of each dNTP, 50pmol of each primer, 50ng 
of template DNA, 5 units of Taq polymerase (Roche), lOmM Tris-HC, pH 8.3, 50mM 
KCl, 1.5mM MgCh, in a total volume of 50pl overlaid with mineral oil. The PCRs 
were performed in a Thermal Cycler from MJ Research Inc (PTC-100).
2.3 Cell culture methods
2.3.1 Cell lines
The cell lines used on transfection and transactivation assays were CaCo2 and 
IEC-6 cells. CaCo2 cells or Caucasian colon carcinoma cells are colon cancer cells 
from human origin that display very similar characteristics to intestinal enterocytes. 
These cells can be grown to differentiation very quickly; so comparative studies on 
gene expression can be performed. IEC-6 cells are normal intestine cells from rat 
origin, which display all the characteristics of intestinal epithelial cells and do not 
express Cdxl and Cdx2 genes.
2.3.2 Cell cultures
All cells were cultured at 37°C and 5% CO2 . All media components were 
purchased from Gibco Invitrogen: Dulbeccos Modified Eagle Media (DMEM), non- 
essential amino acids and the foetal calf serum provided by Labtech Int. were 
purchased sterile or filter sterilised through a 0.2pm filter. Trypsination of cells for 
expansion or freezing was performed by aspirating the culture medium, washing the 
monolayer with PBS, adding 3-5ml of trypsin (Gibco) and immediately aspirating to 
leave a thin layer of trypsin covering the cells. The cells were incubated at 37°C until 
the cells detached from the surface, fresh medium was added and the cells re­
suspended with a pipette.
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2.3.3 Freezing cells
All cell lines were stored in liquid nitrogen as single cell suspensions in 40% 
DMEM, 50% FCS, 10% DMSO (freezing medium) in cryovials. The cells were 
trypsinised, and then pelleted by centrifugation at 1,500 rpm for 5min. The cell pellet 
was re-suspended in freezing medium and the cryovials were frozen overnight in dry 
ice and then stored under liquid nitrogen until use.
2.3.4 Transfection by Fugene™ reagent
The day before transfection, cells were plated at 1-3X105 cells into 30mm 
dishes at low density (10-15% confluency). The cells were at 50-80% confluency on 
the day of the transfection. One hour prior to transfection the medium was changed. 
The Fugene™ procedure was used to transfect cells. In a labelled tube, 97pl of serum 
free media was added and incubated for 5 min. at room temperature. To a second set 
of labelled tubes the required amount of DNA was added. The mix of Fugene™ and 
media was added to the DNA and incubated at room temperature for 15 minutes. The 
resulting mixture was added to the plates.
Chloramphenicol acetyl transferase (CAT) reporter plasmids (equimolar 
amount of reporter constructs and empty vector) were co-transfected with 0.5pg of 
CMV Cdxl or CMV Cdx2. 0.5pg of p27 LacZ or pNLS LacZ was used as internal 
control to normalise for variations in transfection efficiency. Bluescript II SK+ 
plasmid (Stratagene) was used to adjust the total amount of transfected DNA to 1- 
1.5pg. The cells were incubated for 48 hrs at 37°C and 5% CO2.
2.3.5 Staining for p-galactosidase
Cells were washed twice with ice-cold PBS pH7.4 to remove dead cells, and 
then fixed on ice for 3.5 min. in fixative containing 2% formaldehyde/0.2% 
gluteraldehyde/PBS. The cells were then washed with PBS pH7.4 and incubated in 
substrate solution (1 mg/ml X-gal- Boehringer -  5mM potassium hexacyanoferrite, 
5mM potassium hexacyanoferrate, 2mM MgCl2), at 37°C. Staining was carried out 
from 1-24 hours. The stained cells were washed with PBS and stored at 37°C in 10% 
glycerol/PBS. The number of blue cells was counted to check for transfection 
efficiency.
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2.3.6 Protein extraction
For (3-gal and CAT assays, protein extracts were prepared from transfected 
cells. The medium was removed from the samples, which were then washed three 
times with ice-cold PBS pH7.4 to remove dead cells. 0.5ml of IX lysis buffer was 
added to the samples and incubated with stirring for 30min. The samples were 
collected in pre-cooled eppendorf tubes and centrifuged at 4°C during lOmin. The 
aqueous phase was transferred in 250pl aliquots into pre- cooled eppendorf tubes and 
stored at -70°C.
2.3.7 Protein estimation
Protein estimation was performed using the BCA Protein Assay Reagent Kit 
from Pierce; protein was estimated either in test tubes or in micro- plates. For the first 
method 0.1ml of each replicate standard curve or unknown sample was loaded into its 
own-labelled test tube and 2.0ml of Working Reagent (WR) was added to each tube 
and mixed. Samples were incubated at 73°C for 30min. Absorbance was measured in 
a spectrophotometer at 562nm. Standards were prepared using bovine serum albumin 
(BSA) 2.0mg/ml. For the micro-plate method, 25 pi of each standard or unknown 
solution was loaded into the microplate well and 200pl of WR was added to each 
well. The plate was covered and incubated for 30minutes. Absorbance was measured 
in a spectrophotometer at 562nm.
2.3.8 p-gal and CAT ELISA assays
Promoter activity in transfected mammalian cells is generally studied by 
linking the promoter sequence to a bacterial gene encoding a detectable reporter 
protein such as CAT or p-galactosidase (p-gal). These two reporter genes have 
become standard markers used to measure transfection in most cell lines. The 
bacterial CAT, having no eukaryotic equivalent, has become a useful marker used in 
transfection experiments with eukaryotic cells. In the case of p-gal the system used 
can differentiate between endogenous lysosomal P-gal activity and the transfected 
bacterial enzyme.
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2.3.9 p-galactosidase ELISA assays
p-gal enzyme-linked immunosorbent assay (ELISA) assays were performed 
using the P- galactosidase ELISA kit (Roche) for quantitative determination of P-gal 
from E coli in transfected eukaryotic cells. Each transfection experiment was carried 
out in duplicate or triplicate.
2.3.10 CAT ELISA assays
CAT ELISA assays were performed using the CAT ELISA colorimetric 
enzyme kit (Roche) for quantitative determination of CAT from E coli in transfected 
eukaryotic cells. All CAT ELISA values were normalised for transfection efficiency 
by calculating the ratio of CAT activity to p-gal in each transfected plate. Each 
transfection experiment was carried out in duplicate or triplicate.
2.3.11 Characterisation of the APC regulatory region
CAT activity of the promoter constructs was measured relative to the 
promoterless pCAT BASIC. pCAT CONTROL (Promega), containing SV40 
promoter and enhancer sequences, was used as a positive control. A 607bp fragment 
spanning positions -290 to +317 of APC was subcloned, in the correct orientation, 
upstream of the CAT gene to generate pApcSP (Wedgwood et a l 2000).
2.4 Resources available at the MRC UK HGMP Resource Centre
2.4.1 The Fugu genomic clone libraries
The Fugu cosmid and BAC libraries have inserts that range from 
approximately 35 to 45Kb (average 40Kb) and 60 to 120Kb (average 80Kb), 
respectively. The vectors used are Lawrist 4 for cosmids and pBeloBACII for BACs. 
All Fugu clones are available from MRC geneservice (http://www.hgmp.mrc.ac.uk/ 
gene service/index.shtml). The initial clones sequenced during this project were 
cosmids, as these were identified in the Fugu Landmark Project 
(http://fugu.hgmp.mrc.ac.uk/) as containing the genes of interest. In July 1999, a
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Fugu BAC library was produced by Incyte Genomics. These genomic clones 
replaced the cosmids in the analysis due to their larger insert size.
2.4.2 The Fugu BAC library
The Fugu BAC library was prepared at Incyte using Fugu genomic DNA 
supplied by Dr. Greg Elgar (MRC UK HGMP Resource Centre). The library contains 
42,624 clones arrayed in 111 (384-well) plates. The library plates are numbered from 
176-286. The Fugu group at the MRC UK HGMP Resource Centre prepared high- 
density filters of the library. The library is equivalent to approximately 1 OX coverage 
of the entire Fugu genome.
2.4.3 Primer synthesis and usage
Primers were synthesised by the Sanger Centre Synthesis Group (Wellcome 
Trust Genome Campus, Hinxton Hall, Cambridge). These were supplied in ammonia 
that was removed by centrifugal vacuum evaporation (Jouan centrifugal evaporator 
RCT90-RC1022) for 45 minutes. Primers were quantified by measuring their optical 
density (OD) at 260 nm. Their concentration was calculated using the equation: 
Concentration in mM = [(O.D. at 260nm) (20) (dilution factor)] / [(325) (oligo length 
in bp)]. The value of twenty was used as the single stranded DNA constant 
(Sambrook et al., 1989). A working stock of the primer was made at a concentration 
of 10 pM.
2.4.4 General PCR conditions
General polimerase chain reaction (PCR) reactions were usually carried out in 
a 25 pi reaction volume using: 5 pi 10X buffer, 5 pi 2mM dNTPs, 1.5 pi 50mM 
MgCk, 26.5 pi double distilled water, 1 pi Taq polymerase (Bioline), lpl DNA 
(20pl/ml) and 5 pi per primer pair. The reactions were denatured at 95 °C for 30 
seconds, annealed at 55°C to 65°C for 30 seconds (according to the Tm of the primers 
being used), and extended at 72°C for 60 seconds with a total of 30 to 35 cycles. A 
standard initial 95 °C for 2 minutes denaturation step and a final 72°C for 7 minutes 
elongation step were also used for the PCR reactions.
The PCR reactions were also conducted with limited dilutions of dNTPs and 
vector primers (an eighth of the normal concentration of dNTPs and a fourth of the
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normal concentration of primers). These conditions allowed the direct sequencing of 
PCR products without the requirement of product purification, and also reduced the 
number of non-specific bands obtained during the amplification of DNA.
2.4.5 Reverse transcription polymerase chain reaction (RT-PCR)
RT-PCR was used to confirm the exon/intron boundaries of the identified 
genes in Fugu, as well as to examine the expression patterns. 1 pg of total RNA was 
used for cDNA synthesis (using the RNA stocks available from the Fugu Genomics 
group). The genomic contamination in the total RNA stocks was removed using 
DNAse treatment. The cDNA synthesis was carried out using the reverse transcriptase 
(RT) kit (Promega) following the manufacturer’s instructions. Using actin primers 
after cDNA strand synthesis assessed the quantity and quality of the cDNA obtained. 
The actin primers used included actin forward (5’acagactacctcatgaagatcct3’) and actin 
reverse (5’gaggccaggatggagcctcc3’). The primers were specifically designed to 
amplify Fugu actin sequences that span an intron, and therefore were used to detect 
genomic contamination of the cDNA. The design of the primers was based on 
published Fugu actin sequences (Venkatesh et a l 1996).
The PCR was carried out in a 25 pi reaction, consisting of 1 pi of cDNA with 
limited dilutions of dNTPs and primers, repeated 25 times with the following PCR 
cycles: initial denaturation at 96°C for 2 minutes only, 95°C for 30 seconds, 58°C for 
30 seconds, 72°C for 1 minute, and a final extension of 72°C for 5 minutes. When 
PCR products were difficult to obtain, PCR enhancing agents were used, namely 2% 
DMSO, which was added during the first and second round of PCR. DMSO 
optimises the PCR amplification by facilitating strand separation by disrupting base 
pairing.
2.4.6 Identification of the 5’ end of genes
5’ Rapid Amplification of cDNA Ends (RACE) allowed the amplification of 
unknown sequences at the 5’ end of the mRNA. The BD SMART™ RACE cDNA 
amplification kit (BD Biosciences Clontech) was used in an attempt to obtain the 5’ 
end of genes. The principle of the 5’RACE consists first, in the synthesis of cDNA 
from total or polyA+ RNA using a modified oligo (dT) primer, termed the 5’-CDS 
primer: 5’- agg cag tgg tat caa cgc aga gta c(t) 25 V N-3’ ,the BD SMART II A
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oligonucleotide 5’- aag cag tgg tat caa cgc aga gta cgc ggg -3’ and the BD RT. Then, 
a 5’RACE PCR is carried out using gene-specific primer and the long universal 
primer: 5’- eta ata cga etc act ata ggg caa gca gtg gta tea acg cag agt -3’. A second 
5’RACE PCR is performed using the short universal primer 5’- eta ata cga etc act ata 
ggg c -3’and a nested specific primer. The final 5’RACE PCR product is then 
purified, cloned and sequenced.
The first strand cDNA synthesis was done using 1 pg of total RNA extracted 
from Fugu gut tissue, lpl 5’-CDS primer and lpl BD Smart II A oligo, incubated 
70°C for 2min. followed by 2min. at 4°C; then 2pl 5X buffer, lpl DTT (20mM), lpl 
dNTPs (lOmM) and lpg BD reverse transcriptase were added to a final vol of lOpl; 
samples were incubated at 42°C for 1.5hrs. lOOpl ofTricine-EDTA buffer were added 
to the reaction.
The first 5’RACE PCR reaction was prepared adding 2.5pl of the cDNA 
reaction, 5pi universal primer mix (UPM) (10X), lpl gene specific primer (GSP1) 
(10mM)[5’ ggee egg cga ttc tgg aac cag ate 3’], 5pl 10X 2 PCR buffer, lpl dNTPs 
(lOmM), lpl BD polymerase mix and 34.5pl water. The PCR program was 94°C for 
lmin.; 94°C 30sec, 72°C for 3min. during 5 cycles; 94°C for 30sec, 70°C for 30sec, 
720C for 3min. during 5 cycles the final cycling was at 940C for 30sec, 68°C for 
30sec, 72°C for 3min. during 27 cycles followed by 72°C for 5min. For the second 5’ 
PCR reaction, 5pl of the first PCR product were diluted into 245pl of Tricine EDTA 
buffer; 5 pi of the diluted primary PCR were used as a template, using lpl NUP (10X) 
and lpl of the NGSP (10mM)[5’ aggc tga ggg ctg tgg cca get ccg 3’], the remaining 
components were kept as the first reaction. A positive control was prepared using the 
human placental total RNA provided for the kit, which was prepared exactly in the 
same conditions as the sample.
2.4.7 DNAse treatment of RNA
Total RNA from different tissues was treated with DNAse to remove genomic 
contamination. A mixture of 120 pi lOOmM MgCE/lOmM DTT, 2.4 pi DNAse I, 1.2 
pi RNAse inhibitor and TE buffer was added to a 1 pg RNA sample, to make a final 
volume of 700 pi. The samples were incubated at 37 °C for 3 hours. RNA was then 
extracted by adding 50 pi of phenol:chloroform:isoamyl alcohol (25:24:1), vortexed 
and centrifuged for 1 minute. The top aqueous layer was removed to a fresh
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eppendorf. 75 pi of chloroform was added, vortexed and centrifuged for 1 minute. 
The top layer containing the RNA was pipetted into a fresh eppendorf, precipitated 
with 300 pi 25:1 K Acetate/ethanol and then washed twice with 70% (v/v) ethanol. 
The resulting pellet was air-dried, resuspended in 100 pi of double distilled water, and 
used directly during RT-PCR.
2.4.8 Cloning PCR products into vectors
PCR products were cloned into the pGEM R -T Easy Vector System (Promega) 
or pBluescript vector prior to sequencing. The pBluescript vector (Statagene) used for 
cloning PCR products did not have the 5’-phosphate group removed by 
dephosphorylation from the vector after being linearised. This is because PCR 
products do not have a 5’-phosphate group, which when provided by the vector, is 
needed by the enzyme T4 DNA ligase 400 (U/pl) during the ligation reaction.
2.4.9 Cloning into the pGEM Easy Vector
The pGEM R -T Easy Vector System (Promega) allowed the cloning of PCR 
products prior to sequencing. The vectors contain T7 and SP6 RNA polymerase 
promoters flanking a multiple cloning region within the a-peptide coding region of 
the enzyme p-galactosidase (used for colour screening of recombinant clones). The 
PCR products were ligated into the pGEM vector, following the manufacturer’s 
instructions, and PCR amplified with T7 short (5’ taatacgactcactatagg 3’) and SP6 
short (5’ gatttaggtgacactatag 3’) primers. PCR products were then sequenced using 
T7 long (5’ taatacgactcactatagggcga 3’) or SP6 long (5’ gatttaggtgacactatagaatac 3’) 
primers.
2.5 Bioinformatics toois and programs
2.5.1 BLAST
The Basic Local Alignment Search Tool, or BLAST program (Altschul et al. 
1997) enables the rapid identification in a large database of regions with similarity to 
a given query sequence. The process works by using local alignment algorithms that 
attempt to isolate regions in sequence pairs that have high levels of similarity. 
Although BLAST does not guarantee to find the best local alignment, it is the most
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effective heuristic search method available, in particular when used against large data 
sets.
2.5.2 NIX- a nucleotide identification program
Once the genomic sequence around the region of interest in Fugu was 
produced, the next step involved the process of finding and identifying genes. A 
nucleotide identification program (NIX) (http://www.hgmp.mrc.ac.uk/Registered/ 
Webapp/NIX/) is an integrated automated DNA sequence analysis tool. It masks the 
sequence for repeat regions, carries out BLAST searches against databases, and also 
runs ab initio exon-finding programs, displaying all the results graphically. Viewing 
all the results in conjunction offers a collective way of interpreting the predictions and 
BLAST matches of the genomic sequence being analysed, facilitating the 
identification of exons and prediction of proteins. The range of programs displayed in 
NIX include: Eponine, GRAIL, TSSW, GENSCAN and Fgenes for promoter 
predictions; FEX, Hexon, MZEF and Genemark for exon predictions; GRAIL, 
Genefinder, Fgene, GENSCAN, Fgenes and HMMGene for gene predicitions; and 
finally GENSCAN, Fgenes and GRAIL for polyA predictions. BLAST sequence 
similarity searches against unigene, mRNA, EST, EMBL, E. coli and vectors, as well 
as RepeatMasker, are also included.
2.5.3 Internet resources
A range of websites was used regularly during this project. The European 
Molecular Biology Laboratory (EMBL) represents Europe’s primary nucleotide 
sequence database. The database contains a collection of DNA and RNA sequences, 
with new entries being updated daily. EMBL was used to retrieve orthologous or 
paralogous sequences to be used in the comparative analyses. The Ensembl website 
generates and maintains annotation for eukaryotic genomes, including human, mouse, 
zebrafish, mosquito and Fugu, and has been a major source in the annotation of the 
Human Genome Project draft sequence. The National Centre for Biotechnology 
Information (NCBI) is a central internet resource that offers a general repository for 
molecular biology. Links within the main website include: online mendelian 
inheritance in man (OMIM), map viewer, BLAST, links to literature (Pubmed), 
Entrez data-mining tools, the cancer genome anatomy project, gene annotations, and
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the LocusLink gene viewer. SRS6, produced by Lyon Bioscience AG, allowed the 
retrieval of sequences deposited in the public databases.






DNA sequences were manipulated using EMBOSS, a sequence analysis tool 
(Rice et a l 2000). EMBOSS is a free open source software analysis package 
encompassing over 100 programs. The programs used during this project included 
sequence alignments, rapid database searching and nucleotide sequence pattern 
analysis. EMBOSS was used to translate Fugu genes and deduce their putative protein 
sequences.
2.5.5 ClustalX
ClustalX (Thompson et a l 1994) generates multiple sequence alignments and 
displays the results in a graphical interface. Although the default parameters were 
used for all the alignments during this project, these can be changed accordingly. The 
multiple sequence alignment parameters used included: Gap opening penalty 10.00, 
Gap extension penalty 0.20 and DNA transition weight of 0.5, using a Gonnet 250 
protein matrix.
2.5.6 Mlagan
Mlagan is a global aligment tool kit (Brudno et al 2003) used to do pairwise 
and multiple alignment of large scale sequences. Mlagan works by first creating a 
local alignment of sequences, it is that genes or sequences with very high homology 
present in the complete sequence are aligned first, then a rough global map is created 
in base to the local alignments and finally, a computation of a final global alignment 
is done using the best alignment from the rough global map. The final Mlagan
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alignment is visualized as Vista plot, which allows and easy identification of the 
conserved sequence in the complete alignment.
Mlagan was used to look for the conserved non-coding sequences surrounding 
the genes of study; sequence conservation was measure using a 40 bp window and a 
60% identity. The Fugu sequence was in most of the cases used as base line sequence.
2.5.7 Theatre
Theatre is a software tooi designed for the comparative analysis of genomic 
sequences. Theatre predicts positions of coding regions, repetitive sequences and 
transcription factors binding sites present in the studied sequence. Theatre 
incorporates a repertoire of programs required for the complete analysis of the 
sequence. It uses Clustal W V.1.74 to perform an alignment of sequences, Blast V. 
2.2.3 and Gene Mark V. 2.3 to identify protein coding regions and open reading 
frames, Matlnspector V.2.2 and Tfscan (EMBOSS) V.2.5.1 to predict transcription 
factors binding sites and CpG plot (EMBOSS) V.2.5.1 and RepeatMasker to identify 
repeats in the sequence. Theatre provides a pairwise or multiple alignment of 
sequences with the transcription factor binding sites present and conserved in the 
aligment (Edwards et a l 2003).
2.6 Fish maintenance and embryo injection
Zebrafish were raised and bred at 28.5°C. Embryos were staged accordingly
with the number of hours after fertilization (hpf). Embryos were injected using 
100ng/pl of coiled DNA and 0.1% of phenol red. Injections were done into zebrafish 
embryos produced by natural mating between the one to eight cells stage using an 
Eppendorf (Hamburg, Germany) FemtoJet pressure injection system. Injected 
embryos expressing GFP were anaesthetized in Tricaine and analyzed using an 
Olympus (Tokyo, Japan) 1X81 motorized inverted microscope. Images were captured 
using an FVII CCD monochrome digital camera and analySIS image-processing 
software. For embryos injected with LacZ, embryos were fixed at the desired stage 
and stained for LacZ activity.
2.7 X-gal staining and histological analysis of embryos
p-gal staining allows identification of embryonic tissues/cells expressing lacZ
marker protein by development of pigmented (blue) product in the presence of lacZ 
enzymatic activity.
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Transgenic embryos were fixed in 0.1% glutaraldehyde-PBS for 5 min., 
followed by three washes with PBS for 5 min. at room temperature. Staining was 
carried out for 5-12 h at 37°C in PBS containing 1 mg/ml X-gal, 5 mM K3Fe(CN)6, 5 
mMK4Fe(CN)6, and 2 mM MgCE. Stained embryos were washed twice with PBS and 
immediately stored in 0.1% glutaraldehyde in PBS. Embryos were washed with PBS 
(3 changes of 5 min. each, followed by incubation of 30 min. each in 30%, 50% and 
70% ethanol, and stored in ethanol at -20°C.
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3.1 Introduction
The homeobox genes are transcription factors involved in the determination 
and sculpture of the body plan in early development. One of the main characteristics 
of these genes is a 180bp region named the homeobox, which codes for the 
homeodomain in the protein. This homeodomain is highly conserved across species, 
and due to this level of conservation, several homeobox genes from different 
organisms have been identified to date. The Cad genes are homeobox genes. The 
Drosophila Caudal gene was the first identified by its homology with the Ant 
homeobox transciption factors (Mlodzik et al. 1985).
The murine Cdxl was the first vertebrate Caudal homeobox gene to be 
isolated using a Drosophila Cad probe from a 8.5 dpc mouse embryonic cDNA 
library. It is a 1.8Kb transcript that encodes a 268aa sequence (Hu et a l 1993). The 
murine Cdx2 was isolated using a cDNA library made from mRNA of colonic crypts 
from adult mouse and a fragment with the Cdx2 homeodomain as a probe based in the 
Drosophila homeodomain sequence. The murine Cdx2 is a 1.8Kb transcript, which 
translates into a 311aa. protein (James et al. 1994). The murine Cdx4 was isolated 
using an 8.5 dpc mouse cDNA library and two thirds of the homeobox as a probe. The 
Cdx4 transcript is the smallest of the murine Cdx genes with 856bp length and 
encoding 282aa. protein (Gamer and Wright 1993). There is a high degree of 
conservation of the gene sequence between various species. The Cdx genes contain 
three coding exons and two introns. The first intron is normally very long compared 
with the second intron. The homeobox is usually contained between the end of the 
second exon and the first part of the third exon. The homeobox codes for 60aa. 
peptide, the homeodomain; upstream of the homeodomain there is a hexapetide 
sequence (HEX) which is used to classify the Caudal -like genes (Burglin et a l 
1989).
The human Cdx genes display a high level of sequence identity with the 
mouse Cdx genes. The nucleotide and amino acid sequence, the genomic structure and 
the map position of the locus are also conserved. The three human Cdx genes also 
contain three coding exons and two introns; the homeobox is also located between the
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second and third exon and the hexapeptide domain which is separated from the 
homeobox by the first intron is also maintained in mouse and human Cdx genes 
(Bonner et a l 1995).
Not much is known about the biochemistry of the Cdx proteins. There are well 
conserved motifs in the proteins across the family and across species; the proline rich 
regions present in the sequence have been suggested to act in the transactivation and 
oligomerisation of the protein. The presence of phosphorylation and acetylation sites 
are also characteristics of the Caudal proteins; the phosphorylation site is thought to 
be involved in DNA binding along with the homedomain of the protein.
Given the high conservation of these genes across species, it is likely that the 
elements involved in the regulation of Cdxl are also conserved across species. To 
identify the conserved regulatory elements involved in the regulation of the Cdxl 
gene, I reverted to the use of comparative genomics and the Fugu genome. The 
primary idea was to identify the Fugu Cdxl gene in the pufferfish genome, and based 
on gene conservation, I aimed to look for the conserved non- coding sequences 
present in the upstream, downstream and intronic regions that might be candidates for 
the regulatory elements of the Cdxl across species.
3.2 Materials and methods
3.2.1 Expression of Fugu Cdx by RT-PCR
Total RNA from wild type adult pufferfish was obtained from Dr. Greg Elgar 
(MRC UK HGMP Resource Centre). Primers for JrCdxl expression, forward: 5’- 
ATCCCAGGCCCCTATGA -3’ and reverse: 5’-caggaaagcatcagacc -3’. PrimerS for 
frCdx2 expression, forward: 5’-ggactaaagacaagtaccgg -3’, reverse: 5’-
gaagatctggttccagaatc -3’ and primers for the frCdx4 expression, forward: 5’- 
ggaccagtaagaagatcaag -3’ reverse: 5’-gcagagctaaagagaggaag -3’ Internal primers for 
the p-actin gene were designed to confirm that there was no contamination of 
genomic DNA. The sequence of the jfiactin primers were: forward primer 5’- 
tacagactacctcatgaagatcc-3’ and the reverse primer 5’-gaggccag gatggagcctcc-3’. The 
PCR product size for the P-actin was 500pb.
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The PCR was performed in 20pl containing lpl cDNA product from the 
reverse transcription and 25pM of each primer, with the following program: 
annealing temp. 65°C for 30s; extension temp. 72°C for 40s; 35 cycles. The PCR 
product size for the FrCdxl was 910bp and the PCR product size.
3.3 Results
3.3.1 Identification of Fugu Cdx genes
This work was done subsequent to the completion of the Fugu genome 
sequencing. The Fugu genomics project database was used to search for the Fugu Cdx 
genes; all Fugu DNA sequences were extracted from this database. The genomic 
sequence for the Cdx genes for human and mouse were extracted from the Ensembl 
database. This section will describe how we identified the Fugu Cdx genes by 
homology using the mouse and human Cdx sequences from the Ensembl database. 
The mouse and human Cdx genes (including aa sequence, transcriptional organisation, 
coding sequences and intergenic distances) have been described and analysed 
previously, and we make use of this available information to characterize the Fugu 
Cdx genes in an improved manner.
To identify the Cdxl gene in Fugu, we extracted the aa sequence of the mouse 
Cdxl (NM_009880), and blasted it against the Fugu genome database. The blasted 
sequence hit three mayffolds, MOO 1324, M000598 and M000580. Each mayffold was 
displayed using the NIX program, which is one of the features contained in the Fugu 
database used for the analysis of a single clone. The NIX program contains a package 
of exon-finding programs that predict the gene structure, gene sequence, aa sequence 
and gene location in a specific DNA sequence.
The NIX program showed that the three mayffolds contain a predicted Caudal 
gene. This suggested that Fugu contains the three Cdx genes present in mammals. 
However, assignation of the distinctive name and a complete characterisation of the 
Fugu Cdx genes were not available yet. The first attempt to assign a name to each 
Caudal Fugu gene was made using the aa sequence predicted by NIX. However, the 
prediction only showed the homeodomain, which is highly similar between the three
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genes; because the gene structure is exactly the same for the three Cdx genes, we 
opted to use the linkage of the genes to distinguish among them.
Using the transcriptional organisation from mouse and human Cdxl, Cdx2 and 
Cdx4, we assigned the Fugu Cdxl (frCdxl) to the mayffold 1324 (MOO 1324); the 
Fugu Cdx4 (frCdx4) was allocated to the mayffold 598 (M000598) and the Fugu 
Cdx2 (frCdx2) was assigned to the mayffold 580 (M000580). The blast of the aa 
sequence of human CDX1 and mouse and human Cdx2 and Cdx4 hit the same 
mayfflods in the same order.
3.3.2 Transcriptional organisation of Fugu Cdx genes
3.3.2.1 Transcriptional organisation of Fugu Cdxl
Comparison of the genomic organisation of the Fugu, mouse and human Cdxl 
shows synteny conservation between the genes. A specific chromosome location for 
the Fugu Cdxl has not been assigned yet; the gene can be located in the mayffold 
1324, which contains the complete genomic sequence of the gene plus the flanking 
regions of the gene.
At the 5’ end of the frCdxl, the nearest gene is the beta platelet- derived 
growth factor receptor precursor gene (Pdgfrfi), located at 11.9Kb, followed by the 
macrophage colony stimulator factor I receptor precursor (Mcsfr), located 15Kb 
upstream of the Fugu Cdxl. At the 3’ end, the nearest gene is the slow nerve growth 
factor receptor gene (TrK-A), located 953pb downstream of the frCdxl (Figure 3.1).
The human CDX1 is located on chromosome 5. The beta platelet- derived 
growth factor receptor precursor gene (PDGFR/J) is the 5’ proximal gene to the CDX1 
located at 11.13Kb; the second nearest gene is the macrophage colony stimulating 
factor I receptor precursor (CSF1R) situated 11.5Kb from the CDX1 gene. In the 3’ 
region, the nearest gene is the solute carrier family 6 (neurotransmitter- transporter, L- 
proline) gene (SLC6A7) placed at 6.2Kb, followed by the calcium/calmodulin- 
dependent protein kinase type I alpha chain (CAMK2A) located 8.4Kb from the 
CDXl.
The mouse Cdxl is positioned on chromosome 18; synteny is highly 
conserved between mouse and human in both the 5’ and 3’ regions. The nearest 5’
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gene to the Cdxl is the Pdgfrp located at 8.951Kb; the second proximal gene is the 
Csflr located at 29.5Kb from the Cdxl. In the 3’ end, the nearest gene to the Cdxl is 
the mSlc6a7 placed at 4.66Kb; the second neighbouring gene at this end is the 
Camk2a situated 11.8Kb from the Cdxl (Figure 3.1).
In contrast with the human and mouse Cdxl in which transcriptional 
orientation is well conserved, in the frCdxl, synteny conservation with mouse and 
human Cdxl is only present in the 5’ end of the gene, where the pdgfrp and the Csflr 
{Mcsfr in the case of Fugu) genes are well preserved. However, conservation is 
broken at the 3’ region of the gene.
The mpdgfrp and hPDGFRp contain a distinctive long intron between the 
5’UTR and the 1st coding exon of the gene. The 5’UTR of the Fugu pdgfrp has not 
been characterised yet. Comparison analysis of the upstream Fugu pdgfrp upstream 
region did not show any sequence conservation with the human or mouse 5’UTRs. 
The distance between the frCdxl and the frpdgfr/3 used here is from the 1st coding 
exon of both genes.
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Figure. 3.1. Transcriptional orientation of the Cdxl gene in human mouse and Fugu. 
The Cdxl genomic regions from human and mouse were extracted from 
Ensembl. The genomic DNA extracted was up to the two nearest neighbouring 
genes. The Fugu Cdxl genomic region (MOO 1324) was extracted from the Fugu 
database. Black boxes indicate the position of each gene through the 
chromosome; genes located above the line are transcribed 5’->3’; genes located
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under the line are positioned in the reverse DNA strand and are transcribed in the 
opposite orientation. The scale bar for the human, mouse and Fugu is 2Kb.
3.3.2.2 Transcriptional organisation of Fugu Cdx2
The Fugu Cdx2 was mapped in the mayffold 580 (M000580). This mayffold 
contains the complete frCdx2 gene and the flanking regions to the nearest genes. In 
the 5’ region, the two nearest genes to the frcdx2 are the adapted related complex 
subunit gene (ARCS) and the arrestin 02 red cell isoform gene {Carr). The immediate 
5’ gene is Carr, located 4.5Kb away from the frCdx2 followed by the ARCS placed 
9.9Kb from the frCdx2. To the 3’end, the nearest gene is the ring finger protein 26 
(RFP) situated at 10.7Kb; the second nearest gene is the insulin precursor protein (IP) 
located 13.2Kb from the frCdx2 (Figure 3.2).
In the case of human and mouse Cdx2, the gene is located in chromosome 13 
and 5 respectively; synteny is well conserved between these two species in the 5’ end. 
The closest gene to the Cdx2 is the cytokine receptor precursor (Flt3), which in the 
case of human is located at 34Kb and in the case of mouse is 23.9Kb from the Cdx2. 
The second nearest gene to the Cdx2 is a predicted gene which in the case of the 
human as been assigned as Q9H7FL, and in the mouse as Q9C2M6 located at 40.8Kb 
and 152.9Kb respectively from the Cdx2. Although no name or function to this gene 
has been assigned in mouse and human, the gene probably is not conserved between 
these two species, especially regarding the difference in the intergenic distance 
between the predicted gene and the Cdx2 gene. To the 3’ end, the gene immediatly 
next to Cdx2 is the insulin promoter factor (Ipfl) situated 36.8Kb in human and 25Kb 
in mouse from the Cclx2. The second nearest gene, Gshl encodes a homeobox protein, 
which locates 162.8Kb in the human and 105Kb in the mouse away from the Cdx2 
(Figure 3.2).
The transcriptional organisation of the Fugu Cdx2 does not show any synteny 
conservation when compared with mouse and human. None of the neighbouring genes 
seems to be conserved, except for the predicted insulin precursor {IP) gene in Fugu, 
which is reminiscent of the Ipfl present in human and mouse. However, Ipfl is the 
closest gene in the 3’ end in mouse and human, and IP is the second nearest gene 
located in the 3’ end of the frCdx2.
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Figure. 3.2. Transcriptional orientation of the Cdx2 gene in human mouse and Fugu. 
The Cdx2 genomic regions from human and mouse were extracted from 
Ensembl. The genomic DNA extracted was up to the two nearest neighbouring 
genes. The Fugu Cclx2 genomic region (M000580) was extracted from the Fugu 
database. Black boxes indicate the position of each gene through the 
chromosome, genes located above the line are transcribed 5’->3\ genes located 
under the line are positioned in the reverse DNA strand and are transcribed in 
opposite orientation. The scale bar for the human and mouse is 20Kb.
3.3.2.3 Transcriptional organisation of Fugu Cdx4
A chromosomal location for Fugu Cdx4 has not been assigned yet; the frCdx4 
was located in the Mayffold 598 (M000598), which contains the complete JrCdx4 and 
the neighbouring flanking genes. The 5’ flanking gene is tyrosine kinase receptor 
(FLK1) at 7.3Kb; the second neighbouring gene in this end is the testis express gene 
(TXS) located 16.3Kb from the frCdx4. At the 3’ end, Chid  is the first gene situated 
1.1Kb away from the frCdx4, followed by a member of the zinc finger family, the 
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The mouse and human Cdx4 has been located on X chromosome; synteny 
seems to be conserved specially in the 3’ region. The nearest gene in the 3’ end is 
C h id ; a cysteine rich hydrophobic protein, in human it is located at 108.6Kb and in 
mouse at 26.2Kb from Cdx4. The second nearest gene in the human is an X (inactive) 
specific gene (XIST), placed 241.8Kb from CDX4; in the mouse is a testis specific 
gene (7fo) that is positioned at 48.4Kb from its respective Cdx4 (Figure 3.3).
Synteny appears to be broken in the genes located at the 5’ region of the 
human and mouse Cdx4. In human, the immediate gene is a member of the Cl family, 
the DMRTC1, which is located 598.4Kb from CDX4, the second nearest gene is 
peptidyl-prolyl cis-trans isomerase gene (PIN4) positioned 1.17Mb from CDX4. in the 
mouse, the nearest 5’ gene is Ppnx gene placed 64.7Kb from Cdx4, the second nearest 
gene is the riken gene (Rik) at 338.9Kb from Cdx4 (Figure 3.3).
The transcriptional organisation of the Fugu Cdx4 showed to some extent 
conservation with the human and mouse organisation, mainly at the 3’ flanking 
region; the Chid gene is conserved in the three species as the nearest 3’ gene. 
However, conservation in the 5’ end is different even for the mouse and human Cdx4.
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Figure. 3.3. Transcriptional orientation of the Cdx4 gene in human mouse and Fugu. 
The Cdx4 genomic regions from human and mouse were extracted from
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Ensembl. The genomic DNA extracted was up to the two nearest neighbouring 
genes. The Fugu Cdx4 genomic region (M000598) was extracted from the Fugu 
database. Black boxes indicate the position of each gene through the 
chromosome, genes located above the line are transcribe 5’->3’, genes located 
under the line are positioned in the reverse DNA strand and are transcribed in 
opposite orientation. The scale bar for the human is 100Kb, mouse is 10Kb and 
Fugu is 1Kb.
3.3.3 Gene organisation o f the Fugu Cdx genes
3.3.3.1 Gene structure of Fugu Cdxl
The gene structure of the Fugu Cdx genes is well maintained with their 
orthologues in human and mouse. The frCdx genes also contain three coding exons 
and two introns; the introns show similar characteristics to the mammalian Cdx, the 
first intron is much larger than the second intron (Figure 3.4).
In order to obtain the gene structure of the Fugu Cdx genes, the intron-exon 
boundaries were the base to delimit the length of each exon. The intron-exon faces are 
perfectly conserved between the three species. The first exon, the intron-exon face is 
+1 (G GG) and for the second exon, the intron-exon face is +0 (CAG).
The human Cdxl is over 17.705Kb, contains 3 coding exons, 2 introns and 5’ 
and 3’ UTRs. The 5’ UTR of the gene is 81 bp long and is located upstream of the first 
exon. This exon extends over 445bp and is followed by the 1st intron, the largest in the 
gene with 15446pb in length. The second exon is 146bp in length. The 2nd intron, 
situated between the second and third exons, extends over 560bp in length. The third 
exon is the final coding exon of the gene and is 207bp in length. After the third exon, 
the 3’ UTR extends over 820bp.
The mouse Cdxl shows a very high level of conservation with its human 
orthologue; the structure is maintained with 3 coding exons, two introns and the 5’ 
and 3’ UTRs. The length of the gene is 17.338Kb. The 5’UTR is 79bp in length and is 
located upstream of the first coding exon which is 445bp in length. The 1st intron 
positioned between the first and second exon is also the largest of the gene with 
15156bp in length. The second coding exon, 146bp in length, is followed by the 2nd
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intron 432bp in length; the final coding exon extends over 215bp downstream of the 
final coding exon and the 3’UTR extends over 865bp.
The Fugu Cdxl gene, extending over 2.893Kb, is around 5.8 times smaller 
than its orthologues. The gene structure of the frCdxl is similar to human and mouse, 
having three coding exons, 2 introns and 5’UTR. The 5’UTR is 81 bp in length, the 
same as the human 5’UTR, and 2bp longer than the mouse 5’UTR. The first exon 
extends over 398pb, 47bp shorter than the mouse and human ones. The 1st intron is 
1436bp, one tenth the size of the human and mouse 1st intron.
The second exon is 146bp in length, the same length as the human and mouse 
second exons. The 2nd intron is located between the second and third exons, and is 
703bp in length; this second intron is 143pb and 271 bp larger than the human and 
mouse 2nd introns respectively. The third coding exon extends over 180bp, 35bp 
shorter than the mouse third exon and 27bp shorter than the human third exon. The 
homeodomain is also encoded by the second and third exons as in the case of mouse 
and human (Figure 3.4).
The 3’UTR of the Fugu Cdxl has not been described yet, however, due to the 
high conservation level that the frCdxl shows with its orthologues, the existence of a 
conserved 3’UTR is probable.
Comparison of the nucleotide sequence shows that the 5’UTR is 32.09% 
conserved between the three species (26/8 lpb). Between mouse and human the 
conservation is 87%, Fugu and mouse or Fugu and human show 14% identity in the 
5’UTR. The first exon is 40.70% conserved with mouse and human (162/398bp). The 
second exon, which has the same length for the three species, has 70.57% 
conservation with the mouse and human second exon (103/146pb). The third exon 
shows 48.33% conservation between species (87/180bp). The conservation of the 
homeodomain is 69.44% between the three species (125/180bp). To compare the 
3’UTR, 861 bp downstream of the third coding exon of the frCdxl were used for 
comparison against the human and mouse 3’UTRs. Mouse and human have 66% 
conservation. The human and Fugu show 4% conservation, mouse and Fugu have 2% 
conservation in their 3’UTRs (Appendix section 1A).
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Figure. 3.4. Comparison of the human mouse and Fugu Cdxl genes. Filled boxes 
represent coding exons. The length of each exon and intron is indicated. The 
splicing acceptor and the intron exon face are shown.
3.3.3.2 Gene structure of Fugu Cdx2
The human and mouse Cdx2 have been also sequenced and characterized. 
Their structures are well conserved with three coding exon and two introns, the 1st 
intron being larger than the 2nd one. In the mouse the first coding exon extends over 
538bp and 541 bp in the human; the 1st intron is 3118bp and 3450bp in mouse and 
human respectively. The second exon extends over 146bp in both human and mouse; 
the third exon is 252bp in length in mouse and 255bp in human, the human 2nd intron 
is 1500bp in length and the mouse 2nd intron is 1087bp.
The Fugu Cdx2 was the most incomplete of the three frCdx genes; the 
comparative analysis using the mouse and human Cdx2 transcripts and aa. sequences 
showed the presence of the 2nd and 3rd coding exons. However we were unable to 
identify the 1st coding exon by a bioinformatic approach. We resorted to the 5’ RACE 
technique to try to identify the first exon of the frCdx2 gene.
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3.3.3.3 Race of the Fugu Cdx2
Specific primers for the 2nd exon of the frCdx2 gene were designed; we used 
total mRNA extracted from adult Fugu gut, the BD SMART™ RACE cDNA 
amplification kit from BD Biosciences Clontech. Specific primers for the Fugu Actin 
gene were used as internal positive controls. The cDNA was prepared using the 
modified oligo (dT) primer; the integrity and quality of the cDNA was checked using 
specific primers for the Fugu Actin (Figure 3.5, line 6). The PCR product showed that 
the cDNA quality was good; a sharp band was observed at 480bp, which is the size 
expected; no distinctive genomic DNA was observed.
The external positive control was prepared using human placental total RNA. 
Using the cDNA prepared and specific primers for the transferrin receptor gene, a 
PCR was performed to produce a 2.6Kb PCR fragment (Figure 3.5, lane 5).
Negative controls were done using in one reaction the specific primers for the 
gene GSP1 and NGSP1 without the addition of the UMP primer (Figure 3.5, line 3). 
The second control was prepared using UMP only without specific gene primers 
(Figure 3.5, line 4); these controls are meant to not generate any PCR product.
The cDNA prepared from the gut mRNA was used to prepare the 5’ RACE 
PCR reaction, after the primary PCR amplification, a smear product was obtained 
(Figure 3.5, line 1). A second 5’ RACE PCR reaction was prepared using as a 
template a 1/50 dilution of the primary PCR and a nested primer specific for the gene. 
Two distinctive PCR products were obtained, an 800bp band and an approx. 350bp 
band. The larger band matched with the sized expected. In the mouse Cdx2, the 1st 
exon extends over 538bp, whereas the 5’UTR is 267bp in length, this results in an 
805bp fragment. The larger band was purified and subcloned into pGEM vector and 
positive clones were sent to sequence.
The sequence obtained was translated into three different frames using the 
EMBOSS program. The sequencing result showed that the larger PCR product 
obtained by 5’RACE is effectively the frCdx2 gene. Unfortunately, the product 
obtained was a genomic fragment of the gene, which contains the region of the second 
exon where the GSP1 and NGSP1 specific primers were designed and a region that 
belongs to the first intron of the gene.
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Figure. 3.5. Agarose gel electrophoresis of 5’-RACE product. Total RNA from gut 
adult Fugu was used to prepare the first strand synthesis. Following the first 5’- 
RACE PCR amplification, which produced a smear like product (line 1). A 
nested PCR produced an 800bp approx. band (line 2). The negative controls 
were performed using the GSP1 and NGSP1 (line 3) and UMP only (line 4). 
External positive control was performed using the cDNA from human placental 
total RNA and specific primers for the transferrin receptor gene, which produced 
a 2.6Kb PCR fragment (line 5). The internal positive control was performed 
using the gut adult Fugu cDNA and specific primers for the Actin gene to 
produced a 480bp PCR fragment (line 6). Lanes M indicate the molecular mass 
markers. The sizes (in bp) of the molecular markers are indicated.
Based on the sequence obtained from the Fugu genome database and the 
comparative analysis using the mouse and human Cdx2, the frCdx2 second coding 
exon extends over 146bp; the 2nd intron located between the second and last exon is 
121 bp in length and the third exon is 222bp, 33bp shorter than the human exon.
Using the NIX program, the best open reading frame was located at 1136bp 
upstream of the second exon, the putative first coding exon, which has the same open 
reading frame as the mouse and human Cdx2. It extends over 67bp, the 1st putative 
intron extends over 1074bp in length (Figure 3.6).
A comparative analysis of the nucleotide sequence shows that the frCdx2 
second coding exon, which shares the same length as that of the human and mouse 
exon is 76.02% conserved (11 l/146bp) with the mouse and human second exon. The 
third exon is 52.70% conserved (117/222bp) among species. The first putative first 
exon is 40.29% conserved (27/67bp), using the Fugu sequence as base of comparison, 
although this has still to be verified. The frCdx2 homeobox is 67.77% conserved 
(122/180bp) with the mouse and human homeobox (Appendix section IB).
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Figure. 3.6. Comparison of the human mouse and Fugu Cdx2 gene. Filled boxes 
represent coding exons the length of each exon an intron is indicated. The 
splicing acceptor and the intron exon face are shown. The frCdx2 first exon is 
still to be confirmed
3.3.3.4 Gene structure of Fugu Cdx4
The human and mouse Cdx4 also preserves the characteristic gene structure of 
the Caudal genes. Three coding exons and two introns are located between each exon. 
The human first coding exon is 496bp and the mouse is 503bp. The 1st intron is the 
largest intron of the gene, although not as large as the first Cdxl intron. The human 1st 
intron extends over 5.953Kb whereas the mouse 1st intron extends over 5.761Kb. The 
second exon is 146bp in length for both human and mouse; the human 2nd intron is 
larger with 7.166Kb in length compare with the mouse, which is 1.279Kb in length. 
The third exon is 207bp in length in both human and mouse.
The Fugu Cdx4 gene extends over 2.473Kb in length; 3.26 times shorter that 
the mouse Cdx4 and 5.57 times shorter than the human CDX4. The gene contains 
three coding exons and two introns. The 5’ and 3’ UTRs of the frCdx4 have not been 
mapped yet. The first exon is 432bp in length; 64bp and 71 bp shorter than the mouse 
and human respectively. The 1st intron, the largest of the gene is 1.148Kb, however, is
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almost 5.3 times shorter than the mouse and human 1st intron. The second exon is 
146bp in length, the 2nd intron is located between the second and third exon, 
extending over 493bp in length. The last coding exon is 207 bp in length. The second 
and third exons are the same length compared to the human and mouse exons whereas 
the 2nd intron is almost 2.59 shorter than the mouse and 14.53 times shorter than the 
human 2nd intron (Figure 3.7).
Analyses of the nucleotide sequence of the frCdx4 exons of the gene shows 
that the first exon is 40.87% conserved (177/433bp) compared with mouse and 
human. The second exon is 60% conserved (106/146bp) among species and the third 
coding exon is 57.97% conserved (120/207bp) with the mouse and human third exon. 
The homeobox shows a very high conservation 77.77% (140/180bp); however the 





































Figure. 3.7. Comparison of the human mouse and Fugu Cdxl gene. Filled boxes 
represent coding exons the length of each exon an intron is indicated. The 
splicing acceptor and the intron exon face are shown.
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3.3.4 Expression analysis o f Fugu Cdx by RT-PCR
3.3.4.1 Expression of Fugu Cdxl
The second phase of expression of mouse and human Cdxl is restricted to 
embryonic and adult intestinal tissue. To examine the tissue distribution of Fugu 
Cdxl, an RT-PCR was performed using RNA extracted from various Fugu adult 
tissues. The RT-PCR showed that the Fugu Cdxl is restricted to the gut adult tissue; 
the other tested tissues, gonads, gills, kidney, spinal cord, spleen, eye and heart were 
shown to be negative in expression for the gene (Figure 3.8). Although the RT-PCR 
performed does not quantitate the amount of gene expression, the amount of product 
produced by the gut frCdxl compared with the amount of product produced by the 
Actin appears to be roughly equal, which may indicate that frCdxl is well expressed 
in the adult gut tissue in Fugu.
M 1 2 3 4 5 6 7 8 9
frCdxl 
Actin
Figure. 3.8. Fugu rubripes Cdxl mRNA in adult tissues. The Fugu Cdxl mRNA- 
specific primers amplified a PCR product from total RNA extracted from the 
gut(l), gonads(2), gill (3), kidney(4), spinal cord (5), spleen(6), eye(7) 
heart(8)and no template(9). A RT-PCR product corresponding to the 
constitutively expressed Actin gene was used as internal control.
3.3.4.2 Expression of Fugu Cdx2
The expression of mouse and human Cdx2 is restricted to the small intestine 
and colon in the adult organism. To investigate the expression of Cdx2 in Fugu, an 
RT-PCR was performed using RNA extracted from different Fugu adult tissues. 
Primers specific for the Actin gene were designed to check quantity and quality of the 
cDNA prepared. The RT-PCR showed that the frCdx2 is specifically expressed in the 
adult gut tissue in Fugu-, gonads, gill, kidney, spinal cord, spleen, eye and heart were
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negative for the frCdx2 expression (Figure 3.9). The RT-PCR also showed that the 
amount of product produced for the frCdx2 is less than the amount produced for the 
Actin gene. This may be an indication that the frCdx2 is not so highly expressed in the 
Fugu gut.
M 1 2 3 4 5 6 7 8  9
frCdx2 
Actin
Figure. 3.9. Fugu rubripes Cdx2 mRNA in adult tissues. The Fugu Cdx2 mRNA- 
specific primers amplified a PCR product from total RNA extracted from the 
gut(l), gonads(2), gill (3), kidney(4), spinal cord (5), spleen(6), eye(7) heart(8) 
and no template(9). A RT-PCR product corresponding to the constitutively 
expressed Actin gene was used as internal control.
3.3.4.3 Expression of Fugu Cdx4
The third Caudal gene, the Cdx4, is highly active during the early stages of 
development. However, no expression has been detected after 10.5dpc in mouse 
development. To investigate JrCdx4 expression in Fugu, an RT-PCR was carried out; 
RNA from different adult Fugu tissues was extracted and analysed for the expression 
of the frCdx4. The result showed that frCcbc4 is not expressed in any of the Fugu adult 
tissues tested (gut, gonads, kidney, spinal cord, spleen eye and heart). The product 
obtained for the Actin gene showed that the cDNAs prepared were of good quality 
(Figure 3.10). This result indicates that the frCdx4 is not expressed in the adult 
organism as with the mouse and human Cdx4.
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Figure. 3.10. Fugu rubripes Cdx4 mRNA in adult tissues. The Fugu Cdx4 mRNA- 
specific primers amplified a PCR product from total RNA extracted from the 
gut(l), gonads (2), kidney(3), spinal cord(4), spleen(5), eye(6), heart(7) and no 
template(8). A RT-PCR product corresponding to the constitutively expressed 
Actin gene was used as internal control.
3.3.5 Analysis o f the Fugu Cdx protein sequence
3.3.5.1 Amino Acid sequence of Fugu Cdxl
The human CDX1 protein is 265aa in length. The first exon codes for 152aa, 
the second and third ones codes for 51 and 62aa respectively. The mouse Cdxl 
protein is 268aa, three amino acids longer than the human CDX1; the first and second 
coding exons are conserved in length with the human. The difference is in the third 
coding exon, which codes for 65aa.
The frCdxl protein sequence was predicted using the genomic sequence of the 
gene and the predicted transcript of the gene. It extends over 225aa in length; it is 40 
and 43aa shorter than the human and mouse Cdxl respectively. The first exon 
encodes for 120aa, 32aa shorter than the mouse and human first coding exons. The 
second coding exon extends over 51aa, which is the same length for the mouse and 
human. The third coding exon is 54aa in length, 8aa shorter than the human and 1 laa 
shorter than the mouse third coding exons.
The protein sequence of the Fugu Cdxl shows an overall conservation of 
74.22% (167/225aa) with the human and mouse Cdxl, considering the identical aa. 
and the conserved substitutions. The first coding exon is 65.83% conserved 
(79/120aa). The second exon shows 96.07% conservation (49/5laa) and the third 
coding exon is 72.22% (39/54aa) conserved between the three species, when using the 
Fugu aa. sequence as a basis for comparison.
Analysis of the characteristic motifs of the Cdxl reflects a good level of 
conservation of the Cdxl across species. The homeodomain, the main domain of the 
protein, which represents almost V* of the complete protein, shows 96.66% (58/60aa) 
of conservation. The hexapeptide domain (Hex domain); which is characteristic of the 
Homebox proteins is 66.66% (4/6aa.) conserved in Fugu\ it is located 16 residues
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upstream of the homeobox, exactly in the same position as the human and mouse Hex 
domain. Although the conserved residues present in the Fugu Hex domain are not 
entirely identical, they are amino acids with similar characteristics to the mouse and 
human Hex domain (Figure 3.11).
Specific domains show a high degree of conservation; the N terminal arm, 
which marks the start of the homeodomain, is 100% (8/8aa) conserved; the 
phosphorylation sites SGK, TIRRK and TER are 100% conserved; in the second 
phosphorylation site in Fugu the isoleucine is substituted by a methionine (I->M), 
another conserved substitution is present in the TER domain where the threonine 
changed to serine (T-^S). The turn domain (3/3aa), and the phosphatase-binding site 
(4/4aa) are 100% conserved between the three species. The Fugu acetylation site, 
although with a 100% (6/6aa) conservation with the human and mouse, shows two 
substitutions in its sequence, the valine changed to methionine (V->M) and the 
second lysine to arginine (K->R), see figure 3.11.
3.3.5.2 Amino Acid sequence of Fugu Cdx2
Using the mouse and human Cdx2 amino acid sequence, the putative Fugu 
Cdx2 aa sequence was characterized by comparison. Firstly, human CDX2 is a 3 B aa 
sequence, 2aa longer than mouse Cdx2. The difference in those 2aa, arises because 
the human first and third exons are one aa longer than the mouse ones with 184 and 
78aa respectively. The second exon is the same length in mouse and human with 
5 laa.
The Fugu Cdx2 protein was predicted to extend over 146aa, almost two times 
shorter than the human and mouse Cdx2. However, it has 78.76% conservation 
(115/146aa) with mouse and human. The prediction for the first exon translates in to 
27aa, almost 7 times smaller than the human first exon. The second Fugu exon is 5 laa 
in length, the same length than the mouse and human second exon. The third exon is 
68aa in length, lOaa shorter than the human and 9aa shorter than mouse third exon 
(Figure 3.12).
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The first Fugu exon is 77.77% (21/27aa.) conserved with mouse and human, 
using the Fugu protein as a base sequence for comparison. However, as mentioned 
earlier this may not be the first exon or just a part of it. The second exon is 100% 
conserved (51/5laa.) and the third exon shows 63.23% conservation (43/68aa.) with 
the mouse and human third exon. The frCdx2 homeodomain shows a very high level 
of conservation, it is 100% conserved (60/60aa.) compared with mouse and human.
The specific motifs in the Cdx2 protein are also well conserved in the frCdx2. 
The N- terminal region is 100% conserved as well as the turn domain and the 
phosphatase-binding site. The putative phosphorylation sites of the protein, TIRRK 
and SER are also 100% conserved among species. The acetylation site is 100% 
conserved with the human; the mouse acetylation domain is one aa shorter. The 
glutamine region after the acetylation site seems to be reduced to only two aa in Fugu 
(Figure 3.12).
3.3.5.3 Amino Acid sequence of Fugu Cdx4
The Cdx4 aa sequence has been also fully characterized for mouse and human. 
Human CDX4, as for the human CDX2, is 2aa longer than the mouse Cdx4. The first 
human exon is 171aa, whereas the mouse first exon is only 169aa. The second and 
third exons are conserved in length between mouse and human with 51 and 62aa 
respectively.
Fugu Cdx4, the longest of the Fugu Cdx, extends over 267aa. It is 17aa 
shorter than the human and 15aa shorter than the mouse Cdx4. The first exon is 148aa 
in length, 23 and 2laa shorter than the mouse and human respectively. The second 
exon as all the Cdx genes is 5laa in length; the final exon is 68aa, interestingly 6aa. 
longer than the mouse and human third exon. Taking together the identical amino 
acids and the conserved substitutions, the frCdx4 has 76.77% conservation with the 
mouse and human. The first Fugu exon is 72.97% conserved (108/148aa), the second 
exons shows 98.03% conservation (50/5laa) and the third exon 69.11% conservation 
(47/68aa) among species (Figure 3.13).
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The homeodomain is encoded by the second and third exons, it is 98.33% 
conserved 59/60aa among species. The Hex motif is 12 residues upstream of the 
homeodomain. The Hex motif appears to be reduced to 5 residues in Fugu\ it is 
66.66% conserved (4/6aa). Conserved substitutions have taken place in the Fugu Hex 
motif. The tyrosine has been substituted to phenylalanine (Y->F), the alanine to 
glutamine (A->Q) and the arginine to aspargine (R->N).
Specific domains in the protein also show high conservation when compare to 
the human and mouse Cdx4; the phosphorylation sites TGK, TIRRK AND SER are 
100% conserved, the turn domain and the phospahtase binding site are also 100% 
conserved. The acetylation site shows 100% conservation with only one conserved 
substitution, the second methionine has changed to leucine (M->L), the rest of the 
motif remains adentical (Figure 3.13).
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Figure. 3.11. Clustal W alignment of Cdxl amino acid sequences
Alignment of motifs are shown: Phosphorylation site (purple box), Turn domain (green box), Phosphatase binding site (yellow box), N 
terminal arm (red box), hexapeptide domain (grey box), KIKX acetylation site (pink box) and Glutamine region (blue Q). The amino acid 
sequences were taken from Ensembl: Cdxl human ENSP00000231656, Cdxl mouse ENSMUSP00000025521
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Figure. 3.12. Clustal W alignment of Cdx2 amino acid sequences
Alignment of motifs are shown: Phosphorylation site (purple box), Turn domain (green box), Phosphatase binding site (yellow box), N 
terminal arm (red box), hexapeptide domain (grey box), KIKK acetylation site (pink box) and Glutamine region (blue Q). The amino acid 
sequences were taken from Ensembl: Cdx2 human ENSP00000298359, Cdx2 mouse ENSMUSP00000031650
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Figure. 3.13. Clustal W alignment o f Cdx4 amino acid sequences
Alignment of motifs are shown: Phosphorylation site (purple box), Turn domain (green box), Phosphatase binding site (yellow box), N terminal 
arm (red box), hexapeptide domain (grey box), KIKK acetylation site (pink box) and Glutamine region (blue Q). The amino acid sequences were 
taken from Ensembl: Cdx4 human ENSP00000253572, Cdx4 mouse ENSMUSP00000033689
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3.3.6 Discussion
The Fugu genome has been primarily used for the detection and 
characterisation of genes in higher organisms, and recently for the identification of 
conserved non-coding regions involved in the regulation of genes. In my search for 
the regulatory elements involved in the regulation of mCdxl, we used the pufferfish as 
a comparative model. The comparative analyses performed using bioinformatic 
approaches showed that the three Caudal genes are present in Fugu; linkage, gene 
structure and sequence were well conserved when compared to the mouse and human 
Cdx genes. Amino acid sequence comparison and expression of the genes were also 
found to be conserved across species
The Fugu Cdx genes were identified and categorised based on their linkage 
conservation. The frCdxl was identified by its linkage with the Pdgfrp and Csflr 
genes, located at the 5’ end of the gene. Early reports show a conserved linkage 
between these Fugu and human tyrosine kinase receptors, PDGFRP and CSF1L (How 
et al. 1996). However, this work did not describe the linkage between Pdgfrp and 
Cdxl and their conservation with human. Here we show the linkage conservation 
between the Fugu Cdxl and Pdgfrp. This conservation is also maintained in mouse 
and human as shown by the physical maps from the Ensembl database.
The Fugu Cdx2 was identified mainly by its linkage with the insulin promoter 
factor (Ipfl). Studies performed in Amphioxus showed that Cdx2 belongs to the 
Parahox genes, a cluster of genes originated by duplication that resemble the Hox 
genes and are expressed in an anterior posterior spatial co-linearity. The Parahox 
cluster is formed by Gshl, a gene expressed in the forebrain and midbrain; Ipfl (also 
known as Pdxl), expressed in the pancreatic (3 cells and in duodenum; and the Cdx2 
gene, expressed in the proximal colon with a gradual expression in the ileum and 
jejunum (Brooke et al. 1998). The JrCdx2 seems to have the 3’ end region conserved 
with the insulin precursor (IP) gene, which appears to be the Fugu homologue to the 
Ipfl gene. However, the IP gene is placed as the second proximal gene to the frCdx2; 
the ring finger protein 26 (RFP) is the most proximal 3’ gene to the frCdx2.
For the Fugu Cdx4, transcriptional organisation was conserved principally at 
the 3’ flanking region. The Chicl gene is conserved in mouse, human and Fugu as the
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nearest 3’ gene. Synteny seems to be lost in the 5’ end, not only between Fugu and 
mouse or human, but also between human and mouse.
The gene structure of the frCdx genes seems to be well conserved. Three 
coding exons (except for frCdx!) and two introns placed between each exons is the 
general structure of the Caudal genes. Nevertheless, the first exon was slightly 
shorter, at least in the case of the frCdxl and frCdx4\ this was reflected in the low 
nucleotide conservation of the exon. This is not the case for the second and third 
exons, especially for the second exon, where length and nucleotide sequence are 
better conserved. The length of the introns also showed the characteristic size 
reduction of the Fugu genes, although the 1st intron of the Cdx remains longer than the 
2nd intron. Like the human and mouse homeodomains, the Fugu homeodomains are 
coded by the second and third exons; in the three Fugu genes, they extend over 180bp 
and show a high degree of conservation with the mouse and human homologues.
Even though we were not able to obtain the first coding exon of the frCdx2, 
the 5’ RACE result showed that the designed GSP1 and NGSP1 primers were very 
specific for the JrCdx2 gene. Sequencing of the product showed that 120bp belong to 
the second exon, and that the 1st intron extends at least over 780bp. One of the key 
steps in the identification of the 5’end of the genes is to avoid and remove any 
genomic contamination. This is achieved by treating the RNA with DNAsel. Despite 
the fact that the samples were treated with DNAsel, a complete degradation of the 
genomic material was not achieved; this could have resulted in the use of genomic 
DNA as a template, instead of the cDNA.
The expression analyses of the Fugu Cdx genes showed that, as in human and 
mouse, the expression of these genes is restricted to the gut tissue in the adult 
pufferfish, in the case offrCdxl and JrCdx2. The absence offrCdx4 expression in the 
Fugu adult tissue also reflects the conservation of function with the mouse Cdx4, 
where no expression has been detected after 10.5dpc. Further experiments using Fugu 
RNA from different embryonic stages will indicate if the expression of the frCdx 
genes is also present in the early stages of development and if it is comparable to the 
expression of other organisms.
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Based on the coding sequence obtained, the amino acid sequence of the Fugu 
Cdx proteins showed a high degree of conservation among species. Especially, the 
specific domains of the protein are 100% conserved and the hexapeptide domain, 
which is a characteristic feature of all Cdx proteins, is conserved between each Fugu 
Cdx and its homologue. Furthermore, the Hex domain of the zebrafish Zcadl 
(SYQWMS), which has been described as the Cdxl homologue in zebrafish, seems 
more similar to the Fugu Cdx4 (FQWMN). The frCdx4 Hex is 83.33% conserved 
(5/6aa.) with the Zcadl Hex domain.
The frCdxl and frCdx4, which showed the same gene structure, seem to have 
a very short first exon that is translated into a shorter peptide, compared to the mouse 
and human Cdxl and Cdx4 proteins. The frCdx 1 and frCdx4 proteins appear to have 
lost the regions rich in proline residues, which are codified by the first exon of the 
gene.
Even though the frCdx2 shows a lack of the first peptide region, the start of 
the N- terminal region is conserved with the human and mouse Cdx2. The frCdx2 
homedomain is the most conserved of the Fugu Cdx with 100% sequence identity 
with the human and mouse Cdx2. The glutamine residues located after the acetylation 
domain, although reduced to two residues, are also conserved in the frCdx2.
Using comparative genomics and a set of bioinformatic tools, we have 
identified and characterized almost completely the Fugu Cdx genes from the Fugu 
genomics project database. We found that the three Cdx genes are present in the Fugu 
genome, that the physical linkage of the Cdx and neighbouring genes are conserved in 
Fugu, mouse and human, and that the structure of the frCdx genes and proteins as 
well as their expression are also conserved with human and mouse. A functional 
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4.1 Introduction
4.1.1 Early zebrafish development
The development of the zebrafish embryo, like other cyprinids, involves the
main processes present in mammalian development. The zebrafish undergoes seven 
main stages through its development- the zygote, cleavage, blastula, gastrula, 
segmentation, pharyngula and hatching. Contrary to mammalian development, 
zebrafish development occurs very quickly after the egg is fertilized; in 72hrs the 
embryo has almost completed its development. The new larva is able to swim, seek 
for food and adopt avoiding behaviours.
The zygote and cleavage periods occur in the first 2 hours after fertilization, 
where cell division and arrangement of blastomeres take place. The cleavage does not 
occur in the yolk region, the blastomeres are located above the yolk. The final 
cleavage results in the blastoderm, with a single outer layer of flattened cells and a 
inner layer of rounded cells (Wolpert et al. 2002) During the 2 to 43/4 hpf, the embryo 
is in the blastula period. The blastoderm expands to the vegetal pole to cover the yolk 
in a process known as epiboly. Gastrulation begins by 51/2hpf, during which the future 
endodermal and mesodermal cells involute or move interiorly at the margin of the 
blastoderm. These cells migrate towards the future dorsal side. The embryo begins to 
elongate in an anterior posterior direction (Wolpert et a l 2002).
During the 80% epiboly, which is between 8 and 9hpf, the dorsal side of the 
embryo becomes distinctly thicker, the brain rudiment begins to thicken and the 
notochord rudiment becomes distinguishable from the segmental plate.
By the 14 somite stage, the embryo is 0.9mm. The otic placode, brain 
neuromeres and trunk somites become visible, and the yolk extension is starting to 
form and elongate; the pronephric duct is not visible at this stage.
The hatching period of the zebrafish embryo occurs at 48hpf; by now the 
embryo is 3.1mm in length, the yolk extension begins to elongate, the melanophores 
begin to appear in the lateral stripe and the iridophores are present in the retina. Blood 
circulation is visible in the aortic arches and segmental vessels. The liver and the 
swim bladder appear along with the gut tract. The gut tract locates posterior to the 
pharynx in the region of the anterior yolk ball. At 39hpf, the hindgut endoderm is
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recognizable as a solid plug of midline cells in the anal region more than a hollow 
tube, which looks thicker than the adjacent pronephric ducts (Kimmel et a l 1995).
By day 3 the hatched larva has completed most of its morphogenesis, and it 
continues to grow rapidly. The mouth continues to open and elongate interiorly. By 
day 4, the swim bladder inflates. The gut tube moves more ventrally and the yolk 
extension nearly empties. The larva swims more actively, moves the jaws, opercular 
flaps, pectoral fins and eyes (Kimmel et a l 1995).
4.1.2 Intestinal development of the zebrafish
The main studies of the zebrafish intestinal formation come from Wallace and
Pack (2005) and Wallace et al. (2005). One of the main characteristics of the zebrafish 
is the absence of a stomach. The adult zebrafish intestine is a folded tube that 
occupies most of the abdominal cavity. An anterior-posterior axis is also 
distinguished, and can be subdivided into three segments: anterior, mid and posterior 
intestine. The anterior intestine, usually referred as the intestinal bulb, has a wider 
diameter than the posterior intestine and may function as a reservoir.
During zebrafish intestinal development, two stages can be distinguished. In 
the first stage, the intestine expands rapidly with maturation of polarized epithelial 
cells along with smooth muscle and enteric nerve cells. In the second stage, smooth 
muscle, enteric nervous and epithelial cells differentiate; morphogenesis of the folded 
epithelium also occurs.
In terms of intestinal morphology, the anterior zebrafish intestine has three of 
the four cell types present in the mammalian intestine; the columnar shape absorptive 
enterocytes are the most numerous, present in the anterior and mid intestine. These 
are followed by the goblet cells, which are present in all the intestinal regions. The 
enteroendocrine cells are present only in the anterior region of the intestine. The 
paneth cells have not been identified in any part of the zebrafish intestine (Wallace et 
al 2005).
The zebrafish intestine is joined to the anterior digestive tract by a short 
muscular oesophagus. Digestive enzymes such as the intestinal fatty acid protein (Her 
et a l 2004), are mainly expressed in the anterior region of the intestine. The mid 
intestine lacks enteroendocrine cells; nutrient absorption is possible in this region due
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to the presence of enterocytes and the expression of solute transporters and digestive 
enzymes (Wallace et a l 2005). The posterior region of the mid intestine is mainly 
composed of specialized enterocytes that may function in mucosal immunity; this 
region resembles the mammalian ileum. The posterior intestine starts just after the 
posterior mid intestine; it is a short region where the epithelial folds are short and 
longitudinally arrayed. Absorptive enterocytes are absent in this region, which makes 
it similar to the mammalian colon (Wallace and Pack 2003; Wallace et a l 2005).
Histological studies show that the adult zebrafish intestine is arranged in 
concentric layers with a lesser degree of complexity than the mammalian intestine. 
The zebrafish lacks the equivalent to the muscularis mucosa, a smooth muscle layer 
present in mammals. The enteric nervous system is less complex than in mammals. 
However, the blood vessels and the surrounding smooth muscle layers are almost 
identical to those in mammals (Wallace and Pack 2003).
Instead of the characteristic finger- like villi structure, the zebrafish intestinal 
epithelium is organized in broad irregular folds. The proliferative cells are located at 
the base of these folds; the crypt structures are not present in the zebrafish intestine, 
which resembles the mammalian embryonic intestine (Korinek et a l 1998). At the 
base of the epithelial folds there is a mix of differentiated cells and undifferentiated 
cells. However, it is still unknown if the undifferentiated cells contain multipotent 
characteristics.
4.1.3 Signalling pathways and factors involved in the posterior 
zebrafish development
Studies of disruption, overexpression and inhibition of genes in Xenopus,
mouse and zebrafish have brought to our knowledge the mechanisms and genes 
involved in the formation of the posterior end of the embryo. As in higher vertebrates, 
most of the signalling pathways and factors involved in the early processes of the 
posterior body are present in the zebrafish. Zebrafish tail development is established 
at the end of gastrulation, through a movement of cells from the ventral and dorsal 
margins to the vegetal pole (Kanki and Ho 1997).
The first findings about the interaction between FGF, Cdx and Hox genes and 
their importance in the formation of the posterior region of the embryo were in 
experiments performed in Xenopus (Pownall et al 1996). Inhibition of FGF in 
Xenopus and zebrafish disrupts the formation of the posterior body; the no tail (ntl)
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and spadetail (spt) genes which interact with the FGF pathway participate in the 
formation of the tail in zebrafish (Amaya et al 1993; Griffin et a l 1998).
The non-canonical Wnt pathway also participates in the extension movements 
during gastrulation in zebrafish and Xenopus (Veeman et a l 2003). The Wnt8 and 
Wnt3a signalling pathways participate in patterning during embryogenesis. Wnt8 is 
essential for mesoderm formation during zebrafish gastrulation (Kelly et al 1995). 
Inhibition of either Wnt8 or the Dickkopfl (Dkkl) gene reduces the formation of the 
tail (Lekven et al 2001). Loss of Wnt3a provokes reduction or complete absence of 
posterior structure and somites in mice (Ikeya and Takada 2001). The Wnt3a null or 
hypomorphic mutant (vestigial) mice show a reduction in Cdxl expression without 
affecting Cdx2 or Cdx4 expression (Ikeya and Takada 2001; Prinos et a l 2001). The 
Wnt3a and Wnt8, and Cdxl/Cdx4 morphant embryos also fail to promote 
somitogenesis during mid gastrulation.
The inhibition of Xcad3, which is the Xenopus orthologue of Cdx4, inhibits 
formation of the posterior body in the frog embryo (Isaacs et a l 1998); mutations in 
the Cdx4/kugelig genes reduce the formation of the posterior body in zebrafish 
(Davidson et a l 2003). Although Cdxl and Cdx4 mediate the Wnt-dependent axis 
formation, Cdxl and Cdx4 expression is dependent on FGF signalling. FGF signalling 
is required for Hoxa9a expression via Cdxl.
4.1.4 Cis- regulatory elements and transcription factors
The regulation and expression of genes is a well-regulated and complex
process. The instruction for regulation and control of this process is contained in the 
cis- regulatory modules, which direct the binding of specific transcription factors or 
signalling molecules to switch on or off the expression of specific genes. The cis- 
regulatory elements or modules are non-coding genomic DNA located either 
immediately upstream of the transcription start site of the genes or a few kilobases 
upstream of the genes; these elements can also be located in the intronic or 
downstream region of the genes that they control. A cis- regulatory element is 
constituted of multiple binding sites for transcription factors; these binding sites can 
be for specific transcription factors or for ubiquitous transcription factors that may be 
involved in DNA looping, or required to build the basal transcription complex 
(Amone et a l 1997). Each cis-regulatory element contains several binding sites for
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different transcription factors; however, two or more transcription factors must bind to 
the cis-regulatory sequence to activate or repress the gene (Davidson et al 2002).
Seipel et al. (1992) showed that the transcriptional function of the binding 
domain is dependent of the binding site location; if the binding site is placed in a 
proximal or distal position relative to the transcription start site, the transcription 
factor may be active or not, or may show different transcriptional levels. For instance, 
p65, NKkB or TFE3, which contain a negative charge domain, or the ITF factors, 
which contain a serine/threonine domain, are activators in distal and proximal 
promoters. On the other hand, AP2 and CTF/NF1 (proline domain) and Oct-1, Oct-2 
and Spl (glutamine domain) factors show mainly proximal promoter activity.
In the case of Cdx2, studies showed that the protein can bind consensus AT 
motifs in either proximal or distal regions (Suh et a l 1994; Troelsen et a l 1997; 
Colnot et a l 1998). The Cdxl factor also binds to the same consensus site as Cdx2, 
however, this binding might be restricted by other mechanisms and not only the 
binding site (Moucadel et a l 2001). Due to the similar binding site shared by Cdxl 
and Cdx2, different factors may be implicated in the interaction with Cdx to 
discriminate their specific targets (Moucadel et a l 2002).
4.1.5 Use of zebrafish in developmental biology
A strategy to test the functionality of the conserved non- coding sequences is
the use of a reporter gene expression system in an in vivo model. As proposed by 
Rothenberg (2001), in the search for regulatory regions, two main conditions have to 
be satisfied: first, the assertion that the essential regulatory sequences are actually 
present in the DNA to be tested, and second, the use of an expression system that 
allows us to follow the expression of the investigated genomic sequence.
Both conditions can be difficult to achieve because regulatory elements can be 
placed upstream or downstream or even in the intronic regions of the gene (Amone et 
al 1997), and also because mammalian models designed to look for genes expressed 
at different developmental stages are costly and slow.
Barton et al. (2001) suggested that by focusing on teleost fishes as sources for 
genes and assay systems, both of the above conditions can be reached. The zebrafish 
can provide a valuable model system for the study of gene regulation and 
development genetics.
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To search for the regulatory sequences that control the expression of the Cdxl 
gene, we returned to the use of comparative genomics. This chapter describes the use 
of Fugu rubripes as a model organism to search for the elements involved in the 
regulation of the Cdxl gene in mouse and Fugu. Putative cis-regulatory regions from 
both species were assayed in in vitro and in vivo systems to identify the transcription 
factors involved in the regulation of Cdxl.
4.2 M aterial and methods
4.2.1 Sequencing of the Mouse Cdxl upstream non- coding region
The sequencing of the Cdxl upstream regulatory region was carried out in two
sections. The first 5.7Kb, which corresponds to the intron/ exon junctions of the gene, 
was cloned into BSKS2+ vector using the Hind III sites (Figure 4.1). The sequence 
was provided by Dr Subramanian (unpublished data). For the distal region, a 5.2Kb 
fragment of the Cdxl upstream regulatory region was cloned into BSKS2+ vector 
using the Hind III sites (Appendix section 2B). The sequencing was performed from 
the 5’ end of the fragment. The primers were designed according to the new sequence 
obtained. The primers used were: Cdxl T7 (5’-aaggaaaagagtggctgat-3’), Cdxl TT7 
(5’-atgtagggcaatagtt-3’), 3T7 Cdxl (5’-ttctcttccactttc-3’), 4T7 Cdxl (5’- 
gtcatagaggagc-3’), 5T7 Cdxl (5’- aagacacagcgtaga-3’) and 6T7 Cdxl (5’- 
acagcaggtaagtcag-3’). The primer positions are shown in figure 4.1. The complete 
sequence of the distal promoter region is shown in the appendix section 2A.
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Figure. 4.1. Sequencing of the distal Cdxl upstream region. The 5.2Kb fragment 
cloned into BSKS2+ was sequenced from the 5’end of the insert. The black 
arrows show the position where the primers were designed and the name of 
the primer.
4.2.2 Cloning of the upstream sequence of the Fugu Cdxl
PCR primers were designed based on the upstream sequence of the Fugu Cdxl
gene. The oligonucleotide primers synthesized are: 4.0Kb FW frCdxl (5’-ggg get gga 
atg tgt tat etc taa-3’) to produce a 4.0Kb PCR product, 2.0Kb FW frCdxl (5’-aaa gcc 
ctg eta gca gta gtt agc-3’) to produce a 2.0Kb PCR product and 1.0Kb FW frCdxl (5’- 
tca ttg tga ctg atg tat egg tgc-3’) to generate a 1.0Kb PCR fagment. An EcoRI site was 
added to these three forward primers. To the reverse primer, RV frCdxl (5’-ttc ctg cgt 
cct ggt geg taa aat-3’) an Xhoi site was added. The Bac: b238N08 from the Fugu 
genomic Bac library (Elgar et a l 1999) was used as a template.
PCR was performed in a Perkin Elmer thermo- cycler. The reaction mix was 
as follows: 5jul buffer (10X), 3pl MgCE (50mM), lpl dNTPs (lOmM), primers 1 jllI 
each (10juM), 1 jliI DNA and 0 .5 j l x 1 ROCHE™ Taq polymerase (1.5 U/pl) and 37.5pl 
of H2O. Amplification was achieved with an initial denaturation at 94°C for 2mins, 
followed by 35 cycles of 20sec annealing at 60°C, 2min extending at 72°C (2min for
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the 1 and 2Kb fragments and 4mins for the 4Kb fragment) and lmin denaturing at 
95°C, then a final 5min extension at 72°C. The products of the reaction were checked 
by running a 2pl aliquot on a 1% agarose 0.5X TBE gel.
4.2.3 Transgene constructs of the Fugu Cdxl gene
All the PCR were run in a IX TAE agarose gel and the band excised and
electroeluted. This was then dissolved in 85pl of H2O, lOpl 10X buffer and 5pi 
restriction enzyme (5U) and incubated at 37°C for 2hrs. The digested DNA was then 
phenol/chloroform extracted and precipitated with ethanol. The fragment was then 
ligated into the EcoRI/XhoI site of BlueScript. Constructs were sequenced using the 
T7 and T3 primers.
The pCS2 CMV-GFP and pCS2 CMN-LacZ (Muller et a l 2002) were 
modified by excising the CMV promoter using the Sall/Hindlll sites. Sites were 
blunted by T4 polymerase (ROCHE) and the vector was religated.
Construct 4Kb frCdxl GFP was generated by subcloning the EcoRI/XhoI 
fragment in BlueScript into the EcoRI/XhoI site of the pCS2 GFP'CMV, Construct 2Kb 
frCdxl GFP was generated by subcloning the EcoRI/XhoI fragment in BlueScript into 
the EcoRI/XhoI site of the pCS2 GFP’CMV and Construct 1Kb frCdxl GFP was 
generated by subcloning the EcoRI/XhoI fragment in BlueScript into the EcoRI/XhoI 
site of the pCS2 GFP"CMV. Alternatively, the 1Kb and 2Kb fragments were subcloned 
using the BamHI/XhoI into the pCS2 CM\-L acZ  (Appendix section 2C).
4.2.4 Transgene constructs of the mouse Cdxl gene
A 8.9Kb fragment that corresponds to the upstream sequence of the mouse
Cdxl was cloned into pBSKS+2 (Stratagene) in to separate fragments, a 5.7Kb 
fragment that harbours the first -3.750Kb upstream sequence of the gene plus the first 
coding exon. The second fragment cloned into BSKS+2 was a 5.2Kb fragment that 
contains the -3.751Kb to -8.951Kb upstream sequence of the gene (Subramanian, 
unpublished data).
Reporter constructs were generated using the pTkLacZ vector that contains the 
herpes simplex thymidine kinase (Tk) minimal promoter, the bacterial LacZ gene and 
the SV40 polyadenylation site (obtained from V. Subramanian). The 5.2Kb 
mCdxlTkLacZ was constructed by subcloning the 5.2Kb fragment from BSKS2+; the 
5.2Kb fragment was released using Hindlll sites and end filling with T4 polymerase.
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The pTkLacZ vector was prepared using the Xbal site, which is located in front of the 
Tk promoter and end filling with T4 polymerase and blunt end ligation. Orientation of 
the insert was checked by sequencing.
The 2.1Kb mCdxlTkLacZ was constructed by subcloning a 2.1Kb fragment 
from the 5.7Kb BSKS2+; this 2.1Kb fragment (-3771 to -1671bp) was released using 
Hindlll/PvuII sites and end filling with T4 polymerase. The pTkLacZ vector was 
prepared using the Xbal site, end filling with T4 polymerase and blunt end ligation. 
Orientation of the insert was checked by sequencing. The 1.4Kb mCdxlTkZacZ was 
constructed following the same strategy, a 1.4Kb fragment from the 5.7Kb BSKS2+; 
was subcloned releasing the fragment using BamHI (-1112 to -2582bp), end filling 
with T4 polymerase. The pTkLacZ vector was prepared using the Xbal site, blunt end 
ligation and sequencing to check orientation.
The 1Kb mCdxlTkLacZ was constructed by producing a 1Kb PCR fragment 
(+79 to -921bp), primers: RPPlCdxl 5’-ata etc gag cat get gtt gcc tgg ege cg-3’ and 
RPlCdxl 5’-ata etc gag att gcc cac gta cat ggt ga-3’ (Fail safe PCR kit buffer I). The 
PCR were run in a IX TAE agarose gel and the band excised and electroeluted. The 
DNA was then phenol /chloroform extracted and precipitated with ethanol, end filling 
with T4 polymerase. The pTkLacZ vector was prepared by removing the Tk promoter 
using Hindlll, end filling with T4 polymerase, blunt end ligation and sequencing to 
check orientation and sequence (Appendix section 2B).
4.3 Results
4.3.1 Sequencing of the Mouse Cdxl upstream region.
The mouse Cdxl upstream sequence was subcloned and sequenced. The
joined sequence comprises 8.9Kb upstream of the gene, which is the actual distance to 
the neighbouring 5’ gene. The total upstream sequence was compared with the 
sequence provided from the mouse Ensembl database; it showed 98.99% identity. The 
obtained sequence was used for consequent comparative genomic analysis, e.g. to 
look for putative transcription factors binding sites (TFBS) and create reporter 
constructs to screen for cis-regulatory elements in the mCdxl gene.
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4.3.2 Conserved regions in the 5’ region of the Fugu Cdxl
The Fugu rubripes genome has been a useful model for comparative
genomics, not only in the search for new gene structures but also in the identification 
of conserved non-coding sequences with enhancer or regulatory value. As described 
in Chapter 3, the Fugu Cdxl non-coding sequences were extracted from the Fugu 
genome database mayffold MOO 1324. The upstream sequences of the mouse and 
human Cdxl were extracted from the Ensembl database. For the three species, the 
length of the upstream sequence used for the comparisons was 12Kb.
In the Fugu Cdxl, the upstream region between the frCdxl and the 
neighbouring frPdgfrfi is 11.946Kb (see Chapter 3). Because the 5’ UTR of the 
frPdgfrp has not been mapped yet, we used a comparative analysis approach to look 
for the fr  Pdgfrp 5’UTR. The mouse and human Pdgfrp 5’UTR were used as base 
sequences for the comparison. The position of the human 5’UTR was used to anchor 
the sequences. The Vista and Mlagan programs showed 57% level of conservation 
between the mouse and human Pdgfrp 5’UTRs. However, the programs failed to 
predict a conserved 5’UTR in the frpdgfrP gene. The alignment using the Fugu 
sequence also shows the absence of conserved non-coding regions upstream of the 
frCdxl gene (Figure 4.2).
PDGFRp
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Figure. 4.2. Vista plot of the Cdxl-PdgfrP upstream region. (A) A plot using the 
human upstream region as the base sequence for comparison with the mouse. 
The plot defines the conserved region corresponding to the Pdgfrp 5’UTR 
(blue colour) and the conserved non-coding regions (pink colour). The start of 
the Cdxl gene is at the left end of the plot, the Pdgfrp starts at the right end. 
(B) Vista plot using the FrCdxl region as base sequence for comparison, no 
conserved 5’ UTR and conserved non-coding sequences were identified by the 
Vista and Mlagan programs.
A second alignment of the upstream sequences of the Cdxl gene was done 
using the mouse and Fugu sequences to create one pairwise alignment, and the human 
and Fugu sequences to create a separate pairwise alignment. The Vista and Mlagan 
programs predicted small conserved non-coding sequences; each set of sequences 
were different in each plot. A default pairwise alignment (due to the high level of 
conservation between the two species) was done using the mouse and human 
sequences (Figure 4.3). We concluded that if the conserved non-coding regions 
predicted between mouse and Fugu and between human and Fugu are present in the 
pairwise alignment created by mouse and human, the former predicted sequences 
must be conserved among the three species. Each predicted element was linked to its 
homologue element to create a map of the conserved non-coding elements present in 
the Cdxl upstream region in mouse, human and Fugu (Figure 4.3).
A total of 15-conserved non-coding sequences were identified among the three 
species. All the predicted conserved regions are distributed evenly in the upstream 
regions of the genes without any special pattern or formation; the length of each 
element varies from 9 to 63bp (Table 4.1, Figure 4.3). However, the predicted 
conserved regions seem to be too small in length to be considered as conserved 
regulatory regions with putative regulatory characteristics. Most of the conserved 
non-coding regions with regulatory meaning have been identified between 500bp and 
several hundred base pairs long (Bejerano et al 2004; Woolfe et a l 2005). The 
homology in the sequences predicted could be created just by chance without any 
significant meaning.
Nevertheless, the two main features to be noticed in this alignment experiment 
are: firstly, in the mouse conserved elements, the most distal element predicted was at
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8.6Kb, relative to the translation start site. This means that no conserved regions were 
predicted further than 9Kb, which is the actual length of the mCcbcl upstream region. 
Secondly, the first Kb upstream of each gene showed a well-conserved set of non­
coding elements, located almost in the same positions (Figure 4.3).
Conserved
element Comparison
Position of the conserved element length (bp)F u gu mouse human
1 f/h 1953-1990 3396-3847 1793-1830 38
2 f/h 2432-2468 4899-5021 2338-2375 24
3 f/m 2287-2328 3293-3333 1249-1351 37
4 f/m 3660-3688 4774-4800 2237-2288 9
5 f/m 3820-3872 4929-4982 2351-2478 54
6 f/h 4819-4906 6201-6260 4218-4296 41
7 f/m 4917-4955 6122-6161 4125-4158 10
8 f/h 5193-5231 6373-6478 4509-4548 9
9 f/m 5998-6063 7353-7416 5984-6030 29
10 f/m 8424-8461 9365-9401 8297-8407 38
11 f/m 9459-9498 10135-10174 9529-9685 25
















Table 4.1. Conserved non-coding sequences identified by pairwise alignments. The 
table shows the 15 conserved sequences found in the different alignments, 
Fugu/human (f/h) and Fwgw/mouse (f7m), the position of each element in their 












Figure. 4.3. 5’ conserved non- coding regions in the mouse, human and Fugu Cdxl gene. Representation of the Cdxl upstream region in human, 
mouse and Fugu. 12Kb of genomic non-coding sequence of each gene was used in the alignment, the red bars represent each conserved 
non-coding region which is linked to its homologue region. The position of the first conserved element relative to the translation start site 
is indicated in each species.
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4.3.3 Promoter comparison for the Cdxl gene
On the basis of the results obtained with the global alignments, and the high
level of conservation present in the first Kb upstream of each Cdxl gene, 1Kb 
upstream of each sequence {Fugu, mouse and human Cdxl gene) was extracted from 
their respective databases; transcription factor binding site elements characteristic for 
promoters were predicted using the Possum program, (http://zlab.bu.edu/ 
-mfrith/possum/), each sequence was screen for TATA boxes, Spl sites (sites rich in 
GC sequences) and CCAAT boxes.
The prediction of the program shows that the 1Kb upstream sequence of the 
Fugu Cdxl contains one TATA box located at -131 bp relative to the translation start 
site (TSS) and two Spl sites at -443 and -816pb relative to the TSS. Using the Mat 
inspector program (Quandt et al 1995) three Tcf/LEF binding sites were predicted for 
the sequence, one at -774bp, the second at -356bp and the third one at -39bp. The 
third Tcf/LEF site lies in the 5’UTR of the gene. No predictions for RARE or RXR 
were predicted for the frCdxl (Table 4.2, Figure 4.4).
For the mouse Cdxl 1Kb upstream sequence, three TATA boxes were 
predicted at -121, -167, and -236bp relative to the TSS position. Three Spl sites were 
predicted at positions -344, -420 and -456bp and one CCAAT box in position -674bp 
relative to the TSS (Table 4.2, Figure 4.5).
According to (Lickert and Kemler 2002), the 0.7Kb upstream of the mouse 
Cdxl gene is enough to drive the expression in the early mouse embryo. The authors 
postulate that the 0.7Kb fragment harbours two Tcf/LEF and an atypical RARE 
binding site, which are involved in the regulation of the gene
We used the Matlnspector program (Quandt et a l 1995) to look for any 
Tcf/LEF or RARE binding sites in the 1Kb mouse upstream sequence. One RXR site 
(which is not a RARE site) was predicted at -83bp, which is just before the start of 
the transcription start site. Two Tcf/LEF binding sites were predicted, the first at -  
167bp, this site overlaps with a TATA box predicted form the Possum program; the 
second 7c/7LEF site is located at -202pb from the TSS (Table 4.2, Figure 4.5).
The 1Kb upstream sequence of the human Cdxl showed the presence of three 
TATA boxes at positions -125, -169 and -235bp relative to the TSS and two Spl sites 
at positions -156 and -567bp. Using the Mat inspector program (Quandt et a l 1995)
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two Tcf/LEF binding sites were predicted at -199bp and -166bp from the TSS, the 
second Tcf/LEF site overlaps with the second TATA box predicted by the Possum 
program. One RXR binding site was predicted at -81bp, which lies just at the 
beginning of the 5’UTR (Table 4.2, Figure 4.6).











Human -125,-169,-235bp NP -156, -567bp -81 bp
-199,
-166bp
Table 4.2. Analysis of the 1Kb upstream sequence of the mouse, human and Fugu
Cdxl gene, the sequence was analysed for the presence of conserved TFBS.
The table summarizes the position of each binding site in the sequences. NP:
No predicted site.
Using the THEATRE program (Edwards et a l 2003) one TATA box was 
presented in the three sequences after alignment, in Fugu at -136bp, in mouse at -  
126bp and in human -123bp. These predictions match with the predictions from the 
Possum program, suggesting that the first TATA boxes present in the sequence may 
be essential for the minimal promoter of the Cdxl gene across the species
The analysis of the 1Kb upstream of the Cdxl gene showed conserved 
transcription factor binding sites between human, mouse and Fugu. The Fugu 1Kb 
region showed three Tcf/LEF binding sites, two Spl binding sites and a TATA box; 
no CCAAT is present in the frCdxl. The human and mouse 1Kb Cdxl region showed 
almost the same conservation of binding sites and positions except that the human 
does not contain a CCAAT box. The two human Spl sites are located almost in the 
same position to the Fugu Spl sites. The Figures 4, 5, and 6 show the actual 
sequences with the predicted transcription factors binding sites and the position of 
each one relative to the translation start site.
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A A ACCGTTT AT AATTTATGCGG ACAAGTTTGC ATGAC A AGTTTCCG ATCTG  
GTTCAGCTGTCAATCGTTGGCATTATTCTGCCCCCCTGTGGTCAATCTGGG  
A AATG ACACG GACGAAACAAAGG CAACTTTACTTGAACATTTATCAGTCA  
TATATTTACCAATGACACATTATAGAAATTAGATATTCACAGAATAAGAA  
AATGTTTCTTTATTTAGCACTCAGTGTTGTCTCTCTACATCGTCACAAAGCT  
GT A A  AAGC ATTC A A A AT A AT ACT A A  AATTG AT AATA A ATG AT GGTTAAC A 
A A A ACTCT A AT A AT A
CTCGGATGCATTTTGCAGTTGTTTGAATAAATCAAATTTGGCCATTTCAAT  
GC AGCGTCGTT A A AC AG AAG AG AGG AG AAGTG AAATCTTTTC A AT ATT AA  
TG TGG TAAAAGTAAATG CTTCCGATATl CGAGGTGGGATTTATGACTTGC  
ATGTTGCT ATCAATAAT ATT AATCTTTC ATGTTT AGTGT ATCTGTCTACATT  





A ACTCCTCGGCAGT A AATCT AT AA AGGTGTGTAAAGTCTCCCTGCACAGG  
g a a t c t g a a c c t t a g a c t g g a g t g a g c a g c g g G A A T G C T G G G A G A C C  
T G AC AT GAT CC C A G C TC TI I G A TTTTTG TCCAGTGT C AC ATTTT 
ACGCACCAGGACGCAGGAAAATG
Figure. 4.4. 1Kb upstream of the Fugu Cdxl. The underlined sequence shows the 
5’UTR of the gene; sequence in red colour show the TATA box and the 
sequence in green colour represent the Spl sites predicted for the Possum 
program. The sequence in brown shows the Tcf/LEF binding sites, the first 
Tcf/LEF site overlaps with the 5’UTR of the sequence. These binding sites 
were predicted using the Matlnspector program
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>mmprom
ACT CGGGCT G ATGT GT GT AGGGGT A AA ACG AC AT G A AGCCT GG A ATTT GT
TTTT AAATT GTT CCG A A AAT GCTTT AGG A A AA A A AAC AAAAGGC AGT AG A
TTT AAAA AAAAAAAAAAAAAAAAAAG AGGT G AC AG A AACCCG AT A AGT A
ATGGAAGCTGCAAGGTAGGTACACAATGCAACTCGGTGTATATGTATGTT
TG AAAC ATTTC AGC AATG AT AAT GT CaAGGT AAT ACGC AT CaA AAGTTT GT
G AAGTTT CCC AAGGTGTCCCC AG AAACCCCCCT GGT CC AC ACCTTT GAGA
ATTT CT CT GGGG AGCC AAT AAGAG AAAC AGT AGCTT GC AG ACT GGCT AT
CT GC AT AT GC AC AT C ACC AT AGCTTT CAT CT GGG ACCCG AAgGGT CGT G AC













Figure. 4.5. 1Kb upstream of the Mouse Cdxl. The underlined sequence shows the 
5’UTR of the gene; sequences in red colour show the TATA boxes, the 
sequences in green colour represent the Spl sites and the sequence in blue 
colour the CCAAT box predicted for the Possum program. The sequence in 
brown shows one of the Tcf/LEF sites, the second Tcf/LEF site overlaps the 
first TATA box in the sequence. The sequence in dark green shows the RXR 
binding site predicted by the Matlnspector program.
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>hsprom
A C T T C A G A A A A G C G G G G A G T A G G T G A A A T A A G T G T G A C A A A A C C T T A A T
A G T T G T T G A A G C G G G G T G A T G G G T A C A C A G C A G T T C A T T A T A C A A T T C T A
C T T T T G T G T A T G C T T G A A A C C T C T C A A T T A A A A A A A G A G G G T A G A G A G T C
A T C A A G A T A A T T T A C T A A A A G T T T C C T G T A A T G T C C C C A G A A G A C C C C C C T
A A C T C A C A C A C A C A C A C A C C C A C A C A C A C A C T G C C T T T T G A G A A C T T T C T C
T A G A A G G C C A A C C C A G G C A G T C C C C C A A C T G T A A G G A A G A C T C G T G T A T G
T A T G T G C A T A T G T G C A T T T C C C C A G G G A A A A A C A T C C A C A G C T T C C A T G A
C G A G A G G G G T C G T G A C C C C T C C C C G C C A A A A G A T T A A G G A C C T G C G A T C C
T A C A G A C C G G A G C C C T G T T TG A A G T C TG C G TT G C C C C T C A C C TC A A G C T G G
T C A C T G T G T G A A G T T G G C C T A G A A T C C C C C G G C C C C G C T G A A G T A T G T A G
G G G T A A A A T G A C A T G A T G T C T G G A A T T T G T T T T A A A A T T G G G A G C T T G T T C
C T C C G C C T G T A A A A T G G G G C T G C A G G G C C G T C C A C G C G G C C A C C G G A A G G
A C A A G G T G T T C A G G C C G C T A G G C C G C T C C C T G G C A A G C G A T T C C C A C T C G
C A G C G C G G C C T C G A C C C T C G C C C A A G A C G C G C C C T C C G C G C C C C C A C C C C
C TC C A G G C C C T G G C C A G T C C A C C TC C C G C T TG G G G C G G C A A T T TG T C T C C T
TTT G A A C C C C C C G C C C C C G A C G G G T TTC C C C C T T TG A T T C G C G G C C C G G A G
G C T TC C C C C C G C T T T G A A A T G C A A AC CC G C C TC G G C TG G G G C C G C G G G C G




Figure. 4.6. 1Kb upstream of the Human Cdxl. The underlined sequence shows the 
5’UTR of the gene; sequences in red colour show the TATA boxes and the 
sequences in green colour represent the Spl sites predicted for the Possum 
program. The sequence in brown shows one of the Tcf/LEF sites, the second 
Tcf1LEF site overlaps the second TATA box in the sequence. The sequence in 
dark green shows the RXR binding site predicted by the Matlnspector 
program.
4.3.4 Conserved transcription factors in the upstream region of the 
Cdxl gene
Based in the global pairwise alignments and the analysis of the proximal 1Kb 
region, conserved transcription factors binding sites were predicted using the 
Matlnspector and TESS programs for each of the upstream sequences. Due to the high 
number of transcription factor binding sites predicted for each sequence, we 
eliminated those transcription factors that we considered not to be important in the 
regulation of the Cdxl gene. Based on the literature, those transcription factors, which 
are expressed in the intestine, epithelial cells or during early development, were kept.
Each individual transcription factor or cluster of transcription factors was 
located in the upstream element cloned in to the GFP or LacZ expression vector. For
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the mouse Cdxl constructs, the 5.2Kb fragment contains binding sites for Pax, RXR 
and RAR factors which are expressed in intestinal tissue as well as being involved in 
vertebral patterning. Tcf/Lef complexes and Cdx binding sites are also present in this 
element; A STAT complex binding site was predicted, the STAT factor has been 
involved in chromatin remodelling (Table 4.3).
The 2.1 and 1.4Kb elements harbour RAR and Est binding sites, these factors 
are involved in vertebral patterning and brain development. The 1Kb upstream 
element, besides the transcription factors already described above, was predicted with 
HNF, GATA and Oct binding sites, which are widespread factors (Table 4.3).
The final consensus binding sites predicted for the Fugu elements show a very 
similar repertoire of TFBS compared with the mouse elements. The 1 and 2Kb 
elements contain GATA, HNF, Cdx and Oct binding sites, all these factors are know 
to be expressed in intestinal tissue. The 4Kb element has RXR, RORA and Pax 
binding sites, which are very similar to the binding sites present in the 5.2Kb mouse 
element (Table 4.3).
The final consensus binding sites present in each construct are summarized in 
table 4.3. The figures 4.7 and 4.8 show the mCdxl LacZ and frCdxl LacZ constructs 
and the position of the fragment in the 5’upstream region of the mouse and Fugu 
Cdxl. The conserved non-coding regions are also shown; however, as mentioned 
earlier these regions were not considered for the TFBS analysis.
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1 . . .  " 1
1.0 Kb LacZ
Figure. 4.7. Cis- regulatory elements in mCdxlLacZ reporter constructs. Orange lines 
show the upstream fragments fused to the reporter vector, dotted lines show 
where the cis- elements lie in the upstream sequence and the distance between 






Figure. 4.8. Cis- regulatory elements offrC dxl LacZ reporter constructs. Orange lines 
show the fragments fused to the reporter vector, dotted lines show where the 
cis- elements lie in the upstream sequence and the distance between the 
translation start site and the element.
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c o n s t r u c t T F  c o m p l e x T F  n a m e T F  e x p r e s s i o n
c E S T / G A T A
G A T A / T C F - L E F / P a x 1 P a x 1  e x p r e s s e d  i n  d e v e l o p i n q  v e r t e b r a l  c o l u m n
F o x A / O C T 1 / T h i n g 1 F o x A ,  F o r k  h e a d  d o m a i n  f a c t o r  s i m i l a r  t o  H N F T h i n g  1  e x p r e s s e d  i n  a  v a r i e t y  o f  e m b r y o n i c  t i s s u e s
S T A T / S T A T
s i g n a l  t r a n s d u c e r  a n d  a c t i v a t o r  o f  t r a n s c r i p t i o n  
f r o m  t h e  C / E B P  f a m i l y
a c t i v a t o r  f a c t o r ,  i n v o l v e d  i n  c h r o m a t i n  r e m o d e l l i n g
G A T A / P D X 1 P d x 1 , p a n c r e a t i c  h o m e o d o m a i n  f a c t o r e x p r e s s e d  i n  t h e  i n t e s t i n e
c E S T / R O R A a / H N F 4 / G
A T A / F O X L 1
R O R A ,  n u r  s u b f a m i l y  o f  n u c l e a r  r e c e p t o r s e x p r e s s e d  i n  t h e  i n t e s t i n e
F O X L 1 ,  s i m i l a r  t o  H N F
O C T 1 / A P / T h i n g 1 A P ,  a c t i v a t o r  p o r t e i n
R O R A / T 3 R a T 3 R ,  t h y r o i d  h o r m o n e  r e c e p t o r
w - f c i ' D  i K L t f C Z  rncuxi
R A R / C A A T R A R ,  r e t i n o i c  a c i d  r e c e p t o r
v e r t e b r a l  p a t t e r n i n g ,  d i f f e r e n t i a t i o n  a n d  g r o w t h  o f  
e p i t h e l i a l  c e l l s
T A T A / C D X 2 T A T A ,  b a s i c  b i n d i n g  s i t e  f o r  m i n i m a l  p r o m o t o r s C D X  f a m i l y  e x p r e s s e d  i n  t h e  i n t e s t i n e
T C F / L E F
F O X D ,  s i m i l a r  t o  H N F 4
F O X D 1 / R X R
R X R ,  r e t i n o i c  X  r e c e p t o r
d i f f e r e n t i a t i o n ,  g r o w t h  a n d  h o m e o s t a s i s  o f  
e p i t h e l i a l  c e l l s  i n  v a r i o u s  t i s s u e s
R X R / R X R / A P A P ,  a c t i v a t o r  p o r t e i n
T C F - L E F / G A T A T C F ,  t r a n s - a c t i n g  T - c e l l  f a c t o r
T C F - L E F / T A T A / C D X 2
R A R a R A R ,  r e t i n o i c  a c i d  r e c e p t o r v e r t e b r a l  p a t t e r n i n g
2 . 1 K b  TkLacZ m Cdxl &
T C F - L E F / C C A A T :
C C A A T
C C A A T ,  e n h a n c e r  b i n d i n g  p r o t e i n  b e t a
E R e s t r o q e n  r e c e p t o r
7 . * f r \ u  1 KLaCz. fT K s u X  7
C E S T / G A T A E S T ,  l y m p h o i d  d i f f e r e n t i a t i o n  f a c t o r
E s t 1  &  E s t 2  e x p r e s s e d  i n  d e v e l o p i n g  b r a i n ,  g u t  
a n d  s k i n ,  i n v o l v e d  i n  p r o l i f f e r a t i o n  a n d  
d i f f e r e n t i a t i o n
E R E / T C F 1 1 / A P 1 E R E ,  e s t r o g e n  r e s p o n s e  e l e m e n t
1 . 0 K b  LacZ m Cdxl
H N F 3 / H N F 4 / G A T A H N F ,  h e p a t i c  n u c l e a r  f a c t o r
e x p r e s s e d  i n  e p i t h e l i a l  c e l l s  a n d  e n d o d e r m  a n d  
m e s o d e r m  d e r i v i e d  o r q a n s
G A T A G A T A ,  w i d e s p r e a d  e x p r e s s i o n
F O X F 2 / O C T 1  / O C T 1
T C F / L E F L E F ,  l y m p h o c y t e  f a c t o r
f o r m s  a  c o m p l e x  w i t h  p - c a t e n i n ,  e x p r e s s e d  i n  
i n t e s t i n e
H N F 4 e x p r e s s e d  i n  t h e  i n t e s t i n e
L E F 1 / R X R / H N F 4
T A T A / C D X 2 T A T A  b o x ,  C a u d a l  f a c t o r
P a x 3 p a i r e d  d o m a i n  p r o t e i n e x p r e s s e d  d u r i n q  e m b r y o q e n e s i s
O C T 1 / F O X C 1
1 . 0 K b  LacZ frCdxl  &  
2 . 0 K b  LacZ frCdxl T C F 1 1 / T C F - L E F
i n v o l v e d  i n  t h e  W n t  s i g n a l  t r a n s d u c t i o n  p a t h w a y
G A T A / H N F 1 / F O X A 2 /
C C A A T
G A T A / H N F  c o m p l e x  e x p r e s s e d  i n  t h e  i n t e s t i n e
G A T A / P D X 1
C D X C a u d a l  f a c t o r e x p r e s s e d  i n  e a r l y  d e v e l o p m e n t  a n d  i n t e s t i n e
C R E B c A M P - r e s p o n s e  e l e m e n t  b i n d i n q  p r o t e i n
G A T A / O C T 1
O C T 1 / O C T 1 / O C T 1 T F  f r o m  t h e  P O U  d o m a i n  f a m i l y n e u r a l  f a t e  s p e c i f i c a t i o n
R X R
R X R / A p 1 A p 1 ,  a c t i v a t o r  p r o t e i n
P a x 1 e x p r e s s e d  i n  t h e  d e v e l o p i n q  v e r t e b r a l  c o l u m n
4 . 0 K b  LacZ frCdxl P a x 3
e x p r e s s e d  d u r i n g  e m b r y o q e n e s i s
P d x 1 p a n c r e a t i c  a n d  i n t e s t i n a l  h o m e o d o m a i n  f a c t o r
C d x / R O R A R O R A , n u r  s u b f a m i l y  o f  n u c l e a r  r e c e p t o r s R O R A  e x p r e s s e d  i n  t h e  i n t e s t i n e
S p 1 s t i m u l a t i n g  p r o t e i n w i d e s p r e a d  e x p r e s s i o n
C D X / T A T A / H N F 1 / O c t 1
Table 4.3. Representative transcription factors binding sites contained in each of the 
expression constructs for the mouse and Fugu Cdxl. Individual or complexes 
of transcription factors are shown with the place where they have found to be 
expressed (Gaub et al. 1990; Tranche and Yaniv 1992; Kane et al. 1995; 
Lopez-Rodriguez et al. 1997; Singh et al. 1997; Dussault et al. 1998; Emami 
et al. 1998; Larsson et al. 1998; Lee et al. 1999; Allan et al. 2001; Smits et al.
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2001; Consales and Amone 2002; Flock and Drucker 2002; Jacobsen et al
2002; van Heel et al 2002; Almeida et a l 2003; Afouda et al 2005; Moore-
Scott and Manley 2005).
4.3.5 Reporter assays in CaCo2 cells
To investigate which are the regulatory regions involved in the regulation of
the Cdxl gene, reporter assays were performed in Caco2 cells. Transfection of the 
reporter constucts shows that the mCdxl LacZ 5.2Kb element, which is situated in the 
distant end of the 5’ upstream region, presents a 42.6 fold induction when compared 
to the pLacZ vector. The 2.1Kb and the immediate 1Kb element were also able to 
drive the expression of the reporter with 31.5 and 3.6 fold induction respectively. The 
1.4Kb element did not show induction of the reporter. The Fugu Cdxl LacZ 
constructs were also able to drive the expression of the reporter in CaCo2 cells. The 
1Kb upstream of the gene showed 37.3 fold induction, and the 2Kb element 3.8 fold 
induction when compare to the basal activity of the pLacZ vector (Figure 4.9).
The results of the transfection assays indicate that the mouse and Fugu 
upstream regions contain regulatory elements able to drive the expression of the 
reporter in intestinal cells. The 5.2Kb element of the mouse Cdxl, which is located in 
the distal region of the gene, drives the expression of the reporter as high as the 
positive control (pNLSLacZ), which is the highest expression of all the mouse 
constructs, indicating that this region is possibly an intestinal enhancer of the Cdxl 
gene.
The 2.1 and 1.4Kb are two elements that overlap in the upstream region of the 
gene (see Figure 4.7), the 2.1Kb element is able to drive the expression of the reporter 
with a very decent induction; this is not the case for the 1.4Kb element, which shows 
a null induction of the reporter, suggesting the presence of a repressor element in the 
overlapping region or in the complete 1.4Kb region. The 1Kb upstream of the mouse 
Cdxl is also able to induce the expression of the reporter; this element is one of the 
most conserved in terms of non-coding regions and transcription factors with the 
Fugu and human Cdxl, suggesting that the basic machinery to induce the expression 
of the gene is contained in this region in the three species.
The transfection result also shows expression of the frCdxl-LacZ constructs in 
CaCo2 cells. In contrast with the 1Kb mouse element, the Fugu 1Kb upstream region
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shows very high induction of the reporter, indicating that not only the minimal 
promoter is contained in this element but also some elements which enhance the 
expression of the gene. The 2Kb Fugu element that extends from the TSS is able to 
drive the expression of the reporter but not as high as the 1Kb element, suggesting the 
presence of a repressor in the second Kb of this region.
50
Figure. 4.9. Activation of the mouse and Fugu Cdxl upstream regions. CaCo2 cells 
were transfected with mCdx-LacZ and frCdxl-LacZ constructs, pNLsLacZ 
was used as a positive control and pBSKS2+ (pBS) as a negative control for 
transfection. Each bar represents the average fold of induction of normalized 
values ± range bars of triplicate points of 2 experiments.
4.3.6 Analysis of the frCdxl cis-regulatory elements in the 
developing zebrafish embryo
To test if the upstream region of the Fugu Cdxl gene is sufficient to control 
the expression of the gene in early and late stages of development, three GFP 
expression constructs containing different frCdxl non- coding sequence lengths were 
constructed. Expression constructs were injected into the 1-2 cell-stage embryo. 
Embryos were analysed at 5, 24 and 48hrs post- injection (hpi) for GFP expression.
The Fugu Cdxl expression constructs were injected at three different 
concentrations, 15, 25 and 50ng/pl. The 15 and 25ng/pl concentrations showed a 
similar percentage of GFP expression for the three constructs. The 50ng/pl
106
Chapter Four.Cis- regulatory elements in mouse and Fugu Cdxl J.L. Judrez-Morales 2005
concentration produced a high level of mortality to the injected embryos. The few 
survivors showed severe malformations after the gastrulation stage (Table 4.4).
construct concentration GFP exp/ #embryos injected80% epiboly tissue expression 14 som ites 2 dpf 4 dpf
tail bud 12 9 4
4KbfrCdx1 25ng/pl 60/96 distributed exp 16 13 7SC/NC 0 0 0
total 65 61 61
tail bud 4 2 2
4KbfrCdx1 15ng/pl 34/60 distributed exp 5 0 0
SC/NC 0 0 0
total 26 24 24
tail bud 7 0 0
2KbfrCdx1 25ng/|jJ 41/45 distributed exp 12 9 6SC/NC 0 0 0
total 27 27 27
tail bud 8 2 2
2KbfrCdx1 15ng/jJ 28/43 distributed exp 8 11 9
SC/NC 0 0 0
total 31 20 18
tail bud 10 10 6
1 KbfrCdxl 25ng/pl 64/70 distributed exp 15 7 7SC/NC 0 0 0
total 50 48 32
tail bud 9 8 7
1 KbfrCdxl 15ng/pl 26/48 distributed exp 12 15 14
SC/NC 0 0 0
total 45 40 36
2KbfirCdx1 50ng/jJ Most of the embryos were dead by 80% eoiboly. The survivors embryos showed malformations
1 KbfrCdxl 50ng/jjj Most of the embryos malformations
were dead by 80% eoiboly. The survivors embryos showed
Table 4.4. Expression of the frCdxl-GFP reporter constructs in to the zebrafish 
embryo. Embryos were screened for GFP expression at 80% epiboly, 14 
somite stage, 2 and 4dpf. Expression was observed in tail bud and distributed 
expression along the embryo. The spinalcord (SC) and notochord (NC) did not 
show GFP expression.
A GFP reporter construct carrying the frCdxl upstream from position -4000 to 
+81 bp relative to the transcription start site was designed to look for the regulatory 
elements involved in the regulation of the gene. Expression of the transgene was
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observed at 80% epiboly; 64.4% of the injected embryos showed expression at this 
stage. At the 14 somite stage, 16 out of 91 embryos showed GFP expression in the tail 
bud region. By 2 and 4dpf, the number of embryos expressing the transgene in this 
region decreased to 11 and 6 embryos respectively. A distributed expression was 
detected at the 14 somite stage, 21/91 embryos showed this expression. By 2dpf 13/85 
embryos retained this pattern of expression and by 4dpf, only 7/85 embryos showed 
expression. This distributed expression was mostly present in muscle cells, 
mesodermal cells and neural crest cells. No expression was detected in the spinal cord 
(SC) or notochord (NC) in any of the three stages screened (Table 4.4).
A second frCdxl'. GFP construct containing -2000 to +81 bp relative to the 
transcription start site was generated to look for regulatory regions. Injection of this 
construct into the zebrafish embryo produced the same pattern of GFP expression 
obtained with the 4KbfrCdxl: GFP construct; 78.4% of the embryos (69/88) of the 
embryos expressed the reporter at 80% epiboly; 25.86% of the GFP expressing cells 
were located in the tail bud region at 14 somite stage. By 2 and 4dpf, only two 
embryos remained with this pattern of expression. A similar GFP distribution pattern 
was observed with this construct, 34.5% of the embryos (20/58) showed expression at 
14 somite stage. By 2dpf, 42.5% of the embryos (20/47) remained with this 
expression and by 4dpf, 33.3% of the embryos (15/45) maintained the same 
expression pattern. No GFP expression on the notochord (NC) and spinal cord (SC) 
was detected at any stage with the TKbfrCdxl: GFP construct (Table 4.4).
A smaller frCdxl'. GFP construct expanding from -1000 to +81 bp relative to 
the transcription start site was constructed to investigate whether the cis-regulatory 
elements and the promoter are contained in the first Kb proximal to the gene. 
Transient zebrafish embryos expressing the \KbfrCdxl: GFP construct resembled the 
same pattern of expression obtained with the two anterior constructs. Expression of 
the reporter was first observed at 80% epiboly stage, 76.3% of the embryos (90/118) 
showed GFP expressing cells. By the 14 somite stage, 20% of the embryos (19/95) 
showed GFP expression in the tail bud region. At the same stage, 28.4% (27/95) 
showed a distributed GFP expression. By 2dpf, 20.4% of the embryos (18/88) 
retained the expression in the tail bud region and 25% (22/88) retained the same 
distributed expression. Expression of the transgene was still present at 4dpf, 19.1% of 
the embryos (13/68) kept the tail bud region expression and 30.8% (21/68) of the
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embryos showed distributed GFP expression. No GFP expression on the notochord 
(NC) and spinal cord (SC) was detected at any stage with the IKbfrCdxl: GFP 
construct (Table 4.4). The distributed GFP expression was present mainly in muscle 
cells, mesodermal cells and neural crest cells, a minority of blood cells and heart 
muscle cells showed expression, few cells near the gut expressed GFP. The transient 
GFP expression analysis of the frCdxl reporter constructs into the zebrafish embryois 
shown in the appendix section 5A.
4.4 Discussion
I have analysed and characterized the upstream non-coding region of the 
mouse and Fugu Cdxl in search of conserved regulatory elements involved in the 
regulation of the gene. The reporter assay data indicate that specific regions of the 
mCdxl and frCdxl are able to produce reporter expression in intestinal cells. 
Furthermore, expression of the frCdxl elements in transgenic zebrafish are able to 
reproduce, to some extent, the expression of the wild type gene.
Using a comparative genomics approach, we analysed and compared the 
upstream region of the human, mouse and Fugu Cdxl. As discussed in Chapter 3, 
there is a high level of conservation in the coding region of the genes; however, no 
conserved non-coding sequences were identified in the upstream region of the gene. 
Further analyses using the intronic regions and the 3* downstream region showed the 
same result. Small non-coding sequences were conserved among the three species; 
however, the functionality and significance of these non-coding regions remains 
elusive.
Unexpectedly, a search of transcription factor binding sites in the upstream 
region of the gene showed a conserved repertoire of binding sites. The region that 
shows a high level of conservation is the first Kb upstream of the gene. The three 
species contain a TATA box in their promoter, and Spl sites, which are characteristic 
elements for the basic transcription machinery of gene. Remarkably, the three species 
contain a Tcf/Lef binding site in this region. Previous reports suggested that the mouse 
Cdxl is controlled by a Tcf/Lef element located in the first -700bp of the gene (Lickert 
et al 2000), which suggests that the trans-acting factor involved in the Cdxl 
expression has been conserved across species and during evolution.
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Further analyses of the upstream region showed a defined group of conserved 
transcription factors along the sequence. RARE and RXR sites were predicted in both 
sequences, either in distal or proximal position. Previous studies indicate that RARE 
is necessary for the expression of mCdxl and, RARE and RXR factors are crucial for 
normal vertebral patterning (Houle et a l 2003). Biochemical and embryo culture 
studies have found that Cdxl autoregulates its expression, although this regulation 
may be mediated via LEF1 factor and not by direct protein/DNA interaction (Prinos et 
a l 2001; Beland et a l 2004). The analysis of the upstream sequences also shows the 
presence of Cdx and Tcf/Lef in the distal region of the gene, suggesting a conserved 
mechanism in the regulation of Cdxl across species.
The data obtained from the transfection assays suggests that the TFBS 
predicted for each of the elements might be playing an important role in the activation 
of Cdxl. The mouse 5.2Kb fragment possibly contains enhancer regulatory sequences 
important for the intestinal expression; important factors such as CDX, GATA, LEF 
and STAT, which are expressed in the intestine, are contained in this fragment. The 
fold induction obtained for the overlapping 2.1 and 1.4Kb elements suggest that some 
of the transcription factors in these two regions, especially in the 1.4Kb fragment, 
may act as repressors or co-repressors of the Cdxl expression. This may be also the 
case for the Fugu 2Kb element in which a reduced fold induction was obtained. 
Although the TFBS predicted have been described as activators, some may act as 
repressors when combined with specific factors. The 1Kb upstream element showed 
activity in intestinal cells in both species. As the anterior reports and the TFBS 
analyses suggest, this region contains the necessary elements to activate the gene in 
intestinal cells in both species.
Comparative genomics studies have found clusters of conserved non-coding 
sequences across the genome, mainly located in introns or in flanking regions of 
regulatory genes involved in development. These conserved sequences with suggested 
regulatory characteristics were not found near the CDX1 gene (Bejerano et al 2004; 
Woolfe et a l 2005). However these studies do not answer how some regulatory 
genes, which also participate in development and have no significant level of 
conservation in their flanking sequences, are regulated.
The absence of conserved non-coding regions nearby the coding sequences is 
not an uncommon characteristic of the genes; a clear example is the regulatory region
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of the even-skipped gene in Drosophila melanogaster and Drosophila 
pseudoobscura; these two species shared a common ancestor from 40 to 60 million 
years ago, and their cis-regulatory region drives the same detail of expression pattern 
in both species despite the underlying sequences being highly dissimilar. Even though 
the regulatory sequence of the ancestral even-skipped gene has gradually changed in 
the two fly species, the functional activity of the cis-element has not changed (Boffelli 
et a l 2004).
The deletion promoter analysis using the upstream region of the frCdxl 
showed that the upstream region of the gene controls early expression in the zebrafish 
embryo. The earliest expression identified in the transient embryos was at 80% 
epiboly, which is slightly later than the in situ studies reported for the ZfCdx, where 
expression starts at 50% epiboly, but is evident at 80% epiboly (Joly et a l 1992). The 
three expression constructs extending from +1 to 4Kb were able to drive the 
expression of the reporter at this stage, indicating that the 1Kb upstream of the 
translation start site contains the elements necessary to regulate the expression of the 
gene at this early stage. The three constructs showed the same level of GFP 
expression. Previous studies have not been able to identify the Cdxl regulatory 
regions involved during the gastrulation period.
By the 14 somite stage, the frCdxl reporter constructs were mainly expressed 
in the tail region. This agrees with the ZfCdx and the mCdxl expression reported for 
the same stage; however, both genes are also expressed in other tissues. The ZfCdx is 
also expressed in spinal cord and notochord (Joly et a l 1992). In mouse, Cdxl also 
shows expression at the level of the posterior hindbrain, dorsal margin of the neural 
folds, anterior and posterior somites, and in the mesodermal cells of the forelimb and 
hindlimb buds (Meyer and Gruss 1993). Even though we were unable to identify 
expression in the notochord, spinal cord and developing neural tube, some of the 
distributed GFP expression was in mesodermal cells (which may form part of the 
notochord) and in the neural crest cells. This agrees with the mouse expression at 
8.75dpc, when the embryo is around the 14 somite stage.
By the 2 and 4dpf, the frCdxl-GYV expression remained unchanged; the tail 
bud still showed expression of the transgene and no notochord or spinal cord 
expression was detected. By 22hpf, the ZfCxd is expressed in neuroectodermal cells, 
spinal cord and tail bud; after 48hpf, no expression has been detected (Joly et al
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1992). In the mouse, by lOdpc the embryo has developed to the 30 to 34 somite stage, 
which corresponds to the 22-24hpf stage in the zebrafish. At this stage the mCdxl 
expression is located in the forelimb and hindlimb bud and in the tail bud. The latest 
expression is seen at 12dpc in the somites (Meyer and Gruss 1993). The results 
obtained still agree with the wild type expression of the gene in the tail bud region. 
Because the GFP protein still remains active for a period of time, it is difficult to 
know exactly when the activity of the transgene finished.
It is possible that the regulatory elements involved in the expression of the 
gene in these specific tissues are located in the intronic regions, in the 3’ region or 
even further up of 4Kb in the 5’ region of the gene. Studies performed by Gaunt et al. 
(2003) using the chick Cdxl (CdxA) non-coding region demonstrated that the gene 
requires 1.4Kb of the upstream region and 2.1Kb of the first intron to drive the 
expression of the reporter in the neural tube and in the first somites (E8.5). Further 
analyses of the non-coding CdxA sequence revealed the presence of one RARE site 
and a 7c/7(3-catenin binding site in the intronic region of the gene; independent 
disruption of either of the sites causes a down regulation or lack of specific expression 
in the neural tube and somites.
We were also unable to identify expression of the trangenes in the intestinal 
tissue. By 5dpf the zebrafish intestine becomes active, but is not until 7dpf that most 
of the genes are expressed in this tissue (Wallace et al. 2005). Further analyses at later 
stages will indicate if the frCdxl elements are active in the zebrafish intestine and if 
they show a gradient of expression.
Further investigation of the actual mechanism that governs the expression of 
the frCdxl and mCdxl will have to be carried out. Of special interest will be to look 
for the cis-regulatory elements responsible for neural tube and spinal cord expression. 
More detailed studies, for example, mutation of specific binding sites, or deletion of 
specific regions, will define which are the factors involved in the regulation of Cdxl. 
Finally, transient zebrafish carrying the mCdxl upstream elements will allow 
identification of the regions involved in the expression of the gene at different 
developmental stages.
The data presented here, although preliminary, indicate that the frCdxl 1Kb 
contains the elements necessary to activate the expression of the gene at early stages
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of development, during development and later in the intestine. The distal region of the 
mCdxl contains enhancer elements important for the activity of the gene in intestinal 
cells. The TFBS present in the Cdxl upstream region and especially the binding sites 
located in the proximal upstream region, strongly suggest that the regulatory 
mechanisms that govern Cdxl have been preserved through evolution.
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5.1. Introduction
One of the main roles of the Adenomatous Polyposis Coli protein is to 
contribute to the formation of a phosphorylation complex that regulates p-catenin in 
the Wnt signalling pathway. APC also contributes to the migration of intestinal cells 
in the crypt-villus axis; over expression of APC results in an altered migration of 
intestinal cells (Mahmoud et a l 1997). Most studies of this protein address its 
contribution to the development of colon cancer; mutations or complete loss of APC 
have been found to precede the formation of polyps, which are the precursors of 
adenomas and adenocarcinomas in colon (Fodde 2002).
There are two types of specific domains contained in APC, the domains near 
to the N-terminus of the protein, and the domains in the C-terminus of the protein. 
The oligomerization domain and the armadillo repeats are located in the N- terminus 
of the protein. The 15aa repeats and the 20aa repeats are located in the central portion. 
The basic domain, the EB1 and human disc large (HDLG) binding domain are 
situated in the C-terminus of the protein.
The heptad repeats in the N-terminus permit APC to form homo- dimers (Su et 
al 1993). The armadillo domain is constituted by seven repeats; it is highly similar to 
the p- catenin domain. This region also binds to the phosphatase 2A protein (PPA2), 
an enzyme that also binds to Axin (Hsu et a l 1999; Seeling et a l 1999). This domain 
also binds to the APC- stimulated guanine nucleotide exchange factor (Asef). The 
APC/Asef complex activates the Rac and Rho GTP binding proteins, triggering a 
mechanism involved in the stabilization and motility of the actin cytoskeleton scaffold 
(Kawasaki et a l 2000).
The 15aa repeats also bind to P- catenin; however, this binding does not cause 
its down regulation. These repeats are unique to the APC protein and there are no 
similar domains in the p-catenin protein (Ozawa et a l 1989; Rubinfeld et a l 1993). 
There are seven 20aa repeats located in the central region of APC; these repeats also 
bind to p- catenin after being phosphorylated by GSK3P; although the seven 20aa 
repeats are phosphorylated, only three are necessary for the down regulation of P- 
catenin (Figure 5.1). The majority of APC mutants lack the complete set or many of
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the 20aa repeats, suggesting that this domain is important in tumorigenesis (Polakis 
1997; Rubinfeld et al. 1997).
The three Axin-binding sites in APC are contained between the third and 
fourth 20aa repeats, the fourth and fifth 20aa repeats, and the seventh 20aa repeats and 
the basic domain. Axin facilitates the complex formation of APC/(3-catenin and 
therefore phosphorylation of both proteins by GSK3p. Overexpression of Axin down 
regulates p- catenin. As in the case of APC, Axin acts as a negative regulator of the 
Wnt signalling pathway (Hart et al. 1998; Kishida et al. 1998).
In the C-terminus domain of APC lies the basic domain of the protein. This 
domain is rich in arginine and lysine residues (basic amino acids), and a high number 
of proline residues (Groden et al. 1991). Studies have shown that the C-terminus 
binds to microtubules and stimulates proliferation of tubulin in vitro (Munemitsu et 
al. 1994). This domain is not affected in colorectal tumours (Figure 5.1).
The EB1 and the HDLG binding domains are also contained in the C- 
terminus of the protein. The EB1 protein is involved in the binding to the centromere, 
the mitotic spindle and the distal (+) tip of the microtubules (Berrueta et al. 1998; 
Morrison et al. 1998). APC also associates with the + microtubules in the 
cytoskeleton; the removal of the EB 1 domain in APC reduces the binding capacity of 
the protein to the + ends of the microtubules (Timauer and Bierer 2000). Although the 
majority of colorectal cancers have mutation(s) in the C-terminus, mutations in or 
lack of the EB1 domain in APC has not been associated with intestinal tumours 
(Smits et al. 1999). The human disc large binding domain is situated in the final end 
of the C-terminus in APC (Figure 5.1). The APC-HDLG complex is involved in the 
cell cycle progression from the Go/Gi to the S phase (Baeg et al. 1995).
Although the presence of APC in the nucleus has been confirmed (Henderson 
2000), the exact position of the domain with nuclear location signal is still unclear. 
Three putative nuclear signals have been identified, carrying the LXXXXLXXLXL 
and VXXXVXXVXV motifs. Deletion of two of these motifs disrupts the binding of 
APC with CRM1 (a nuclear export protein), and APC accumulates in the nucleus 
(Henderson 2000). Rosin-Arbesfeld et. al. (2000) confirmed that APC shuttles p- 
catenin from the nucleus to the cytoplasm in a CRM1 depended process. This study 
also demonstrated the presence of three nuclear localisation signals in APC, each
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signal with the repeat LXXLXL/I/M/V. These nuclear signal motifs are contained in 
the third, fourth and seventh 20aa repeats of the protein. Two other putative nuclear 
signal motifs were found, one in the N-terminus and the second after the armadillo 
region.
It has been also suggested that APC can bind to DNA. Three putative binding 
sites have been located in the protein with the S/TPXX motif; these domains bind to 
A/T rich nucleotide sequences, however, regulation of transcription has not been 
shown yet (Deka et a l 1999).
Inactivation of APC or direct inactivation of P-catenin by mutations in its APC 
binding site provoke accumulation of p-catenin in the cytoplasm. Studies have shown 
that introduction of wild type APC into cells with mutated APC protein reduces the 
pool of P-catenin (Korinek et a l 1997; He et a l 1998). Once p-catenin is inside the 
nucleus, it associates with Tcf/Lef to activate the transcription of genes involved in 
cell cycle progression, such as c-myc, cyclin D1, conexin 43, metalloproteinase 
matrylsin and Cdxl, among other genes (van der Heyden et a l 1997; Crawford et al 
1999; Shtutman et a l 1999).
One of the roles of APC outside of the Wnt pathway is in intercellular 
adhesion. The cytoplasmic domain in cadherins responsible for cell adhesion is the 
SLSSL, that is found in four of the seven 20aa repeats in APC (Nagafuchi and 
Takeichi 1988; Jou et a l 1995). Whereas p-catenin associates with E-cadherin in a 
complex to bind to the a-catenin and the actin network, APC binds to the 
microtubules that do not belong to the actin network and localizes at the edges of the 
cells (Smith et a l 1993; Neufeld and White 1997).
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Figure. 5.1. Diagram showing the main domains in the Apcl protein, adapted from 
Polakis (2000)
APC2 was identified by virtue of its homology with APC 1 from a Drosophila 
expressed- sequence tag (EST) database. The APC2 is highly expressed in the central 
nervous system as well as the spinal cord and foetal brain. The mouse Apc2 contains 
an open reading frame of 2274aa, whereas the human APC2 spans over 2302aa (van 
Es et al. 1999). APC1 and APC2 show high similarity in the amino-terminal end of 
the protein, mainly in the armadillo repeat region; this homology is lost in the 
carboxy-terminal end of the protein. Although most of the specific domains of the 
protein are present in APC2, the 15aa repeats seem to be absent in the protein. 
Another interesting characteristic is that APC2 contains only six of seven of the 20aa 
repeats of APC 1.
The SAMP domains specific for axin binding, have been found to interact 
with conductin in vitro; the APC1 contains three SAMP domains located after the 
third, fourth and seventh 20aa repeats, All of the domains are necessary for this 
interaction. In contrast, APC2 contains only two SAMP domains placed after the 
fourth and seventh 20aa repeats.
Although the complete functions of APC2 have not been completely 
elucidated, studies indicate that both APC proteins have overlapping functions. 
Studies performed in Drosophila reveal that the armadillo repeats in APC2 are 
sufficient to regulate the Arm protein levels. However, the two APC proteins show 
different cellular distributions, APC2 is localised in the cortex of the cells, whereas 
APC1 is mainly localised in cytoplasmic microtubules.
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Comparative genomics allows for the identification of homologous genes in 
higher organisms. We used homologies with the mouse and human Apcl and Apc2 to 
characterise and describe the Fugu Apcl and Ape2. We have compared transcriptional 
organisation, gene structure and amino acid sequence to analyse how well conserved 
these genes are across species. Furthermore, we looked for conserved protein domains 
and tissue distribution of the Fugu Apcl and Apc2 genes.
5.2. Materials and methods
5.2.1 Expression analysis of Fugu Apcl by RT-PCR
Total RNA from pufferfish wild type adult and 2.2 and 4.6 day embryos were
obtained from Dr. Greg Elgar (MRC UK HGMP Resource Centre). The primers 
designed for JrApcl expression are: forward primer 5’- aggagagggatgccgactgt -3’ and 
reverse primer 5’- ggttctcctgccaactccaa -3’. Internal primers for the (3-actin gene were 
designed to confirm that there was no contamination with genomic DNA. The P-actin 
primers were: forward primer 5 ’-tacagactacctcatgaagatcc-3’ and the reverse primer 
5’-gaggccag gatggagcctcc-3’.
For the JrApcl, the PCR was performed in a 20pl reaction containing lpl 
cDNA product from the reverse transcription, lOmM dNTPs, 25mM primers, 2 units 
Taq polymerase, 1.5mM MgCb and IX Buffer (BioLine). A PTC-225 Peltier Thermal 
Cycler (MJ Research) was used with the following program: 95°C, 2 min; 35 cycles at 
95°C for 30s; 65°C for 30s; 72°C for 40s; final extension was at 72°C for 5min. The 
PCR product was separated in a 1% agarose gel. The PCR product size for the 
FrApcl was 800bp and the PCR product size for the P-actin was 500bp.
5.2.2. Expression analysis of Fugu A pcl by RT-PCR
Total RNA from pufferfish wild type adult and 2.2 and 4.6 day embryos were
obtained from Dr. Greg Elgar (MRC UK HGMP Resource Centre). The primers used 
for JrApc2 expression are: forward primer 5’-ggctgctgtccattcttacta-3’ and reverse 
primer 5’-aacaaggctggacacatttcg-3\ Internal primers for the p-actin gene were 
designed to confirm that there was no contamination with genomic DNA. The p-actin 
primers were: forward primer 5’-tacagactacctcatgaagatcc-3’ and the reverse primer 
5’-gaggccag gatggagcctcc-3’.
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For the frApc2, the PCR was performed in a 20pl reaction containing lpl 
cDNA product from the reverse transcription, lOmM dNTPs, 25mM primers, 2 units 
Taq polymerase, 1.5mM MgCb and IX Buffer (BioLine). A PTC-225 Peltier Thermal 
Cycler (MJ Research) was used with the following program: 95°C, 2 min; 35 cycles at 
95°C for 30s; 65°C for 30s; 72°C for 40s; final extension was at 72°C for 5min. The 
PCR product was separated in a 1% agarose gel. The PCR product size for the FrApc2 
was 900bp and the PCR product size for the fi-actin was 500bp.
5.3. Results
5.3.1. Identification of Fugu genes
The Fugu Ape genes were identified using the Fugu genomics project 
database. This work was also carried out after the completion of the Fugu genome- 
sequencing project. The mouse and human Ape genes, the transcriptional organisation 
of the genes, gene structure and aa sequence were taken from the Ensembl database. 
And in the same way mentioned in chapter 3, we used the information provided from 
the Ensembl database to identify and characterize the Fugu Ape genes.
The Fugu genes were identified mainly; by gene structure, nucleotide 
sequence conservation and amino acid sequence conservation. It was not possible to 
identify the genes by synteny, because it was not conserved. To identify the Fugu 
Apcl, the mouse Apcl amino acid sequence (NM_031488) was blasted against the 
Fugu genome database. The first hit was the Mayffold 281 (M000281). The mayffold 
was analysed using the NIX program, which showed the complete predicted Ape gene 
plus the 5’ and 3’ region of the gene. By comparative analysis using the aa sequence 
of the human and mouse Apcl (discussed below), the predicted Fugu gene was 
designated as the Fugu Apcl {JrApcl).
Using the same strategy, the Fugu Apc2 was identified blasting the mouse 
Apc2 aa sequence against the Fugu genome database. The best hit was the Mayffold 
1664 (MOO 1664), which contains the putative Fugu Ape gene. Analysis of the 
predicted gene by NIX showed a truncated gene located at the beginning of the 
mayffold. This partial gene contains the last 7 coding exons. To identify the first 
exons, a blast of the first 7 coding exons against the Fugu scaffold database hit the 
scaffold 11727; which contains the first and second coding exons of the gene
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(described below). By comparative analysis, the gene contained in the MOO 1664 and 
scaffold 11727 was assigned as Fugu Apc2 (JrApc2).
5.3.2. Transcriptional organisation o f Fugu Ape genes
5.3.2.1. Transcriptional organisation of Fugu Apcl
The mouse and human Apcl genes have been sequenced and characterized
previously. The chromosomal locations of the genes provided by the Ensembl 
database were used to determine the intergenic distances between Fugu Apcl and its 
neighbouring genes. For the JrApcl, the intergenic distances were calculated using the 
locations predicted by the NIX program in the Mayffold.
The human and mouse Apcl genes are located on the chromosomes 5 and 18 
respectively. Synteny is well conserved between these two species; the nearest gene to 
the 5’ end is the EPB4.1L4A for the human and the Epb4.1l4a for the mouse. The 
second nearest gene to this end is the neural protein Csorfl3 gene in the human and 
related lipid transferred protein 4 Sartd4 in mouse. At the 3’ end of the APC1, the 
nearest gene in human is the signal recognition particle SRP19; in the mouse it is the 
polyposis locus protein 1 Dpi. The second nearest gene at this end in the human is the 
DPI gene and in the mouse the polycystic kidney 2-like protein PKD212 gene (Figure 
5.2).
The Fugu Apcl is located in the Mayffold 281 in the Fugu database. This 
mayffold contains the complete gene and its flanking neighbouring genes. The 
immediate 5’ gene to the Fugu Apcl is the Fukutin gene (FR) located 4.12Kb from 
the gene; the second nearest gene at this end is the glyceraldehyde-3-phosphatase 
dehydrogenase GPD gene, placed 13Kb away from the JrApcl. At the 3’ end, the 
closest gene is the alpha fucosyltransferase oFT gene, at 2.49kb; the second gene is a 
glycoprotein, the low-density lipoprotein receptor Megalin, situated 39.8Kb from the 
JrApcl (Figure 5.2).
Synteny of Fugu Apcl seems broken when compared to the transcriptional 
orientation of the human and mouse; none of the neighbouring genes is conserved in 
Fugu. The intergenic distances in Fugu have been reduced almost 52 times compared 
to the mouse and 77 times compared to the human in the 5’ region. The 3’ region is 
also reduced 10.5 times compared to the mouse and approximately 6 times compared 
with the human.
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Figure. 5.2. Transcriptional organisation of the Apcl gene in human mouse and Fugu. 
The Apcl genomic regions from human and mouse were extracted from 
Ensembl. The Fugu Apcl genomic region (M000281) was extracted from the 
Fugu database. Black boxes indicate the position of each gene through the 
chromosome; genes located above the line are transcribed 5’->3’; genes located 
under the line are positioned in the reverse DNA strand and are transcribed in 
opposite orientation. The scale bar for the human and mouse is 10Kb.
5.3.2.2. Transcriptional organisation of Fugu Apc2
The human and mouse Apc2 genes have also been previously characterized.
The human gene is located on the chromosome 19 and the mouse gene on the 
chromosome 10; genomic organisation is well conserved between the mouse and 
human Apc2. The proximal 5’ gene in the two species is the ribosomal protein SI5 
(Rspl5), the second proximal gene for both species is the Daz associated protein 1 
(Dazapl). At the 3’ end, the gene immediately next to the human Apc2 is C19orf25, 
which is a predicted gene without an assigned function or name; the second 
neighbouring gene is convertase subtisilin kekintype 4 gene (PCSK4). In the mouse, 
the nearest 3’ gene to Apc2 is a predicted gene named Rik; the second proximal gene 
is, as in the human, the Pcsk4 gene (Figure 5.3).
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The Fugu Apc2 is placed in the mayffold 1664; seven exons corresponding to 
the last 7 coding exons of the mouse and human, exons 8 to 14, are located at the 
beginning of the mayffold; no 5’ neighbouring genes are located at this end. The blast 
of the amino acid region corresponding to the first 7 exons, did not hit any mayffold 
in the Fugu database, however, the blast of the same region against the Fugu scaffolds 
database showed that the first two coding exons of the gene are present in the scaffold 
11727 (discussed later); no neighbouring genes were predicted for this scaffold using 
the NIX program. The two proximal neighbouring genes predicted in the 3’ end of the 
frApc2 are the ribonucleoprotein RP gene, situated 4.6Kb from the gene, and a 
predicted gene located 13Kb away from the gene (Figure 5.3).
Although synteny is well conserved between mouse and human Apc2, the 
synteny conservation is broken in frApc2\ even the intergenic distances are larger in 
Fugu than in mouse and human.
DAZAPl RSP15 APC2
I  8  5.8Kb ■ 2.21Kb
Human 5 \~ *  1------h " ^ -------- 1-------1-------1-------1---------------  h - J -------1-------I - — t 1-------1-------1-------1-------1
Chr 19 3 ’ 2.69Kb 1.57Kb ■  1
C19orf25 PCSK4
Dazapl Rspl5 Apc2
m ■  7.77Kb ■
t— ^ ------1------ 1------ 1------ b— I------ 1------ 1— ™---- 1 - m
Chr 10 3 ’ ■  > 5 *
.  _ _  _  2.23Kb 1.29Kb
Mouse 5 F  I ~ ------- ------- -------1-------1-------1-------1--------1 ^ ----- -------H b H -------1-------1-------1-------1-------1-------1-------1 3
1.51Kb
Rik Pcsk4
Apc2 r p  PredProt
1 4.6Kb ■  8.54Kb-I 1--------1--------1--------1- ■Fugu J ------ 1------ 1------ 1------ h " H ------ 1------ 1------ 1------ \
MOO 1664 3 ’
1Kb
Figure. 5.3. Transcriptional organisation of the Apc2 gene in human mouse and Fugu. 
The Apc2 genomic regions of human and mouse were extracted from Ensembl. 
The Fugu Apc2 genomic region (M0001664) was extracted from the Fugu 
database. Black boxes indicate the position of each gene through the 
chromosome; genes located above the line are transcribed 5’->3’; genes located 
under the line are positioned in the reverse DNA strand and are transcribed in 
opposite orientation. The scale bar is 1Kb.
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5.3.3. Gene organisation of Fugu Ape genes
5.3.3.1. Gene structure of Fugu Apcl
Comparative analyses using the coding sequences of human and mouse Apcl,
and analysis of the splicing acceptor donors, show that the Fugu Apcl contains 15 
coding exons and 14 introns placed in between each exon, extending over 6768bp, 
almost 2Kb shorter than the mouse and human gene. The structure of the gene is 
preserved among the three species; the length of the first 14 exons is well conserved, 
except for the 6th and 8th exons of Fugu, which are shorter than the human and mouse 
exons. The sixth Fugu exon is 20bp shorter, whereas the eighth exon is 56bp shorter; 
however, the exon-intron phases are preserved (Figure 5.4). The 15th exon, which is 
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Figure. 5.4. Gene structure of the human, mouse and Fugu Apcl. The Apcl gene is 
organized in 15 coding exons and 14 introns. Boxes indicate the exons. The exon 
length, intron-exon phase and the amino acid of each boundary is indicated for 
each exon.
The nucleotide coding sequence shows a high level of conservation among the 
three species. Each coding exon was aligned individually using the ClustalW 
program; percentage of conserved nucleotides was estimated for each exon using the
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Fugu sequence as a base of comparison. Table 5.1 shows the conserved nucleotides of 
each exon among the three species. Exons 1, 4, 9, 10, 11, 12 and 13 are the best- 
preserved exons of the gene with more than 70% conservation, whereas exons 3, 7 
and 15 show low level of conservation. Exon 3, which shares the same length as the 
human and mouse, is 43.21% conserved. The low percentage of conservation in the 
exon 7 is due to the length of the exon, which is shorter in Fugu. The exon 15, the 
largest exon of the gene, is just 51.41% conserved among the three species (Appendix 
section 3A).
















Table 5.1. Nucleotide conservation of Apcl exons among mouse, human and Fugu. 
The deduced Fugu exons were used for comparison. The percentage of 
conservation was calculated based on the conserved number of nucleotides 
among the three species and using the Fugu sequence for comparison.
5.3.3.2. Gene structure of the Fugu Apc2
The Apc2 gene structure of the human and mouse consists of 14 coding exons
and 13 introns. As in the Apcl gene, the last exon is the largest of the gene. The 
human Apc2 extends over 6909 nucleotides, whereas the mouse Apc2 is 683 lnt in 
length.
The JrApc2 structure was obtained using the intron-exon boundaries of each 
exon and the alignment of the mouse and human exons against the putative Fugu
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exons. For the present exons of the frApc2, the intron-exon faces are well conserved. 
The putative frApc2 gene extends over 6800nt; 9 coding exons of the 14 exons were 
identified; exons 1, 2, 8, 9, 10, 13 and 14 are present in the gene; exons 11 and 12 are 
fused to form one exon which is 195bp in length, the same length than the mouse and 
human exon 11 and 12 together. The Fugu exon 8 is 400bp in length, 9 and 24bp 
larger than the human and mouse 8th exon respectively. The frApc2 exon 14 extends 
over 5543bp, 484bp larger than the human exon and 550bp larger than the 
mouseexon; the Fugu exon 14 contains sequences of 10 to 20bp, which are not 
present either in human and mouse (Figure 5.5). We were unable to identify the exons 
3 to 7 of the gene in the Fugu database.
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Figure. 5.5. Gene structure of the human, mouse and Fugu Apc2. The Apc2 gene is 
organized in 14 coding exons and 13 introns. Boxes indicate the exons. The exon 
length, intron-exon phase and the amino acid of each boundary is indicated for 
each exon.
Nucleotide comparative analysis of t frApc2 showed that the existing exons of 
the gene have a high degree of conservation with the human and mouse Apc2 exons. 
Each coding exon was aligned individually; percentage of conservation was estimate 
based on the Fugu sequence. The exons 1, 2, 9, 10, 11, 12 and 13 show more than
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60% conservation. Exons 8 and 14 show 55.75 and 39.97% conservation respectively, 
this low conservation may be due to the difference in the length of the exons (Table 
5.2 and Appendix section 3B).















Table 5.2. Nucleotide conservation of the Apc2 exons among mouse, human and 
Fugu. Alignment of the deduced Fugu exons with the mouse and human Apc2 
exons, the percentage of conservation were calculated based on the conserved 
number of nucleotides among the three species. The Fugu sequence was used to 
estimate the percentages.
5.3.4. Expression analysis o f Fugu Ape by RT-PCR
5.3.4.1. Expression of frApcI gene in Fugu adult tissues
To investigate the JrApcl expression in Fugu, RT- PCR was carried out in
wild type embryos and adult tissues from Fugu. Expression of JrApcl was detected in 
gut, spleen, gonads, kidney, eye, spinal cord, gill and heart in the adult Fugu, 
expression was also present in the Fugu embryo at 53.3hpf. an early somites stage and 
111.5hpf. In the first stage, the developing organs are starting to form and at 111.5 
hpf., all the organs have gone to completion, although the Fugu embryo has not 
hatched yet (Figure 5.6).
These data indicate that the expression of JrApcl is present in the majority of 
adult organs in Fugu. Furthermore, expression is also present in a very early stage of
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development, which is the somites stage. This expression continues during 
development through the adult organism. Expression offrApcl seems to be unvarying 
during development and in the adult tissues except for the kidney, which shows a 
slightly reduced presence of transcript. In the case of the gut tissue, the presence of 
frApcl expression does not indicate if the transcript is present in all the intestinal 
tissue, in an anterior or posterior region, or in a specific group of cells.
M l  2 3 4  5 6 7 8 9  10
JrApcl 
Actin
Figure. 5.6. Fugu rubripes Apcl mRNA in adult tissues. The Fugu Apcl mRNA- 
specific primers amplified a PCR product from total RNA extracted from the gut 
(1), spleen (2), gonads (3), kidney (4), eye (5), spinal cord (6), gill (7) heart (8), 
53.3hpf embryo (9) and 111 .5hpf embryo (10). A RT-PCR product 
corresponding to the constitutively expressed Actin gene was used as internal 
control.
5.3.4.2. Expression of frApc2 gene in Fugu adult tissues
To look for the frApc2 expression, RT- PCR was also performed in wild type
embryos and adult tissues from Fugu. Expression offrApc2 was detected in heart, gill 
and gonads in adult tissues; however, expression was not observed in spleen, spinal 
cord, eye, kidney and gut. Expression offrApc2 was also identified in the developing 
Fugu embryo at 53.3 hpf. that is, the 5-6 somites stage and at 111.5 hpf. a later 
developmental stage (Figure 5.7).
In contrast with the expression of frApcl, frApc2 expression seems to be 
restricted to specific organs in the adult Fugu. The frApc2 transcripts were present in 
both of the developing stages of the embryo. As in the frApcl, frApc2 expression 
seems identical during development and in the adult tissues.
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Actin
Figure 5.7. Fugu rubripes Apc2 mRNA in adult tissues. The Fugu Apc2 mRNA- 
specific primers amplified a PCR product from total RNA extracted from the 
gonads (1), heart (2), gill (3), spleen (4), spinal cord (5), kidney (6), 111 .5hpf 
embryo (7) 53.3hpf embryo (8), eye (9) and gut (10). A RT-PCR product 
corresponding to the constitutively expressed Actin gene was used as internal
Previous studies have identified the expression of the murine Apcl and Apc2 
in a repertoire of different adult tissues and during developmental stages. The Apcl 
expression has a similar tissue distribution in mouse and Fugu', the gene is also 
expressed during developmental stages in both species (Table 5.3).
The mouse and Fugu Apc2 expression have some similarities and some 
differences. In mouse and Fugu the gene is expressed in the developing embryo. In 
the adult, the gene is expressed in the gonads in both species. In Fugu expression is 
also seen in heart and spleen. In mouse, the gene is not expressed in heart and spleen 
expression is seen in spinal cord and eye. No expression is seen in both species in the 
kidney and gut (Table 5.3).
control.
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Spp. Embryo stage and adult tissue
Embryo Gonads Heart Spleen Spinalcord Kidney Eye Gut
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Table 5.3. Comparison of Apcl and Apc2 gene expression in Fugu and mouse. 
Expression of the murine Apc2 in the embryo at E10, 11, 13 and 15 was 
characterized by in situ hybridisation, the E l4 and E l8 stages were done by 
northen blot according with the MGI database (www.informatics.jax.org).
5.3.5. Analysis o f the Fugu Ape protein sequence
5.3.5.1. Amino Acid sequence of the Fugu Apcl
A comparison of the deduced amino acid sequence of the frApcl with the
human and mouse orthologues indicates that the translated exons are well conserved 
among the three species. The coding sequence of the Fugu Apcl extends over 2199aa; 
it is 642aa shorter than the human protein. The table 5.4 shows the amino acids 
conserved in each exon and their percentage of conservation; many of the exons show 
more than 90% conservation when compared with the mouse and human exons. The 
exons 3 and 7 are the less conserved exons with 68.18% and 53.33% conservation 
respectively, the exon 15, which codes for more than half of the protein and contains 
many of the main domains of the protein is 78.92% conserved.
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Table 5.4. Amino acid conservation of Apcl. Alignment of the aa sequence of each 
exon was done to estimate the number of aa conserved and percentage of 
conservation among human, mouse and Fugu. The Fugu aa sequence was used to 
estimate the level of conservation.
Previous studies have identified and characterised specific domains in the 
human and mouse Apcl; the mouse Apcl was used to identify those specific domains 
in the Fugu Apcl protein (Feamhead et al 2001). The table 5.5 shows the 
conservation of each domain among human, mouse and Fugu.
The seven main domains of the protein are present and well conserved in the 
frApcl, the 7 armadillo repeats, which are located between the 453-767aa, were 
analysed as one domain. The 15aa repeat located between the 1020- 1170aa were also 
analysed as one domain. And the 20aa repeats which are series of seven repeats, were 
characterized by their specific core sequence TPXXFSXXXSL (Groden et al. 1991).
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Amino acid Domain Num. of aa conserved
Percentage of 
conservation
6- 57 Oligomerisationdomain 51/51 100%
453- 767 Armadillo region 305/314 97.13%








2200-2400 Basic Domain 86/200 43.0%
2559-2771 EB1 binding site 130/212 61.33%
2772-2843 HDLG binding site 49/72 68.05%
Table 5.5. Specific domain conservation of Apcl. Specific domains were delimited 
using the described domains in the mouse Apcl. The number of aa and 
percentages are the conservation among human, mouse and Fugu domains.
The 3 SAMP repeats are also conserved in the frApcl, they are placed after 
the 3rd, 4th and 7th 20aa repeats. The first repeat is 80% (24/30aa) conserved with the 
mouse and human. The second repeat is 14aa in length; it is 15aa shorter than the 
mouse and human and 12 of the 14aa are conserved (85.71%). The third repeat is 
88.88% conserved (24/27aa) with the mouse and human repeat (Figure 5.8)
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f r E l 5  DNIDNLSPKTAHRK--------------------------------------------------GRGCNSASGTASTARPYTNTPVLSS 1 5 9
. . .  . .  • . ★ ★ • ★★ ★★ ★ ★
h s E l 5  SSSSRGSLDSSRSEKDRSLERERGIGLGNYHPATENPGTSSKRGLQISTTAAQIAKVM EE 2 3 9  
m inE l5  SSSSRGSLDSSRSEKDRSLERERGIGLSAYHPTTENAGTSSKRGLQITTTAAQIAKVM EE 2 3 9  
f r E 1 5  PKNGDG--------------------------------------------------------------------------------------------------------------------------------  1 6 5
h s E l 5  VSAIHTSQEDRSSGSTTELHCVTDERNALRRSSAAHTHSNTYNFTKSENSNRTCSMPYAK 2 9 9  
mmE15 VSAIHTSQDDRSSASTTEFHCVADDRSAARRSSASHTHSNTYNFTKSENSNRTCSMPYAK 2 9 9  
f r E 1 5  ----------------------------------------------------------------------------------------------------------------------------------------------
h s E l 5  LEYKRSSNDSLNSVSSSDGYGKRGQM KPSIESYSEDDES KFCSYGQYPADLAHKIHS 3 5 6
ramEl5 VEYKRSSNDSLNSVTSSDGYGKRGQMKPSVESYSEDDES KFCSYGQYPADLAHKIHS 3 5 6
f r E l 5   ASSDSLNSVTSADGYGNRGKNKPSTEPFYSSDESGANKCCVYRKYPADLAHKIRS 2 2 0
•  •k "k "k ' k  -k • ★ ★ ★  ★  ★  "k • ' k ' k ' k ' k ' k ' k ' k ' k ' k m ' k
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h s E 1 5  ANHM DDNDG-lLDTPINYSLKYSDEQLNSGRQSPSQNERW ARPKHIIEDEIKQSEQRQSR 4 1 5  
m m E l5 ANHMDDNDG-Il DTPINYSLKYSDEQLNSGRQSPSQNERWARPKHVIEDEIKQNEQRQAR 4 1 5  
f r E 1 5  ANHMADDDGAELDTPINYSLKYSDEQLNSGRQSPSHRVGMD--------------SDDDDEEDGRLRR 2 74
★  ★ ★ ★  ★  •  ★ ★  • k 'k ' k 'k ' k 'k ' k 'k ' k ' k 'k ' k 'k ' k 'k ' k 'k ' k ' k 'k ' k 'k ' k 'k ' k
h s E 1 5
mmE15
f r E 1 5
JQSTTYPVYTESTDDKHLKFQPHFGQQECVSPYRSRGANGSETNRVGSNHGINQNVSQSL i
5QNTSYPVYSENTDDKHLKFQPHFGQQECVSPYRSRGTSGSETNRMGSSHAINQNVNQSL  
IN D G SD SV SSG S--------------------- ■
4 7 5
- R I I S V P P P R Y V V T A & i® |------------------------------------------ 3 0 4
h s E 1 5  
mmE15  
f  r E 1 5
CQEDDYEDDKPTNYSERYSEEEQHEEEE-RPTNYSIKYNEEK , :
c q e d d y e d d k p t n y s e r y s e e e q h e e e e e r p t n y s i k y n e e k : :
 |YGGDPAG------------------------------------------------------------------------------E Q PIDYSLK YG SDG - 3 2 5
h s E l 5  SSQKQSFSFSKSSSGQSSKTEHM SSSSENTSTPSSNAKRQNQLHPSSAQSRSGQPQKAAT 5 9 4  
m m E l5 SSQKPSFSFSKNSSAQSTKPEHLSPSSENTAVPPSNAKRQNQLRPSSAQ-RNGQTQKGTT 5 9 4
f r E l 5  -A H K P L F --------------------------K PE E SA A SSV K T P T P SSSA K L R  PPAPAN 3 5 9
: : : *  * :  : . **  : * . . * . * . * *  . . . .  : .
h s E 1 5  C K V S S I N Q E T IQ T Y C V E D |p IC F S R C S S L S S L S S -A E D E IG C N Q T T Q E A D S A N -T L Q IA E  6 5 2  
m m E l5 C K V P SIN Q E T IQ T Y C V E D JP IC FS R C S SL S SL S S-A D D E IG C D Q T T Q E A D SA N -T L Q T A E  6 5 2  
f r E 1 5  RAVAK ANQESTQTYCVEDfPICFSRGSSLSSLSSEEEEEVDVIERRGASGGGNGEYPTVP 4 1 9  
*  ^ * * * .  * * * * * * * * * * * * * *  * * * *****  : : . . . *
h s E l 5  IK EK IG TRSAEDPVSEVPAVSQH PRTK SSRLQ GSSLSSESARH -K AVEFSSGA KSPSK SG  7 1 1  
m m E l5  VKENDVTRSAEDPATEVPAVSQNARAKPSRLQASGLSSESTRHNKAVEFSSGAKSPSKSG 7 1 2  
f r E l 5  VSEKDAREQQQRHQKEAESQTAAVTAPSTRGRRS-------------HHHHHHGHHHHHHHHVASSSG 4 74
h s E l 5  AQ TPKSPPE-H YVQ E  
m m E l5 AQ TPKSPPE-H YVQ E  
f r E 1 5  ARTPKSPPEPPYAQE
TPLMFSRCTSVSSL
TPL V FSR C T SV SSL
TPLM FSRCTSVSSL
D S F E S R S IA S S V Q S -E P C S G M V S G IIS P S D L  7 6 9  
D S F E S R S IA S S V Q S -E P C S G M V S G IIS P S D L  7 7 0  
D S F S T SS IA S SV R SS E P C SG M P SG V V SP SD L  5 3 4
★  ★ ★ ★ ★  •  •k 'k 'k 'k 'k 'k 'k 'k 'k 'krkJc 'k * * * * * * * * * * * *  ★ * . . * ★ ★ * *
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h s E l 5  PDSPGQTMPPSRSKTPPPPPQTAQTKREVPKNKAPTAEKRESGPKQAAVNAAVQRVQVLP  
mmE15 PDSPGQTMPPSRSKTPPPPPQTVQAKREVPKSKVPAAEKRESGPKQTAVNAAVQRVQVLP  
f r E 1 5  PDSPGQTMPPSRAKTPPLPPTTHKTNKQENTKKKDEDE--------------------------------------------------S
k k k k k k k k k k k k m k k k k  k  k  ★ • • • • •  ★ ★ • • •  • •
h s E l 5  DADTLLHFATES  
m m E l5  DVDTLLHFATES
T P D G F S C SS SL S A L S L
T P D G F S C SS SL S A L S L
DEPFIQKDVELRIMPPVQENDNGNETESEQPK  
DEPFIQKDVELRIMPPVQENDNGNETESEQPE  
f r E 1 5  SADVLLHFATE! T P H G F SR A SS L SA L S V D E PF IT A E L K E --------------EEEDKGSEQRVEEAP
k k k k k k k k k k  k  k  k k  k  k  k  k  k  k  • k  k  k  k  k
h s E 1 5  ESNENQEKEAEKTIDSEKDLLDDSDDDD-IEILEECIISAMPTKSSRKAKKPAQTASKLP 
mmE15 ESNENQDKEVEK-PDSEKDLLDDSDDDD-IEILEECIISAMPTKSSRKAKKLAQTASKLP 
f  r E 1 5 ----------------------------------------- KAVLDESDDDDDIEILEACINMAMP-KSSRKPKKPQQAAP-----
,  J .  • • k  k  k  k  k  k  k  k  k k k » k k k k k  k  k  k  • k
h s E l 5  PPVARKPSQLPVYKLLPSQNRLQPQKHVSFTPGDDMPRVYCVEGTPINFSTATiRSDLTI  
m m E l5 PPVARK PSQ LPVYK LLPAQNRLQ AQ KH VSFTPG DDVPRVYCVEG TPINI'STAtB3DLTI  
f r E 1 5   RKASQLPVYKLRVQS QPRKDVP-PPAEEVPRVYCVEGTPLNFSTAT&LSDLTI
■jt ★  k k k k k k k k k k k k k k k k k k • k k k k k k k k k k k k k
h s E 1 5  ESPPNELAAGEGVRGGAQSGEFEKRDTIPTEGRSTDEAQGGKTSSVTIPELDDNKAEEGD  
mmE15 ESPPNELATGDGVRAGIQSGEFEKRDTIPTEGRSTDDAQRGKISSIVTPDLDDNKAEEGD  
f r E 1 5  DSPPNEEA A----------------------------------------------------------------------------AV AAA ILPEGPPASTQ ED-
• • • • •  • • •  k •  * • k
h s E 1 5  ILAECINSAMPKGKSHKPFRVKKIMDQVQQASASSSAPNKNQLDGKKKKPTSPVKPIPQN  
m m E l5 ILAECINSAMPKGKSHKPFRVKKIMDQVQQASSTSSGANKNQVDTKKKKPTSPVKPMPQN
f  r E 1 5 --------------RAGHPEGE----------------------------------------NAMTSLPNVSALLCPKPNPGS-----------------Q
.  _     .  . +  _  *  _  .  *  . *  * _
h s E 1 5  TEYRTRVRKNADSKNNLNAERVFSDNKDSKKQNLKNNSKVFNDKLPNNEDRVRGSFAFDS  
m m E l5 TEYRTRVRKNTDSKVNVNTEETFSDNKDSKKPSLQTNAKAFNEKLPNNEDRVRGSFALDS
f r E 1 5  SEWQMTTTTAAKTKP---------------------------------------------------------------------------------------------GFAFDS
.  ......................
8 2 9
8 3 0  
5 7 3
8 8 9





1 0 0 8
1 0 0 8
7 1 8
1 0 6 8
1 0 6 8
7 4 5
1 1 2 8
1 1 2 8
7 7 5
1 1 8 8
1 1 8 8
7 9 6
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h s E l 5  
mmEl 5 
f  r E 1 5
h s E l 5  
mmEl 5 
f r E 1 5
h s E 1 5  
mmEl 5 
f r E 1 5
h s E 1 5
mmE15
f r E 1 5
h s E 1 5  
mmE15  
f  r E 1 5
h s E 1 5
mmE15
f r E 1 5
h s E 1 5  
mmEl 5 




TPY C F SR N D SL SSL
TPY C F SR N D SL SSL




★ • ★ ★ ★ ★ ★ ★ ★ ★ ★  ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★  • k  k
n q q s a n k t q a i a k q p i n r g q p k p i l q k q s t f p q s s k d i p d r g a a t d e k l q n f a i e n | ^
SQQAASKSQASIKHPANRAQSKPVLQKQPTFPQSSKDGPDRGAATDEKLQNFAIENTPVC  
------------------------------------------------- KRKQQTAAVFPRTKAN----------- ATSSD EK Q K FA IEDfPVC
F S H N S S L S S L
F S R N S S L S S L
F S R N S S L S S L







T P V C F S R N S S L S S l  SIDSEDDLLQECISSAMPKKKKPSRLKGDNEKHSPRNMGG
T P V C F SR N SS L SS L
T P V C F SR N SS L SS L
SIDSEDDLLQECISSAMPKKKRPSRLKSESEKQSPRKVGG  
IDSEDDLLQECISSAMPKKKKKAAASATPSTVAAPPAAP
k k k k k k k k k k k k k k k k k k k k k k k k k k k k k k k k k k k k k k k k  •
IL G E DL T L DL K DIQ RPDSE — HGLSPDSENFDWKAIQEGANSIVSSLHQ-AAAAACLSRQ  
ILAEDLTLDLKDLQRPDSE— HAFSPDSENFDWKAIQEGANSIVSSLHQAAAAAACLSRQ  
KAENSILAEEEPPEM PSEVPRSPASPDSESFDW KAIQEGANSIVSSLNAAAAAATSLSRQ
• • • • • k  k  k  k  k  k  k k k k k k k k k k k k k k k k k m  k  k  k  k  •  ★ ★ ★ ★
A S S D S D S IL S L K S G IS L G S P F H L T P D Q ------------------- EEKPFTSNKGPRILKPGEKSTLET
A S S D S D S IL S L K S G IS L G S P F H L T P D Q ------------------- EEKPFTSNKGPRILKPGEKSTLEA
A S S D S D S V L S L K S  VGSPFHLPSANNNAEEDKVDEAEEVAVKRGARILKAGERTTLDA
» * k k k k k k  • ★  • • • • k  k k k k  k k » » k k » »
-  : :: ■ : : g k v r s n s e i s g q m k q p l q a n m p s i s r g r t m i h i p g v
: : G K IRSN SEISSQ M KQ PLPTN M PSISR GR TM IHIPG I
k k e e d e e e a k g v r g g k k v y r s l i t | k v r a e i | ------------------------------------- |A R G R ------------------
★ ★ k  k  k k » » k k k k k k * k k k k k k » k » *  • • •
1 2 4 8
1 2 4 8
8 4 2
1 3 0 8
1 3 0 8
8 7 6
1 3 5 6
1 3 5 7  
9 3 6
1 4 1 6
1 4 1 7  
9 9 6
1 4 7 3
1 4 7 5
1 0 5 6
1 5 2 4
1 5 2 6
1 1 1 3
1 5 8 2
1 5 8 4
1 1 4 9
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: : RNSSSSTSPVSKKGPPLKTPASKSPSEGQTATTSPRGAKPSVKSELSPVARQTP
: RN SSSST SPV SK K G PPL K T PASK SPSE G PG AT T SPR G T K PAG K SE L SPIT R Q T SQ ISG SN
f r E 1 5 ---------------------  S KPRAAAVAKAPGGGDAADHG-------------------------------------------------------------
•  • • » • •  •  ★  •  •  ★  •  ★  - A-  ★  •  •  •  ^  •  •  • •  •  ^
h s E 1 5  J a P SR SG S R D ST P SR P A Q Q P L S R P IQ SP G R N S ISP G R N G IS P P N K L S Q L P R T S SP ST A ST  
m m E l5 K G S SR SG SRD ST PSR PT Q Q PL SRPM Q SPG RNSISPG RNG ISPPNK L SQ L PRT SSPST A ST  
f r E 1 5  G A S S R D S T P S R S S N V N I C j-------------------------------------------- GGKLSQLPRAAS PGSAS S
. # ******** . .  i _****+**;;**_: **:
. KSSGSGKMSYTSPGRQMSQQNLTKQTGLSKNASSIPRSESASKG  
m m E l5 KSSGSGKMSYTSPGRQLSQQNLTKQASLSKNASSIPRSESASKG|LNQMSNGNGSNKKVEL
f r E l f  T S S ------------------ SASRAAKQSGVTKG------ STG TN GLPRSESASR -----------  1 -  -
*  *  .  * *  *  .  . * * * * * * ★ . ^  ^ *  _ *  *
h s E 1 5  SR M SST K SSG SE SD R SE R PV L V R Q ST FIK E A PSPT L R R K L E E SA SF E SL SPSSR P A SPT R  
m m E l5  SR M SST K SSG SE SD R SE R PA L V R Q ST FIK E A PSPT L R R K L E E SA SF E SL SPSSR P D SPT R
f r E 1 5 --------------------------Q KTEPEKPALVRQSTFIKEAPSPTLKRKLEESA------------------------PAAPSE
. _ , * ; * , * * * * * * * * * * * * * * * *  . * * * * * * * .  . *  : * : .
h s E l 5  SQAQTPVLSPSLPDMSLSTHSSVQAGGWRKLPPNLSPTIEYNDGRPAKRHDIARSHSESP  
mmE15 SQAQTPVLSPSLPDMSLSTHPSVQAGGWRKLPPNLSPTIEYNDGRPTKRHDIARSHSESP  
f  r E 1 5 -------------------S P T S P D I F L P S A G --------------------------------------------------------------RRHDVNRSHSESP
* *  . * * .  * * * *  . * * * * * * *
h s E 1 5  S R L P -------------- INRSGTWKREHS----------------------- K H S S S L P lV S T W R R T G S S S S IL S A S S E i
m m E l5 S R L P ---------------INRAGTWKREHS----------------------- K H S S S L p lv S T W R R T G S S S S IL S A S S E J
f r E i s  s r p q e a t s s r f s r t g t w k r e n s s t g a g g g s a g k h s t s l p I v g t w k r t g s s s s v l s a s s e ^
h s E 1 5
mmE15
f r E 1 5
s e k a k s e d e k h v n s i s g t k q s k e n q v s a k g t w r k i k e n e f s p t n s t s q t v s s g a t n g a e s
s e k a k s e d e r h v s s m p a p r q m k e n q v p t k g t w r k i k e s d i s p t g m a s q s a s s g a a s g a e s
SEKGRSEED-------------------------------- GSLRSKGTWRKTK--------------------- SSGGDSSAGRGGS-  -
1 6 4 2
1 6 4 4
1 1 7 0
1 7 0 2
1 7 0 4
1 2 0 7
1 7 6 2
1 7 6 4
1 2 4 8
1 8 2 2
1 8 2 4
1 2 8 7
1 8 8 2
1 8 8 4
1 3 1 3
1 9 2 6
1 9 2 8
1 3 7 3
1 9 8 6
1 9 8 8
1 4 0 8
139
h s E 1 5  KTLIYQMAPAVSKTEDVW VRIEDCPINNPRSGRSPTGNTPPVIDSVSEKANPNIKDSKDN 2 0 4  6 
mmE15 KPLIYQ M APPVSKTEDVW VRIEDCPINNPRSGRSPTG NTPPVIDSVSEK G SSSIK DSK DT 2 0 4  8 
f r  E 1 5 ------------------------ NKAEDVWVRLEDCPVNNPRSSSSCSARSP T S G N A P P II D S P T P S
. ' + . *•*■****.**•*■*. *•*•***_ * . * .
h s E l 5 QAKQNVGNGSVPMRTVGLENRLNSFIQVDAPDQKGTEIKPGQNNPVPVSETNESSIVERT 2 1 0 6  
m in E l5 HGKQSVGSGS- PVQTVGLETRLNSFVQVEAPEQKGTEAKPGQSNPVSIAETAETCI AERT 2 1 0 7  
f r E 1 5  K I L S S S S S S S  SNLNLRRSYESLDDKPPPPERPQQQQRNQQRSGAVAAR ~ U  1 5 0 2
h s E 1 5  PFSSSSSSKH SSPSG TV A A R V T PFN Y N PSPR K SSA D ST SA R PSQ IPT PV N N N T K K R D SK T D ST E SSG T Q SPK R H SG SY L V T S¥ 2 1 8  9 
m m E l5 P FSSSSSSK H SSP SG T V A A RVT PFNYN PSPR K SSA DST SARPSQ IPT PVST NT K K R DSK T DST E SSG A Q SPK R H SG SYL VT SV 2 1 9 0  
f r E 1 5  P F N Y T P SP R K SN ------------- A D A S S T S T T P T T T P S S S S A T P P R P S L IP T P V ------ TKKREPKGGEGGAGGGGAS-GERGSYIVTSV 1 5 7  5
k  k  •  k  •  •  k  • • •  k  • k  • k  k  •  k k k k k k k k  k  k  k  k  m k  • • k k k » k k k k
Figure. 5.8. Clustal W aligment of the Apcl amino acid sequences. Alignment of the human, mouse and Fugu Apcl translated exons. Specific 
motifs are shown: oligomerisation domain (grey box), armadillo region (yellow box), 15aa repeat (red box), 20aa repeat (green box), basic 
domain (dark green box), EB1 binding site (pink box), HDLG binding site (blue box) and SAMP repeats (blue characters)..
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5.3.5.2. Amino Acid sequence of the Fugu Apc2
The Apc2 gene codes for 14 coding exons, the deduced frApc2 amino acid
sequence from exon 8 to 14 extends over 2148aa, although the length of each 
translated exon is well conserved with the human and mouse exons, exon 14 is 155aa 
longer than the human and 137aa longer than the mouse exon 14 (Table 5.6).
The first Fugu exon codes for 40aa, this is because the sequence that codes for 
the first seven amino acids is not present in the scaffold, however, the amino acids 
present in the exon show 90% conservation with the mouse and human exon. The 
remaining exons are well conserved in the three species. In the Apc2, most of the 
specific domains are encoded by the exon 14; the overall conservation of the exon is 
59.47%.















Table 5.6. Amino acid conservation of the Apc2. Alignment of the aa sequence of 
each exon was done to estimate the number of aa conserved and percentage of 
conservation among human, mouse and Fugu. The Fugu aa sequence was used to 
estimate the level of conservation.
The Apc2 protein is very closely related to its paralogue Apcl, six of the 
seven main domains of the protein are present in the Apc2 protein with exception of 
the 15aa repeat (van Es etal. 1999), as mentioned earlier, it contains 14 exons, the last 
exon encodes for most of the specific domains of the protein. We used the alignment 
produced for each translated exon and the domains characterized in the mouse Apc2
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to identify the specific protein domains of the frApc2. Table 5.7 shows the number of 
amino acids and the degree of conservation (in %) of each domain between the 
human, mouse and Fugu. Interestingly, none of the specific domains of the protein are 
located in the exons 3 to 7, which are the missing exons in the frApc2.
The oligomerisation domain is encoded within the first and second exons of 
the gene; the exons 9, 10, 11, 12, 13 and 14 encode the seven armadillo repeats and 
the remaining specific domains are encoded by exon 14. The basic domain, the EB1 
binding site and the HDLG binding site show a low level of conservation (50.50, 
44.81 and 50% respectively). The low level of conservation shown by the Fugu EB1 
binding domain is due to the difference in length, it is 21aa longer than the human and 
mouse domain. The Apc2 20aa repeats also contain the same TPXXFSXXXSL 
characteristic signature, however only six repeats were identified within this core 
sequence (Figure 5.9).
Amino acid Domain Num. of aa conserved
Percentage of 
conservation
6- 57 Oligomerisationdomain 47/51 92.15%
453- 767 Armadillo region 303/314 96.49%
1020- 1170 15 aa repeat - -
• 13/14 92.85%
14/14 100%





2200-2400 Basic Domain 101/200 50.50%
2559- 2771 EB1 binding site 95/212 44.81%
2772-2843 HDLG binding site 36/72 50.0%
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Table 5.7. Specific domain conservation of the Apc2. Specific domains were 
delimited using the described domains in the mouse Apc2. The number of aa and 
percentages are the conservation among human, mouse and Fugu domains.
The two Fugu SAMP repeats are also located after the fourth and seventh 20aa 
repeat; the first repeat is 29aa in length, the same length than human and mouse, it is 
89.65% conserved (26/29aa) with the mouse and human repeat (Figure 5.9). The 
second Fugu SAMP repeat is three amino acids shorter than the mouse and human, it 
is 65.38% conserved (17/26aa).
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h s E l  MASSVAPYEQLVRQVEALKAENSHLRQELRDNSSHLSKLETETSGMK 4 7  
mmEl MTSSMASYEQLVRQVEALKAENTHLRQELRDNSSHLSKLETETSGMK 4 7
f r E l  ---------------- YDQLAHQVAALRKENCHLRRELEDNSNQLSKLETETFGMK 4 0
*  ★ .  *  *  * * * • * ■ ■ * ■ ■ * ■ * *  *  *  *
h s E 2  IVLKHLQGKLEQEARVLVSSGQTEVLEQLKAL 3 2  
mmE2 $VLKHLQGKLEQEARVLVSSGQTEVLEQLKAL 3 2  
f r E 2  EVLKQLQSKLEQEAGTLASSGRSDVLHQLK—  3 0
h s E 8  VEVVFWLLSMLATRDQEDTARTLLAMSSSPESCVAMRRSGCLPLLLQILH--------GTEAAA 5 6
mmE8 VEVVFWLLSMLATRDQEDTARTLLAMSSSPESCVAMRRSGCLPLLLQILH--------GTEAGS 5 6
f r E 8  VEMVFWLLSILTNRDKDEMSRTLLALSSSPDSCIAMRKSGCVPLLVQILHDGSGGTSSLE 6 0
h s E 8  GGRAGAPGAPGAKDARMRANAALHNIVFSQPDQGLARKEMRVLHVLEQIRAYCETCWDWLQARDGGPEGGGAGSAP- 1 3 2
mmE8 VGRAGIPGAPGAKDARMRANAALHNIVFSQPDQGLARKEMRVLHVLEQIRAYCETCWDWLQARDSGTE----------- S A P -  1 2 7
f r E 8  QSASCATVTGCSREAKSRASATLHNIIFCQQDEGQARREKRVLLLLEQIRTHCDTGWDWIENHTVTSTG--------- TRTN 1 3 3
.   ^ * * * * * * * * * * *  * .  *  *  *  . *  *  *  *  . * * * * * . . * , *  * * *  .  .
h s E 9   IPIEPQICQATCAVMKLSFDEEYRRAMNELGG 3 2
mmE9  VPIEPQICQATCAVMKLSFDEEYRRAMNELGG 3 2
f r E 9  DVPEPMDPQICQAVCAIMKLSFEEEYRHALKELG- 3 3  
* . . * * * * * * ^ * * .  * * * * * .  * * * * . * .  . * * *
h s E l O  LQAVAELLQVDYEMHKMTRDPLNLALRRYAGMTLTNLTFGDVANK 4 5  
mmElO LQAVAELLQVDYEMHKMTRDPLNLALRRYAGMTLTNLTFGDVANK 4 5 
f r E l O  LQVIAELIHLDQETHGMQNDPINMALRRYAGMAMTNLTYGDVVNK 4 5  
* *  ^  . * * * . . . *  *  *  *  _ * * . * . * * * * * * * * . . * * * * . * * * _ * *
h s E l l  ATLCARRGCMEAIVAQLASDSEELHQ 2 6  
m m E l l  ATLCARRGCMEAIVAQLGSESEELHQ 2 6  
f r E l l  ATLCSKRSCLQALVAQLASDSEELHQ 2 6  
**** . ; .*.****_*.******
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h s E 1 2  VVSSILRNLSWRADINSKKVLREAGSVTALVQCVLRATK 3 9  
m m E l2 WSSILRNLSWRADINSKKVLREVGSMTALMECVLRASK 3 9  
f r E 1 2  W SSILRNLSW RADINSKRVLRDIGCVSALM TCALQATK 3 9
h s E 1 3  ESTLKSVLSALWNLSAHSTENKAAICQVDGALGFLVSTLTYKCQSNSLAIIESGGGILRNVSSLVATREDYRQ 7 3  
m m E l3 ESTLKSVLSALWNLSAHSTENKAAICQVDGALGFLVSTLTYRCQGNSLAVIESGGGILRNVSSLIATREDYRQ 7 3  
f r E 1 3  EST LKSILSALW NLSAHSIDNKVAICSVDGALGFLVSTLTYRCQTNSLAIIESGGGILRNVSSLVATREDYRQ 7 3
h s E l 4 VLRDHNCLQTLLQHLTSHSLTIVSNACGTLWNLSARSARDQELLWDLGAVGMLRNLVHS 5 9  
m m E l4 VLRDHNCLQTLLQHLTSHSLTIVSNACGTLWNLSARSPRDQELLWDLGAVGMLRNLVHS 5 9  
f r E 1 4  ILRDHNCLQTLLQHLRSHSLTIVSNACGTLWNLSARSSKDQELLWELGAVSMLRNLIHS 5 9
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Figure. 5.9. Clustal W aligment of the Apc2 amino acid sequences. Alignment of the human, mouse and Fugu Apc2 translated exons. Specific 
motifs are shown: oligomerisation domain (grey box), armadillo region (yellow box), 20aa repeat (green box), basic domain (dark green 
box), EB1 binding site (pink box), HDLG binding site (blue box) and SAMP repeats (blue characters).
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5.4. Discussion
The tumour suppressor gene Apcl codes for a multifunctional protein that 
performs both signalling and structural functions. One of the main roles of this protein 
is in the Wnt pathway, where it acts as a component of the p-catenin suppressor 
complex together with the axin and GSK-3 proteins. Ape 1 is also involved in cell 
adhesion and maintaining the internal cell scaffold. The second member of the Ape 
family is Apc2, which shares most of the functional domains of the protein and is able 
to down regulate cellular p-catenin (Nakagawa et al. 1998).
Using a comparative genomics approach, the Fugu Apcl and Apc2 genes were 
identified from the Fugu genomic database. The transcriptional organisation of both 
genes shows no conservation with the mouse and human genomic organisation. 
However, gene structure, nucleotide and amino acid sequences are well conserved, 
especially the functional domains of the protein. Moreover, the tissue distribution of 
the genes seems to be well conserved across species.
Niether of the Fugu Ape genes has any synteny with either of the mammalian 
Ape genes containing genomic regions. However, there is also no synteny between the 
mouse and human Apc2 containing genomic regions. Most importantly, the intergenic 
distances in both Fugu Ape genes are enormously reduced compared to the 
mammalian genes; this feature is useful to locate regions involved in the regulation of 
the genes.
The gene structure of the Fugu Ape genes is highly conserved when compared 
to the vertebrate Ape genes, especially for the Apcl, where the exon length and intron 
exon phases are well preserved. For the existing Apc2 exons that were characterised 
there is also high degree of homology with the mouse and human.
We were unable to identify the complete Apc2 sequence using a comparative 
genomics approach, however, our finding of the first two coding exons would 
facilitate the completion of the gene; specific PCR primers can be designed for 
remaining exons and complete the structure and coding sequence of the gene.
Previous studies have identified the expression of Ape genes in a wide range 
of foetal and adult tissues; both genes are highly expressed in whole brain and foetal
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brain, and both of them have similar levels of expression in the tissues where they are 
expressed (van Es et a l 1999). Expression analysis by RT-PCR shows that Fugu 
Apcl is expressed in all the adult tissue and embryo stages tested; this expression 
matches with the pattern of expression reported for mouse Apcl. The expression 
analysis of the frApc2 reveals expression of the gene during development in the whole 
embryo, which agrees with the expression reported for the human APC2 that is 
expressed in the foetal brain. The expression obtained in the heart also concurs with 
the expression reported for hAPC2. However, van Es et al. (1999), by probing dot 
blots of normalized poly (A) mRNA, reported a very high expression of the hAPC2 
transcript in the spinal cord and a low level of expression in the small intestine and 
foetal kidney. In contrast with these results, we did not obtain expression in these 
Fugu adult tissues. Although we found expression in the whole embryo, it could be 
that the Apc2 is expressed only in the developing kidney and stops once the organ 
completes its formation. With respect to the spinal cord and gut tissue, we have not 
found a possible explanation. However, our results of the kidney and gut expression 
agree with the results reported in the MGI database for the mouse Apc2 (see Table 
5.3).
Studies performed in the N-terminus of the protein showed that the first 177aa 
are sufficient and the first 55aa of the protein are necessary for the formation of 
homodimers (Su et al 1993). This region is encoded by the first and second exons in 
both the Ape genes, which is highly conserved in Fugu. The armadillo repeats, which 
are coded by the exons 10 to beginning of 15 in the frApcl, and the exons 9 to 
beginning of 14 in the JrApc2, are involved in nuclear transport, cell cycle control and 
microtubule stability. They have an overall conservation of more than 96% when 
compared with the human and mouse. The high degree of conservation may indicate 
that the Fugu Ape proteins carry out the same activities of the mouse and human 
proteins. The armadillo repeat also binds to the Rac-specific guanidine nucleotide 
exchange factor Asef (Kawasaki et a l 2000); this complex regulates the actin 
cytoskeleton, cell morphology and migration.
The three 15aa repeats and the seven 20aa repeats bind to p-catenin, although 
only the 20aa repeats seem to be essential for this interaction. The frApcl 15aa 
repeats have a low degree of conservation compared with mouse and human, whereas 
this domain is not present in the Apc2 proteins.
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The 20aa repeats are well conserved in the frApc proteins, suggesting that the 
function of the domains in Fugu may be in the Wnt pathway, regulating the levels of 
P-catenin in the cell. The SLSSL motifs in the 20aa repeats are well conserved in the 
Fugu APC genes; these motifs have been involved in the intercellular cell adhesion. 
The nuclear signal LXXL/I/M/V that are contained in the 3rd, 4th and 7th 20aa repeats 
in human and mouse are also present and conserved in the frApcl and the 7th repeat in 
the frApc2.
The three and two SAMP repeats of the frApcl and ffApc2 respectively are 
placed in the same positions than in the human and mouse, with around 80% of 
conservation for most of the repeats. The SAMP domains act in the binding of axin 
and axin-conductin, a complex necessary for the inhibition of the Wnt pathway.
In human and mouse, the basic domain involved in microtubule association is 
a very rich region of proline (P), arginine (R) and lysine (K) residues (Polakis 1997). 
Interestingly, the frApcl basic domain seems to lack these residues (see Figure 5.8), 
whereas the frApc2 retains them (see Figure 5.9).
Finally, the EB1 and hDLG domains contained in the C-terminal end of the 
APC proteins are much better preserved in the frApcl than in the frApc2. The EB1 
site is associated to the binding of microtubules during mitosis, and the hDLG site is 
involved in cell-cell contact. As in the N-terminal, the conservation of the Fugu C- 
terminal suggests that the frApc proteins perform the same functions in the cell that 
the mammalian Ape proteins.
In general, the Fugu Ape proteins are well conserved between the human and 
mouse proteins, mainly in the functional domains of the proteins. Although functional 
assays are necessary to confirm the functions of the Fugu Ape, the high conservation 
of the gene and protein, and the tissue distribution showed by the frApc genes strongly 
suggests that the role of these proteins in Fugu is exactly the same as the vertebrate 
proteins. This high degree of conservation indicates that the regulation of the genes 
may be conserved across species, which means that the regulatory region and 
transcription factors involved in this regulation may be preserved. In addition, the 
analysis of the transcriptional organisation of the frApcl already shows that the 
intergenic distances are much reduced in Fugu than in mammals, facilitating the 
screening for conserved regulatory regions in the non-coding sequences of the gene.
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6.1 Introduction
The Cdxl and Cdx2 homeodomain proteins are key players in the regulation 
of the differentiated intestinal epithelium along the crypt villus axix. The Cdx2 
protein activates and regulates the expression of genes involved in cell proliferation 
and differentiation such as sucrase isomaltase, carbonic anhydrase 1, apolipoprotein 
B, the pancreatitis associated protein I (PAPI), cyclin D1 among others (Suh et al 
1994; Drummond et a l 1996; Lee et a l 1996). The Adenomatous Polyposis Coli, a 
multifunctional protein involved in cell adhesion, cell migration and in the canonical 
Wnt signalling pathway, is also expressed in intestinal epithelium. APC is often 
mutated in colorectal cancer, where truncated versions of the APC protein are unable 
to down regulate p-catenin, allowing this protein to enter into the nucleus, form a 
transcriptional complex with TCF/Lef transcription factors, and as a complex activate 
a repertoire of genes.
APC is also expressed in a variety of tissues in the central nervous system 
such as olfactory bulb, hippocampus, brain stem, spinal cord, dorsal root ganglia and 
cerebellum; and it has also been associated to brain tumours (Senda et a l 1998). 
Many alternative transcripts have been identified for the Ape, however, two main 
transcripts of 10 and 12Kb in length have been identified in brain with approximately 
similar level of expression in this tissue. The 10Kb transcript is also expressed in 
lung, liver, skeletal muscle, testis and kidney; the 12Kb transcript is also expressed in 
these tissues, but in a lower intensity (Wedgwood et a l 2000).
Although several studies have addressed the role of Ape in the maintenance of 
the intestinal epithelium and its function in colorectal cancers, little is known about 
the regulation of the Ape gene in the intestinal epithelium.
It is likely that the Ape gene is positively regulated by Cdx2 and negatively 
regulated by Cdxl in the intestinal epithelium in accordance with the expression 
pattern and function that each Cdx factor plays in the crypt villus intestinal axis. Ape 
and Cdx2 exhibit the same expression gradient in the intestinal epithelium (James et 
al 1994; Jette et a l 2004); APC and Cdx2 are able to regulate the expression of the 
retinol dehydrogenase L (RDHL), an enzyme required for the conversion of retinol 
into retinoic acid; retinoids induce cell differentiation, decrease cell proliferation and 
increase cell adhesion (Jette et a l 2004). Although the mechanism in which RDHL is
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regulated is unclear, this may not be via Ape regulating Cdx2; studies show that 
familial adenomatous polyps (FAP) tissues express normal levels of Cdx2 (Hinoi et 
al 2001). Inactivation of Cdx2 or APC results in the development of multiple 
intestinal polyp lesions (Beck et a l 1999) and Apc+/- Cdx2+I- mice show more 
colonic polyps than the Apc+/- Ccbc2+/+ mice (Aoki et a l 2003).
Combinations of different transcription start sites make the Apcl gene a 
difficult target to study its regulation. A variety of transcripts have been identified in 
human colon and brain and different spliced forms have been described in mouse, rat 
and human (Santoro and Groden 1997). Transcripts containing combinations of 
different untranslated exons have also been identified, such as 0.3, 0.2 and 0.1 exons 
in combination with exons 1A or IB (Horii et a l 1993). The 0.3/1 A transcript was 
identified to contain a TATA less promoter; reporter assays carrying lOObp upstream 
of the 0.3 exon showed expression of the reporter in colon carcinoma cells (Thliveris 
et al 1994). Recently, a new mApcl promoter was localized about 40Kb upstream 
from the ATG; neither TATA nor CAAT boxes were identified in this promoter, but 
potential Spl, AP2, API, YY1 and C/EBP binding sites were identified, this promoter 
was found to be active in a mouse embryonic stem cell line (Karagianni et al 2005).
Using sequence analysis, I have identified Cdx binding motifs in the 5’ 
upstream regionof the mApc gene. Promoter activity has already been seen for the 
sequence located upstream of the exon 0.3 in the human and mouse Ape gene. The 
exon 0.3 is the most 5’ exon of the Ape gene. We asked whether a 607bp region 
upstream of the mouse Ape contains the necessary elements to drive the expression of 
the gene in intestinal cells. We performed a series of transfection and transactivation 
studies in CaCo2 and IEC-6 cells in order to investigate the regulation of Ape. And we 
investigated whether Cdxl or Cdx2 transcription factors activate or repress expression 
of Ape in intestinal cells. This chapter also describes a comparative analysis 
performed to locate conserved non-coding regions and TFBS with potential value for 
the regulation of the Fugu and mouse A pcl.
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6.2 Methods
6.2.1. Transfection and transactivation assays
CAT activity of the promoter constructs was measured relative to the 
promoterless pCAT Basic, pCAT Control (Promega), containing SV40 promoter and 
enhancer sequences, was used as a positive control (Appendix section 4A). A 607bp 
fragment spanning positions -290 to +317 of mApc was subcloned, in the correct 
orientation, upstream of the CAT gene to generate p ^ c S P  (Wedgwood et al., 2000). 
Transactivation assays were performed using expression vectors containing the cDNA 
of Cdxl (CMV-Cdxl), Cdx2 (CMV-Cdx2) provided from Dr. V. Subramanian, and 
GATA4 (pCDNA-GATA4) from Invitrogen (Paisley, UK). PBSKS2+ (BSK) from 
Promega (Southampton) was used to level the amount of DNA for each sample and as 
a negative control for transactivation.
The upstream sequence of the mApc gene (GeneBank accession number 
AF209031) was analysed using the Transcription Element Search System (TESS) 
program and the Searching Transcription Factor Binding Sites (TFSEARCH) 
program.
Based on the results of the analysis of the Ape upstream sequence, transfection 
and transactivation assays were planned and performed. Further assays were 
performed, whose relevance was suggested by the results of the former assays.
6.2.2. Cloning of the upstream sequence of the Fugu Apcl
PCR primers were designed based on the upstream sequence of the Fugu Apcl 
gene. The oligonucleotides primers synthesized are: 4.0Kb FW frApcl (5’-ta gga tcc 
tcc aaa teg gtg ate tgt gtc cc-3’) to produce a 4.0Kb PCR product, 2.0Kb FW frApcl 
(5’-ag gga tcc tcc ga agg gca gaa gtc caa atg-3’) to produce a 2.0Kb PCR product and 
1.0Kb FW frApcl (5’-gc gga tcc tcc cac cct get tta ctg att aa-3’) to generate a 1.0Kb 
PCR fragment. A BamHI site was added to these three forward primers. To the 
reverse primer, RV frApcl (5’-ta ctcgag tcc gtt gga gga tgc agg ttt ga-3’) anX h o lsite 
was added. The Bac: b227B17xl from the Fugu genomic Bac library (Elgar et al. 
1999) was used as a template.
PCR was performed in a Perkin Elmer thermo- cycler. The reaction mix was 
as follows: 5pl buffer (10X), 3jli1 MgCh (50mM), lpl dNTPs (lOmM), primers lpl 
each (10pM), lpl DNA and 0.5pl ROCHE™ Taq polymerase (1.5 U/pl) and 37.5pl
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of H2O. Amplification was achieved with an initial denaturation at 94°C for 2mins, 
followed by 35 cycles of 20sec annealing at 60°C, 2min extending at 72°C (2min for 
the 1 and 2Kb fragments and 4mins for the 4Kb fragment) and lmin denaturing at 
95°C, then a final 5min extension at 72°C. The products of the reaction were checked 
by running a 2pl aliquot on a 1% agarose 0.5X TBE gel.
6.2.3. Transgene constructs of the Fugu Apcl gene
All PCR products were run in a IX TAE agarose gel and the band excised and 
electroeluted. This was then dissolved in 85pl of H2O, IOjliI  10X buffer and 5pl 
restriction enzyme (5U) and incubated at 37°C for 2hrs. The digested DNA was then 
phenol /chloroform extracted and precipitated with ethanol. The fragment was then 
ligated into the T ends of the pGEM-T vector (Promega). Constructs were sequenced 
using the T7 and SP6 primers.
The pCS2 CMV-GFP (Muller et a l 2002) was modified by excising the CMV 
promoter using the Sall/Hindlll sites. Sites were blunted by T4 polymerase (ROCHE) 
and the vector was religated.
Construct 4Kb frApcl GFP was generated by subcloning the BamHI/XhoI 
fragment in pGEM-T into the BamHI/XhoI site of the pCS2 GFP'CMV, Construct 2Kb 
frApcl GFP was generated by subcloning the BamHI/XhoI fragment in pGEM-T into 
the BamHII/XhoI site of the pCS2 GFP'CMV and Construct 1Kb frApcl GFP was 
generated by subcloning the BamHI/XhoI fragment in pGEM-T into the BamHI/XhoI 
site of the pCS2 GFP'CMV (Appendix section 4B).
6.3 Results
6.3.1 Characterisation of the mApc regulatory region
We found that Cdx binding sites are present upstream of the mApc 
Transcription Start Site (TSS). Six putative Cdx binding sites were found upstream of 
the TSS, positions -7, -50, -78, -233, -251 and -282bp; one Cdx binding site was 
found at position +18 and putative GATA binding sites were found at positions -215, 
-184 and +60bp relative to the TSS (Figure 6.1). Other transcription factor binding 
sites found in the 600bp mApc region include, Octl, Apl, Ap2, HNF1 and Nkx2.
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Figure. 6.1. Structure of the upstream region of the mApc gene analysed using the 
TESS and TFSEARCH programs. The yellow boxes indicate the Cdx binding 
sites and the green box indicates the GATA binding sites, the TSS is 
underlined and part of the exon 0.3 is indicated in a red box.
6.3.2 Endogenous Cdx activates transcription of mApc gene
Transfection assays were used to examine the ability of endogenous Cdx 
factors to activate transcription of an mApc-CAT reporter vector containing two single 
Cdx motifs upstream of the TSS. CaCo2 cells were transfected with CAT reporter 
vectors, and a p-galactosidase control vector. The reporter showed a 6.47 fold- 
increase in induction when compared to pCAT- Basic (Figure 6.2), indicating that 
endogenous factors like Cdx could be interacting with the mApc promoter region.
158
Chapter Six: Cis-regulatory elements in the mouse and Fugu Apcl J.L. Juarez-Morales 2005
35 -I 
30 -
pCAT-Control prrV\PC-CAT pCAT-Basic BSK untransfected
Figure 6.2. Activation of the mApc upstream region in CaCo2 cells. CaCo2 cells 
were transfected with pCAT- Basic, pCAT- Control, pmApc- CAT and 
pNLsltfcZ or pllLacZ  (0.5 pg) as a normalization vector. The -290/+317 
Ape fragment showed a 6.47 fold induction in comparison with the pCAT- 
Basic vector.
6.3.3 Cdx2 activates the mApc regulatory region
Transactivation analysis was performed in IEC-6 cells, which do not express 
Cdxl or Cdx2 factors. The IEC-6 cells were transfected with the pCAT expression 
vectors, the CM\-Cdx2 expression vector and a p-galactosidase control vector. Cdx2 
enhanced the reporter transcription by approximately 2.77 fold when compared to the 
promotorless pCAT- Basic (Figure 6.3).
The pmApc-CATIQMN-Cdx2 normalized values were compared with the 
pCA T-Basic/CMV-Cdx2 normalized values using a 2-sample t test with unequal 
variances. The 2 datasets (pmApc-CAT/CMV-Cdx2 and pCAT-Basic/CMW-Cdx2) 
followed a normal distribution. The activity showed by the pmApc-CAT/CMW-Cdx2 
is significantly higher than the pCAT-Basic/CMV-Cdx2 activity (t=14.24, n=3, 
P=0.005). This result indicates that Cdx2 is able to activate the mApc regulatory 
region in intestinal cells. This result suggests that other factors are involved in the 
regulation of mApc gene.
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Figure 6.3. Transcriptional activation of mApc upstream region by Cdx2. IEC-6 cells 
were transfected with pCAT- Basic, pCAT- Control, pmApc- CAT (lpg), 
CM\-Cdx2 (0.5 pg) and pNLsLacZ or p21LacZ (0.5 pg). Cdx2 is able to 
drive the expression of the reporter by 2.77 fold in comparison with pCAT- 
Basic vector. The grey bars indicate the activity of the pCAT vectors plus the 
CM\-Cdx2 vector; the white bars indicate the activity of the pCAT vectors 
used without the presence of the CMV- Cdx2 vector. Each bar represents the 
average fold of induction of normalized values ± range bars of triplicate points 
of three independent experiments.
6.3.4 Cdx1 does not activate the mApc upstream region
A transactivation analysis was performed in IEC-6 cells. The IEC-6 cells 
were transfected with the pCAT expression vectors, the CMV-Cdxl expression vector 
and a (3-galactosidase control vector. Cdxl did not enhance the reporter transcription 
when compared to the promotorless pCAT- Basic (Figure 6.4). The result of these 
transactivations suggests that Cdxl is not acting as an activator of the mApc gene in 
intestinal cells.
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Figure. 6.4. Transcriptional activation of mApc upstream region by Cdxl. IEC-6 cells 
were transfected with pCAT- Basic, pCAT- Control, pmAPC- CAT (lpg), 
CMV-Cdxl (0.5 pg) and pNLsZacZ, or yllLacZ  (0.5 pg). Cdxl vector and 
pCAT- Basic vector show the same expression of the reporter, indicating that 
Cdxl is unable to drive the expression of the reporter. The grey bars indicate 
the activity of the pCAT vectors plus the CMV-Cdxl vector; the white bars 
indicate the activity of the pCAT vectors used without the presence of the 
CMV-Cdxl vector. Each bar represents the average fold of induction of 
normalized values ± range bars of triplicate points of three independent 
experiments.
6.3.5 Cdxl represses the expression of mApc over the activation of 
Cdx2
A transactivation analysis was done using IEC-6 cells. The IEC-6 cells were 
transfected with the pCAT expression vectors, the CMV-Cdx2 expression vector, 
CMV-Cdxl expression vector and a (3-galactosidase control vector. Cdxl repressed 
the activity of the reporter; no induction was obtained when compared to the 
promotorless pCAT- Basic (Figure 6.5). The initial activity showed by Cdx2 (2.77 
fold induction) in the second experiment was repressed by the presence of Cdxl, 
suggesting that Cdxl may compete for the binding sites present in the upstream 
sequence of mApc and repress the activity of the gene in intestinal cells.
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□ +Cdx1/Cdx2
□ -Cdx1/Cdx2
Figure. 6.5. Transcriptional activation of mApc upstream region by Cdxl and Cdx2. 
IEC-6 cells were transfected with pCAT- Basic, pCAT- Control, pmAPC- CAT 
(lpg), CMV-Cdxl (0.5pg), CM\-Cdx2 (0.5pg) and pNLsLacZ or p27LacZ 
(0.5 pg). Cdxl repressed the expression of the reporter over the activation of 
Cdx2, there was no induction compared to the pCAT- Basic vector. The grey 
bars indicate the activity of the pCAT vectors plus the CMV-Cdxl and CMV- 
Cdx2 vectors; the white bars indicate the activity of the pCAT vectors used 
without the presence of the CMV-Cdxl and CMV-Cdx2 vectors. Each bar 
represents the average fold of induction of normalized values ± range bars of 
triplicate points of three independent experiments.
6.3.6 GATA4 does not activate the mApc upstream region
IEC-6 cells were transfected with the pCAT expression vectors, the pCDNA- 
GATA4 expression vector and a (3-galactosidase control vector. Knowing that 
GATA4 is an activator transcription factor in the intestinal epithelium, we asked if 
this transcription factor would be able to enhance the expression of mApc in IEC-6 
cells to the level of expression shown by the construct in CaCo2 cells. The 
transactivation assay showed that GATA4 does not enhance the reporter transcription 
over the promotorless pCAT- Basic (Figure 6.6).
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Figure. 6.6. Transcriptional activation of mApc upstream region by GATA4. IEC-6 
cells were transfected with pCAT- Basic, pCAT- Control, pmAPC- CAT(lpg), 
pCDNA-GATA4 (0.5pg), and pNLsLacZ or p27LacZ (0.5 pg). GATA4 does 
not activate the expression of the reporter in comparison with pCAT- Basic 
vector. The grey bars indicate the activity of the pCAT vectors plus the 
pCDNA-GATA4 vector; the white bars indicate the activity of the pCAT 
vectors without the presence of the pCDNA-GATA4 vector. Each bar 
represents the average fold of induction of normalized values ± range bars of 
triplicate points of three independent experiments.
6.3.7 GATA4 may act as a repressor of mApc
IEC-6 cells were transfected with the pCAT expression vectors, the CMV- 
Cdx2 and yCBN\-GATA4 expression vectors and a (3-galactosidase control vector. 
The reporter activity showed by the pmApc-CAT vector was 1.65 fold induction when 
compared to the promotorless pC4T-Basic (Figure 6.7). This result may suggest that 
GATA4 is able to repress to some extent the expression of mApc over the activation 
of Cdx2 (2.77 fold). A 2-sample t test with unequal variances was used to compare 
the pmApc-CAT/CM'V-Cdx2/pCDNA-GATA4 normalized values with the pCAT- 
BsLSic/CMV-Cdx2/pCDNA-GATA4 normalized values. The 2 datasets followed a 
normal distribution. The activity showed by the pmApc-CAT/CMV-Cdx2/pCDNA- 
GATA4 is significantly higher than the basal activity (t=3.60, n=3, P=0.037).
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However, the comparison between the pmApc-CAT/CMV-Ccbc2/pCDNA-GATA4 
(1.65+0.27 fold) and pmApc-CAT (1.45+0.05 fold) do not show a considerable 
difference in activity. This result suggests that even though the activity of mApc was 
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Figure. 6.7. Transcriptional activation of mApc upstream region by Cdx2 and 
GATA4. IEC-6 cells were transfected with pCAT- Basic, pCAT- Control, 
pmApc- CAT (lpg), CM\-Cdx2 (0.5pg), pCDNA-Gz!7M4 (0.5pg), and 
pNLsIacZ or \>T!LacZ (0.5 pg). GATA4 seems to express the reporter 
expression of mApc (1.65+0.27 fold, P=0.037) in comparison with pCAT- 
Basic vector. However, the difference in activity between the mApc plus 
Cdx2/GATA4 and the mApc without Cdx2/GATA4 (1.45+0.05 fold) is not 
significant. The grey bars indicate the activity of the pCAT vector plus the 
CWJ-Cdx2 and $CDN\-GATA4 vectors; the white bars indicate the activity 
of the pCAT vectors only. Each bar represents the average fold of induction of 
normalized values ± range bars of triplicate points of three independent 
experiments.
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6.3.8 C dxl and GATA4 do not activate the mApc upstream region
IEC-6 cells were transfected with the pCAT expression vectors, the CMV- 
Cclxl and pCDNA-GATA4 expression vectors and a p-galactosidase control vector. 
Cdxl and GATA4 did not enhance the reporter transcription when compared to the 
promotorless pCAT- Basic (Figure 6.8). The result of this transactivation corroborates 
that Cdxl does not act as an activator of the mApc gene and GATA4 may not be 
involved in the regulation of mApc when tested in intestinal cells.
Figure. 6.8. Transcriptional activation of mApc upstream region by Cdxl and 
GATA4. IEC-6 cells were transfected with pCAT- Basic, pCAT- Control, 
pmApc- CAT (lpg), CMV-Cdxl (0.5 pg), pCm\-GATA4  (0.5 pg) and 
pNLsLacZ, or p27LacZ. Cdxl and GATA4 were unable to drive the 
expression of the reporter in comparison with pCAT- Basic vector. The grey 
bars indicate the activity of the pCAT vectors plus the CMV-Cdxl and 
pCDNA-GATA4 vectors; the white bars indicate the activity of the pCAT 
vectors used without the presence of the CMV-Cdxl and pCDNA-GATA4 
vectors. Each bar represents the average fold of induction of normalized 
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6.4. Characterization o f the f r A p d  upstream  region  
6.4.1 Analysis of the frA pd  non-coding region
To identify the conserved non-coding regions in the Fugu Apcl upstream 
region, a comparative analysis was done using the human, mouse and Fugu Apcl 
upstream sequences. The human and mouse Apcl upstream sequences were extracted 
from the Ensembl database; to locate and prepare an annotation file, each sequence 
was blast against the 0.3 mApcl sequence (NCBI accession number: AF209032), 
producing a 73.25% and 98.42% sequence identity respectively. The Fugu Apcl 
upstream sequence was extracted from the Fugu Databse (M000281, see chapter 5).
A multiple alignment was done using the Mlagan program; the mouse 
upstream sequence was used as base sequence. The mouse and human 0.3 exon 
sequences aligned in the predicted position, the Fugu upstream sequence failed to 
produced any significative alignment with the mouse 0.3 exon (Figure 6.9). A 
multiple alignment using the Fugu upstream sequence as a base sequence also failed 
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Figure. 6.9. Vista plot representing the Fugu, mouse and human upstream and coding 
sequence alignment. The mApcl sequence was used as base sequence for the
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alignment. The mouse and human (m/h) contain conserved non-coding region 
in the upstream and intronic regions of the gene. The mouse and Fugu 
alignment (m/f) failed to produce any conserved non-coding region. The 
5’UTR is indicated in light blue, the 0.3 exon and each coding exon are in 
dark blue.
6.4.2. TFBS in the frApd  upstream region
A 4.0Kb frA p d  upstream region was isolated to investigate putative TFBSs 
present in the sequence. Based on the literature, potential transcription factors or TF 
complexes were located according to their position in the GFP constructs (see section
6.2.3.). The predicted transcription factors are summarized in table 6.1.
TFBS in the f r A p d  upstream region
4.0Kb f r A p d  G F P 2.0Kb f r A p d  G F P 1.0Kb f r A p d  G F P
GATA1/CDX CEBPp/CDX/CEBPa GATA2/GATA1 CDX/CDX/AP1
GATA1/CDX/AP4 CDX/CDX/CEBP [3 SP1/GC box AP4/CDX/GATA1
GATA2/GATA1/AP4 TATA/CDX/CEBPa SP1/GATA2/GATA1 GATA1/Sox5/CDX
cEts/cEts/CDX TATA/GATA/OCT1 AP4/CCAAT/GATA1/AP4 AP4/CDX
Ap1/Oct1/Ap1/CDX/ Ap1 CDX/GATA1/CDX SP1/GCbox/SP1/AP4 CDX/Sox5/Ets/CDX/OCT1
CDX/TATA GATA2/CEBP0/CDX GATA1/CDX/GATA2 GATA1/CEBP
AP1/CDX/HNF GATA2/GATA3 CEBPa/CEBPp/GATA2 OCT1/S8/CDX/OCT1
Sox5/Sox5 OCT1/Ets1/Ets1 Sox5 OCT1/CDX
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Table 6.1. The frA p d  upstream sequence was examined for TFBS; the significant 
transcription factors were placed in one of the GFP expression constructs 
(Szpirer et al 1992; Tronche and Yaniv 1992; Kelly and Moon 1995; Zhang et 
a l 1996; Karg H et a l 1997; Lopez-Rodriguez et al 1997; Larsson et al 
1998; Oates et a l 1999; Allan et a l 2001; Boudreau et a l 2002; Consales and 
Amone 2002; Flock and Drucker 2002; Jacobsen et a l 2002; van Heel et a l 
2002; Beland et a l 2004; Afouda et a l 2005; Jacobsen et a l 2005; Seligson et 
a l  2005).
Several TFBS were found in the frA p d  5’ flanking region. Most of the factors 
contain developmental regulatory functions in intestinal cells. The distal region (-4 to 
-2Kb) harbors CDX/CDX, GATA/CDX, Oct/CDX/Apl and CEBP/CDX complexes. 
The region contained between -2  to -1Kb from the TSS, contains almost the same 
repertoire of binding sites, some GC boxes and YY1 binding sites are present in this 
element. The TFBS predicted in the proximal upstream region (-1000 to +lbp) are 
mainly HNF, GATA, CDX, TATA binding sites. Although most of the factors have 
many binding sites in the full length of the region, the possible combination of factors 
is different, suggesting that Apcl may be regulated by a specific group of transcription 
factors.
6.4.3. Analysis of the Fugu Apcl promoter
The possible absence of the 0.3 exon in the JrApcl gene may suggest that the 
promoter region is located nearby the translation start site of the gene. A search for 
promoter-proximal elements was carried out in 1Kb upstream of genomic DNA 
(Figure 6.10). The survey of the proximal region revealed two consensus motifs for 
Spl (a GC binding protein) placed at -161 and -789bp form the TSS. Two binding 
sites for Apl positioned at -258 and -487bp from the TSS. One consensus GATA site 
is predicted at position -280bp and three TATA boxes were located at -304, -598 and 
-942bp from the TSS. These predicted binding sites suggest that the JrApcl promoter 
may be located around this proximal 5’ region.
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a c t g a t t a a a a t c g t t a c c c a g g c t g a t t a g t g g a g c t c a g c a g g c c g g c  
ga gca cc  t c t a a a  t g c t c a a g a a g t g a g g a t t a t g g a  g a t t g t t t t a a a t  
a t  aa t  gg aa a t t a a a c g ^ a c o a g  a g a t  c  11 c a cc  gc gc t  g cc  t  g t  t t  a g 
ca g t  c  eg  a a c H H H H H H t  ga g e t  caa a g t  cc  a gg 11 11 g t  c t  c t  
gg t  c c  t  c  g c a g c t t t t g t  t  gg a gc a t  gag a g a g t t t a a a c a g g  t  c t  c c  t  c  
t a  t o t t t H H H H H t  t g a t c  c t  g g a H H H H H p g  c t  a cg  t t  
aa a H B H H V H H & a t  c g t  ta  a t t  aga t t c  t c  t t a  t t a  caa c t  ta  
a a g a t a a a a t g g t c c g t g c a g a g g g g t t t a c t g t g e a e g e t e a t g c a t a c  
a t g t a g t a c a g e t g c t a t g g a g t t a t g t t g t g g t c t a t c a t a a a t c a g t g  
g t c a t g t g a c a t t t t t t t a g c t t g g g t g a a a c a t c a H H H H H g c c  
t t g t a a c a g a c g t g c t c g t a t c a g t g t g g t t g a g a g c a t g g a g g a a a g c c  
atgcragciaaacac t g c a t  c c a a a t  aa a ta  a g t aa t  aa tg c  g ta  a a g H I  
■ H f lB H B B H a a t a a a c a c c g a t t g a c t g a a a a t g t t t a a a a g c t g t t t  
t c c t t c t c c t c a t t g t t c a g g a t t c t a a a a a t a c a a c g a a t g c a c a t t t g  
a t  cag  a t t t a  age aa aga t t t  c g t  c t  g a t  ggc g ta  c g t a c t o a a a t t a o t  
ac  t t  ta g  t t a  11  c a t  t c  t  g t c  c c t  gc  tg a  a ca g t  c  ca a B I H H H H I  
I  g t  c tg a g c  t g c a g a g t  g ta  aa t  gc  t t c  c t g  t  c t  ggagc g t  c aaa gc gg 
g t t a g t t a g t t g g t t a g t t g a g t g g t g g g c c t g c a e g t g t a a a a a a c a c a  
a c a c i a  aca g g t  ageg a  c a g g c g tg tc r t  gga g g t  ac  c g t  t S H H H H  
M U S t c t g a a a g a g c a c a c g g t t a g t t t c a a a t g c a t t t c t t a c a t t g  
g tc tg c a g g tc a a a c c tg c a tc c tc c a a c a A T G
Figure. 6.10. Sequence and putative TFBS in the proximal 5’upstream region of 
frApcl. The translation start site is indicated (ATG). The potential TFBS are 
color boxed: Spl sites (dark blue), API sites (pink), GATA sites (light blue), 
TATA box (red).
6.4.4. Analysis of the frA pd  cis-regulatory elements in the developing 
zebrafish embryo
To investigate if the upstream region of the Fugu Cdxl gene is sufficient to 
control the expression of the gene during development and in intestinal tissue, three 
GFP expression constructs containing different frC dxl non- coding sequence lengths 
were constructed. Expression constructs were injected into the 1-2 cell-stage embryo. 
Embryos were analysed at 5 hours post- injection (hpi) for GFP expression.
The Fugu Apcl expression constructs were injected at three different 
concentrations, 15, 25 and 50ng/pl. The three concentrations used produced a high 
level of mortality in the injected embryos; no survivors were obtained after the 
gastrulation stage.
6.5 D iscussion
We investigated the regulation of mApc using a 607bp upstream region of the 
gene. Transfection assays in CaCo2 cells showed a 6.47 fold induction. 
Transactivation assays using Cdxl or Cdx2 showed that these factors might regulate
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mApc in an antagonistic way. Further analysis of mApcl upstream region, showed the 
presence of GATA factor binding sites. However transactivation assays using GATA4 
and combinations of GATA4 and Cdxs factors failed to reveal any involvement of 
GATA4 in the regulation of the mApc.
We started to analyse the mApc promoter with transfection analyses using 
CaCo2 and IEC-6 intestinal cell lines. Initial transfection studies showed that there is 
activation of the mApc promoter in CaCo2 cells (6.47 fold induction), indicating that 
endogenous Cdx may be involved in the regulation of the gene. Previous studies have 
used the same mApc region in L-cells; the reporter showed an expression of 8.6 fold 
when compare to the basal activity (Wedgwood et al 2000).
To investigate if the Cdx factors were involved in the regulation of mApc, 
transactivation assays were carried out using Cdxl, Cdx2 cDNA or a combination of 
both; Cdx2 induced the expression of the reporter to 2.77 fold induction when tested 
in IEC-6 cells. Due to the expression obtained in CaCo2 cells, this result suggests 
that Cdx2 may not act alone in the control of mApc expression. The activity shown 
by the reporter when transfected with Cdxl was null. Moreover, when both Cdx 
factors were transfected, the induction previously shown by Cdx2 was abolished, 
indicating that the Cdx factors may be acting in an antagonistic way in the regulation 
of mApc, and that the repressor role of Cdxl may be stronger than the activator role 
shown by Cdx2.
The activation of mApc shown by endogenous Cdx and the activation obtained 
in the transactivation assay using Cdx2 suggest that Cdx factors do not act alone in 
the activation of the mApc gene, other factors may be also involved in this regulation.
Studies have shown that the Cdx2 protein can bind consensus AT motifs in 
either proximal or distal regions of the genes (Suh et a l 1994; Troelsen et al 1997; 
Colnot et al 1998). The Cdxl factor, also binds to the same consensus site. Due to 
the similar binding site shared by Cdxl and Cdx2, the binding mechanism of these 
proteins might be restricted by other mechanisms than just the binding site itself 
(Moucadel et a l 2001); different factors may be implicated in the interaction with 
Cdx to discriminate their specific targets (Moucadel et a l 2002).
We continued analysing the promoter region of mApc, looking for transcription 
factors that are also specifically expressed in the intestine and have binding sites in 
the upstream region of mApc and may interact with the Cdx factors to regulate
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expression. Three putative GATA binding sites were found at position -215, -184 
and +60bp relative to the TSS of the gene; the GATA binding site located at position 
-215bp was found to be 9bp away from one Cdx binding sites, which could set a good 
spatial scenario for these two transcription to interact if they are involved in the 
regulation of mApcl.
GATA factors have been shown to be expressed during development, cell fate 
specification, differentiation and proliferation. In contrast to other transcription factor 
families like the homeobox or winged helix, which have several members, the GATA 
family only has 6 members in vertebrates (Patient and McGhee 2002). During 
development, GATA4 is expressed in the primitive and definitive endoderm, and 
mice lacking GATA4 expression do not have a proper differentiation of the gastric 
epithelium (Jacobsen et al 2002).
A previous study showed that HNF-la, GATA4 and Cdx2 are essential for the spatial 
and temporal expression the Sucrose Isomaltase gene (SI). The HNF-la protein is 
present in enterocytes in the villus, with a very reduced expression in the crypt; the 
GATA4 protein is also expressed in the villus, and no expression is detected in colon. 
HNF-la, GATA4 and Cdx2 factors interact with each other to form a complex and 
regulate the expression of the SI gene (Boudreau et a l 2002).
We then asked if GATA4 was involved in the regulation of mApc; the transactivation 
assay showed no induction of the reporter, suggesting that GATA4 may not be 
involved in the regulation as an activator of the gene. However, when Cdx2 and 
GATA4 were co-transfected, the 2.77 fold induction showed by Cdx2 was reduced to 
1.65 fold induction; at this point GATA4 may be acting as a repressor rather than an 
activator. However, the values between the mApc promoter transfected with GATA4 
and Cdx2 (1.65 ±0.013 fold induction) and the Ape alone (1.45+0.024 fold induction) 
are not markedly different. Therefore, it is difficult to assign to GATA4 a repressor 
role in the regulation of mApc. Co-transfection of Cdxl and GATA4 corroborated 
that these proteins do not activate the expression of the reporter in IEC-6 cells. 
Reports have described that GATA proteins can activate transcription of genes via 
protein complex formation, without a direct contact with the DNA (Merika and Orkin 
1995). The GATA5 and HNF-la interact to activate the lactase promoter, in this 
case, GATA5 does not make a physical DNA contact (Krasinski et a l 2001). It may
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be possible that other GATA factors are involved in the regulation of the mApc gene 
without a direct protein DNA interaction.
The results from this study confirm that the immediate upstream region of the mApc 
exon 0.3 is able to induce the expression of the reporter gene, not only in L-cells (as 
shown by Wedgwood et al., 2000) but also in colon intestinal cells. However, the 
transactivation assays using Cdxl, Cdx2 or GATA4, or the combination of them were 
unable to confirm in a consistent way that these factors really participate in the mApc 
regulation. Further studies, for example mutation of the Cdx binding sites or 
electromobility shift assays, would confirm the binding of these factors to the 
upstream region of the mApc.
The initial activity obtained in CaCo2 cells suggests that the number of transcription 
factors in the cell may be limited, or that Cdxl and Cdx2 may act in an antagonistic 
way. There is also the possibility that other factors apart from the Cdxs and GATA4 
are involved in the regulation of mApc, such as HNF factors or other GATA factors. 
Another possibility is that the 600bp fragment might not contain the regulatory 
elements involved in the expression of this gene in the intestinal epithelium.
In our attempt to characterize the mApcl regulatory regions, comparative 
analyses of the non-coding regions were performed using the Fugu rubripes Apcl 
gene. Comparison of the 5’ flanking region of the gene showed low level of 
conservation between mouse and Fugu. Further comparisons revealed that the mouse 
and Fugu upstream sequences shared a common repertoire of TFBS, suggesting a 
conserved regulatory mechanism between species. These TFBS can be categorized in 
three main groups: 1) transcription factors expressed in intestinal cells, e.g. Cdx, 
GATA and HNF; 2) transcription factors involved in developmental processes e.g. 
Cdx, S8, YY1, Sox5, Octl and 3) activator and stimulator proteins e.g. Spl, Apl and 
CEBP.
The analysis of the JrApcl proximal upstream region showed the presence of 
binding sites characteristic of promoter sequences, indicating that JrApcl promoter 
may be contained in the first Kb upstream of the translation start site.
Unfortunately, expression assays in zebrafish embryo failed to confirm the 
relevance of these potential trascription factors. There are two possible explanations 
for the embryo death produced by the JrApcl reporter constructs. 1) The concentration 
used could have been so high that it caused toxicity to the cells at early stages of
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development. However, the same range of concentrations and the same expression 
vector were used in the frCdxl expression constructs (see chapter 4) and no toxicity 
was observed. 2) It could be possible that the JrApcl reporter constructs are highly 
expressed in early developmental stages (earlier than 80% epiboly) and caused 
toxicity to the cells.
In situ experiments indicate that the ZfApc is expressed by the 20 somites 
stage (30-36 hrs) in the zebrafish embryo. Expression is detected in telencephalon, 
diencephalon, hindbrain, cranial ganglia, tegmentum ventricular zone and spinal cord 
(Sprague et al. 2001). In addition, the RT-PCR data (see chapter 5) shows that JrApcl 
is expressed at 53.3 and 111.5hpf in the Fugu embryo. This indicates that the Apcl 
gene is expressed during development in both zebrafish and Fugu.
There are still some questions to be addressed to fully characterize the 
upstream region of the JrApcl; 1) to confirm the presence of the 0.3 exon or any other 
possible translation start site and 2) obtain the 5’UTR of the gene. Based on the 
comparative analysis performed here, the presence of these elements (if any) may 
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Conclusion
The development of the organism is controlled by specific and well-structured 
mechanisms; the expression and regulation of genes involved in this process are 
tightly regulated from the simplest tissues to the most specialized cells.
Several reports have described the role of transcription factors during 
development, and their role in specifying the formation of tissues and body structures. 
In the intestinal epithelium, the Cdx proteins are involved in maintaining the 
architecture and structure of the CV axis. The Cdx genes also intervene during 
development in specifying the AP axis. Despite of our understanding in the formation 
and architecture of the intestine, the exact mechanisms in how these processes happen 
are far from understood.
In this work, we aimed to identify and characterize the regulatory elements 
involved in the regulation of Cdxl and Apcl. We made use of a variety of tools from 
comparative genomics and the use of the Fugu genome as a comparative model, to the 
application of reporter systems and functional gene expression in the developing 
zebrafish.
Using comparative analyses, we have identified, for the first time, the Fugu 
Cdx family (frCdxl, frCdx2 and frCdx4) and the Fugu Apcl and Apc2 genes. The 
Fugu Ape and Cdx genes were almost completely characterized. The genomic, gene 
and amino acid structures of the Fugu showed high level of conservation when 
compared to the human and mouse orthologs. Most of the main and functional 
domains in the mammalian Ape and Cdx proteins are also contained in the Fugu 
proteins, indicating a conserved functional role across species.
Expression studies of the frCdxl and frCdx2 genes showed that the expression 
of these genes is restricted to the intestine, as the mouse and human Cdx genes are. 
The Fugu Ape genes were expressed during development and in adulthood; some of 
this specific expression agrees with the expression reported for the mouse Ape genes. 
Specific domains in the Ape proteins are present in the frApc proteins, suggesting that 
their role and function was determined early in the evolution of vertebrates.
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More detailed studies were performed with the Fugu Cdxl and Apcl. Analyses 
of the 5’ flanking region of these two genes, revealed potential binding sites for 
transcription factors, which may be involved in their regulation. Specially in the Fugu 
Apcl where the reduced and diverged 5’ region will provided important information 
of the structure and regulation of the gene.
The putative transcription factors are involved during development in 
vertebrae formation, and in intestinal proliferation and differentiation. Strangely, the 
frCdxl and frA p d  did not show conserved non-coding regions when compared with 
the human and mouse homologs.
A complete study of the proximal Fugu Cdxl upstream region shows a well- 
conserved set of TFBS with the mouse and human regions. Interestingly, reporter 
assays performed in intestinal cells showed that the Fugu and mouse Cdxl upstream 
regions are able to drive, and in some cases, to enhance the expression of the reporter 
in the cells. We conclude that the 1Kb upstream region of the mouse and Fugu Cdxl 
contains the necessary elements to drive the expression of the gene; these data agree 
with reports for the regulation of the mouse Cdxl.
Functional characterization of the frCdxl cis-regulatory elements in the 
zebrafish embryo showed that the upstream region of the frCdxl also contains 
elements to drive the expression of the transgene during zebrafish development. 
Expression of the transgene was detected early during development at the gastrulation 
stage; later, the expression was restricted to the posterior part of the embryo, in the 
tail bud.
We investigated if the regulation of the mApcl gene is controlled by the Cdx 
factors in intestinal epithelium. Transfection and transactivation assays confirmed that 
Cdxl and Cdx2 regulate to some extent the mApcl transcription. Comparative 
analyses using the frA p d  revealed that the human and mouse 5’ flanking regions 
have diverged from the Fugu upstream region during evolution.
Further analyses will confirm if the potential transcription factor binding sites 
predicted in the Fugu and mouse Cdxl and Apcl upstream regions are important for 
the regulation of the genes. More functional assays will prove the specific non-coding 
regions and the transcription factors involved in the spatial expression of these genes.
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The use of comparative genomics comes from the idea that sequences that 
regulate gene expression are often conserved between species. Because most of the 
Fugu genome has been sequenced and almost completely characterized, and a Fugu 
genome database has been released and is available for use, the Fugu genome is a 
useful model to look for conserved non-coding sequences. Despite this, we were 
unable to identify conserved non-coding sequences between the mouse and Fugu 
Apcl and Cdxl genes.
The use of distant orthologous sequences can bring some disadvantages. 
Studies have shown that the chicken orthologous sequences contain conserved non­
coding regions with mouse and human; however, this represents only a subset of 
elements of the complete set of conserved sequences. Several human-mouse 
conserved non-coding elements (which are not conserved in chicken) have been 
confirmed to regulate gene expression. The use of comparative multispecies studies 
can, sometimes, fail to spot specific mammalian regulatory sequences (Pennacchio 
and Rubin 2001).
There are different model systems to look for gene functions and functionality 
of conserved non-coding elements; as mentioned earlier, the system has to satisfy two 
conditions. First, the regulatory elements to be tested have to be easy to screen. This is 
sometimes hard to satisfy; some genes with complex patterns of expression contain 
their regulatory elements dispersed among introns, and sometimes in distant flanking 
regions. Second, the spatial and temporal expression of the genes or regions tested has 
to be easy to visualize. This condition can also be difficult to meet, especially for 
mammalian genes that are expressed in multiple tissues at different developmental 
stages; cell lines cannot duplicate those patterns in expression, and mammalian 
models are costly and slow.
We found that the zebrafish can satisfy these two conditions and is a useful 
model to look for non-coding sequences implicated in development. The fertilization 
of the zebrafish eggs takes place externally and the embryo development occurs very 
quickly. Most of the organs’ structures and functions are developed by 48hpf. The 
majority of the developmental processes, signalling pathways and genes are 
conserved in the teleost through the amniotes. The use of the green fluorescent protein 
as a transgene in the zebrafish embryo has been a useful tool for developmental and
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genetic studies; the product of GFP is very easy to track in the clear zebrafish embryo, 
allowing us to follow the spatial and temporal expression of genes.
In this work, we have identified and characterized the frCdx and frApc genes. 
We analysed and functionally characterized the upstream sequence of the frCdxl and 
JrApcl genes. The data presented here will contribute to complete our understanding 
in the characterization and function of non-coding regions (in some cases conserved 
across species, in some cases not), which contain a potential value in the regulation of 
genes.
This study also tried to complete the knowledge that we have of the regulation 
of specific intestinal genes, one a transcription factor (Cdxl), the other a signaling 
protein (Apcl). Both perform different functions in the cell, but contribute to maintain 
the architecture and structure in the intestinal epithelium.
The regulation of genes is not a linear interaction between one transcription 
factor and the DNA, or between two proteins. It is a complex mechanism where 
molecules, signals and proteins are in a cross-talk communication.
A complete understanding of how architecture and structure are maintained in 
the regulatoiy systems is only possible through the understanding of the regulation of 
all its components and the interactions amongst them. A gene regulatory network 
representing the transcription factors and signaling molecules involved in the 
formation and specification of the endoderm and mesoderm in sea urchin has been 
created using a variety of techniques (e.g. bioinformatics, genomic data, cis- 
regulatory analyses and molecular embryology). This network is only one component 
of a more complex system; each component in the system performs different (and 
related) biochemical and cellular processes in the cells, but these tasks are given from 
a genomic regulatory control system (Davidson et al. 2003; Davidson 2004).
Finally, we tried to study and increase our knowledge of the fascinating, but 
complex system of the intestinal epithelium. This system is determined by an 
exchange of signals between the endoderm and the mesenchyme. Specific region 
differentiation, gut patterning and smooth muscle differentiation are directed not only 
by the BMP, Notch, Wnt and Hedgehog signalling pathways, but also by the Hox, 
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Appendix, Section 1A 
Cdxl nucleotide alignment
5 ' UTR C d x l
m m Cdxl5U TR -------------GCAGTCGCTGGTCGTCGGGGCGGCTCGCTCGGGCGCGGCGGCGCCAGGGCCCAG 54
h sC d x l5 U T R  AGGTGAGCGGTTGCTCGTCGTCGGGGCGGC CGGCAGCGGCGGCTCCAGGGCCCAG 5 5
fr C d x l5 U T R  GAATGCTGGGAGACCTGACATGATCCCAGCT CTTTGATTTTTGTCCAGTGTCACAT 5 6
*  *  *  *  *  *  * *  *  *  *  *  *  * *
m m Cdxl5U TR CATGCGCGGGGGACCCTGCGGTCACCATG 83  
h s C d x l5 U T R  CATGCGCGGGGGACCCCGCGGCCACCATG 84  
f r C d x l5 U T R  TTTACGCACCAGGACGCAGGAA-------ATG 81
k  k  k  k  k  k  ★ k  k  k  k
2 nd e x o n  C d x l
ramCdx1 GTAAGACCCGAACCAAGGACAAGTACCGTGTGGTCTACACAGACCACCAACGCCTAGAGC 6 0 
h s C d x l  GTAAGACTCGGACCAAGGACAAGTACCGCGTGGTCTACACCGACCACCAACGCCTGGAGC 60  
f r C d x l  GGAAGACTCGCACTAAGGACAAGTACAGGGTGGTGTACACTGACAAACAGCGGATGGAGC 6 0  
* * * * * *  * *  **  * * * * * * * * * * * *  * * * * * *  * * * * *  * * *  * **  * *  * * * * *
m m Cdxl TGGAAAAGGAGTTTCACTACAGCCGGTACATCACTATCCGGCGCAAGTCCGAGCTGGCTG 1 2 0  
h s C d x l  TGGAGAAGGAGTTTCATTACAGCCGTTACATCACAATCCGGCGGAAATCAGAGCTGGCTG 1 2 0  
f r C d x l  TGGAGAGGGAGTTCCAGAGCAACCGCTACATCACCATGCGCAGGAAAGCAGAGCTGTCGA 1 2 0  
* * * *  * * * * * * *  * *  * *  * * *  * * * * * * * *  * *  **  * **  * * * * * * *  *
m m Cdxl CTAACCTGGGGCTCACAGAGCGGCAG 14  6 
h s C d x l  CCAATCTGGGGCTCACTGAACGGCAG 14  6 
f r C d x l  TCACGCTGGGCCTCTCAGAGAGACAG 14  6
★ k  k  k  k  k  k  k  k  k  k  k  k  k  k  k
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3 rd e x o n  C d x l
m m Cdxl GTAAAGATCTGGTTCCAGAACCGCCGGGCCAAGGAGCGCAAAGTAAACAAGAAGAAACAG 6 0  
h s C d x l  GTGAAGATCTGGTTCCAAAACCGGCGGGCAAAGGAGCGCAAAGTGAACAAGAAGAAACAG 6 0  
f r C d x l  ATAAAAATATGGTTTCAGAACAGGCGTGCCAAAGAAAGAAAAATGAACCGGAAGAAGCTG 6 0  
*  * *  * *  * * * * *  * *  * * *  *  * *  * *  * *  * *  *  * * *  *  * * *  * * * * * *  *  *
m m Cdxl CAGCA GCAGCAGCCCCTGCCTCCCACACAGCTGCCCCTGCCCCTGGATGGCACTCCC 1 1 7
h s C d x l  CAGCA GCAACAGCCCC--------------------CACAGCCGCCGATGGCCCACGACATCACGGCC 1 0 8
f r C d x l  CAGCATTCGCAGCAGGCCTC TACGACCACCCCCGCCTCCCCGGGCCTCGCTG 1 1 2
* * * * *  * * *  * * *  * *  * *  *  * *  *  *  *  *  *
m m Cdxl ACACCATCAGGGCCACCCCTAGGAAGTCTATGCCCTACTAATGCTGGCCTTCTGGGCACC 1 7 7  
h s C d x l  ACCCCAGCCGGGCCATCCCTGGGGGGCCTGTGTCCCAGCAACACCAGCCTCCTGGCCACC 1 6 8
f r C d x l  AGCCCGTGGAAGCCCACCCC GGCATGAGCCCCAACGGCTTT------ TTTTCAGACACC 1 6 5
★ ★★ ★★★ ★★★ ★ ★ ★ ★★ ★ ★ ★★★★★
m m Cdxl CCCTCCCCAGTGCCCGTCAAGGAGGAGTTTCTACCCTAG 2 1 6  
h s C d x l  TCCTCTCCAATGCCTGTGAAAGAGGAGTTTCTGCCATAG 2 0 7  
f r C d x l  CTGTCAAAAGAATAT-------------------------------------------------------- 1 8 0
Appendix, Section 1B 
Cdx2 nucleotide alignment
1 st e x o n  C d x2
mmCdx2 ATGTACGTGAGCTACCTTCTGGACAAGGACGTGAGCATGTATCCTAGCTCCGTGCGCCAC 60  
h s C d x 2  ATGTACGTGAGCTACCTCCTGGACAAGGACGTGAGCATGTACCCTAGCTCCGTGCGCCAC 60  
f r C d x 2  ATGTATGTATGTCTATATGTTAATATGAGGACAGTTCTGTCATATTGTTGC-TGTGCGTG 5 9
★  ★ ★ ★ ★ ★ ★  "k ★  ★ ★ ★  ★ ★ ★  ★ ★ ★ ★ ★ ★ ★ ★
mmCdx2 TCCGGCGGCCTGAACCTGGCTCCGCAGAACTTTGTCAGTCCTCCGCAGTACCCGGACTAC 1 2 0  
h s C d x 2  TCTGGCGGCCTCAACCTGGCGCCGCAGAACTTCGTCAGCCCCCCGCAGTACCCGGACTAC 1 2 0  
f r C d x 2  TCTAGTTG--------------------------------------------------------------------------------------------------------------------  67
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* *  *  *
mmCdx2 GGTGGTTACCACGTGGCGGCCGCGGCGGCTGCTACGGCGAACTTGGACAGCGCTCAGTCC 1 8 0  
h s C d x 2  GGCGGTTACCACGTGGCGGCCGCAGCTGCAGCGGCAGCGAACTTGGACAGCGCGCAGTCC 1 8 0  
f r C d x 2  --------------------------------------------------------------------------------------------------------------------------------------
mmCdx2 CCAGGGCCATCCTGGCCCACCGCGTACGGCGCCCCTCTCCGCGAGGACTGGAATGGCTAC 2 4  0 
h s C d x 2  CCGGGGCCATCCTGGCCGGCAGCGTATGGCGCCCCACTCCGGGAGGACTGGAATGGCTAC 2 4  0 
f r C d x 2  --------------------------------------------------------------------------------------------------------------------------------------
mmCdx2 GCACCCGGGGGCGCTGCGGCAGCC AACGCGGTAGCCCACGGTCTCAATGGTGGCTCC 2 97
h s C d x 2  GCGCCCGGAGGCGCCGCGGCCGCCGCCAACGCCGTGGCTCACGGCCTCAACGGTGGCTCC 3 0 0  
f r C d x 2  --------------------------------------------------------------------------------------------------------------------------------------
mmCdx2 CCGGCCGCCGCTATGGGCTACAGCAGCCCCGCCGAATACCACGCGCACCATCACCCGCAT 3 5 7  
h s C d x 2  CCGGCCGCAGCCATGGGCTACAGCAGCCCCGCAGACTACCATCCGCACCACCACCCGCAT 3 6 0  
f r C d x 2  --------------------------------------------------------------------------------------------------------------------------------------
mmCdx2 CATCACCCGCACCATCCGGCCGCCTCGCCGTCCTGCGCCTCCGGCTTGCTGCAGACGCTC 4 1 7  
h s C d x 2  CACCACCCGCACCACCCGGCCGCCGCGCCTTCCTGCGCTTCTGGGCTGCTGCAAACGCTC 4 2 0  
f r C d x 2  --------------------------------------------------------------------------------------------------------------------------------------
mmCdx2 AACCTCGGCCCCCCGGGGCCCGCAGCCACCGCCGCCGCCGAACAGCTGTCCCCCAGCGGC 4 7 7  
h s C d x 2  AACCCCGGCCCTCCTGGGCCCGCCGCCACCGCTGCCGCCGAGCAGCTGTCTCCCGGCGGC 4 8 0  
f r C d x 2  --------------------------------------------------------------------------------------------------------------------------------------
mmCdx2 CAGCGGCGAAACCTGTGCGAGTGGATGCGGAAGCCCGCGCAGCAGTCCCTAGGAAGCCAAG 5 3 8  
h s C d x 2  CAGCGGCGGAACCTGTGCGAGTGGATGCGGAAGCCGGCGCAGCAGTCCCTCGGCAGCCAAG 5 4 1  
f r C d x 2  --------------------------------------------------------------------------------------------------------------------------------------
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2 nd e x o n  C d x2
iranCdx2 TGAAAACCAGGACAAAAGACAAATACCGGGTGGTGTACACAGACCATCAGCGGCTGGAGC 6 0  
h s C d x 2  TGAAAACCAGGACGAAAGACAAATATCGAGTGGTGTACACGGACCACCAGCGGCTGGAGC 60  
f r C d x 2  GAAAAACGCGGACTAAAGACAAGTACCGGGTGGTTTACACCGACCACCAGCGGCTGGAGC 60  
* * * * *  * * * *  * * * * * * * *  * *  * *  * * * * *  * * * * *  * * * * *  * * * * * * * * * * * * *
mmCdx2 TGGAGAAGGAGTTTCACTTTAGTCGATACATCACCATCAGGAGGAAAAGTGAGCTGGCTG 1 2 0  
h s C d x 2  TGGAGAAGGAGTTTCACTACAGTCGCTACATCACCATCCGGAGGAAAGCCGAGCTAGCCG 1 2  0 
f r C d x 2  TGGAAAAGGAGTTTCACTACAGCAAGTACATCACCATCAGGAGGAAATCGGAGCTGGCCA 1 2 0
★  ★ ★ ★  ' k ' k ' k ' k ' k ' k ' k ' k ' k ' k ' k ' k ' k  ★ ★  ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★  ★ ★ ★ ★ ★ ★ ★ ★  •* •★ ★ ★ ★  ★ ★
mmCdx2 CCACACTTGGGCTCTCCGAGAGGCAG 14  6 
h s C d x 2  CCACGCTGGGGCTCTCTGAGAGGCAG 14  6 
fr C d x 2  CAGCCCTCAGCCTATCAGAGCGACAG 14  6 
*  *  * *  *  * *  * *  * * *  *  * * *
3 rd e x o n  C dx2
mmCdx2 GTTAAAATTTGGTTTCAGAACCGCAGAGCCAAGGAGAGGAAAATCAA GAAGAAGCAG 57
h s C d x 2  GTTAAAATCTGGTTTCAGAACCGCAGAGCAAAGGAGAGGAAAATCAACAAGAAGAAGTTG 60  
f r C d x 2  GTGAAGATCTGGTTCCAGAATCGCCGGGCCAAAGAGCGCAAAATCAACAAGAAGAAGCTC 6 0  
* *  * *  * *  * * * * *  * * * * *  * * *  *  * *  * *  * * *  *  * * * * * * * *  * * * * * * *
mmCdx2 CAGCAGCAACAGCAGCAGCAGCAACAACAGCCTCCACAGCCGCCGCCACAACCTTCCCAG 1 1 7  
h s C d x 2  CAGCAGCAACAGCAGCAGCAGCCACCACAGCCGCCTCCGCCGCCACCACAGCCTCCCCAG 1 2 0  
f r C d x 2  CAGCAGC— CTGCCTCCTCCACGACCACGCCCACGCCTCCCGCCAGCAC— CGGTGCCAG 1 1 6  
* * * * * * *  *  * *  *  *  *  * *  * *  * *  *  *  * * * * *  * * *  *  * * * *
mmCdx2 CCTCAGCCGGGTGCCCTGCGG-AGCGTGCCCGAGCCCTTGAGTCCTGTGACCTCCTTGCA 1 7 6  
h s C d x 2  CCTCAGCCAGGTCCTCTGAGA-AGTGTCCCAGAGCCCTTGAGTCCGGTGTCTTCCCTGCA 1 7 9  
f r C d x 2  CCTCCACGGAAACGGTGGCAGCAGCGTCGCCATGGTGACAAG— CAGCAGCGGCAGTAAC 1 7 4
mmCdx2 AGGCTCAGTGCCTGGTTCTGTCCCTGGGGTTCTGGGGCCAGCTGGAGGGGTTTTAAACTC 2 3 6  
h s C d x 2  AGCCTCAGTGCCTGGCTCTGTCCCTGGGGTTCTGGGGCCAACTGGGGGGGTGCTAAACCC 2 3 9
f r C d x 2  GGGCT-GGTTTCTCCTTCCTCCCTTC— CTTTGAACATCAA— AGAGGAGTAC--------------- 2 2 2
★ ** ** *★ ★★ ★★ ★ ★★ ★★ ★ ★★ ★★
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mmCdx2 CACTGTCACCCAGTGA 2 5 2  
h s C d x 2  CACCGTCACCCAGTGA 2 5 5  
f r C d x 2  -----------------------------------
Appendix, Section 1C 
Cdx4 nucleotide alignment
1 st e x o n  C dx4
h s C d x 4  ATGTACGGAAGCTGTCTTTTGGAGAAAGAAGCAGGCATGTACCCGGGCACTCTCATGAGC 6 0  
mmCdx4 ATGTATGGAAGCTGCCTTTTAGAAAAAGAAGCGGGCATGTACCCAGGCACTCTCAGGAGC 6 0
f r C d x 4  ATGTATG---------------------------------------------------------------------------------- TTGGATATATTTTGGA- 2 3
* * * * *  *  * * * * *
h s C d x 4  CCTGGGGGCGACGGCACAGCTGGGACAGGCGGCACAGGGGGCGGTGGGAGTCCGA-TGCC 1 1 9  
mmCdx4 CCTGGAGGAAGCAGTACAGCCGGAGTGGGCACCTCTGGGGGCAGTGGTAGTCCTC-TGCC 1 1 9  
f r C d x 4  — TAAGGAGAGCGGCAT-GTATCACCAGGGACCAGTAAGAAGATCAAGCATCAACCTGCC 8 0  
*  *  *  *  *  *  * *  *  *  * *  * * * *
h s C d x 4  AGCCTCCAATTTCGCTGCGGCACCGGCTTTCTCGCACTATATGGGGTATCCTCATATGCC 17  9 
mmCdx4 TGCCTCCAACTTTACTGCAGCCCCAGTTTACCCACACTACGTGGGTTACCCTCATATGTC 1 7 9  
f r C d x 4  CCCCCAGAACTTTGTTTCAACTCCACAGTATCCTGATTTTACCGGATACCATCATGTGCC 1 4 0  
* *  * *  * *  *  *  *  * *  *  *  *  *  * *  * *  *  * * * *  * *  *
h s C d x 4  CAGCATGGATCCTCACTGGCCGTCTCTGGGAGTCTGGGGCTCACCCTACAGTCCCCCGCG 2 3 9  
mmCdx4 CAACATGGATCCTCACGGGCCTTCGCTGGGAGCCTGGAGCTCACCCTACAGTCCGCCCCG 2 3 9  
f r C d x 4  GAACATGGATACGCACGCACAGTCTGCGGGGAGTTGGGGGTCTTCGTACGGCGCTCCACG 2 0 0  
*  * * * * * * *  *  * * *  *  * *  * * *  * * *  *  * *  *  * * *  *  *  * *  * *
h s C d x 4  AGAAGACTGGAGCGTGTAT— CCTGGG-CCGTCTAGTACAATGGGCACAGTGCCGGTGAA 2 9 6  
mmCdx4 GGAAGACTGGAGTACATAC— CCTGGG-CCGCCCAGTACAATGGGCACAGTGCCCATGAA 2 9 6  
f r C d x 4  AGAGGATTGGGGTGCATACAGCCTGGGACCACCTAATACTAT TCCCGCCCCTATGAG 257
★  ★  ★ ★  ★  'k  'k  ★ ★ ★ ★ ★ ★  ★ ★  ★ ★  ★ ★ ★  ★ ★  ★ ★  ★ ★  ★ ★ ★
J.L. Juarez-Morales 2005
210
Appendix J.L. Juarez-Morales 2005
h s C d x 4  CGACGTGACCTCTAGCCCCGCCGCTTTCTGCTCGACCGACTACAGCAACTTGGGCCCTGT 3 5 6
mmCdx4 TGACATGACCT------------- CCCCAGTTTTCGGATCCCCAGACTACAGCACTCTGGGCCCCAC 3 5 0
f r C d x 4  CAACTCATCTCCCGGACAGGTTCCATACTGCTCACCTGAGTACAGTCATATGCACCCTCC 3 1 7  ★* * * * ★ ★★ ★ ** ★★★★* ★★ ***
h s C d x 4  GGGCGGTGGAACTAGCGGCAGCAGCCTACCAGGCCAGGCTGGCGGGTCGCTTGTCCCGAC 4 1 6  
mmCdx4 CAGCGGTGCAAGCAACGGCGGTAGCTTGCCAGACGCGGCCAGCGAGTCACTGGTTTCTCT 4 1 0  
f r C d x 4  AGGATCTGCGGC— GCTACAGCCGCCT-CCGGAAAACGTCTCTGTTGCGCAACTTTCTCC 3 7 4  
*  * *  *  *  *  * *  *  * *  *  *  * * * * *
h s C d x 4  GGACGCAGGCGCCGCCAAGGCCAGTTCCCCCAGCAGGAGCCGCCACAGCCCCTATGCATG 4 7 6  
mmCdx4 TGACTCCGGCACCTCAGGCGCCACTTCTCCCAGCAGGAGCCGTCACAGCCCCTACGCATG 4 7 0  
f r C d x 4  GGACAGAGAAAGACTTTCTTTCCAGTGGATGAATAAAA— CTGCGCAATCCTCTTCCACA 4 3 2  
* * *  * * *  * * * * *  * *  **  * *
h s C d x 4  GATGCGCAAGACGGTGCAGGTGACGG 5 0 2  
mmCdx4 GATGCGCAAAACTGTGCAGGTGACGG 4 9 6  
f r C d x 4  G--------------------------------------------------------4 3 3
2 nd e x o n  C d x4
h s C d x 4  GGAAAACCAGGACAAAAGAAAAGTATCGTGTAGTTTACACTGATCATCAAAGATTGGAGC 6 0  
mmCdx4 GGAAAACCAGGACAAAAGAAAAGTATCGTGTGGTCTACACAGATCATCAACGGCTGGAGC 6 0  
f r C d x 4  GAAAAACAAGAACGAAGGAGAAGTACAGAGTGGTTTATACAGACCACCAGAGGCTGGAGC 6 0  
* * * * * *  **  * *  **  **  * * * * *  * * *  **  **  **  **  **  **  * * * * * * *
h s C d x 4  TGGAAAAGGAATTCCATTGCAATAGATATATCACCATCCAGAGAAAATCAGAGCTGGCAG 1 2 0  
mmCdx4 TGGAAAAGGAATTTCACTGCAATAGATACATCACCATCAGGAGGAAGTCAGAGCTGGCAG 1 2 0  
f r C d x 4  TGGAGAAAGAGTTTCATTTCAACAGATACATCACCATCAGGAGGAAATCTGAACTGGCTG 1 2 0  
★★★★ ★★ ★★ ★★ ★★ ★ ★★★ ★★★★★ ★★★★★★★★★ ★★★ ★★ ★★ ★★ ★★★★★ ★
h s C d x 4  TTAACCTGGGCCTTTCCGAGAGACAG 1 4 6  
mmCdx4 TTAACCTGGGCCTTTCTGAGAGACAG 1 4 6  
f r C d x 4  TCAGCCTCGGCCTGTCGGAGAGACAA 14 6 
* * * * *  * * * * *  * *  * * * * * * * *
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3rd exon Cdx4
hsCdx4 GTGAAAATCTGGTTTCAGAATCGCAGAGCCAAGGAGAGAAAGATGATCAAAAAGAAAATC 60 
mraCdx4 GTGAAAATCTGGTTTCAGAATCGCAGAGCCAAGGAGAGGAAGATGATAAAAAAGAAAATC 60 
frCdx4 GTGAAAATCTGGTTCCAGAATCGCAGAGCTAAAGAGAGGAAGCTGATCAAGAAGAAGCTG 60
k k k k k k k k k k k k k k  k k k k k k k k k k k k k k  k  k  ★ ★ ★ ★ ★  ★ ★ ★  k  k  k  k  ★ ★  k  k  k  k  k  ★
hsCdx4 TCCCAGTTTGAGAATAGTGGAGGCTCGGTGCAAAGTGACTCTGACTCCATCAGCCCTGGG 120 
mmCdx4 TCCCAGTTTGAGAACACTGGAGGTTCCGTGCAAAGTGACTCTGGCTCCATCAGCCCCGGA 120 
frCdx4 GGCCAGTCTGATGGCAGCGGCGGGTCAGTGCACAGTGACCCGGGCTCGGTCAGCCCTCTG 120 
* * * * *  * * *  *  * *  * *  * *  * * * * *  * * * * * *  *  *  * * *  * * * * * * *
hsCdx4 GAACTACCTAACACTTTTTTCACCACAC-CATCTGCTGTTCG-TGGATTTCAACCTATTG 178 
mmCdx4 GAACTGCCTAACGCTTTCTTCACCACTC-CATCTGCTGTCCG-TGGATTTCAGCCAATCG 178 
frCdx4 CCCGTGCCCGGTTCTCTCAGTCCCACGGACGTGCACGGTTCTCTGTACCCTCCCCAGGGG 180
★ ★ ★ k  k  k  k  k  k  k  ★ ★  ★ ★ ★ ★  k  k  k  k  k  k
hsCdx4 AGATACAGCAGGTTATAGTCTCCGAATGA 207 
mmCdx4 AGATACAGCAGGTCATAGTTTCTGAATGA 207 
frCdx4 ATGAACCCCCTCCCATCTATCAGGAAT—  207
★ k k  k  k  k  k  k  k  k
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Appendix, Section 2A









































































































Figure. mCdxl 5’ upstream regulatory region. The 5.2 Kb fragment was sequenced 
from the distal upstream sequence of the Cafr/gene. The bold characters show 
the primer position in the sequence.
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Appendix, Section 2B 
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Figure. Plasmid map of 2.1 kb mCdxJTYHacZ. The parent plasmid is shown (A). 
Digestion with Hindlll/ PvuII releases the 2.1 kb fragment. The dotted square 
indicates the 2.1 kb Cdxl fragment. (B) The 2.1 kb Cdxl fragment cloned into the 
Xbal site of the pTKLacZ vector. The grey square represents the TK promoter 
and the open square shows the LacZ gene. The ampicillin resistance gene is 
indicated by the black arrow.
216






mHI BannHI , .... Bat  ^ 1.4Kb ^ nHI ATG
r * 3’












Figure. Plasmid map of the 1.4kb mCdxlTYHacZ. The parent plasmid is shown (A). 
Digestion with BamHI releases the 1.4kb fragment. The dotted square indicates 
the 1.4kb Cdxl fragment. (B) The 1.4kb Cdxl fragment cloned into the Xbal site 
of the pTKLacZ vector. The grey square represents the TK promoter and the 
open square shows the LacZ gene. The ampicillin resistance gene is indicated by 
the black arrow.
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Figure. Plasmid map of 5.2kb mCdxlTYXacZ. The parent plasmid is shown (A). 
Digestion with Hindlll releases the 5.2kb fragment. The dotted square indicates 
the 5.2kb Cdxl fragment. (B) The 5.2kb Cdxl fragment cloned into the Xbalsite 
of the pTKLacZ vector. The grey square represents the TK promoter and the 
open square shows the LacZ gene. The ampicillin resistance gene is indicated by 
the black arrow.
218











Figure. Plasmid map of l.Okb mCdxlTKLacZThc parent plasmid is shown (A). The
dotted square indicates the region were the 1.0Kb PCR product was amplified.
(B) The l.Okb Cdxl PCR fragment was cloned into the Hindlll site of the
pTKLacZ vector. The open square shows the LacZ gene. The ampicillin
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Figure. Plasmid map of pTKXacZThe parent plasmid is shown (A). The grey square 
represents the TK promoter and the open square shows the LacZ gene. The 
ampicillin resistance gene is indicated by the black arrow.
Appendix , Section 2C  
frCdxl GFP reporter constructs
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frCdxl PCR fragments- BSKS2+
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frCdxl deletion constructs- pCS2:GFP'CMV
Figure. Plasmid map of frCdxl deletion constructs- pCS2:GFP'€MV. (A). Shows the 
cloning of the frCdxl PCR products into BSKS2+ using the EcoRl/Xhol sites. 
The dotted square indicates the 4.0, 2.0 and 1.0 Kb frCdxl PCR products. (B) 
Cloning of the frCdxl PCR products into the pCS2:GFP<™ vector. The open 
square shows the GFP gene and the black square indicates the SV40polyA. The 
ampicillin resistance gene is indicated by the black arrow.
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Apc1 nucleotide alignment
E l h s  ATGGCTGCAGCTTCATATGATCAGTTGTTAAAGCAAGTTGAGGCACTGAAGATGGAGAAC 
E1mm ATGGCTGCAGCTTCATATGATCAGTTGTTAAAGCAAGTTGAGGCACTGAAGATGGAGAAC 
E l f r  ATGGCGGCAGCGTCATACGACCAGCTGCTAAGGCAGGTGGAGGTGTTGAAGATGGAGAAC
k  k  k  k  k  k  k  k  k  k  ★ ★ ★ ★ ★  ★ ★  ★ ★ ★  k  k  k  k  k  ★ ★ ★  ★ ★  ★ ★ ★ ★  ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★
E l h s  TCAAATCTTCGACAAGAGCTAGAAGATAATTCCAATCATCTTACAAAACTGGAAACTGAG 
Elmm TCAAATCTTCGACAAGAGCTAGAAGATAATTCCAATCATCTTACAAAACTGGAAACTGAG 
E l f r  TCTAACCTGCGACAGGAGCTGCAGGACAACTCCAACCATTTGACCAAACTGGAGACGGAA 
* *  * *  * *  * * * * *  * * * * *  *  * *  * *  * * * * *  * * *  *  * *  * * * * * * * *  * *  * *
E l h s  GCATCTAATATGAAG 1 3 5  
Elmm GCATCTAATATGAAG 1 3 5  
E l f r  GCCTCCAACATGAAG 1 3 5  
★★ ★★ ★★ ★★★★★★
E 2 h s  GAAGTACTTAAACAACTACAAGGAAGTATTGAAGATGAAGCTATGGCTTCTTCTGGA------
E2mm G AAG T AC T T AAGCAGC T AC AGGG AAGT AT T GAAG AT GAG ACT ATG AC T T CTGGA 
E2 f r  GAAGTGCTGAAGCAGCTGCAGGGCACCATAGAAGAAGAGTCTGGAGAGGCATCTGGATCT 
* * * * *  **  **  **  **  * *  * *  *  * *  * * * * *  * *  * *  * * * * *
E 2 h s  CAGATTGATTTATTAGAGCGTCTTAAAG 8 5  
E2mm CAGATTGACTTACTAGAGCGTCTTAAAG 82  
E 2 f r  CAGCTTGAGCTCATCGAAAGACTGAAGG 88
★ ★ ★  ★ ★ ★ ★  ★ ★ ★ ★  ★ ★ ★  ★ ★  - k
E 3 h s  AGCTTAACTTAGATAGCAGTAATTTCCCTGGAGTAAAACTGCGGTCAAAAATGTCCCTCC
E3mm AATTTAACTTAGATA GTAATTTCCCCGGAGTGAAACTACGCTCAAAAATGTCCCTTC
E 3 f r  AAATGAGCCTCGA-ATCAGCAGGCTTCA-AACACAGGACT-CGGCCTCCGATGCCCACCT
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E 3 h s  GTTCTTATGGAAGCCGGGAAGGATCTGTATCAAGCCGTTCTGGAGAGTGCAGTCCTGTTC 
E3min GCTCCTACGGAAGTCGGGAAGGATCTGTATCCAGCCGTTCAGGAGAATGCAGTCCTGTCC
E 3 f r  CCTCTCCCAGTGCCTCTG GTTCTGGAGCTCCTGGTGCAGCAGGTGGAGGCCCCCAGG
* *  *  *  *  * * * *  *  *  * *  *  *  * *  *  *  * *
E 3 h s  CTATGGGTTCATTTCCAAGAAGAGGGTTTGTAAATGGAAGCAGAGAAAGTACTG------ GAT
E3mm CCATGGGGTCATTCCCAAGAAGAACATTTGTAAATGGAAGCAGAGAGAGTACTG------ GGT
E 3 f r  CAAGCGCCGCCTTCGGCAGGAGAGGGATGCCGACTGTGGGCAGAGAGAGCCACGACCGCT
★ ★ ★ ★★★ ★★★★★ ★ ★★★ ★★★★★★★★★ 'k ★★
E 3 h s  ATTTAGAAGAACTTGAGAAAGAGAG 2 0 2  
E3mra ATCTAGAAGAGCTTGAAAAAGAAAG 1 9 9  
E 3 f r  GCCTGGAGGAGCTGGAGT^AGGAGAG 1 9 9  
* ** ** ** ** ** *★ **
E 4 h s  GTCATTGCTTCTTGCTGATCTTGACAAAGAAGAAAAGGAAAAAGACTGGTATTACGCTCA 
E4mm ATCATTACTCCTTGCTGATCTTGACAAAGAAGAGAAGGAAAAGGACTGGTATTATGCTCA 
E4 f r  GTCTCTCCTGTTGGCTGAACTAGAGAAGGAAGAGAAGGAGAAGGACTGGTATTACGCTCA 
* *  *  * *  *  * * * * *  * *  * *  * *  * * * * *  * * * * *  * *  * * * * * * * * * * *  * * * * *
E 4 h s  ACTTCAGAATCTCACTAAAAGAATAGATAGTCTTCCTTTAACTGAAAAT 1 0 9  
E4mm ACTTCAGAACCTCACAAAAAGAATAGATAGCCTGCCTTTAACTGAAAAT 1 0 9  
E 4 f r  GCTGCAGAATCTCACCAAGAGGATCGACAGCCTGCCGCTCACTGAAAAT 1 0 9  
**  * * * * *  * * * * *  * *  * *  * *  * *  * *  * *  * *  *  * * * * * * * * *
E 5 h s  TTTTCCTTACAAACAGATATGACCAGAAGGCAATTGGAATATGAAGCAAGGCAAATCAGA 
E5mm TTTTCCTTACAGACAGACATGACAAGACGGCAGCTGGAGTATGAAGCAAGGCAGATCAGG 
E 5 f r  TTCACGCTCCAAACAGACAGGAGTCGTCTACAGCTGGAGTTTGAGGCTCGACAGATACGT 
* *  *  *  * *  * * * * *  *  * *  *  * *  * * * *  *  * * *  * *  *  * *  * *  *
E 5 h s  GTTGCGATGGAAGAACAACTAGGTACCTGCCAGGATATGGAAAAACGAGCACAG 1 1 4  
E5ram GCTGCAATGGAGGAGCAGCTTGGCACCTGCCAGGACATGGAGAAGCGTGCACAG 1 1 4  
E 5 f r  TCAGCAATGGAAGAACAGTTGGGCTCCTGTCAGGAAATGGAGAGGAGAGCTCAG 1 1 4  
**  * * * * *  * *  **  * **  * * * *  * * * * *  * * * * *  *  *  * *  * * *
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E6mm CGAAGAATAGCCAGGATCCAGCAAATAGAAAAGGACATACTGCGCGTGCGCCAGCTTTTA 60  
E 6 f r  GCCCGCGTGTCCCGGATTCAGCAGATCGAGAAAGACATCCTGAGACTTGGAGCTCACTTG 60
★ ★ ★ ★  ★ ★ ★  ★ ★ ★ ★ ★  k  k  k  k  k  k  k  k  k  k  k  k  k  k  k  k  k  k  k
E 6 h s  CAGTCCCAAGCAACAGAAGCAGAG 84  
E6min CAGTCCCAGGCGGCGGAAGCGGAG 84  
E 6 f r  CAG------------------------------------------------- 63
k  k  k
E 7 h s  AGGTCATCTCAGAACAAGCATGAAACCGGCTCACATGATGCTGAGCGGCAGAATGAAGGT 6 0  
E7mm AGGTCATCTCAGAGCAGGCATGATGCTGCCTCCCATGAAGCTGGCCGGCAGCACGAAGGC 6 0 
E 7 f r ---------------------------------------------------------------------------------------------------------------- GAGTGAAGTT 1 0
E 7 h s  CAAGGAGTGGGAGAAATCAACATGGCAACTTCTGGTAATGGTCAG 1 0 5  
E7mm CACGGAGTGGCAGAAAGCAACACCGCAGCCTCCAGTAGTGGTCAG 1 0 5
E 7 f r  CAAGCGCTGGGTGACAGCAGTGGATTGGCTGCAGCTCAG------------  4 9
* ★  *  * * *  * *  *  *  *  *  ■* *
E 8 h s  GGTTCAACTACACGAATGGACCATGAAACAGCCAGTGTTTTGAGTTCTAGTAGCACACAC 6 0 
E8mm AGTCCAGCTACACGTGTGGATCACGAAACAGCCAGTGTTTTGAGTTCTAGCGGCACGCAC 6 0  
E 8 f r  ACCGCTAGCAGCCGATTGGACCACGAACCAACCAGTGAAGCAAGTT-------------------------- AC 4 8
E 8 h s  TCTGCACCTCGAAGGCTGACAAGTCATCTGGGAACCAAG 99  
E8mm TCTGCTCCTCGAAGGTTGACAAGTCATCTGGGGACAA—  97  
E 8 f r  TCTGTGCCTCGCCGAATTACAAACCACCTGGGAACAAAA 87  
* * * *  * * * * *  *  *  * * * *  * *  * * * * *  * *  *
E 9 h s  — GTGGAAATGGTGTATTCATTGTTGTCAATGCTTGGTACTCATGATAAGGATGATATGT 5 8  
E9mm AGGTGGAAATGGTGTATTCCTTGTTGTCAATGCTTGGTACTCATGATAAGGACGATATGT 6 0  
E 9 f r  — GTGGAGATGGTGTACAGCCTTCTGTCCATGTTGGGGACTCATGATAAAGATGACATGT 5 8 
* * * * *  * * * * * * * *  *  * * * *  * * *  *  * *  * * * * * * * * * * *  * *  * *  * * * *
E 9 h s  CGCGAACTTTGCTAGCTATGTCTAGCTCCCAAGACAGCTGTATATCCATGCGACAGTCTG 1 1 8  
E 9mm CACGAACTTTGCTAGCTATGTCCAGCTCCCAAGACAGCTGTATATCCATGCGGCAGTCTG 1 2 0
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E 9 f r  CCCGGACTCTCCTCGCCATGTCAAGCTCACAGGACTCCTGCATTGCTATGCGTCAATCAG 1 1 8
★ ★★ ★★★ 'k ★★ ★★ ★★★★★ ★★★★★ ★★ ★★★ ★★★ ★★ ★ ★★★★★ ★★ ★★ ★
E 9 h s  GATGTCTTCCTCTCCTCATCCAGCTTTTACATGGCAATGACAAAGACTCTGTATTGTTGG 1 7 8  
E9mm GATGTCTTCCTCTCCTCATCCAGCTTTTACATGGCAATGACAAAGACTCTGTATTGTTGG 1 8 0  
E 9 f r  GTTGTCTTCCACTACTCATCCAGTTGCTGCATGGCAATGACAAAGACTCTATTTTGCTAG 1 7 8★ ★★★★★★★★ ★★ ★★★★★★★★★ ★ ★ ★★★★★★★★★★★★★★★★★★★★★ ★ ★★★ ★ ★
E 9 h s  GAAATTCCCGGGGCAGTAAAGAGGCTCGGGCCAGGGCCAGTGCAGCACTCCACAACATCA 2 3 8  
E9mm GAAATTCCCGGGGCAGTAAAGAGGCTCGGGCCAGGGCCAGTGCAGCACTCCACAACATCA 2 4  0 
E 9 f r  GTAACTCTCGAGGAAGCAAGGAAGCCCGCGCGAGGGCATCCGCGGCGTTGCACAACATTG 2 3 8  
* * *  * *  * *  **  * *  **  * *  **  * *  **  * * * * *  **  * *  *  * * * * * * * *
E 9 h s  TTCACTCACAGCCTGATGACAAGAGAGGCAGGCGTGAAATCCGAGTCCTTCATCTTTTGG 2 9 8  
E9mm TTCACTCACAGCCTGATGACAAGAGAGGCAGGCGTGAAATCCGAGTCCTTCATCTTTTGG 3 0 0  
E 9 f r  TTCACAGCCAGCCAGATGATAAAAGAGGAAGACGAGAGATCAGAGTGCTTCACCTGCTGG 2 9 8  ★★★★★ ★★★★★ ★★★★★ ★★ ★★★★★ ★★ ★★ ★★ ★★★ ★★★★ ★★★★★ ★★ ★★★
E 9 h s  AACAGATACGCGCTTACTGTGAAACCTGTTGGGAGTGGCAGGAAGCTCATGAACCAGGCA 3 5 8
E9mm AACAGATACGAGCTTACTGTGAAACCTGTTGGGAGTGGCAGGAAGCCCACGAACAAGGCA 3 6 0
E 9 f r  AGCAGGAGCGACATTACTGCGAGGCCTGTTGGAGTTGGCAGGAGAACCACGAGAGGGGCA 3 5 8  ★ ★★★ ★★ ★★★★★★ ★★ ★★★★★★★★ ★★★★★★★★ ★★ ★★ ★★★★
E 9 h s  TGGACCAGGACAAAAATCCAA 3 7  9 
E9mm TGGACCAGGACAAAAACCCAA 3 8 1
E 9 f r  TCGACCAGGAGGACAACCCA- 3 7 8  
★ ★★★★★★★★ ★ ★★ ★★★
E lO h s  TGCCAGCTCCTGTTGAACATCAGATCTGTCCTGCTGTGTGTGTTCTAATGAAACTTTCAT 6 0  
ElOmm TGCCAGCTCCTGTTGAGCATCAGATCTGTCCTGCTGTGTGTGTTCTAATGAAGCTTTCAT 60  
E l O f r  TGCCTTCTCCAGTGGAGCACCAAATCTGTCCAGCCGTCTGTGTCCTGATGAAGCTTTCCT 6 0  
* * * *  * * * *  * *  * *  * *  * *  * * * * * * * *  * *  * *  * * * * *  * *  * * * * *  * * * * *  *
E lO h s  TTGATGAAGAGCATAGACATGCAATGAATGAACTAG 9 6  
ElOmm TTGATGAAGAGCATAGGCATGCAATGAATGAACTTG 96  
E l O f r  T T GAT GAAGAGCAT C GACAT GC CAT GAAT GAACT T G 9 6
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★★★★★★★★★★★★★★ ★ ★★★★★ ★★★★★★★★★★★ ★
E l l h s  GGGGACTACAGGCCATTGCAGAATTATTGCAAGTGGACTGTGAAATGTATGGGCTTACTA 60  
E llm m  GGGGACTGCAGGCCATTGCAGAGTTATTGCAGGTGGACTGTGAGATGTATGGGCTTACTA 60  
E 1 1 f r  GTGGGCTGCAGGCGGTGGCAGAGCTGCTGCAGGTGGACTGTGAGATGTTTGGTCTCACCA 6 0 
* * *  **  * * * * *  * * * * * *  * * * * *  * * * * * * * * * * *  * * * *  * * *  **  **  *
E l l h s  ATGACCACTACAGTATTACACTAAGACGATATGCTGGAATGGCTTTGACAAACTTGACTT 1 2 0  
E l  lmm ATGACCACTACAGTGTTACTTTAAGACGGTATGCTGGAATGGCTTTGACAAACTTGACCT 1 2 0  
E l l f r  GCGATCATTACAGCATCACACTGAGGAGATATGCTGGCATGGCCCTCACTAACCTCACAT 1 2 0  
★ ★ ★★ ★★★★★ ★ ★★ ★ ★★ ★ ★★★★★★★★ ★★★★★ ★ ★★ ★★★ ★ ★★ ★
E l l h s  TTGGAGATGTAGCCAACAAG 1 4 0  
E llm m  TTGGAGATGTTGCCAACAAG 1 4 0  
E l l f r  TTGGAGACGTCGCCAATAAG 1 4 0  
* * * * * * *  * *  * * * * *  * * *
E 1 2 h s  GCTACGCTATGCTCTATGAAAGGCTGCATGAGAGCACTTGTGGCCCAACTAAAATCTGAA 60  
E l2m m  GCTACGCTGTGTTCTATGAAAGGCTGCATGAGAGCACTTGTGGCCCAGTTAAAATCTGAG 60  
E l 2 f r  GCCACGCTGTGCTCCATGAAGGGCTGCATGAGAGCCATGGTGGCCCAGCTCAAGTCGGAC 60  
★ ★ ★★★★★ ★★ ★★ ★★★★★ ★★★★★★★★★★★★★★ ★ ★★★★★★★★ ★ ★★ ★★ ★★
E 1 2 h s  AGTGAAGACTTACAGCAG 7 8  
E12mm AGTGAAGACTTACAGCAG 7 8  
E 1 2 f r  AGTGAGGACCTGCAGCAG 7 8  
* * * * *  * * *  *  * * * * * *
E 1 3 h s  GTTATTGCGAGTGTTTTGAGGAATTTGTCTTGGCGAGCAGATGTAAATAGTAAAAAGACG 60  
El3m m  GTTATTGCAAGTGTTTTGAGGAATTTGTCTTGGCGAGCAGATGTAAATAGCAAAAAGACG 60  
E 1 3  f r  GTGATAGCGAGTGTTTTAAGGAACCTGTCGTGGCGTGCTGATGTCAACAGTAAGAAGACA 6 0 
* *  **  **  * * * * * * * *  * * * * *  * * * *  * * * * *  **  * * * * *  **  **  **  * * * * *
E 1 3 h s  TTGCGAGAAGTTGGAAGTGTGAAAGCATTGATGGAATGTGCTTTAGAAGTTAAAAAG 1 1 7  
E l3m m  TTGAGAGAAGTTGGAAGTGTGAAAGCATTGATGGAATGTGCTTTGGAAGTTAAAAAG 1 1 7  
E 1 3  f r  TTGCGTGAGGTCGGCAGTGTACGAGCACTGACGGGCTGCGCTCTCGTGGTGCAGAAG 1 1 7  
★★★ ★ ★★ ★★ ★★ ★★★★★ ★★★★ ★★★ ★★ ★★ ★★★ ★ ★ ★★ ★ ★★★
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E 1 4 h s  GAATCAACCCTCAAAAGCGTATTGAGTGCCTTATGGAATTTGTCAGCACATTGCACTGAG 
E 1 4mm GAATCAACCCTCAAAAGCGTTTTGAGTGCCTTATGGAACCTGTCTGCACACTGCACTGAG 
E 1 4 f r  GAGTCCACGCTGAAGTCGGTGCTGAGCGCACTGTGGAACCTGTCTGCTCACTGTACGGAG 
* *  * *  * *  * *  * *  * *  * * * *  * *  *  * * * * *  * * * *  * *  * *  * *  * *  * * *
E 1 4 h s  AATAAAGCTGATATATGTGCTGTAGATGGTGCACTTGCATTTTTGGTTGGCACTCTTACT 
El4m m  AATAAGGCTGACATCTGTGCTGTGGATGGAGCACTGGCATTTCTGGTTGGCACCCTCACT 
E 14 f r  AACAAAGCGGACATCTGCGCTGTGGAGGGTGCTCTGGCCTTTCTAGTGGGAACGCTGACC 
* *  * *  * *  **  **  **  * * * * *  **  **  * *  **  **  * * *  * **  **  * *  * *  **
E 1 4 h s  TACCGGAGCCAGACAAACACTTTAGCCATTATTGAAAGTGGAGGTGGGATATTACGGAAT 
El4m m  TACCGGAGCCAGACAAATACTTTAGCCATTATTGAAAGTGGAGGTGGGATATTACGGAAT 
E 1 4 f r  CACTGCAGTCACACTAACACACTCGCCATCATCGAGAGCGGCGGTGGGATCTTGCGAAAT 
*  *  *  *  *  *  *  *  *  *  *  *  *  *  * * * * *  *  *  *  *  * *  * *  * * * * * * * *  * *  * *  * * *
E 1 4 h s  GTGTCCAGCTTGATAGCTACAAATGAGGACCACAG 2 1 5  
El4m m  GTGTCCAGCTTGATAGCTACAAACGAAGACCACAG 2 1 5  
E 1 4 f r  GTTTCCAGCCTTATCGCCACCAATGAGGCGCACAG 2 1 5
★ ★ ★ ★ ★ ★ ★ ★  ★ ★ ★  ★ ★  ★ ★  "k ' k  k  k  k  ★ ★ ★ ★ ★
E l 5 h s  GCAAATCCTAAGAGAGAACAACTGTCTACAAACTTTATTACAACACTTAAAATCTCATAG 
E 1 5mm GCAAATCCTAAGAGAGAACAATTGCCTACAAACTTTATTACAGCACTTGAAATCTCACAG 
E 1 5 f r  GCAGACGCTGCGCGAGCAGGGCTGCCTTCCAACACTGCTTCAGCACCTCAAGTCACACAG 
* * *  *  * *  *  * * *  *  * *  * *  *  * * *  *  *  * *  * * *  *  * *  * *  * *  * *
E 1 5 h s  TTTGACAATAGTCAGTAATGCATGTGGAACTTTGTGGAATCTCTCAGCAAGAAATCCTAA 
E l5m m  CTTGACAATAGTCAGTAATGCATGTGGAACTTTGTGGAATCTCTCAGCAAGAAATCCTAA 
E 1 5 f r  TCTGACCATCGTGTCCAACGCCTGTGGAACGCTCTGGAATCTGTCGGCCAGAGATGCTAA 
* * * *  **  * *  * *  * *  * * * * * * * *  * * * * * * * * *  **  **  * * *  **  * * * *
E 1 5 h s  AGACCAGGAAGCATTATGGGACATGGGGGCAGTTAGCATGCTCAAGAACCTCATTCATTC 
El5m m  AGACCAGGAAGCCTTGTGGGACATGGGGGCAGTGAGCATGCTCAAGAACCTCATTCATTC 
E 1 5 f r  AGACCAGGAGACGTTATGGGAACTAGGGGCTGTTGGCATGTTGCGCAACCTCATTCATTC 
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E 1 5 h s  AAAGCACAAAATGATTGCTATGGGAAGTGCTGCAGCTTTAAGGAATCTCATGGCAAATAG 2 4  0 
El5m m  CAAGCACAAAATGATTGCCATGGGAAGTGCAGCAGCTTTAAGGAATCTCATGGCAAACAG 2 4 0  
E 1 5  f r  CAGGCACAAGATGATAGCCATGGGTAGTGCTGCTGCCCTGCGTAATCTGATGGCTAACCG 2 4 0  
* * * * * * *  * * * * *  **  * * * * *  * * * * *  * * * * * * * * * * *  * * * * *  * * *
E 1 5 h s  GCCTGCGAAGTACAAGGATGCCAATATTATGTCTCCTGGCTCAAGCTTGCCATCTCTTCA 3 0 0  
El5m m  ACCTGCAAAGTATAAGGATGCCAATATCATGTCTCCCGGCTCAAGTCTGCCATCCCTTCA 3 0 0  
E 1 5  f r  GCCAGCACGCTATAAAGATGCTAGTGTGGTGTCCCCGGGTGCTGGCGCCCCGTCGTTACA 3 0 0
★ ★ ★ ★  ★ ★  k  k  k  k  k  k  k  ★ ★ ★ ★ ★ ★ ★  ★ ★  ★ ★  ★ ★ ★ ★  ★ ★  ★ ★ ★
E 1 5 h s  TGTTAGGAAACAAAAAGCCCTAGAAGCAGAATTAGATGCTCAGCACTTATCAGAAACTTT 3 6 0  
El5m m  CGTTAGGAAACAGAAAGCTCTAGAAGCTGAGCTAGATGCTCAGCATTTATCAGAAACCTT 3 6 0  
E 1 5 f r  TGTCCGCAAACAAAAGGCATTATTTGAAGAGCTAGACGCCCAGCAGCTGTCCGAGACGTT 3 6 0  
**  * * * * * *  **  **  * *  * **  * * * *  **  * * * * *  * **  **  * *  **
E 1 5 h s  TGACAATATAGACAATTTAAGTCCCAAGGCATCTCATCGTAGTAAGCAGAGACACAAGCA 4 2 0  
El5m m  CGACAACATTGACAACCTAAGTCCCAAGGCCTCTCACCGGAGTAAGCAGAGACACAAGCA 4 2 0
E 1 5 f r  TGACAACATTGACAACCTAAGCCCCAAAACGGCACACAGGAAGGGGCGGGGCTGTAA  4 1 7
* * * * *  * *  * * * * *  * * * *  * * * * *  *  *  * *  *  *  * *  *  *  * *
E 1 5 h s  AAGTCTCTATGGTGATTATGTTTTTGACACCAATCGACATGATGATAATAGGTCAGACAA 4 8 0  
E 1 5mm GAATCTTTATGGTGACTATGCTTTTGACGCCAATCGACATGATGATAGTAGGTCAGACAA 4 8 0  
E 1 5 f  r ------------------------------------------------------------------------  TAGTGCCAGTGGGACAG-------- 4 3 4
★ ★★ ★ 'k ★★ ★★★
E 1 5 h s  TTTTAATACTGGCAACATGACTGTCCTTTCACCATATTTGAATACTACAGTGTTACCCAG 5 4 0  
El5m m  TTTCAATACTGGAAACATGACTGTTCTTTCACCATATTTAAATACTACGGTATTGCCCAG 5 4 0  
E 1 5 f r  — CCAGCAC-GGCA---------------- CGTCCGTACACCA------------- ACACACCAGTGCTTTCGAG 4 7 7
★ ★★★★★ ★★★★★★★★★ ★★★ ★★★ k ★★★
E 1 5 h s  CTCCTCTTCATCAAGAGGAAGCTTAGATAGTTCTCGTTCTGAAAAAGATAGAAGTTTGGA 6 0 0  
El5m m  CTCTTCTTCCTCAAGGGGAAGTTTAGACAGTTCTCGTTCTGAGAAAGACAGAAGTTTGGA 6 0 0  
E 1 5 f r  CCC---------------------------AAAGAATGGAGATGGTTC----------------------------------------------------------A 4 9 9
★ ★  ★ ★ ★ ★ ★ ★ ★ ★  k
E 1 5 h s  GAGAGAACGCGGAATTGGTCTAGGCAACTACCATCCAGCAACAGAAAATCCAGGAACTTC 6 6 0
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El5m m  GAGAGAGCGAGGTATTGGCCTCAGTGCTTACCATCCAACAACAGAAAATGCAGGAACCTC 6 6 0
E 1 5 f r  AAGAGGAT------------------------------------------------------------------CAACGAGGAACCTGGGTAC 5 2 6
★★★★ ★★★★ ★★ ★★★★
E 1 5 h s  TTCAAAGCGAGGTTTGCAGATCTCCACCACTGCAGCCCAGATTGCCAAAGTCATGGAAGA 7 2 0  
El5m m  ATCAAAACGAGGTCTGCAGATCACTACCACTGCAGCCCAGATAGCCAAAGTTATGGAAGA 7 2 0
E 1 5 f  r ---------------------------------------------------------------------------- GCCCGGAC------------------------------------------ 5 3 4
★ ★ ★ ★ ★ ★
E 1 5 h s  AGTGTCAGCCATTCATACCTCTCAGGAAGACAGAAGTTCTGGGTCTACCACTGAATTACA 7 8 0  
E 1 5mm AGTATCAGCCATTCATACCTCCCAGGACGACAGAAGTTCTGCTTCTACCACCGAGTTCCA 7 8 0
E 1 5 f r  GGTGTTTTCCACTAGTGTC-------------------------------------------------------------------------CGAGCTTC- 5 6 1
★ ★ ★ ★ ★ ★ ★ ★ ★  ★★★★
E 1 5 h s  TTGTGTGACAGATGAGAGAAATGCACTTAGAAGAAGCTCTGCTGCCCATACACATTCAAA 8 4 0  
E 1 5mm TTGTGTGGCAGACGACAGGAGTGCGGCACGAAGAAGCTCTGCCTCCCACACACACTCAAA 8 4 0  
E 1 5 f r  --------------------------------------------------------------------------------------------------------------------------------------
E l 5 h s  CACTTACAATTTCACTAAGTCGGAAAATTCAAATAGGACATGTTCTATGCCTTATGCCAA 9 0 0  
El5m m  CACATACAACTTCACTAAGTCGGAAAATTCAAATAGGACATGCTCTATGCCTTATGCCAA 9 0 0
E 1 5 f r  CAGTGACAGCCTCAACAGCGTGACGAGTGCAGATGG--------------------------------- TTACGGCAA 6 0 6
* *  * * *  * * *  *  *  *  *  * *  * *  *  * * *  *  * * *
E l 5 h s  ATTAGAATACAAGAGATCTTCAAATGATAGTTTAAATAGTGTCAGTAGTAGTGATGGTTA 9 6 0  
El5m m  AGTGGAATATAAACGATCTTCAAATGACAGTTTAAATAGTGTCACTAGTAGTGATGGATA 9 6 0
E 1 5 f r  CCGAGGCAAAAATAAACCGTCAACGGA----------------- GCCGTTTTACTCGT---------------------------6 4 7
* * ** * * ** ** * * * **
E 1 5 h s  TGGTAAAAGAGGTCAAATGAAACCCTCGATTGAATCCTATTCTGAAGATGATGAAAGTAA 1 0 2 0  
E15mm TGGTAAAAGAGGCCAAATGAAACCCTCAGTTGAATCCTATTCTGAAGATGATGAAAGTAA 1 0 2 0  
E 1 5 f r -----------------------------CAGACGAGAGC---------------GGAGCC---------------------------------------- AATAA 6 6 9
E 1 5 h s  GTTTTGCAGTTATGGTCAATACCCAGCCGACCTAGCCCATAAAATACATAGTGCAAATCA 1 0 8 0  
E 1 5mm ATTTTGCAGTTATGGTCAGTATCCAGCTGACCTAGCCCATAAGATACACAGTGCAAATCA 1 0 8 0
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E 1 5  f r  GTGCTGTGTTTACAGGAAGTACCCGGCTGACCTAGCACACAAGATCCGCAGTGCCAATCA 7 2 9  
* **  * * *  * * * *  * *  * *  * * * * * * * *  **  **  * *  * * * * * *  * * * * *
E 1 5 h s  TATGGATGATAATGATGGAG AACTAGATACACCAATAAATTATAGTCTTAAATATTC 1 1 3 7
El5m m  TATGGATGATAATGATGGAG AACTGGATACACCAATAAATTACAGTCTTAAATATTC 1 1 3 7
E 15  f r  CATGGCAGATGATGACGGAGCAGAGCTGGACACGCCTATCAACTACAGTCTGAAGTACTC 7 8 9 
* * * *  * * *  * * * *  * * * *  * **  **  **  **  **  **  ** * * * * *  **  **  **
E 1 5 h s  AGATGAGCAGTTGAACTCTGGAAGGCAAAGTCCTTCACAGAATGAAAGATGGGCAAGACC 1 1 9 7  
E l5m m  AGATGAGCAGTTGAACTCAGGAAGGCAGAGTCCCTCACAGAATGAAAGGTGGGCAAGACC 1 1 9 7  
E 1 5 f r  TGACGAACAGTTGAATTCTGGGAGACAGAGTCC------------------------------------------------------------8 2 2
E 1 5 h s  CAAACACATAATAGAAGATGAAATAAAACAAAGTGAGCAAAGACAATCAAGGAATCAAAG 1 2 5 7  
El5m m  AAAGCATGTGATAGAAGATGAAATAAAGCAAAACGAGCAAAGACAAGCAAGAAGCCAGAA 1 2 5 7  
E 1 5 f r  --------------------------------------------------------------------------------------------------------------------------------------
E 1 5 h s  TACAACTTATCCTGTTTATACTGAGAGCACTGATGATAAACACCTCAAGTTCCAACCACA 1 3 1 7  
E 1 5mm CACCAGTTATCCTGTCTATTCTGAGAATACCGATGACAAACACCTC7VAATTCCAACCACA 1 3 1 7  
E 1 5 f  r  AAGTCACCGCGTCGGTATGGACAGTGATGACGAC------------------------------------------------------8 5 6
E 1 5 h s  TTTTGGACAGCAGGAATGTGTTTCTCCATACAGGTCACGGGGAGCCAATGGTTCAGAAAC 1 3 7 7  
El5m m  TTTTGGACAACAAGAATGTGTTTCCCCATATAGGTCAAGGGGAACCAGTGGTTCAGAAAC 1 3 7 7
E 1 5 f r ----------- GACGAGGAGGACG------------------------GCAGGCTGAGGAGAAGGAACGA— CGGTAGC 8 9 8
* * *  *  *  *  * * *  * *  * *  *  *  *  *  *  *
E 1 5 h s  AAATCGAGTGGGTTCTAATCATGGAATTAATCAAAATGTAAGCCAGTCTTTGTGTCAAGA 1 4 3 7  
E l5m m  AAATCGAATGGGTTCTAGTCATGCAATTAATCAAAATGTAAACCAGTCTCTGTGTCAGGA 1 4 3 7
E 1 5 f r  GACTCGG-----------------------------------------------------------------TGTCGTCCGGTAGCCGC------------------9 2 2
*  * * *  * * *  * * * *  *
E 1 5 h s  AGATGACTATGAAGATGATAAGCCTACCAATTATAGTGAACGTTACTCTGAAGAAGAACA 14 97  
El5m m  AGATGATTATGAAGATGATAAACCTACCAACTACAGTGAACGTTATTCTGAGGAAGAACA 14  97  
E 1 5 f  r ----------- ATTATTTCGGT------------- CCCACCA-CCACGAT— ACGTTGTCAC-------------------------- 9 5 7
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* *** * * ** **** * * *****
E 1 5 h s  GCATGAAGAAGAAGA GAGACCAACAAATTATAGCATAAAATATAATGAAGAGAAACG 1 5 5 4
E 1 5mm ACATGAAGAAGAAGAAGAGAGACCGACAAATTATAGCATAAAATATAATGAAGAGAAACA 1 5 5 7
E 1 5 f r  TGCAGCAG---------------------------CAGCAAACT AT GGCG--------------GTGATCCAGCAGGA—  9 9 4
★★★★★★ ★ ★★★★★★★★★ ★★★ ★★ ★
E 1 5 h s  TCATGTGGATCAGCCTATTGATTATAGTTTAAAATATGCCACAGATATTCCTTCATCACA 1 6 1 4  
El5m m  TCATGTGGATCAGCCTATTGATTATAGTTTAAAATATGCCACTGACATTTCTTCCTCACA 1 6 1 7
E 1 5 f r ---------------GAGCAGCCAATCGACTACAGCCTGAAATATGGCAGTGACGGTGCC---------------CA 1 0 4 1
* *  * * * * *  * *  * *  * *  * *  *  * * * * * * *  * *  * *  *  *  * *
E 1 5 h s  GAAACAGTCATTTTCATTCTCAAAGAGTTCATCTGGACAAAGCAGTAAAACCGAACATAT 1 6 7 4  
El5m m  AAAACCATCATTTTCATTCTCAAAGAATTCATCAGCACAAAGCACTAAACCTGAACATCT 1 6 7 7
E 1 5 f r  TAAAC— CCCTGTTCAAGCCCGAAGAGTCCGCC---------------- GCAT-------------------------CATCT 1 0 8 1
★★★★ ★★★★★★ ★★★★★★★★ ★ ★★★ ★★★★
E 1 5 h s  GTCTTCAAGCAGTGAG7^ATACGTCCACACCTTCATCTAATGCCAAGAGGCAGAATCAGCT 1 7 3 4  
El5m m  CTCTCCAAGCAGCGAGAATACAGCTGTACCTCCATCTAATGCCAAAAGGCAGAATCAGCT 1 7 3 7
E 1 5 f r  GTT----------------------------AAGACTCCCACACCGTCTTC-------------------------- GTCGGCTAAACT 1 1 1 6
*  * *  * *  *  * * *  *  * *  *  *  *  *  * *
E 1 5 h s  CCATCCAAGTTCTGCACAGAGTAGAAGTGGTCAGCCTCAAAAGGCTGCCACTTGCAAAGT 1 7 9 4
E l5m m  GCGTCCAAGTTCAGCACAAA GAAATGGCCAGACTCAAAAAGGCACTACTTGCAAAGT 1 7 9 4
E 1 5 f r  CCGCCC CCCTGC--------------------------------- CCCTGCTAACAGGGCCG-------- TGGCAAAA- 1 1 5 3
* ** * ** * ** * * * * *****
E 1 5 h s  TTCTTCTATTAACCAAGAAACAATACAGACTTATTGTGTAGAAGATACTCCAATATGTTT 1 8 5 4  
E l5m m  CCCCTCCATCAACCAAGAAACAATACAGACTTACTGCGTAGAAGACACCCCAATATGTTT 1 8 5 4
E 1 5 f r   GCTAACCAGGAGTCAACGCAGACCTACTGTGTGGAGGACACGCCCATCTGTTT 1 2 0 6
★★★★★ ★★ ★★★ ★★★★★ ★★ ★★ ★★ ★★ ★★ ★★ ★★ ★★ ★★★★★
E 1 5 h s  TTCAAGATGTAGTTCATTATCATCTTTGTCATCAGCTGAAGATGAAATAG— GATGTAAT 1 9 1 2  
E 1 5mm TTCAAGGTGCAGTTCATTATCATCACTGTCATCAGCTGACGATGAAATAG— GATGTGAT 1 9 1 2  
E 1 5  f r  CTCCCGAGGCAGCTCGCTGTCTTCGCTGTCATCAGAGGAGGAAGAAGAGGTTGATGTCAT 1 2 6 6  
★★ ★ ★ ★★ ★★ ★ ★★ ★★ ★★★★★★★★★ ★★ ★★ ★★★ ★ ★★★★★ ★★
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E 1 5 h s  C----------------- AGACGACACAGGAAGCAGATTCTGCTAATACCCTGCAAATAGCAGAAATAA 1 9 6 4
E l5m m  C----------------- AGACAACACAGGAAGCAGATTCTGCTAATACTCTGCAGACAGCAGAAGTAA 1 9 6 4
E l 5 f r  AGAGAGGAGAGGTGCTAGCGGAGGGGGAAATGGTGAGTATCCAACAGTTCCTGTCAGCGA 1 3 2 6  
★ ★ ★★★★★★★ ★ ★ ★ ★ ★ ★ ★  ★ ★
E l 5 h s  AAGAAAAGATTGGAACTAGGTCAGCTGAAGATCCTGTGAGCGAAGTTCCAGCAGTGTCAC 2 0 2 4  
E l  5mm AAGAGAATGATGTAACTCGGTCAGCTGAAGATCCTGCAACTGAAGTTCCAGCAGTGTCCC 2 0 2 4
E 1 5 f r  GAAGGATGCTCGTGAGCAG— CAGCAGAGGCACCAGAAGGAGG CAG-AGAGTCAG 1 3 7 8★ ★ ★ ★ ★ ★★★★★★★ ★★★ ★ ★★★★★★★★
E 1 5 h s  AGCACCCTAGAACCAAATCCAGCAGACTGCAGGGTTCTAGTTTATCTTCAGAATCAGCCA 2 0 8 4  
E 1 5mm AGAATGCTAGAGCCAAACCCAGCCGACTCCAGGCTTCTGGCTTATCTTCAGAATCAACCA 2 0 8 4  
E 15  f r  ACTGCAGCCGTCACGGCACCGTCTACACGGGGACGGCGAAGTCACCACCATCACCA-CCA 1 4 3 7  
* * * * *  * * * * * * * *  * **  * * *
E 1 5 h s  GGCACAA AGCTGTTGAATTTTCTTCAGGAGCGAAATCTCCCTCCAAAAGTGGTGCTC 2 1 4 1
E l5m m  GGCATAATAAAGCTGTTGAGTTTTCTTCAGGAGCCAAGTCTCCCTCCAAAAGTGGTGCTC 2 1 4  4
E 1 5 f r  CGGTCACCACCACCACC— ACCACCACCACG— TTGCATCATCTTC-------------AGGTGCTA 1 4 8 7
*  *  *  *  * *  *  * *  *  * *  * * * * * *
E 1 5 h s  AGACACCCAAAAGTCCACCTGA ACACTATGTTCAGGAGACCCCACTCATGTTTAGCA 2 1 9 8
E 1 5mm AGACACCCAAAAGTCCCCCAGA ACACTATGTCCAGGAGACTCCGCTCGTATTCAGCA 2 2 0 1
E l 5 f r  GGACTCCCAAGAGTCCTCCAGAGCCACCATATGCCCAGGAGACACCGCTCATGTTCAGCC 1 5 4 7  
★★★ ★★★★★ ★★★★★ ★★ ★★ ★★ ★★★★ ★★★★★★★★ ★★ ★★★ ★ ★★ ★★★
E 1 5 h s  GATGTACTTCTGTCAGTTCACTTGATAGTTTTGAGAGTCGTTCGATTGCCAGCTCCGTTC 2 2 5 8  
E15mm GGTGTACTTCTGTCAGCTCCCTTGACAGTTTTGAGAGTCGCTCCATTGCCAGCTCTGTTC 2 2 6 1  
E 1 5 f r  GCTGCACATCCGTCAGTTCCCTGGACAGCTTTTCAACTTCCTCAATTGCCAGTTCTGTGC 1 6 0 7
★ ★ ★  ★ ★  ★ ★  ★ ★ ★ ★ ★  ★ ★  k  k  k  k  ★ ★  ★ ★ ★  ★ ★ ★ ★  ★ ★ ★ ★ ★ ★ ★ ★  ★ ★  ★ ★  ★
E 1 5 h s  AG AGTGAACCATGCAGTGGAATGGTAAGTGGCATTATAAGCCCCAGTGATCTTCCAG 2 3 1 5
El5m m  AG AGTGAGCCATGTAGTGGAATGGTGAGTGGCATCATAAGCCCCAGTGACCTTCCAG 2 3 1 8
E 1 5  f r  GCTCCAGCGAGCCGTGTAGTGGCATGCCGAGTGGTGTTGTCAGCCCTAGTGACCTACCCG 1 6 6 7
★ ★ ★ ★  ★ ★  ★ ★  ★ ★ ★ ★ ★  k  k  k  k  k  k  k  k  k  k  ★ ★ ★ ★ ★  ★ ★ ★ ★ ★  k  k  k  k  k
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E 1 5 h s  ATAGCCCTGGACAAACCATGCCACCAAGCAGAAGTAAAACACCTCCACCACCTCCTCAAA 2 3 7 5  
E 1 5mm ATAGTCCTGGGCAGACCATGCCACCAAGCAGAAGCAAAACCCCTCCACCTCCTCCACAGA 2 3 7 8  
E 1 5  f r  ACAGCCCGGGACAGACCATGCCGCCAAGCCGTGCAAAGACGCCACCGTTGCCACCGACCA 1 7 2 7  
★ ★★ *★ ★★ ★★ ★★★★★★*★ ★★★★** * *★ ★ ★ ★ ★ ★★ *★ ★★ ★
E 1 5 h s  CAGCTCAAACCAAGCGAGAAGTACCTAAAAATAAAGCACCTACTGCTGAAAAGAGAGAGA 2 4 3 5  
El5m m  CAGTGCAGGCCAAGAGAGAGGTGCCAAAAAGTAAAGTCCCTGCTGCTGAGAAGAGAGAGA 2 4 3 8  
E 1 5 f r  CGCATAAAACCAA-----------------------CAAGCAGGAAAATACC------------------AAGAAAAAAGAT 17  68
★ k  k  k  k  k  k  ★ ★  ★ ★ ★ ★
E 1 5 h s  GTGGACCTAAGCAAGCTGCAGTAAATGCTGCAGTTCAGAGGGTCCAGGTTCTTCCAGATG 2 4  9 5  
E 1 5mm GTGGGCCTAAGCAGACTGCTGTAAATGCTGCCGTGCAGAGGGTGCAGGTCCTTCCAGACG 2 4  98
E 1 5 f r  GAGGACGAGAGCAG---------------------------------------------------------------------------------------------------- TG 1 7 8 4
* ** * **** *
E 1 5 h s  CTGATACTTTATTACATTTTGCCACGGAAAGTACTCCAGATGGATTTTCTTGTTCATCCA 2 5 5 5  
E15mm TGGATACTTTGTTACACTTCGCCACAGAAAGTACTCCAGACGGGTTTTCTTGTTCCTCCA 2 5 5 8  
E l 5 f r  CTGATGTTTTGCTGCACTTTGCTACTGAAAGCACGCCACACGGCTTCTCCAGGGCTTCCA 1 8 4  4 
* * *  * * *  *  * *  * *  * *  * *  * * * * *  * *  * * *  *  * *  * *  * *  *  *  * * * *
E 1 5 h s  GCCTGAGTGCTCTGAGCCTCGATGAGCCATTTATACAGAAAGATGTGGAATTAAGAATAA 2 6 1 5  
El5m m  GCCTAAGTGCTCTGAGCCTGGATGAGCCATTTATACAGAAAGATGTAGAATTAAGAATCA 2 6 1 8
E 1 5 f r  GTCTGAGTGCGCTTAGTGTAGATGAGCCCTTCATC------------ ACTGCAGAGTTAA----------------1 8 9 2
* ** ***** ** ** * ******** ** ** ** ** ****
E 1 5 h s  TGCCTCCAGTTCAGGAAAATGACAATGGGAATGAAACAGAATCAGAGCAGCCTAAAGAAT 2 6 7 5  
E15mm TGCCTCCAGTTCAGGAAAACGACAATGGGAATGAAACTGAATCAGAACAGCCTGAGGAAT 2 6 7 8  
E 1 5 f r -------------------------- AGGAGGAGGA------------GGAGGATAAAGGATCCGAGCAGA------------------------1 9 2 5
★ ★ ★ ★  ★ ★ ★  ★ ' k  ★ ★  ★ ★ ★ ★ ★  k  k  k  k  k
E 1 5 h s  CAAATGAAAACCAAGAGAAAGAGGCAGAAAAAACTATTGATTCTGAAAAGGACCTATTAG 2 7 3 5
E15mm CAAATGAAAACCAGGATAAAGAGGTAGAAAAGCCT GACTCTGAAAAAGACTTATTAG 2 7 3 5
E 1 5 f r -------------------------- GGGTGGAAGAGGCACCAAAAGCA------ GTCCTCGATGA ATCGG 1 9 6 4
E 1 5 h s  ATGATTCAGATGATGATGATATTGAAATACTAGAAGAATGTATTATTTCTGCCATGCCAA 2 7 9 5
J.L. Juarez-Morales 2005
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E15mm ATGATTCTGATGACGATGATATTGAAATATTAGAAGAATGTATTATTTCAGCCATGCCAA 2 7  9 5  
E 1 5  f r  ACGAC GACGACGACATCGAGATTCTGGAAGCCTGCATCAACATGGCCATGCCT- 2 0 1 7
E 1 5 h s  CAAAGTCATCACGTAAAGCAAAAAAGCCAGCCCAGACTGCTTCAAAATTACCTCCACCTG 2 8 5 5  
El5m m  CAAAGTCATCACGCAAAGCCAAAAAACTAGCCCAGACTGCTTCAAAATTACCTCCACCTG 2 8 5 5
E 1 5 f r  — AAATCATCGCGAAAACCAAAGAAACCACAACAAGCAGC--------------------------------------------  2 0 5 5
** ***** ** *** * ** ** * * ** * **
E 1 5 h s  TGGCAAGGAAACCAAGTCAGCTGCCTGTGTACAAACTTCTACCATCACAAAACAGGTTGC 2 9 1 5  
E l5m m  TGGCAAGGAAACCAAGTCAGCTACCTGTGTATAAACTTCTGCCAGCACAGAATAGGCTGC 2 9 1 5
E l 5 f r  -GCCGCGGAAAGCCAGCCAGCTTCCCGTCTACAAGCT-CCGCGTCCA---------------- GTCGC 2 1 0 5
* * ***** * ** ***** ** ** ** ** ** * * ** * **
E l 5 h s  AACCCCAAAAGCATGTTAGTTTTACACCGGGGGATGATATGCCACGGGTGTATTGTGTTG 2 9 7 5  
E 1 5mm AGGCACAAAAACATGTTAGCTTTACACCAGGGGATGATGTGCCCCGGGTGTACTGTGTAG 2 9 7 5  
E 1 5 f r  AGCCAAGGAAGGACGT— GCCGC-CGCCGGCCGAGGAGGTGCCAAGAGTCTACTGTGTCG 2 1 6 2  
★ ★ ★★ ★★★ ★ ★★★★ ★★★★ ★★★★ ★★★★★★★★★★★
E 1 5 h s  AAGGGACACCTATAAACTTTTCCACAGCTACATCTCTAAGTGATCTAACAATCGAATCCC 3 0 3 5  
E 1 5mm AAGGGACACCTATAAACTTTTCCACAGCAACGTCTCTAAGTGATCTGACAATAGAGTCCC 3 0 3 5  
E 1 5  f r  AGGGAACGCCACTGAATTTCTCCACCGCTACCTCACTGAGTGATCTCACCATCGACTCCC 2 2 2 2
★ ★★ ★★ ★ ★★ ★★ ★★★★★ ★★ ★★ ★★ ★★ 'k'k'k'k'k'k'k'k ★★ ★★ ★★ ★★★★
E 1 5 h  s  CTCCAAATGAGTTAGCTGCTGGAGAAGGAGTTAGAGGAGGGGCACAGTCAGGTGAATTTG 3 0 9 5  
E l5m m  CTCCAAATGAATTGGCTACTGGAGATGGGGTCAGAGCGGGTATACAGTCAGGTGAATTTG 3 0 9 5  
E 1 5 f r  CACCCAACGA---------------------GGAGGCGGCGGCGGTGGCGGCG-----------------------------------------  2 2 5 4
* ** ** ** **** ** * * * **
E 1 5 h s  AAAAACGAGATACCATTCCTACAGAAGGCAGAAGTACAGATGAGGCTCAAGGAGGAAAAA 3 1 5 5  
El5m m  AAAAACGAGATACCATTCCTACAGAAGGCAGAAGTACAGATGATGCTCAGCGAGGAAAAA 3 1 5 5
E l 5 f r ------------------------ GCCATCCTGCCCGAGGGCCCGCCCGC----------------- CTCCACTCAGGAAGA 2 2 9 5
**** * * ** *** * *** * ** *
E 1 5 h s  CCTCATCTGTAACCATACCTGAATTGGATGACAATAAAGCAGAGGAAGGTGATATTCTTG 3 2 1 5  
E15mm TCTCATCTATAGTTACACCAGACCTGGATGACAACAAAGCAGAGGAAGGAGATATTCTTG 3 2 1 5
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E l 5 f r  TCGGGCC-------GGACATCCC------------- GAAGGTGAAAATGC--------------- GATGACATCCTTG 2 3 3 8
* * * ** ** * * ** ** * ** ** ****
E 1 5 h s  CAGAATGCATTAATTCTGCTATGCCCAAAGGGAAAAGTCACAAGCCTTTCCGTGTGAAAA 3 2 7 5  
El5m m  CAGAATGTATCAATTCTGCTATGCCCAAAGGAAAAAGCCACAAGCCTTTCCGAGTGAAAA 3 2 7 5  
E l 5 f r  CCGAATGTATCAGCGCTGCTATGCCCAAAGCCAAACCCAGGAAGCCAATCAGAGTGGCAG 2 3 9 8  
★ ★★★★★ ★★ ★ ★★★★★★★★★★★★★★★ ★★★ ★★★★★ ★★ ★ ★★★ ★
E 1 5 h s  AGATAATGGACCAGGTCCAGCAAGCATCTGCGTCTTCTTCTGCACCCAACAAAAATCAGT 3 3 3 5  
El5m m  AGATAATGGACCAAGTCCAACAAGCATCCTCGACTTCATCTGGAGCTAACAAAAATCAAG 3 3 3 5  
E 1 5 f r  TGAACAGCGAGCACGTCCAATCGCCACCC-CTCCCCCCTCCGAAA— AAAAAAAAAAAAG 2 4 5 5  
**  * * *  **  * * * * *  * *  * * * * **  * * **  * * * * *  *
E 1 5 h s  TAGATGGTAAGAAAAAGAAACCAACTTCACCAGTAAAACCTATACCACAAAATACTGAAT 3 3 9 5  
El5m m  TAGACACTAAGAAAAAGAAGCCTACTTCACCAGTAAAGCCCATGCCACAAAATACTGAAT 3 3 9 5
E 1 5 f r  CAGCT— CCAAAAGAAAAAGCCCACCTCCCCTGTGAAGCCAATGCCACAGAG-----------------  2 5 0 5
★★ ★ ★★ ★★ ★★ ★★ ★★ ★★ ★★ ★★ ★★ ★★ ★★ ★★★★★ ★
E 1 5 h s  ATAGGACACGTGTAAGAAAAAATGCAGACTCAAAAAATAATTTAAATGCTGAGAGAGTTT 3 4 5 5  
El5m m  ATAGAACGCGTGTGAGAAAGAATACAGACTCAAAAGTTAATGTAAATACTGAAGAAACTT 3 4 5 5
E 1 5 f  r ------------------------------------------------------------------------------ GGTGGTGTACACCATGA-----------------  2 5 2 2
* * ** * ***
E 1 5 h s  TCTCAGACAACAAAGATTCAAAGAAACAGAATTTGAAAAATAATTCCAAGGTCTTCAATG 3 5 1 5
El5m m  TCTCAGACAACAAAGACTCAAAGAAACCAAGCTTACAAACCAATGCCAAGGCCTTCAATG 3 5 1 5
E 1 5 f r  -CCACGACTACA-----------------------------------------------------------------------------------------------------------  2 5 3 3
* *** ***
E 1 5 h s  ATAAGCTCCCAAATAATGAAGATAGAGTCAGAGGAAGTTTTGCTTTTGATTCACCTCATC 3 5 7 5  
E 1 5mm AAAAGCTACCTAACAATGAAGACAGAGTGCGGGGGAGCTTCGCCTTGGACTCACCGCATC 3 5 7 5
E 1 5 f r  GCTGCCAAA---------------- ACAAAGCCAGGG---------- TTTGCCTTTGATTCACCTCGCC 2 5 7  6
★★★★★★★ ★★★★ ★★ ★★★★★★★★★★★★★★ ★
E 1 5 h s  ATTACACGCCTATTGAAGGAACTCCTTACTGTTTTTCACGAAATGATTCTTTGAGTTCTC 3 6 3 5  
El5m m  ACTACACCCCTATTGAGGGGACGCCGTACTGCTTTTCCCGAAATGACTCCTTGAGTTCTC 3 6 3 5  
E 1 5 f r  ACTACACGCCCATTGAAGGCACGCCGTGCTGTTTCTCCCGTAACGATTCACTGAGCTCAC 2 6 3 6
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* ***** ** ***** ** ** ** * *** ** ** ** ** ** ** **** ** *
E 1 5 h s  TAGATTTTGATGATGATGATGTTGACCTTTCCAGGGAAAAGGCTGAATTAAGAAAGGCAA 3 6 9 5  
El5m m  TGGATTTTGATGATGACGATGTTGACCTTTCCAGGGAAAAGGCCGAGTTAAGAAAGGGCA 3 6 9 5
E 1 5 f r  TCGACTTCGATGAAGACGACGGTG------------------- GGGATAAAGACGAA— GAGCATAAGAA 2 6 8 5
* ** ** ***** ** ** * ** **** ** * ** ** * *
E 1 5 h s  AAGAAAATAAGGAATCAGAGGCTAAAGTTACCAGCCACACAGAACTAACCTCCAACCAAC 3 7 5 5  
E l5m m  AAGAAAGCAAGGATTCCGAAGCCAAAGTTACCTGCCGCCCAGAACCAAACTCAAGCCAGC 3 7 5 5  
E l 5 f r  AACAAAAGAAGAAGATGGGAAGAAGAGGAAGCAGCAAACGGCGGCCGTCTTCCCTCGGAC 2 7 4 5  
**  * * *  * * *  * * * ** * * ** * ** * *
E 1 5 h s  AATCAGCTAATAAGACACAAGCTATTGCAAAGCAGCCAATAA— ATCGAGGTCAGCCTAA 3 8 1 3  
E l5m m  AGGCAGCTAGTAAGTCACAAGCCAGTATAAAACATCCAGCAA— ACAGAGCACAGTCCAA 3 8 1 3  
E 1 5  f r  AAA-GGCCAACGCGACGTCGTCGGATGAAAAGCAGAAGTTCGCCATCGAGGACACACCCG 2 8 0 4  
* ** * * * * * *** ** * *** ** *
E l 5 h s  ACCCATACTTCAGAAACAATCCACTTTTCCCCAGTCATCCAAAGACATACCAGACAGAGG 3 8 7 3  
E l5m m  ACCAGTGCTGCAGAAACAGCCCACTTTCCCCCAGTCCTCCAAAGACGGACCAGATAGAGG 3 8 7 3
E l 5 f r  TCTGCTTTTCCAGAAAC TCCTCCCTCAGCTCTCTGAGCG-ACATTGACCAGGAG 2 8 5 7
* * * ******* * ** *** ** * * ** *
E 1 5 h s  GGCAGCAACTGATGAAAAGTTACAGAATTTTGCTATTGAAAATACTCCGGTTTGCTTTTC 3 9 3 3  
E15mm GGCAGCAACTGACGAAAAACTGCAGAATTTTGCTATTGAAAATACTCCAGTTTGCTTTTC 3 9 3 3
E 1 5 f r  AATAACAACA--------------------------- AGGAGTTTGC-------------------------------------------------------------C 2 8 7 8
* **** ** * ***** *
E 1 5 h s  TCATAATTCCTCTCTGAGTTCTCTCAGTGACATTGACCAAGAAAACAACAATAA AGA 3 9 9 0
El5m m  TCGAAATTCCTCTCTGAGTTCCCTTAGTGACATTGACCAGGAAAACAACAATAACAAAGA 3 9 9 3
E 1 5 f r  CCGCCGCCACCCGCTGAG----------- CAGCAAGATGGA— GGCAAAGCGGTG-----------------------  2 9 2 0
* * * ***** ** * ** ** *** *
E 1 5 h s  AAATGAACCTATCAAAGAGACTGAGCCCCCTGACTCACAGGGAGAACCAAGTAAACCTCA 4 0 5 0  
E l5m m  AAGTGAACCAATCAAAGAAGCTGAACCTGCCAACTCACAAGGAGAGCCCAGTAAGCCTCA 4 0 5 3
E 1 5 f r  AAATCGTCTCCTC--------------CTCGACGGGCAGAATCAAAGCCACGGCCC------------- CCTGC 2 9 6 7
** * * ** ** * * * *** * * ** ***
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E 1 5 h s  AGCATCAGGCTATGCTCCTAAATCATTTCATGTTGAAGATACCCCAGTTTGTTTCTCAAG 4 1 1 0  
E 1 5mm GGCATCCGGGTATGCTCCCAAGTCCTTCCACGTCGAAGACACCCCTGTCTGTTTCTCAAG 4 1 1 3  
E 1 5 f r  AGCTTCTGGCTATGCCCCAAAAGCCTTTCACGTGGAGGACACACCCGTCTGCTTCTCCAG 3 0 2 7  
* * ★★ *★ *★★★★ ** ★ * ★ ★ ★ ★ * ★* ★★ *★ ★ * ★★ ★★ ** ***** **
E 1 5 h s  AAACAGTTCTCTCAGTTCTCTTAGTATTGACTCTGAAGATGACCTGTTGCAGGAATGTAT 4 1 7 0  
El5m m  AAACAGCTCTCTCAGTTCTCTTAGCATTGACTCTGAGGACGACCTGTTACAGGAGTGTAT 4 1 7 3  
E 1 5 f r  GAACTCGTCGCTCAGCTCGTTAAGCATCGACTCGGAAGACGACCTGCTGCAGGAGTGCAT 3 0 8 7  
* ★ ★ ★ ★ * ★ ★ ★ ★ * ★ * * ★ * ★ * * * * * ★ ★ * * ****** * * * ★ ★ ★ * * * *
E 1 5 h s  AAGCTCCGCAATGCCAAAAAAGAAAAAG--------------CCTTCAAGAC--------------- TCAAGGGT 4 2 1 6
E l5m m  AAGTTCTGCCATGCCAAAAAAGAAAAGG--------------CCTTCAAGAC--------------- TCAAGAGT 4 2 1 9
E 1 5  f r  CAGTTCGGCCATGCCCAAGAAGAAGAAGAAAGCCGCTGCCAGCGCCACGCCATCCACTGT 3 1 4 7  
**  * *  **  * * * * *  **  * * * * *  * * * **  * * *  * **
E 1 5 h s  GATAATGAAAA-ACATAGTCCCAGAAATATGGGTGGCATATTAGGTGAAGATCTGACACT 4 2 7 5  
E l5m m  GAGAGCGAAAA-GCAGAGCCCTAGAAAAGTGGGTGGCATATTAGCTGAAGACCTGACGCT 4 2 7 8  
E l 5 f r  GGCAGCACCACCAGCTGCTCCCAAAGCTGAGAACAGCATTCTGGCTGAAGA GGAGCC 3 2 0 4
★ *  *  *  *  *  *  *  *  *  *  *  ' k ' k ' k ' k ' k ' k ' k ' k  ★ *
E 1 5 h s  TGATTTGAAAGATATACAGAGACCAGATTCAGAACATGGTCTATCCCCTGATTCAGAAAA 4 3 3 5  
E l5m m  TGATTTGAAAGATCTACAGAGGCCAGATTCAGAACACGCTTTCTCCCCCGACTCAGAAAA 4 3 3 8
E 1 5 f r  C— CCGGAGATGCCTTCAGAGGTG CCGAGAAGCCCCGCCTCTCCCGACTCGGAGTC 3 2 5 8
** * * ***** * * ** ** ** ** **
E 1 5 h s  TTTTGATTGGAAAGCTATTCAGGAAGGTGCAAATTCCATAGTAAGTAGTTTACATCAAGC 4 3 9 5  
E l5m m  TTTTGACTGGAAAGCTATTCAGGAAGGCGCAAACTCCATAGTAAGTAGTTTGCACCAAGC 4 3 9 8  
E 1 5 f r  CTTTGATTGGAAGGCCATTCAGGAAGGAGCCAACTCCATCGTCAGTAGCCTTAATGCCGC 3 3 1 8  * * * * * * * ★ ★ ★ * ★ ★★★★★★*★★★★ ★ ★ * * * * * * ★ * ★ ★ ★ ★ ★ ★ ★ ★ ★ ★
E l 5 h s  TGCTGC------ TGCTGCATGTTTATCTAGACAAGCTTCGTCTGATTCAGATTCCATCCTTTC 4 4 5 2
El5m m  TGCTGCAGCCGCCGCGTGCTTATCTAGACAAGCGTCATCCGACTCAGATTCCATTCTGTC 4 4 5 8  
E 1 5 f r  CGCTGCCGCCGCCACGTCCTTGTCCCGCCAGGCGTCATCAGACTCTGACTCTGTCCTGTC 3 3 7 8  
* * * * *  * *  * * **  **  * **  **  **  **  **  **  **  **  * **  **
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E 1 5 h s  CCTGAAATCAGG-------------------AATCTC-TCTGGGATCACCATTTCATCTTACACCTGAT—  4 5 0 1
E15mm ACTAAAGTCCGG------------------- CATTTC-TCTGGGATCGCCTTTTCATCTTACACCTGAT—  4 5 0 7
E 1 5 f r  CCTCAAATCTGTGGGCTCACCATTTCATCTGCCATCAGCCAATAATAATGCAGAAGAGGA 3 4 3 8  
* *  * *  * *  *  * *  * *  * * * *  * * *  *  *  * *  *  * *  * *
E 1 5 h s  CAAGAAGAAAAACCCTTTACAAGTAATAA AGGCCCACGAATTCTAAAACCAGG 4 5 5 4
El5m m  CAAGAGGAAAAGCCATTCACAAGCAATAA AGGCCCAAGAATTCTCAAACCTGG 4 5 6 0
E 1 5 f r  CAAGGTGGATGAGGCTGAGGAGGTGGCGGTAAAGCGAGGAGCACGAATCCTCAAGGCTGG 3 4  98  
**** * * * * * *** ** **** * * ** * **
E 1 5 h s  GGAGAAAAGTACATTGGAAACTAAAAAGATAGAATCTGAAAG-------------- TAAAGGAATCAA 4 6 0 8
El5m m  AGAGAAAAGCACATTAGAAGCAAAAAAAATAGAATCTGAAAA-------------- CAAAGGAATCAA 4 6 1 4
E 1 5 f r  GGAGCGCACTACGCTTGATGCTAAAAAAGAGGAGGACGAGGAAGAAGCCAAGGGAGTGAG 3 5 5 8  
★★★ ★ ★★ ★ ★★  ★★★★★★ ★★ ★* ★ ★ ★ ★ ★ ★ ★
E 1 5 h s  AGGAGGAAAAAAAGTTTATAAAAGTTTGATTACTGGAAAAGTTCGATCTAATTCAGAAAT 4 6 6 8  
E15mm AGGCGGGAAAAAGGTTTATAAAAGCTTGATTACGGGAAAGATTCGCTCCAATTCAGAAAT 4 6 7 4  
E 1 5  f r  AGGTGGCAAAAAGGTGTACAGGAGTCTCATTACAGGCAAAGTCAGGGCGGAGCCAGCAGC 3 6 1 8  
*** ** ***** ** ** * ** * ***** ** ** * * * * *** *
E 1 5 h s  TTCAGGCCAAATGAAACAGCCCCTTCAAGCAAACATGCCTTCAATCTCTCGAGGCAGGAC 4 7 2 8
El5m m  TTCCAGCCAAATGAAACAACCCCTCCCGACAAACATGCCTTCAATCTCAAGAGGCAGGAC 4 7 3 4
E 1 5  f  r  GAGGGGGCGGAGCA------- AGCCCAGGGCGGCAGCCGTGGCGAAAGCGCCAGGAGGCGG— C 3 6 7 3
* * * * * *** ** * ** * * * ***** * *
E 1 5 h s  AATGATTCATATTCCAGGAGTTCGAAATAGCTCCTCAAGTACAAGTCCT GTTTCTAA 4 7 8 5
El5m m  GATGATTCACATCCCAGGGCTTCGGAATAGCTCCTCTAGTACAAGCCCT GTCTCTAA 4 7 9 1
E 1 5 f r  GACGCTGCTGACCACGGAGG GGCATCCTCTCGAGATTCCACGCCGTCGCGTTCGTCC 3 7 3 0
* * * * *  * *  * ** * * * ** * * * ** *
E 1 5 h s  AAAAGGCCCACCCCTTAAGACTCCAGCCTCCAAAAGC— CCTAGTGAAGGTCAAACAGCC 4 8 4 3  
E15mm GAAAGGCCCACCCCTCAAGACTCCAGCCTCTAAAAGC— CCCAGTGAAGGGCCGGGAGCT 4 84  9 
E 1 5  f r  AATGTAAATATTCAGAAAGGAGGGAAACTGTCGCAGCTTCCACGTGCAGCATCTCCAGGA 3 7 9 0
★ ★ ★  ★★★ ★ ★ ★  'k'k'k'k'k'k'k'k'k'k ★★
E 1 5 h s  ACCACTTCTCCTAGAGGAGCCAAGCCATCTGTGAAATCAGAATTAAGCCCTGTTGCCAGG 4 9 0 3
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El5m m  ACCACTTCTCCTCGAGGAACTAAGCCAGCAGGAAAGTCAGAGCTTAGCCCTATCACCAGG 4 9 0 9  
E 1 5  f r  AGCGCATCCTCGACCTCATCTTCGGCCTCCAGAGCAGCAAAACAGAGCGGGGTGACCAAA 3 8 5 0  
* * * * *  * * * * * * **  * * * *  * * * *
E 1 5 h s  CAGACATCCCAAATAGGTGGG-TCAAGTAAAGCACCTTCTAGATCAGGATCTAGAGATTC 4 9 6 2  
E15mm CAAACTTCCCAAATCAGTGGG-TCAAATAAGGGGTCTTCTAGATCAGGATCTAGAGACTC 4 9 6 8
E 1 5 f r  GGCAGCACCGGCACCAACGGGCTCCCGCGGAGCG AATCGGCATCCAGGGTGGG 3 9 0 3
★ ★★ ★ ★★★★★ ★ ★★★★★★★★★★
E 1 5 h s  GACCCCTTCAAGACCTGCCCAGCAACCATTAAGTAGACCTATACAGTCTCCTGGCCGAAA 5 0 2 2  
E 1 5mm CACTCCCTCAAGACCTACACAGCAACCATTAAGTAGGCCAATGCAGTCTCCAGGGCGAAA 5 0 2 8  
E 1 5  f r  CGGGTCCGCGGGGGCCAAGAAGCAGAAGACGGAGCCCGAGAAGCCGGCCCTCGTTCGCCA 3 9 6 3  
★ ★ ★ ★  ★★★★ ★ ★ ★ ★ ★ ★ ★ ★ ★
E 1 5 h s  CTCAATTTCCCCTGGTAGAAATGGAATAAGTCCTCCTAACAAATTATCTCAACTTCCAAG 5 0 8 2  
El5m m  CTCAATTTCCCCTGGTAGAAATGGAATAAGCCCTCCTAACAAACTGTCTCAGCTGCCCAG 5 0 8 8  
E 1 5 f r  GTCAACATTCATC AAAGAAGCGCCGAGCCCGAC-------------GCTGAAGAGGAAGCTGGA 4 0 1 4
E l 5 h s  GACATCATCCCCTAGTACTGCTTCAACTAAGTCCTCAGGTTCTGGAAAAATGTCATATAC 5 1 4 2  
El5m m  AACATCATCTCCCAGTACTGCTTCAACTAAGTCCTCCGGTTCTGGGAAAATGTCATATAC 5 1 4  8 
E 1 5  f r  GGAATCGGCCCCGGCGGCACCGTCGGAGTCGCCCACCAGCCCCGACATCTTCCTGCCCTC 4 0 7 4  
* * *  * * *  * * **  * * *  * * * * * *  *
E l 5 h s  ATCTCCAGGTAGACAGATGAGCCAACAGAACCTTACCAAACAAACAGGTTTATCCA-AGA 5 2 0 1  
El5m m  ATCCCCAGGTAGACAGCTGAGCCAACAAAATCTTACCAAACAAGCAAGTTTATCCA-AGA 5 2 0 7  
E 1 5 f r  AGCGGGCAGGAGGCA-CGACGTCAACCGCTCCCACTCCGAGAGCCCGTCGCGACCACAGG 4 1 3 3  
* * * ** ** * * * * *  * * * *  *  * * *  * *
E 1 5 h s  ATGCCAGTAGTATTCCAAGAAGTGAGTCTGCCTCCAAAGGACTAAATCAGATGAATAATG 5 2 6 1  
E15mm ATGCCAGCAGTATCCCCAGAAGTGAGTCGGCATCTAAAGGACTGAATCAGATGAGTAACG 5 2 6 7
E 1 5 f r  AAGCCA CGTCATCGCGCTTCAGCC-GCACCGGCACG-TGGAAGCGGGAGAACAGCA 4 1 8 7
*  * * * *  *  *  * *  *  * *  *  *  *  * *  *  *  * *  *
E 1 5 h s  GTAATGGAGCCAATAAAAAGGTAGAACTTTCTAGAATGTCTTCAACTAAATCAAGTGGAA 5 3 2 1  
E15mm GCAATGGGTCAAATAAAAAGGTAGAACTTTCTAGAATGTCTTCAACTAAATCAAGTGGAA 5 3 2 7
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E 1 5 f r  GCACGGGAGCGGGCGG— AGGGAGCGCCGGCAAACAC-TCCACGTCTTTACCGCGGGTGG 4 2 4 4  
* * ** * *** ** * * * * *★ * ** * * * *
E 1 5 h s  GTGAATCTGATAGATCAGAAAGACCTGTATTAGTACGCCAGTCAACTTTCATCAAAGAAG 5 3 8 1  
El5m m  GTGAATCAGACAGATCAGAAAGGCCTGCATTAGTACGCCAGTCTACTTTCATCAAAGAAG 5 3 8 7
E 1 5  f r  GAACGTGGAAGAGGACGGGAAGCTCCTCCTCCGTG--------CTGTCCGCGTCC-TCGGAGTC- 4 2  9 9
★ * * ** * * *** * * ** * *** * * * * * * *
E 1 5 h s  CTCCAAGCCCAACCTTAAGAAGAAAATTGGAGGAATCTGCTTCATTTGAATCTCTTTCTC 54  41  
E 1 5mm CCCCAAGCCCAACCCTGAGGAGGAAACTGGAGGAATCTGCCTCATTTGAATCCCTTTCTC 5 4 4 7
E 1 5  f r  CAGTGAGAAGGGGCGCAGCGAGGAGGACGGCTCTCTCCGCTCCAAGGGGA------ CGTGGAG 4 3 5 6
★ ★★ ★ ★★★ ★★ ★★★★★★ ★★ ★★
E 1 5 h s  CATCATCTAGACCAGCTTCTCCCACTAGGTCCCAGGCACAAACTCCAGTTTTAAGTCCTT 5 5 0 1  
El5m m  CATCTTCTAGACCAGATTCTCCCACCAGGTCGCAGGCACAGACCCCAGTTTTAAGCCCTT 5 5 0 7
E 1 5 f r  GAAGACCAAGAGCAGCGGCGGCGATTCGTCAGCGGG-ACGGGGC GGGTCCAA 44  07
★ ★★★★★★★ ★ ★ ★  ★ ★★★★★ ★★★
E 1 5 h s  CCCTTCCTGATATGTCTCTATCCACACATTCGTCTGTTCAGGCTGGTGGATGGCGAAAAC 5 5 6 1  
El5m m  CCCTTCCTGATATGTCTCTGTCCACACATCCATCTGTTCAGGCAGGTGGGTGGCGAAAGC 5 5 6 7  
E 1 5 f r  CAAAGCGGAGGACGTGTGGGTCCGCCTGGAGGACTGTCCCGTC-AACAACCCCCGCTCCT 4 4 66  
* * * ** * *** * ★*** * * * **
E 1 5 h s  TCCCACCTAATCTCAGTCCCACTATAGAGTATAATGATGGAAGACCAGCAAAGCGCCATG 5 6 2 1  
E 1 5mm TCCCGCCTAATCTCAGCCCCACTATCGAGTATAATGACGGAAGGCCCACAAAACGGCATG 5 6 2 7
E 1 5 f r  CCTCTTCCTGTTCTGCCCGCTCTCCCACCTCTGGCAACGCCCCTCCCATCAT TG 4 5 2 0
★ ★ ★ ★ ★★★★ ★★ ★★ ★★ ★ ★★
E 1 5 h s  ATA-TTGCACGGTCTCATTCTGAAAGTCCTTCTAGACTTCCAATCAATAGGTCAGGAACC 5 6 8 0  
El5m m  ATA-TTGCACGCTCCCATTCTGAAAGTCCTTCCAGACTACCAATCAACCGGGCGGGAACC 5 6 8  6
E 1 5 f r  ATAGCCCCACGCCCTCA---------- AAAATTCTTTCTTCCTCCTCATCTTCCT CC 4 5 6 7
*** **★* * ** *** * * * * ** * ** * **
E 1 5 h s  TGGAAACGTGAGC-ACAGCAAACATTCATCATCCCTTCCTCGAGTAAGCACTTGGAGAAG 5 7 3 9  
E 1 5mm TGGAAGCGTGAAC-ACAGCAAACATTCCTCGTCCCTTCCTCGAGTGAGTACTTGGAGAAG 5 7  4 5 
E 1 5 f r  TCTAATCTTAATCTACGGCGGAGCTACGAAAGC-----------CTCGA-TGACAAGCCGCCGCCG 4 6 2 1
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*  * *  *  *  *  *  * *  * *  *  *  *  *  * * * * *  *  *  *  *  *  *
E 1 5 h s  AACTGGAAGTTCATCTTCAATTCTTTCTGCTTCATCAG-AATCCAGTGAAAAAGCAAAAA 5 7 9 8  
E l5m m  AACTGGAAGCTCATCTTCTATTCTTTCTGCTTCATCAG-AGTCCAGTGAAAAAGCAAAAA 5 8 0 4  
E l 5 f r  — CCGGAG------- CGTCCGCAGCAGCAGCAGCGCAATCAGCAGCGCAGCGGCGCCGTAGCAG 4 6 7 6
E 1 5 h s  GTGAGGATGAAAAACATGTGAACTCTATTTCAGGAACCAAACAAAGTAAAGAAAACCAAG 5 8 5 8  
E 1 5mm GTGAGGATGAAAGGCATGTGAGCTCCATGCCAGCACCCAGACAGATGAAGGAAAACCAGG 5 8 6 4
E 1 5 f r  CCCGGGTC------AGCCCCTTTAACTACACCCCGAGCCCCAGAAAGAGCAACGCCGAC G 4 7 3 0
* *  *  *  *  *  * *  *  *  * * *  *  *  *  * *  *  * *  *
E 1 5 h s  TATCCGCAAAAGGAACATGGAGAAAAATAAAAGAAAATGAATTTTCTCCCACAAATAGTA 5 9 1 8  
El5m m  TGCCCACCAAAGGAACATGGAGGAAAATCAAGGAAAGTGACATTTCTCCCACAGGCATGG 5 9 2 4  
E 1 5 f r  CCTCCTCGACCAGCACCACGCCGACCACTACGCCTTCATCGTCATCGGCGACGCCCCCGC 4 7 9 0  
* *  *  *  *  * *  *  *  *  *  * *  *  * *
E 1 5 h s  CTTCTCAGACCGTTTCCTCAGGTGCTACAAATGGTGCTGAATCAAAGACTCTAATTTATC 5 9 7 8  
El5m m  CTTCTCAGAGCGCTTCCTCAGGTGCTGCCAGTGGTGCTGAATCCAAGCCTCTGATCTATC 5 9 8 4
E 1 5 f r  GGCCTTCGCTCATCCCCACCCCCGTCACCAAAAAGCGCGAGCCAAAGGG--------GGGCGA—  4 8 4 5
★ ★ ★ ★  ★ ★★  ★ ★ ★  ★ ★ ★ ★ ★ ★  ★
E 1 5 h s  AAATGGCACCTGCTGTTTCTAAAACAGAGGATGTTTGGGTGAGAATTGAGGACTGTCCCA 6 0 3 8  
El5m m  AGATGGCACCTCCTGTCTCTAAAACAGAGGATGTTTGGGTGAGAATTGAGGACTGCCCCA 6 0 4 4
E 1 5 f r  AGGCGGCGCCGGAGGGGGCGGGGCCAGCGGA------------GAGCGCGGCTCGTACATTGTGACT 4 9 0 0
*  * * *  * *  *  *  * * *  * * *  *  *  *  *  *  *  *  * *  *
E 1 5 h s  TTAACAATCCTAGATCTGGAAGATCTCCCACAGGTAATACTCCCCCGGTGATTGACAGTG 6 0 9 8  
El5m m  TTAACAACCCTAGATCTGGACGGTCCCCCACAGGCAACACCCCCCCAGTGATTGACAGTG 6 1 0 4
E 1 5 f r  T------------------------------------------------------------------------------------------------------------------------------------  4 9 0 1
★
E 1 5 h s  TTTCAGAAAAGGCAAATCCAAACATTAAAGATTCAAAAGATAATCAGGCAAAACAAAATG 6 1 5 8  
E l5m m  TTTCAGAGAAGGGAAGTTCAAGCATTAAAGATTCAAAAGACACCCATGGGAAACAGAGTG 6 1 6 4  
E 1 5 f r  --------------------------------------------------------------------------------------------------------------------------------------
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E 1 5 h s  TGGGTAATGGCAGTGTTCCCATGCGTACCGTGGGTTTGGAAAATCGCCTGAACTCCTTTA 6 2 1 8
E15mm TGGGCAGTGGCAGT CCTGTGCAAACCGTGGGTCTGGAAACCCGCCTCAACTCCTTTG 6 2 2 1
E 1 5 f r  --------------------------------------------------------------------------------------------------------------------------------------
E 1 5 h s  TTCAGGTGGATGCCCCTGACCAAAAAGGAACTGAGATAAAACCAGGACAAAATAATCCTG 6 2 7 8  
E15mm TTCAGGTAGAGGCCCCAGAACAGAAAGGAACTGAGGCAAAACCAGGACAGAGTAACCCAG 6 2 8 1  
E 1 5 f r  --------------------------------------------------------------------------------------------------------------------------------------
E 1 5 h s  TCCCTGTATCAGAGACTAATGAAAGTTCTATAGTGGAACGTACCCCATTCAGTTCTAGCA 6 3 3 8  
El5m m  TCTCTATAGCAGAGACTGCTGAGACGTGTATAGCAGAGCGTACCCCTTTCAGTTCCAGTA 6 3 4 1  
E 1 5 f r  --------------------------------------------------------------------------------------------------------------------------------------
E 1 5 h s  GCTCAAGCAAACACAGTTCACCTAGTGGGACTGTTGCTGCCAGAGTGACTCCTTTTAATT 6 3 9 8  
E 1 5mm GCTCCAGCAAGCACAGCTCACCTAGCGGGACTGTTGCTGCCAGAGTGACACCTTTTAATT 6 4 0 1  
E 1 5 f r  --------------------------------------------------------------------------------------------------------------------------------------
E 1 5 h s  ACAACCCAAGCCCTAGGAAAAGCAGCGCAGATAGCACTTCAGCTCGGCCATCTCAGATCC 6 4 5 8  
El5m m  ACAACCCTAGCCCTAGGAAGAGCAGCGCAGACAGCACTTCAGCCCGGCCGTCTCAGATCC 64  61  
E 1 5 f r  --------------------------------------------------------------------------------------------------------------------------------------
E 1 5 h s  CAACTCCAGTGAATAACAACACAAAGAAGCGAGATTCCAAAACTGACAGCACAGAATCCA 6 5 1 8  
El5m m  CTACGCCAGTGAGCACCAACACGAAGAAGAGAGATTCGAAGACTGACAGCACAGAATCCA 6 5 2 1  
E 1 5 f r  --------------------------------------------------------------------------------------------------------------------------------------
E 1 5 h s  GTGGAACCCAAAGTCCTAAGCGCCATTCTGGGTCTTACCTTGTGACATCTGTTTAA 6 5 7 4  
El5m m  GTGGAGCCCAAAGTCCTAAACGCCATTCCGGGTCTTACCTCGTGACGTCTGTTTAA 6 5 7 7  
E 1 5 f r  -----------------------------------------------------------------------------------------------------------------------------
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Appendix, Section 3B 
Apc2  nucleotide alignment
E l h s  ATGGCGAGCTCCGTGGCGCCCTACGAGCAGCTGGTGAGGCAGGTGGAGGCCTTGAAGGCT 6 0  
Elmm ATGACCAGCTCCATGGCCTCATATGAGCAGCTGGTGCGCCAGGTGGAGGCCCTGAAGGCC 6 0
E l f r  TACGATCAGCTTGCCCACCAGGTGGCGGCTCTCCGCAAG 3 9
★ ★ ★★ ★★★★★ ★ ★★★★★★★ ★★★ ★
E l h s  GAGAACAGCCACCTGAGGCAGGAGCTAAGGGACAACTCCAGCCACCTGTCCAAGCTGGAG 1 2 0  
Elmm GAGAACACTCACTTAAGGCAGGAGCTGAGGGATAACTCTAGCCATCTCTCCAAGCTTGAG 1 2 0  
E l f r  GAAAACTGTCACCTGCGGAGGGAGCTGGAGGACAACTCCAACCAACTGTCCAAACTGGAG 9 9
★ ★ ★ ★ ★  ★ ★ ★  ★ ★ ★  ★ ★ ★ ★ ★ ★  ★ ★ ★  " k  ie'  i e i Ir Kir ★  ★ ★ ★  ★ ★  ★ ★ ★ ★ ★  ★ ★  ★ ★ ★
E l h s  ACAGAGACGTCGGGCATGAAG 1 4 1  
Elmm ACAGAGACTTCTGGAATGAAG 1 4 1  
E l f r  ACTGAGACCTTCGGCATGAAG 1 2 0
★ ★ ★★★★★ ★ ★★ ★★★★★★
E 2 h s  GAGGTCCTGAAGCACCTACAGGGAAAACTGGAGCAGGAGGCCCGAGTGCTGGTGTCC 5 7  
E2mm GAGGTCCTGAAACACCTCCAGGGCAAGCTGGAGCAGGAGGCGAGAGTGCTCGTGTCT 5 7  
E 2 f r  GAAGTTCTGAAGCAACTGCAGAGTAAACTGGAGCAGGAGGCCGGAACTCTGGCCTCA 5 7  
**  **  * * * * *  * *  * *  * * *  * * *  * * * * * * * * * * * * * *  **  **  *  * *
E 2 h s  TCGGGGCAGACGGAGGTGCTGGAGCAGCTGAAGG 91  
E2mm TCCGGGCAGACAGAAGTGTTAGAGCAACTGAAAG 91  
E 2 f r  TCCGGGAGGAGCGATGTCCTGCACCAGCTCAAA- 90  
★ ★ ★★★ ★★ ★★ ★★ ★ ★ ★★ ★★ ★★
E 8 h s  GTGGAGGTGGTCTTCTGGCTGTTGTCCATGTTGGCGACGCGCGACCAGGAGGAT 54  
E8mm GTGGAGGTGGTGTTCTGGCTTCTATCTATGTTGGCAACGCGCGACCAGGAAGAT 54  
E 8 f r  GTGGAGATGGTGTTCTGGCTGCTGTCCATTCTTACTAACAGAGATAAGGATGAG 54
★ ★ ★ ★ ★ ★  ★ ★ ★ ★  ★ ★ ★ ★ ★ ★ ★ ★  ★ ★ ★  ★ Vr ★ ★ ★ ★ ★ ★  ★ ★ ★ ★  ★ ★
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E 8 h s  ACAGCGCGCACGCTGCTGGCCATGTCCAGCTCGCCCGAGAGCTGCGTGGCCATGCGCCGC 1 1 4  
E 8mm ACTGCGCGCACACTGCTGGCCATGTCCAGCTCTCCAGAGAGCTGTGTAGCCATGCGCCGC 1 1 4  
E 8 f r  ATGTCTCGGACGCTGCTGGCGTTGTCCAGCTCCCCAGACAGTTGTATCGCCATGAGGAAG 1 1 4  
*  *  * *  * *  * * * * * * * *  * * * * * * * * * *  * *  * *  * *  * *  *  * * * * * *  *
E 8 h s  TCGGGCTGTCTGCCTCTGCTGCTGCAAATCCTCCACGGCA--------------- CCGAGGCCGCGGC 1 6 7
E8mm TCGGGCTGTCTGCCACTGCTGCTCCAGATCCTTCATGGCA--------------- CTGAGGCTGGGTC 1 6 7
E 8 f r  TCTGGCTGTGTCCCCCTGCTGGTCCAGATCCTGCATGACGGATCAGGCGGCACCAGCAGC 1 7 4
★ ★ ★ ★ ★ ★ ★ ★  ★ ★ ★  ★ ★ ★ ★ ★ ★  ★ ★ ★  k  k  k  k  k  ★ ★  ★ ★ ★ ★ ★ ★ ★
E 8 h s  CGGGGGT CGCGCCGGG-GCCCCAGGGGCACCGGGCGCCAAGGACGCACGCATGCGC 2 2 2
E8mm TGTGGGG CGCGCAGGG-ATCCCCGGAGCGCCTGGTGCCAAAGATGCACGCATGCGC 2 2 2
E 8 f r  CTTGAGCAGTCCGCGTCGTGTGCCACGGTGACAGGCTGCAGCCGGGAGGCCAAGTCCAGG 2 3 4  
* * * * * *  * *  * * *  * * *  * *  * *  *
E 8 h s  GCCAACGCGGCGCTGCACAACATCGTCTTCTCGCAGCCGGACCAGGGCCTGGCGCGCAAG 2 8 2  
E8mm GCCAATGCGGCCCTGCACAACATCGTTTTCTCCCAGCCGGATCAGGGCCTGGCACGCAAG 2 8 2  
E 8 f r  GCAAGCGCCACCCTCCACAACATCATCTTCTGTCAGCAGGATGAGGGACAGGCCCGCCGT 2 9 4  
* *  *  * *  *  * *  * * * * * * * * *  *  * * * *  * * * *  * * *  * * * *  *  * * *  * * *
E 8 h s  GAGATGCGCGTCCTGCACGTGCTGGAGCAGATCCGGGCCTACTGCGAGACCTGCTGGGAC 3 4 2  
E8mm GAGATGCGTGTGCTGCATGTGCTGGAGCAGATCCGAGCCTACTGCGAGACCTGCTGGGAC 3 4 2
E 8 f r  GAAAAAAGGGTTCTGCTCCTGCTGGAGCAGATCCGGACACACTGTGACACTGGCTGGGAT 3 5 4  
**  * * * *  * * * *  * * * * * * * * * * * * * * * *  *  * * * *  * *  * *  * * * * * * *
E 8 h s  TGGCTGCAGGCCCGAGACGGCGGGCCCGAG-GGAGGTGGCGCCGGCAGCG 3 9 1
E8mm TGGCTTCAGGCGCGGGACAGCGGGACAGAA-AGTG------------------------------------3 7 6
E 8 f r  TGGATTGAGAACC-ACACAGTGACTTCTACTGGAACTAGAACCAACG  4 0 0
★ ★★★ ★★ -k ★★★★ ★
E 9 h s   CCCCGATCCCCATCGAGCCGCAGATCTGCCAGGCCACCTGTGCTGTTATGAAGCTGT 57
E9mm  CTCCTGTCCCAATCGAGCCGCAGATCTGCCAGGCTACCTGTGCAGTGATGAAGCTGT 57
E 9 f r  ATGTCCCAGAACCGATGGACCCGCAGATCTGTCAGGCTGTTTGTGCCATCATGAAACTCT 60
★ ★ ★ ★  ★ ★  ★ ★  ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★  ★ ★ ★ ★ ★  k  k  k  k  k  k  k  k  k
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E 9 h s  CCTTTGATGAGGAGTACCGCCGTGCCATGAACGAGCTAG 9 6  
E9mm CATTTGACGAAGAATACCGTCGGGCTATGAATGAGCTAG 9 6  
E 9 f r  CCTTTGAGGAGGAGTACCGACACGCCCTGAAAGAGTTGG 9 9
★  ★ ★ ★ ★  ★ ★  ★ ★  ★ ★ ★ ★ ★  ★  ★ ★  'k 'k 'k "k "k ★  *k ★  ★
E 1 O hs GTGGGCTGCAGGCCGTGGCAGAGCTGCTGCAGGTTGACTATGAGATGCACAAGATGACCC 6 0 
ElOmni GGGGGCTGCAGGCTGTGGCAGAACTACTGCAGGTGGACTATGAAATGCACAAGATGACCC 6 0  
E l O f r  GTGGTCTACAGGTCATAGCTGAACTGATCCATCTGGACCAGGAAACGCACGGCATGCAGA 6 0
★  k  k  ★ ★  ★ ★ ★ ★  k  k  k  ★ ★  ★ ★  ★  k  k  'k k  k  k  k  k  k  ★  ★ ★ ★ ★
E lO h s  GGGACCCGCTGAACCTGGCGCTGCGCCGCTACGCGGGCATGACCCTCACCAACCTCACCT 1 2 0  
ElOmm GGGACCCACTCAACCTTGCCCTGCGCCGCTACGCTGGCATGACCCTCACCAACCTCACCT 1 2 0  
E 1 0  f  r  ATGACCCCATTAACATGGCTCTGCGACGCTATGCTGGGATGGCAATGACTAATCTGACCT 1 2 0  
* * * * *  *  * * *  *  * *  * * * * *  * * * * *  * *  * *  * * *  *  *  * *  * *  * *  * * * *
E lO h s  TTGGGGACGTTGCCAACAAG 1 4 0  
ElOmm TTGGAGACGTTGCCAACAAG 14  0 
E l O f r  ACGGTGACGTGGTCAACAAG 14  0
E l l h s  GCCACCCTGTGTGCGCGCCGCGGCTGCATGGAGGCCATCGTGGCCCAGCTGGCCTCCGAC 6 0  
E 1 1mm GCCACACTGTGTGCCCGCCGAGGCTGCATGGAAGCCATTGTGGCCCAGCTTGGCTCTGAG 6 0 
E l l f r  GCCACTTTGTGCTCAAAGAGAAGCTGCCTTCAGGCTCTGGTGGCTCAGCTGGCCTCTGAC 6 0  
★★★★★ ★ * ★★★★★ ★ ★ *★ * ★★★★★ ★ ★ ★★
E l l h s  AGTGAGGAGCTCCACCAG----------------------------------------------------------------------------------------------7 8
E l  1mm AGCGAGGAGCTGCATCAG----------------------------------------------------------------------------------------------7 8
E l l f r  AGCGAGGAGCTCCACCAAGTGGTCTCCAGTATCCTACGAAACCTGTCCTGGAGGGCCGAC 1 2 0  
* *  * * * * * * * *  * *  * *
E l l h s  --------------------------------------------------------------------------------------------------------------------------------------
E l  1 m m --------------------------------------------------------------------------------------------------------------------------------------
E l l f r  ATCAACAGCAAGAGAGTCCTGCGTGATATTGGTTGTGTGTCTGCTCTGATGACCTGTGCC 1 8 0
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E l l h s  ---------------------------------
E l  l m m ---------------------------------
E l l f r  CTACAGGCCACCAAG 1 9 5
E 1 2 h s  ---------------------------------------------------------------------------------------------------------------------------------------
E 1 2 m m --------------------------------------------------------------------------------------------------------------------------------------
E l l f r  GCCACTTTGTGCTCAAAGAGAAGCTGCCTTCAGGCTCTGGTGGCTCAGCTGGCCTCTGAC 60
E 1 2 h s  GTGGTGTCCAGCATCCTTCGGAACTTGTCCTGGAGGGCCGAC 4 2
E l2 m m ---------------------------------------- GTTGTTTCCAGTATTCTGCGTAATCTGTCATGGAGGGCAGAC 4 2
E l l f r  AGCGAGGAGCTCCACCAAGTGGTCTCCAGTATCCTACGAAACCTGTCCTGGAGGGCCGAC 1 2 0
* *  * *  * * * * *  * *  * *  * *  * *  * * * *  * * * * * * * *  * * *
E 1 2 h s  ATCAACAGCAAGAAGGTGCTGAGGGAGGCGGGCAGCGTGACTGCCCTGGTGCAGTGTGTC 1 0 2  
E12mm ATCAACAGCAAGAAGGTGCTGAGGGAGGTTGGCAGCATGACCGCCTTGATGGAATGTGTG 1 0 2  
E l l f r  ATCAACAGCAAGAGAGTCCTGCGTGATATTGGTTGTGTGTCTGCTCTGATGACCTGTGCC 1 8 0  
* * * * * * * * * * * * *  * *  * * *  * **  **  * **  * **  **  **  * * * *
E l 2 h s  CTGCGGGCCACCAAG 1 1 7  
El2m m  CTGCGGGCCTCCAAG 1 1 7  
E l l f r  CTACAGGCCACCAAG 1 9 5  
**  * * * * *  * * * * *
E 1 3 h s  GAGTCCACCCTGAAGAGCGTGCTGAGCGCCCTGTGGAATCTGTCTGCACACAGCACAGAG 60  
El3m m  GAGTCGACCCTAAAGAGTGTGCTCAGTGCTCTGTGGAACCTGTCAGCACACAGCACAGAG 60  
E 1 3  f  r  GAGTCGACGCTGAAGAGCATCCTGAGTGCTCTGTGGAACCTGTCAGCTCACAGCATAGAC 6 0 
* * * * *  * *  **  * * * * *  * * *  **  * *  * * * * * * * *  * * * * *  **  * * * * * * *  * * *
E 1 3 h  s  AACAAGGCGGCCATCTGCCAGGTGGATGGCGCCCTGGGCTTCCTGGTGAGCACCCTGACC 1 2 0  
E l3m m  AACAAGGCAGCCATCTGCCAGGTAGATGGTGCACTGGGTTTCCTGGTGAGCACCCTCACA 1 2 0  
E 1 3 f r  AACAAGGTGGCCATCTGTTCCGTAGACGGAGCACTGGGCTTCCTGGTGAGCACACTTACA 1 2 0  
* * * * * * *  * * * * * * * *  * *  * *  * *  **  * * * * *  * * * * * * * * * * * * * *  **  **
245
Appendix J.Z,. Juarez-Morales 2005
E13hs TACAAGTGTCAGAGCAACTCGCTGGCCATCATCGAGAGCGGCGGCGGCATCCTCCGCAAT 180 
E13mm TACCGTTGCCAAGGGAACTCCCTGGCAGTCATCGAGAGTGGCGGTGGGATCCTGCGCAAC 180 
E13 fr TACCGATGTCAGACCAACTCCCTGGCCATCATCGAGAGTGGCGGTGGGATCCTCCGAAAT 180 
*** ** ** ***** ***** * * * * * * * * * *  * * * * *  * *  * * * * *  * *  * *
E13hs GTGTCCAGCCTCGTCGCCACCCGTGAGGACTACAG 215 
El3mm GTGTCAAGCCTCATTGCCACACGGGAGGACTACAG 215 
E13fr GTGTCCAGCCTTGTTGCCACACGAGAAGACTAC—  213 
* * * * *  * * * * *  *  * * * * *  * *  * *  * * * * * *
E14hs GCAGGTGCTCCGGGATCACAACTGTCTGCAGACGCTGCTGCAGCATCTGACTTCGCACAG 60 
E14mm GCAGGTGCTCCGTGACCACAACTGCCTGCAGACACTGCTGCAGCACCTCACATCACACAG 6 0 
E14 fr ACAAATACTGCGGGATCACAACTGCCTCCAAACGCTGCTGCAGCACCTGCGCTCCCATAG 6 0
k  k  k  k  k  k  k  k  k  k k k k k k k k  k  k  k  k  k  k  k k k k k k k k k k k  k  k  k  k  k  k  k  k
E14hs CCTGACCATCGTGAGCAACGCGTGCGGCACGCTCTGGAACCTGTCGGCCCGCAGCGCCCG 120 
El4mm TTTGACCATCGTGAGCAATGCCTGTGGCACCCTCTGGAACCTGTCTGCCCGCAGCCCCCG 120 
E14fr CCTGACTATAGTTAGTAATGCTTGTGGGACCCTCTGGAACCTGTCTGCAAGAAGTTCCAA 120 
**** ** ** ** ** ** ** ** * *  * * * * * * * * * * * * * *  * *  * * *  * *
E14 h s TGACCAGGAGCTGCTGTGGGACCTGGGCGCCGTGGGCATGCTGCGTAATCTGGTGCACTC 180 
E14mm CGATCAGGAACTGTTGTGGGACCTGGGGGCCGTGGGCATGCTACGCAACCTCGTCCACTC 180 
El4fr AGACCAGGAACTGCTTTGGGAGCTGGGGGCTGTGAGCATGCTGCGCAACCTGATCCACTC 180 
* *  * * * * *  * * *  * * * * * *  * * * * *  * *  * * *  * * * * * * *  * *  * *  * *  * * * * * *
E14 hs CAAGCACAAGATGATCGCCATGGGCAGCGCCGCCGCCCTGCGCAACCTGCTGGCCCATCG 240 
El4mm CAAACACAAGATGATCGCCATGGGTAGTGCTGCTGCTCTGCGGAACCTGCTAGCCCACCG 240 
El4fr CAAGCACAAGATGATAGCAATGGGCAGTGCTGCGGCCCTGAGAAACCTCCTGACCAATCG 240
k  k  k  ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★  ★ ★  ★ ★ ★ ★ ★  ★ ★  ★ ★  ★ ★  ★ ★  ★ ★ ★  k  k  k  k  k  k  k  k  k  k  k  k  k
E14hs GCCCGCCAAGCACCAGGCGGCCGCCACCGCCGTGTCCCCAGGCAGCTGCGTGCCCAGCCT 300 
E14mm ACCCGCCAAGTATCAGGCCGCAGCCATGGCTGTCTCCCCAGGCACCTGCGTGCCCAGTCT 300
El4fr GCCCCTCAAGTACAAGGATACTGCC----- TGTGTCACCTGGTTCGTGCATGCCATCGCT 295
* * *  * * * *  *  * * *  * * * *  * *  * *  * *  * *  * * *  * * * *  * *
246
Appendix J.L. Juarez-Morales 2005
E14 hs GTACGTGCGCAAGCAGCGGGCGCTGGAGGCCGAGCTGGACGCACGGCACCTCGCGCAGGC 360 
E14mm TTACGTCCGCAAGCAGAGGGCTCTGGAAGCTGAGTTGGACACTCGGCACCTGGTGCATGC 360 
E14fr CTACATGAGGAAACAAAAGGCCCTGGAAGCTGAGCTGGATGCCAAACACCTGGCAGAGAC 355
E14hs GCTGGAGCACCTGGAGAAGCAGGGCCCGCCGGCAGCCGAGGCCGCCACTAAGAAGCCGCT 420 
E14mm ACTCGGTCACTTAGAGAAGCAGAGTCTGCCTGAGGCAGAGACCACTTCAAAGAAGCCCCT 420
E14fr TTTTGACATAATCGAGAGACAGAATCC-CAGGCAACTGA CCCTCAACAGGCCACT 409
* *  * * * * *  * * *  * * * * * *  * * *  * * * *  * *
E14hs GCCGCCCCTGCGACACCTGGACGGCCTGGCCCAAGACTATGCTTCCGATTCGGGCTGCTT 480
E14mm GCCACCCCTCCGCCACCTGGACGGGCTGGTGCAGGACTATGCCTCTGATTCTGGCTGCTT 480
E14fr AC-------- GGCACATCGAGAGTCTAGCAAAGGATTACGCGTCTGATTCAGGCTGTTT 460
★ ★ ★★★ ★ ★★ ★ ★★ ★ ★ ★★ ★★ ★★ ★★ ★★★★★ ★★★★★ ★★
E14hs TGACGACGACGATGCACCGTCATCCCTGGCTGCGGCCGCGGCCACCGGGGAGCCAGCCAG 54 0
El4mm TGACGATGATGATGCACC ATCCCTGGCTGCTGCTGCCACCACAGCTGAGCCCGCCAG 537
E14fr TGATGACGATGAAGCTCC TAGCGTGCCTAGTAATCTGGACACAGGG AG 508
* * *  * *  * *  * *  * *  * *  * * *  * *  * * *  * * *
E14hs CCCTGCCGCGCTGTCCCTCTTCCTGGGCAGCCC CTTCCTGCAGGGGCAG— GCGCTG 595
El4mm CCCAGCAGTGATGTCTATGTTCCTTGGCGGTCC CTTCCTTCAGGGCCAG— GCACTG 592
El4fr CTTCTCTATGCTGTCTATGTTTCTTACCAATTCTAACTTCTCACAGAACCAACAACGCAA 568 
* * * **** * ** ** * * **** *** ** * *
E14hs GCTCG-CACCCCGCCCACCCGCCGAGGCGGCAAGGAGGCAGAGAAGGACACCAGTGGGGA 654 
El4mm GCCCG-CACCCCACCTGCCCGCCAGGGTGGCCTAGAAGCCGAGAAGGAGGCTGGTGGGGA 651 
E14fr AAGGGACAATGAACCCGAGAGAGACGGAGATTCACCAGCAAGTGGCGAGAACAAATATCC 628 
*  * *  * *  *  * *  * * *  * *
E14hs GGCAGCCGTGGCGGCCAAGGCCAAGGCCAAGCTGGCGCTTG------------CAGTGGC 702
El4mm GGCAGCTGTGGCTGCCAAGGCCAAGGCCAAGCTGGCGTTGG------------CTGTGGC 699
E14 f r AGCCGATGCCGTATCTGCTGCTGCAGATAAACTGGCGCAGAAAATCACCAACACTGTGGC 688 
** * * * * ** *  * *  * * * * * *  * * * * * *
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El4hs GCGCATCGACCAGCTGGTGGAGGACATCTCCGCCCTGCACACCTCGTCCGACGATAGCTT 762 
El4mm TCGGATCGACAGATTGGTGGAGGACATCTCTGCCCTGCACACCTCATCAGACGACAGCTT 759
El4 fr CAAGATTGACAGATTGGTGGATGACATTACTA--- TGCACACGTCTTCTGAGGACAGTTT 745
* *  * * *  * * * * * * *  * * * * *  * * * * * * * *  * *  * *  * *  * *  * *  * *
E14hs CAGCCTCAGCTCTGGAGACC-CGGGACAGG-------- AGGCGCCACGGGAGGGCCGCGC 813
El4mm CAGTCTCAGCTCGGGGGACC-CTGGGCAGG-------- AGGCGCCAAGGGAGGGCCGTGC 810
E14 fr CAGCCTGTGCTCTGAGGACCACCTGGCAGATTGGCCTTACGGACCACATGAGCTCAACGA 805 
*** ** **** * **** * * *** * * *** *** * *
E14hs CCAG-------- TCCTGCTCGCCATGCC GCGGCCCGGAGGGCGGGCGGCG-AG 857
El4mm TCAG-------- TCCTGCTCTCCATGCC GGGGCACTGAGGGTGGGAGGCG-TG 854
El4fr CCAGACCAAGAGCCCTTCCCTCCTGTCCCATCTATGTGACACCAGCAGTGTGGTCCACAG 865 
★★★ ★ ★ ★ ★ ★ ★ ★  ★★ ★ ★ ★ ★ ★ ★ ★  ★ ★
E14 hs AGGCAGG— AAGCCGGGCGCACCCGCTGCTGCGGCTCAAGGCGGCCCACGCCAGCCTCTC 915 
E14mm AGGCTGG— CAGCCGGGCGCACCCTCTTTTGAGGCTCAAGGCAGCCCACACTAGCCTCTC 912 
E14 fr AGACCGCTTCAGCAGAGCTCGTGCACTCTTGCGTCTGAAAACGGCACAGTCGAGTTTATC 925
★  ★ ★ ★  ★ ★ ★ ★ ★ ★ ★  "k 'k 'k ★ ★ ★ ★ ★ ★ ★  ★ ★ ★ ★ ★  ★ ★ ★  ★ ★ ★
E14 hs CAACGACAGCCTCAACAGCGGCAGTGCCAGCGACGGGTACTGCCCACGCGAACATATGCT 975 
E14mm TAATGATAGCTTGAACAGCGGTAGCACCAGCGATGGCTACTGTACCCGGGAACACATGAC 972 
E14 fr GACAGACAGTCTGAACAGTGGTAGCACAAGTGATGGCTACTGTGGCAGCAAAGACCAGCT 985
*k  ★ ★  ★ ★  ★  ★ ★ ★ ★ ★  ★ ★  ★ ★  'k ★ ★  ★ ★  ★ ★  ★  ★ ★  ★  ★
E14hs GC--CCTG--------- CCCGCTGG-----CCGC---------- ACTGG----------- 998
El4mm GC— CTTG--------- CCCGCTGG-----CTGC---------- ACTGG----------- 995
E14 fr GCAACCTGTTACAAGAGCCCTGATGATGCAACAGCGACCCAAGCAACTGGATCTCAAATT 1045 
** * ** ** * ** * * *  * * * * *
E14hs CTTCGCGCCGCGAGGACCCCAGGTGTGGGCA 1029
El 4 m m  CCGAGCACCGTGATGACCCTGTGCGCGGACA 1026
E14 fr AGCCCACAAAGATTACCAAGAAGCTGACTCTTCTCTTTGTAGTAACACTAATCGCCAGGA 1105
★ ★ ★  ★ ★ ★  ★ Vr
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E14hs GCCTC------- GGCCCAGCCGGC— TTGACCTTGACCTGCC-CGGCTGC---------- 1069
El4mm GACTC------- GGCCCAGCCGAC— TGGACCTGGACCTTCC-CAGCCG----------- 1065
El4fr GATTCCTGAGAGAGATTCTGTGGACAACAAACATTCACCAGTTGCAGATGGAGGCAAAAA 1165 
* * *  * *  *  *  * * *  * * * *  * *  *
El4hs -CAGGCCGAGCCC-------- CCGGCCCGCGAGGCCACC-------TCCGCCGACGCCCG 1113
El 4 m m  GGCTGAGCTT-------- CCTGCCCGGGACACAGCA-------GCCACCGATGCCCG 1107
E14 fr GCAGGTTCAGCCTGTCCAGACACCTGTCAGTGCGTCCACCAAAGTGTCCTCGGATGTCAG 1225 
★ ★ ★★★ ★ ★ ★ ★ ★ ★  ★ ★ ★ ★ ★ ★ ★ ★ ★ ★
E14hs CGTGCGCACCATCAAGCTGTCGCCTACCTATCAGCACGTGCCACTGCTTGAGGGTGCCTC 1173 
E14mm AGTGCGCACAATCAAGTTATCCCCAACCTATCAGCATGTTCCACTGCTGGATGGGGCCGC 1167 
E14 fr CATGGCATCAATAAAACTGTCTCCTTCTTACCAGCAAGTCCCCAGTATTCAGAGTGTGGC 1285 
* * * ** * * * ** * * * ** ***** ** ** * * * * *
E14hs AAGGGCGGGTGCAGAG CCCCTCGCGGGGCCTGGAATCTCTCCAGGGGCCCGGAAGC 1229
El4imn TGGGGCAGGTGTTCGA CCCCTGGTTGGGCCGGGAACCTCCCCGGGGGCTCGGAAAC 1223
E14 fr CAAATTTGGTGTGGAAAAGGCCAGCGGTGATGTCCAGA-CAGCCCAGGCGATGAGGAAAC 134 4 
**** ** * * * ** * * * * **** *
E14hs AGGCCTGGCTGCCGGCAG— ACCACCTGAGCAAGGTTCCCGAGAA GCTGGCGG 1280
El4mm AGGCATGGATACCTGCAG— ACAGCCTGAGCAAAGTCCCTGAGAA ACTGGTGG 1274
E14 fr AGCCCTCGGTCCCCACTGCCATGACAGCAGCGAGCATTACAAAAGCTCCTACATTAGCCT 1404 
* *  * *  * * * *  *  * * * * * *  * * *  * *
E14hs CTGCC CCGCTGTCTGTGGCCAGCAAGGCACTGCAGAAACTGGCGGCGCAAGAGG 1334
El4mm CCTCT CCACTGCCCATAGCTAGCAAGGTGCTGCAGAAGCTGGTCGCACAGGATG 1328
E14 fr CCACCAAAAGCCCGAACATTGGGACGATGGAGACGGTCCAGAAGTACTCAGTGGAGAACA 14 64 
* * * *  * * * *  * * * * * *  * * *
El4hs GGCCACTCTCGCTGTCCCGATGCAGCTCCCTTTCCTCGCTGTCCTCGGCCGGCCGCCCAG 1394 
E14mm GGCCGATGTCCCTCTCCAGGTGCAGCTCTCTGTCCTCTCTATCTTCCACGGGCCATGCTG 1388 
E14fr CCCCCATCTGCTTCTCCCGCTGTAGTTCTCTTTCCTCTCTTTCTTCCGGTGATGGAGCGC 1524 




El4mm TCCCCAGCCAGGCAGAGAACCT TGACAGCGATTCATCCCTGGAGGGGCTTGA---GG 1442
E14 fr TGGATGCACAAAGTGATAATGAGATGGAGAGCGACTCCTCGTTAGAAATAATTGATGTGG 1584
E14hs AGGCCG— GCCCCAGCGA---GGCTGAG---------------------- CTG--GACA 1481
El4mm AGGCTG— GTCCTGGTGA---GGCCGAG---------------------- CTG--GGCA 1472
E14fr AGGATGAAGACTTGGTGAAAAAGGCTGAGGAGGATGAAACCTTGGAAGACCTGACCGATA 1644 
* * *  * *  *  *  * *  * * *  * * *  * * *  * *
El4hs GCACGTGGCGGGCGCCCGGGGCCACCTCGCTGCCC-GTAGCCATTCCGGCTCCC-CGGCG 1539 
E14mm GGGCGTGGCGAGCATCCGGGTCCACCTCTCTTCCG-GTGTCCATCCCAGCCCCG-CAGCG 1530 
E14 fr GCCTGCTGCTGATGACCGACTCCAAATCCTTTCCCAGTAAAGACACTGGTCCCGTCAGTA 1704 
* * ** *** * * * ** * * * * * * * * ** * *
E14hs TAACC------------ GAGGCCGGGGC----CTGGGGG----------------- TGG 1565
El4mm GGGGC------------ GCAGTAGAGGT----CTTGGGG----------------- TGG 1556
E14fr AGACCTGCTCTTCTAAAAAGGAAAAGGTGTTCCTTAGAGCAGTTTCCCCAGCCATAGTGG 1764 
★ ★ ★ ★  ★ ★ ★ ★  ★★★
El4hs AAGACGCCACGCCGTCCAGCTCGTCGGAGAACTACGTGCAGGAGACACCGCTTGTGCTGA 1625 
E14mm AGGATGCAACACCATCCAGCTCATCTGAGAACTGCGTCCAGGAGACGCCTTTGGTCCTGA 1616 
E14fr AAGACCAATCTCCTTCAAGTTCATCTGAACACTACATACATGAGACCCCCCTGGTCATGA 1824 
* * *  * * *  * *  * *  * *  * *  * *  * * *  *  *  * *  * * * * *  * *  * * *  * * *
E14hs GCCGCTGCAGCTCTGTGAGCTCGCTGGGCAGCTTCGAGAGCCCGTCCATCGCCAGCTCCA 1685 
El4mm GCCGTTGTAGTTCCGTGAGCTCCCTGGGCAGCTTCGAGAGCCGCTCCATTGCCAGCTCCA 167 6 
El4fr GCCGCTGCAGCTCGGTTAGCTCGTTAGGCAGCTTTGAGTCTCCCTCTATTGTCAGCTCAA 1884
★ ★ ★ ★  i c  ★ ★ ★  ★ ★  ★ ★  ★ ★ ★ ★ ★  ' k  ★ ★ ★ ★ ★ ★ ★ ★  ★ ★ ★  ★ ★ ★  ★ ★  ★ ★ ★ ★ ★ ★ ★  ★
El4hs TCCCCAGTGAACCTTGCAGCGGGCAGGGCAGCGGCACCATCAGCCCTAGCGAGCTGCCCG 1745 
E14mm TCCCCAGTGACCCGTGCAGCGGGCTGGGCAGTGGCACAGTGAGTCCCAGCGAGCTGCCAG 1736 
El4fr TCCAGAGCGATCCCTGCAGCGAGATGATCGATGGAACAATAAGCCCGAGTGATCTTCCCG 1944 
* * *  * *  * *  * *  * * * * * * *  * * * * *  * *  * * *  * *  * *  * *  * *  * *  *
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E14 h s ACAGCCCCGGACAGACCATGCCTCCCAGCCGGAGCAAGACGCCACCGCTGGCGCCCGCGC 1805
E14mm ACAGCCCCGGGCAGACGATGCCACCGAGCCGCAGCAAGACGCCACCG---------GCAC 1787
El4fr ACAGCCCTGGACAGACCATGCCTCCCAGTCGAAGTAAGACGCCATGTTGC CTTGAGT 2001
* * * * * * *  * *  * * * * *  * * * * *  * *  * *  * *  * *  * * * * * * * * *  *
E14hs CACAGGGTCCCCC— CGAGGCCACCCAGTTCAGCCTGC-AGTGGGAGAGCTACGTGAAGC 1862 
E14mm CTCCTGGGCAGCC— TGAGACCAGCCAGTTCAGCCTGC-AGTGGGAAAGCTATGTGAAGC 184 4 
El4fr CACATGTTCAAGAAACACAGACGGCAGGAATAGTCAGCCAATGGGAAGGCAGCCTGCGGA 2061
★  ★  ★  ★  ★  -k ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★  ★ ★  ★ ★  ★
E14hs GCTTCCTGGACATCGCCGACTGCCGGGAGCGCTGCCGGCTGCCATCTGAGCTGGACGCAG 1922 
El4mm GCTTCCTAGACATCGCAGACTGTCGAGAAAGATGCCAGCCGCCCTCGGAGCTGGACGCGG 1904 
E14 fr CGTTCATGGAAATTGCAGACTCAAAGGACCGACTGAGCCTCCCCCCTGACCTGGACACA- 2120
★  ★ ★  * *  ■k'k 'k-k-k'k  * *  ★  ★  ★ ★  ★  ★ ★  ★ * ★ ★ ★ *  *
E14hs GCAGCGTGCGCTTTACCGTGGAGAAGCCAGACGAGAACTTCTCGTGCGCCTCCAGCCTCA 1982 
El4mm GCAGCGTTCGCTTCACAGTGGAGAAGCCAGATGAGAATTTCTCCTGCGCCTCCAGCCTCA 1964 
El4fr — ATGATTTACTTCACGGTGGAAAAGCCTACTGAAAACTTCTCGTGCGCTTCAAGTTTGA 2178 
★ ★ *★* ★ * ***** *★ ** *★★★★ ***** ★ * ★ ★ * ★
E14 h s GCGCGCTGGCCTTGCACGAGCACTACGTGCAGCAGGACGTGGAGCTGCGGCTGCTGCCCT 2042 
El4mm GTGCACTGGCCCTTCATGAGCTGTATGTCCAGCAGGATGTGGAGCTGCGTCTGAGGCCAC 2024 
E14 fr GTGCCTTGCCTCTTCATGAACACTACATACAGAAGGACGTCGAGCTAAAGTTAACACCAC 2238
★ * * * ★ ★ * * ★ ★ ★ ★ * * ★ * * * * * * * * * * * * * ★ * * ★
E14hs CGGCC--------TGCCCCGAGCGCGGCGGG----GGCGCCGGGGGCGCCGGCCTCCACT 2090
El4mm CTGCC--------TGCCCAGAGCGTGCGGTG----GGTGGTGGGGGCCACCGTCGGAGGG 2072
E14fr TGCTCCAGCAAGGTGACAAAAACCTTTTGTGTCATGATGAAGAGGGCCAGGAATTTGACA 2298 
* * *  *  * * * * * * * * * * *
E14hs TTGCAGGGCACCGGCGGCGGGAGGAGGGGCCGGCGCCCACG----GGTTCTC------ G 2139
El4mm ACG-AGGCTGCCAGCCGCCTG— GATGGTCCAGCACCAGCT----GGTTCTA------ G 2118
E14fr ATGGGGAGCGATA-CAGTGAG-GGAAACTCCGATGATGATATTGAAATCCTAAAAGAATG 2356 
* * * * * ** ** * * *  *
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E14 hs CCCTCGCGGCGCCG------ CGGACCAGGAGCTGG-AACTGCTGCGGGAGTGCCTGGGA 2191
E14mm GGCTCGGTCAGCAA-------CTGATAAAGAACTGG-AGGCTTTGCGTGAATGCCTGGGG 2170
E14fr TATTAACTCAGCAATGCCCTCCAAATTTAGAAAAGTTAGACCTTCCCTGATGACCCAAAT 2416 
* ** * * ** * * * * * *  * *
E14hs GCCGCC------ GTGCCTGCCCGGCTGCGCAAGGTGGCC---- TCCGCGCTGGTGCCAG 2240
El4mm GCAGCC------ ATGCCCGCCCGGCTCCGCAAGGTGGCC---- TCGGCCTTGGTGCCTG 2219
E14 fr CCCTCCTCATCTTGTGAGCTCTCAGACCCATAAACCAATCCATCTCCCAGTTTACATGAT 2476 
* ** ** * * * * ** * ** *
E14hs GTCGCCGC GCACTCCCCGTGCCCGTCTA— CATGTTGGTGCCCGCCCC------GGC 2289
El4mm GCCGCCGC TCATTGCCAGTCCCTGTGTA— CATGTTAGTGCCCGCCCC GGC 2268
E14fr GTTCCCGAATGGCAAAACCCAAATCTGTCCGGGCAGGAAAGTCATCGTTTCACACAAGGA 2536 
★ ★★ *★ ★ ★★ *★ ★ ★★ ★★ ★ ★★
E14hs CCCGGCCCAGGAGGACGACTCCTGCACTGACTCCGCGGAGGGCACGCCGGTCAACTTCTC 234 9
E14mm TC------GGGGTGATGACTCGGGCACGGACTCCGCAGAGGGCACACCCGTTAACTTTTC 2322
E14fr TCTGAAATTAGACGATTCGTCCCTCACAGATTCCGCTGAAGGAACACCTGGTAACTTCTC 2596 
★ ★ ★★ ★★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★  ★★★★★★★
E14 h s TAGCGCCGCCTCGCTCAGCGACGAGACGCTGCAGGGACCCCCCAGGGACCAGCC-CGGGG 2408 
E14mm CAGTGCAGCCTCGCTCAGTGACGAGACCTTACAGGGACCCTCCAGGGACAAGCC-AGCCG 2381 
E14fr CACAACAACATCGCTAAGTGACGACACGCTTCAGTATCCAGTGAAGCACAGGGGGAGCAA 2656 
* * * ***** ** ***** ** * *** ** * * ** * *
E14 hs GACCAGCGGGCAGGCAAAGACCCACCGGCCGCCCCACCTCTGCCAGACAGGCCATGGGGC 2468 
El4mm GGCCTGGGGACAGGCAGAAACCTACAGGCCGAGCTGCCCCTGCCAGGCAGACCCGATCTC 2441 
E14fr AGACTGCTTATCTACCAGTATCATCAAG— GAGCAAGAGCTTGATGACGAAAAGAGGATC 2714
E14hs ACCGGCACAAGGCGGGAGGCGCCGGCCGCAGCGCGGAGCAGTCTCGGGGCGCGGGCAAGA 2528 
E14mm ACCGGCCCAAAGCAGCAGGCGCTGGTAAGAGCACAGAACACACCCGGGGGCCCTGTAGGA 2501
E14f r G AAG AT T T GAGG AT AT T CT CAC AC T T CCAC AAAC T GAAC AGG AC AAAC AAC CC T G---GA 2771
* * * * * * * *  * *  * * * *
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E14hs ACAGAGCAGGGCTGGAGCTGCCCCTGGGCCGGCCCCCGAGCGCCCCCGCAGAC-- AAGG 2585
E14mm ACCGGGCAGGATTGGAGCTACCACTCAGCAGGCCCCAGAGTGCTCGGTCCAAC-- AGGG 2558
E14fr ACACAGAAAAACCGACAC-ATCACTC— CGACTCAGAGGGTGCTGATGCAAAGCAAAGAG 2828 
★ ★ ★ ★ * * * *★ ★ ★ * * ★* * * ★ ★
E14hs ACGGCTCAAAGCCCGGCCGGACCCGCGGGGACGGGGCGCTCCAGTCGCTGTGCCTCACGA 2 645 




El4fr CAGACCGTGTCAAGATCTTGTTCGGAATCTGGCGCTTCCTGTCATAATGAAAAGTGACCA 2947 
* * *  *  * * *  * * * * *  * * * *  * * *
E14hs GCGGCCGCGCCCACGCCAACCCACCGGCGCACATCGGCCATCCCTCGCGCTTTTACGCGG 27 64
El4mm GCCACTGCACCACCACC TCGGCGGGCATCCGCCATCCCACGGGCTCTAAAGCGC 2725
E14fr AGATGCAGGATTCCAGAAAAGAAACATAATATGTAAAAAGATTGCACATTTTCTACATGA 3007 
* * * * * ★
E14hs GAGCGTCCGCAGGGCCGGAAGGAGGCCCCTGCCCCGTCCAAGGCTGCACCAGCTGCCCCG 2824
El4mm GAGAAACCGGCAGGCAGAAAGGAGA------CTCCATCCAGGGCAGCCCAGCCTGCCACA 277 9
E14fr CAATAACTATGTGTGTGAAGACAG-------CAATGCTAACAGCGACGCTTTTGGACAGA 3060
*  *  * *  * * *  *  * * * * *  * *
E14 hs CCGCCCGCCCGGACCCAGCCCAGCCTCATTGCTGACGAGACCCCGCCCTGCTACTCCCTG 2884 
E14mm CTCCCTGTGAGAGCCCAACCCAGACTGATCGTGGATGAGACCCCGCCCTGCTATTCCCTG 2839
E14 fr CGACCCG----AAAACAGACCAG-- GGAAGCAAATGCAGCCAATACTGGCAAGAAGGAG 3113
* * *  * * *  * * * *  * *  * * *  * * *  * *
E14hs AGCTCCTCCGCCAGCTCCCTCAGCGAGCCCGAGCCCTCGGAGCCGCCGGCCGTCCATCCA 2 94 4 
El4mm ACTTCCTCAGCTAGTTCCCTCAGTGAGCCTGAGGCCCCTGAACAGCCGGCCAACCATGCT 2899
E14 fr AATTCCCAAGGAAAA---CACAGAGGCTTTCAGAGAATAAAACAAA-GTCTTCTCAAGGA 3169
*  * * *  * *  * * * *  * * *  * * * * * *
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E14h s CGAGGCCGGGAGCCCGCGGTCACCAAGGACCCGGGCCCAGGAGGCGGACGCGACAGCTCG 3004
El4mm CGAGGCCCGGAGCA------------------------ GGGTAGTAAACAGGACAGCTCT 2 935
E14fr TGAATCTATGGAGGGTTATTCGCTCAGCTCCTCCCTCAGCTCACTGAGTGATGCTGAGTT 3229 
* *  * * * *
El4hs CCCAGCCCGCGGGCCGCGGAGGAGCTTCTGCAGCGGTGCATCAGCTCGGCCCTGCCCAGG 3064 
E14mm CCTAGCCCAAGGGCAGAAGAGGAACTTCTGCAGAGATGTATCAGCTTGGCCATGCCCAGG 2995
E14fr TGAGGC GGGCAAATCAAAAGCCCAGCAAACGTGGTACAAAAACAGACAGAACAAAA 3285
* *  * * * *  * * * * * * * *  * * * *
E14hs CGCCGGCCCCCCGTGTCTGGCCTGCGGCGCC-GCAAGCCCCGAGCCACCCGGCTGGATGA 3123 
El4mm CGCCGGACCCAGGTGCCTGGCTCACGGCGTC-GCAAGCCCAGAGCCTTGAGGTCAGACAT 3054
E14fr CGCTGAATGCG---GTCCAACAAACGAAGCCCGTGAGCATTCACAGTCAATATGAGGAGC 3342
* * *  * * *  * *  * *  * * * * * *  * *
E14h s GCGGCCCGCAGAGGGGTCCCGGGAACGCGGCGAGGAGGCAGCGGGCTCGGACCGGGCCTC 3183 
E14mm AAGGCCCACTGAGATAACCCAGAAATGCCAGGAGGAGGTGGCTGGCTCCGATCCAGCCTC 3114 
E14 fr CCAGCTCCACGAGCTCTGTCAGTA-TGGATTCAGAGGATGATCTCCTCCAGAAATGCATA 3401 
** * *** * * * * ** * *** ** *
E14 h s CGACCTG GATAGCGTGGAGTGGCGCGCCATCCAGGAGGGCGCCAATTCAATTGTCA 3239
El4mm TGACCTA GACAGTGTGGAGTGGCAGGCTATCCAAGAGGGCGCAAACTCCATTGTCA 3170
E14fr ACATCTGCGATGCCAAAGCAGAGAAGGAAGCACGCAGCAAGGAAGAAGAAAGCAATGAAT 3461 
*  * *  * *  * * * *  *  * *  * * * *  * * * * *
E14hs CGTGGCTGCACCAGGCAGCAGCT GCCACGCGGGAGGCCTCGTCCGAGTCCGACTCCA 3296
E14mm CATGGCTGCATCAGGCAGCGGCCAAAGCCAGCCTGGAAGCATCTTCTGAGTCTGACTCCC 3230
E14fr AGTGACAAAGGTAAGAAGGCCCT GGATGCCTGGAAGC TGGAGGAGGAATTAGA 3514
* *  * * * * *  * * * * * *  * *  * * * *
E14hs TCCTGTCCTTCGTATCCGGGCTGTCAGTGGGATCCACCCTACAGCCCCCCAAGCACAGG- 3355 
El4mm TCTTGTCTTTGGTGTCCGGGGTGTCAGCAGGCTCCACCCTCCAGCCCTCCAAGCTCAGG- 3289 
E14fr TAGTGATGATGCAGATTCAGATCTCAACAGTGTTGAGTGGAGAGCTATCCAAGAAGGTGC 3574 
* * *  * * * * * *  * * * * * *  * * * * *  *
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E14hs --AAGGGACGACAGGCGGAGGGAGAAATGGGCAGTGCCCGGCGGCCAGAGAAAAGGGGCG 3413 
E14mm — AAAGGGCGAAAGCCTGCAGCAGAGGCTGGAGGTGCCTGGCGTCCTGAGAAACGGGGCA 3347 
E14fr CAACTGGTTGTCACTGGGCTGCAGGCCTCAAAATCTCAAGAGCCTTCCTCTGAAGAGACT 3634 
* * *  * * * * * *  * * * * * *
E14 hs CAGCCTCAGTCAAGACCAGCGGGAGCCCCCGTTCCCCTGCAGGCCCCGAGAAGCCACGTG 3473 
E14mm CAACTTCCACTAAGATCAATGGGAGTCCCCGGCTACCTAACGGTCCTGAGAAGGCAAAGG 34 07 
E14fr GAATCGGTCATTTCATTCATGTCAACCTCTAGCTTCACGCCTAAAGAAAGGAAGTTTTGC 3694 
* * * * * * * * * *
E14 hs GCACACAGAAGACCACGCCCGGGGTGCCAGCTGTGCTC— CGGGGACGAACAGTGATCTA 3531 
El4mm GTACCCAGAAAATGATGGCAGGGGAGTCAACCATGCTC— CGGGGACGGACAGTGATCTA 34 65 
E14fr AAAGACAAAAAGTCA-AACAAACCTCTAGACTTTGCTCAACGCAAGCCCGTCCCAAACTT 3753
E14hs CGTCCCCA-GCCCGGCACCCCGTGCCCAGCCCAAAGGGACCCCCGGCCCCCGCGCCACAC 3590 
El4mm CTCAGCCG-GCCCAGCCTCCCGCACTCAGTCCAAAGGTATTTCTGGACCTTGTACCACAC 3524 
E14 fr TCCAGTTGTGTTCAGAGGCAGGACTGTAATTTACACACCGAGAAAGGAGACA-GCCCCAT 3812
E14hs CGCGGAAGGTGGCGCCCCCTTGCCTGGCACAGCCCGCGGCTCCAGCCAAAGTCCCGAGCC 3650 
E14mm CTAAGAAGACAGGGACATCTGGTACCACTCAGCCAGAAACTGTCACCAAAGCCCCCAGCC 3584 
E14fr CGCAAAGGCCTCCTCCCACCAAACTGACGACCAGCTCAGATCCTCCAAAAAACCCAAACC 3872 
* *  *  * * * * *  * * ★  * * *  * * *
E14h s CCGGGCAGCAGCGGTCGCGGAGCCTACACCGGCCTGCCAAGACCTCGGAGCTGGCGACGC 3710 
E14mm CTGAGCAACAACGTTCACGGAGCCTCCACCGACCGGGCAAGATCTCTGAGCTGGCAGCTT 3644 
El4 fr TTGCTCAACACAGATCAAAGAGCCTTCATCGATTGGG-ACACTCCCAGGAC— ATGGACC 3929 
* * *  * *  * * *  * * * * * *  * *  * *  * * * * *  *
E14 hs TGAGCCAGCCCCCCAGAAGCGCCACACCGCCCGCCCGCCTCGCCAAGACCCCCTCCTCCA 3770 
E14mm TGCGCCACCCGCCCAGGAGTGCCACTCCTCCAGCCCGCCTCGCCAAGACCCCGTCCTCAA 3704 
E14fr TGGCCCTGCCAAAGAGGAGCTCTACTCCACCTCCAAGGATGCAAAAAAGTTCCTCCTCTG 3989 
★★ ★★ ★★ ★★★★ ★ ★ ★ ★ ★ ★ ★  ★ ★ ★ ★★★ ★★★★★★
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E14hs GCTCCTCCCAGACCTCGCCCGCCTCCCAGCCCCTGCCCAGAAAGCGCCCCCCGGTCACCC 3830 
El4mm GCTCTTCACAGACCTCTCCAGCATCCCAGCCCCTGCCTAGGCGGTCCCCTCTGGCCACTC 3764 
E14fr GTTCATCGCAAACCTCGACTCCATCCAAACAGAAG— AAGACAACATCCCTGAGTGGAAC 4047 
* * * * * * * * * * * *  * * * * * * *  * * *  * * * *
El4hs AGGCTGCTGGGGCCCT-------GCCCGGCCCCGGAG---CCTCC-CCGGTGCCCAAAAC 3879
El4mm CCACAGGAGGACCTCT------ GCCTGGCCCTGGGG---GGTCC-CTGGTGCCCAAGTC 3813
E14fr GAATAAAAACATCCCTAAAAAGGGCGTTACGCCGACGAACGGTCCACCAGCTGCTGAAAG 4107 
★ ★★ ★ ★ * * ★ ★ ★ ★
El4hs GCCGGCGCGCACCCTTCTG---------GCGAAGC---- AGCAC— AAGACGCAGAGATC 3924
El4mm ACCAGCACGGGCCCTTCTG---------GCTAAGC---- AACAC— AAGACCCAGAAGTC 3858
E14fr AACAGCAGGTGCAGCCTTGAACTCAGATGAGAAGCCCTCAACACCAAAAACTCAGAAGTC 4167
E14hs GCCCGTGCGGATCCCGTTCATGCAGAGGCCGGCCCGGCGTGGGCCGCCACCGCTGGCTCG 3984 
E14mm ACCTGTGCGGATCCCATTCATGCAAAGGCCAGCCAGGCGAGTGCCACCTCCACTGGCCAG 3918 
E14 fr ACCCGTCCGAATCCCTTTCATGCAGAATCCAGTCAAACCCAGACCCCTGTCACCCCTGGT 4227 
** ** ** ***** ******** * ** * * * ** * * *
E14 hs GGCAGTCCCGGAGCCGGGCCCCAGGGGCCGGGCGGGGACCGAGGCGGGCCCGGGGGCGCG 4044 
E14mm GCCATCCCCAGAACCTGGCTCTAGGGGCCGAGCTGGGGCTGAGGGTACTCCTGGGGCACG 3978 
E14fr TACAAACCAAACAGCTGGC— AAACCAGCAAATATGGTCCATGGGAAAGT-GGTGTCGCC 4284 
** ** * *** * * ** * ** * * * *
E14hs CGGGGGCCGCCTGGGCCTGGTGCGTGTGGCCTCAGCCCTCTCCAGCGGCAGCGAGTCCTC 4104 
E14mm TGGCAGCCGCCTGGGCCTGGTGCGTATGGCTTCAGCTCGCTCCAGTGGCAGCGAGTCCTC 4038 
E14fr TGCCAGTCGATTAGAACTGCTCCGGATGACCTCAGCT-------- GGTCGTGAGTCC—  4333
★  ★ ★ ★  ★ ★  ★ ★ ★ ★ ★ ★  ' k ' k ' k ' k ' k ' k ' k ' k  ★ ★  ★ ★ ★ ★ ★ ★ ★
E14hs CGACCGCTCGGGCTTCCGGCGACAGCTAACCTTCATCAAGGAGTCGCCGGG CTTGCG 4161
El4mm GGATCGCTCAGGCTTCCGAAGACAGCTGACTTTCATCAAGGAATCCCCAGGTCTCCTTCG 4098 
El4 fr -GATCGCAATGGATTTTTGAGACAGATGACCTTCATCAAGGAATCAAAGACCGTACAGAA 4392
★ ★ ★  ★ ★  ★ ★  ★ ★ ★ ★ ★  ★  ★ ★  •k'k'k'k'k'k'k'k'k'k'k ★ ★
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E14hs GCGCCGCCGCTCCGAGC-TGTCCTCGGCCGAGTCCGCGG------CCTCTGCCCCCCAGG 4214
E14mm GCGTCGCAGATCAGAGC-TGTCCTCTGCGGACTCCACGG------CCTCCACCTCCCAGG 4151
E14 fr ACACGATAGTGCCAAATGCAGCATGTTCCGATCTCAAAAAAGACCCCTCCACCCTACCGG 4452 
*  * * * * * * * *  * * * * *  * *  * * *
E14hs GCGCCTCGCCCCGCCGCGGCCGGCCCGCGCTGCCCGCCGTCT TCCTCTGC T 4265
E14mm CTGCTTCGCCCCGCCGTGGACGGCCTGCACTCCCTGCTGTCT TTCTCTGC T 4202
E14fr CTCGGGAGCCGCGGCTGTTTTCCTTTGTTCTTCACGTTGTCAGGAACTCAAAGCAGCAGT 4512 
* * *  * *  * * * *  * * * * *  * * *  *
E14hs CCTCGCGCTGCGAAGAGCTC---------- CGAGCGGCACCCCGGCAGGGC------- C 4307
El4mm CCTCTCGTTGCGATGAGCTG---------- CGGGTATCCCCACGGCAGCCC------- C 4244
E14fr TCAAACCCAGAGAAGAACACAAGTAAAAGATCAAGGACAGCCACAACGGGTCAAGAGACC 4572 
*  *  *  * *  * *  * * * * *  * * * * *
E14hs CGGCCCCGGCC— CGGCAGCGGCCCCCCGCGGCCCGACCCAGCCCTGGCGAGCG-----  4359
El4mm TGGCAGCA--------CAGAGGTCCCCACAGGCCAAGCCAGGTCTCGCCCCACG-----  4290
E14fr TGATCCTGGCCTTCAGCAGCAGGCAACACTCTCCAGAGCAACCTCCAGCGAAAGGTACAG 4 632 
* * * * * * * * * * * *
E14hs CCCTGCCCGGCGCACCACCTCCGAGAGCCCGTCCCGCCTGCCTGTGC- 4406
E14mm TGCGCCCAGACGCACCAGCTCTGAGAGCCCCTCACGCCTGCCTGTGC- 4337
El4 fr AAACACAAGAGGTTTAAGCAGAAGAACTAGCTCTGAAAGCCCATGCAGGCTGGCAAAGCA 4 692
* * * * *  * * * *  * *  * * * * *  * * * * *  * * *
E14hs------ GCGCGCCCGCCGCCCGGCCGGAGACTG------------------- TCAAGCG 4440
El4mm------ GGGCGAGCCCTGGACGGCCTGAGACAG------------------- TCAAGCG 4371
E14fr AAGCAAAGCTGGCACGGTGTCTGGCGTCAGGCAGCAACAAGACAAGGATACCTTCAAACG 4752 
* * * * *** ** * * **** **
E14 h s CTACGCGTCGCTGCCGCACATCAGCGTGGCCCGCAGGCCCGACGGCGCCGTCCCCGCGGC 4500 
El4mm GTACGCATCCCTGCCACATATTAGTGTGTCCCGCAGGTCCGATAGCGCTGTCTCTGTGCC 4431 
El4 fr TCATGCCTCATCACCAAGCATCAACATACTGAGCCGCGTCACCAGCCGCTCTTCCCTCCG 4812 
* * * * *  * *  * * *  * * * *  * * *  *
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E14hs CCCTGCCTCAGCCGACGCCGCGCGCCG CAGCAGCGACGGGGAGCCCCGGCCGC-TCC 4556
El4mm CACCACCCAGGCCAATGCCACTCGCCG GGGAAGTGATGGCGAGGCCAGGCCGC-TGC 44 87
El4 fr CTCATCATCGTCTGATTCAAGTAGCAGAGCCAAGAGTGAGGACGAGACAAAGAAGTATGG 4 872 
* * * * * * ** * ** ** * *** * * * *
E14hs CCAGGG TGGCCGCGCCG-GGCACGACCTGGCGGCGCATCCGAGATGAGGACGTGCC 4 611
El4mm CCAGGG TAGCTCCTCCG-GGTACGACCTGGCGTCGAATCAAAGATGAAGATGTCCC 4542
El4fr ACAGAAATCCCGGGTACTTGACAGGGCCACCTGGAGGAGGATCAGGGATGAAGATGTTCC 4 932 
*** * * * * ****** * * *** ***** ** ** **
E14hs CCACATCCTGCGCAGCACGCTTCCCGCCACGGCCCTGCCACTGCGGGGCTC--------  4662
El4mm CCACATCCTGCGCAGCACACTGCCTGCCACTGCCCTGCCTCTCAGGGTCTC--------  4593
El4fr TCACATCTTAAAAAGCACCCTCCCGGCTAATGCCTTACCCCTGGTGGCTTCTCCCGAGGG 4 992
★  ★ ★ ★ ★ ★  ★  k  k  k  k  k  ★ ★  ★ ★  ★ ★  ★  ★ ★ ★  ★  'k "k k  k  k  k  k  k
E14hs —  CACGCCCGAGGACG-- CCCCGGCCGGG------------- CCCCCGCCG----- CG 4698
El4mm — GTCACCCGAAGACA-- GCCCCGCTGGA------------- ACTCCACAG----- CG 4629
E14fr GGACCAGCCGAAGCTGCAGGCTCCTTTGGGTAAGTTGCCAACCATTCTGCTGGCCTCCCG 5052
E14hs CAAGACCAGCGACGCCGTGGTCCAGACCGAGGAGGTCGCCGCCCCCAAGACCAACTCCAG 4758 
El4mm CAAGACCAGTGACGCAGTGGTGCAAACAGAGGACGTGGCCACTTCTAAGACCAACTCTAG 4 68 9
El4fr CAAGACAAGTGATGCAACGGTCCAGACCGAGGACTTTTCCAAC-- AAGATCAGCTCCAG 5109
* * * * * *  * *  * *  * *  * * *  * *  * *  * * * * *  * * *  * * * *  * *  * * *  * *
E14hs CACGTCCCCGA------------GCCTGGAGACC----AGGGAGCCCCCCGGG— GCCCC 4800
El4mm CACGTCACCTA------------GCCTGGAGAGC----AGGGATCCGCCACAG— GCCCC 4731
E14 fr CACCTCTCCAACAGTGGAAGTTGGCCCAGAGATCGCAGAAGAAACGGTCCGACCCGCACC 5169
★  ★ ★ ★ ★ ★ ★ ★  ★ ★ ★  ★ ★ ★ ★ ★  ★  ★  ★  ★  k  k  k  k  k
E14hs CGCCGGCGGCCAGCTCTCCCTCCTCGGCAGCGACGTGGACGGTCCCAGCCTCGCCAAGGC 48 60 
El4mm TGCCAGCGGCCCTGTGGCTCCCCAGGGCAGCGATGTGGATGGACCAGTACTCACCAAGCC 47 91 
E14fr GCTCAGAAATGAAGGTACGACCTCCGGAAATAACCTCCA-GGATGGAGACTCAGATTGCT 5228 
* * * * ** * * * * ** *** *
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E14hs TCCC ATCTCCGCACCCTTCGTGCACGAGGGCCTGGGGGTCGCCGTGGGGGGCTTC 4 915
El 4mm TCCT GCCTCAGCGCCCTTCCCCCATGAGGGTCTGAGTGCTGTCATAGCAGGCTTT 484 6
El4fr TGTTAAAAAGCCTCAGCAACGCTTCCATGGGAACGCCAGACAACCACGCTGGTGGGAGTG 5288 
* *** ** * * **• * * * * * ** *
E14hs — CCCGCCAG CCGGCACGGCTCCCCCAGCCGCTCGGCCCGAGTACCCCCCTTCAACT 4 970
El4mm — CCCACCAG CAGGCATGGCTCCCCCAGCAGGGCTGCACGGGTTCCCCCCTTCAACT 4 901
E14fr GGCCGGTCTATTTCCGCCAGGGAACTCCAAGCAAGTCTGCCAGAATCACTCCGTTTAATT 534 8 
** * * * ** ** * ** *** * ** * * * ** ** ** *
E14 hs ATGTGCCCAGCCCCATGGT---GGTCGCAGCCACCACCGACTCGGCCGCGGAGAAAGCCC 5027
El4mm ATGTGCCCAGCCCTATGGCAGCGGCCACAATGGCCAGTGACTCCGCAGTGGAGAAAGCCC 4961 
El4fr ACACACCCAACCCACTGGCCTGCAGTAAAAGCGCACAGAACCAGGCAGCCAAAACCAATG 5408 
* **** *** *** * * ** ** * * *
E14hs CGGCCACTGCCTCCGCCACCCTCCTGGAATAG 5059 
E14mm CGGTCTCCTCTCCAGCCAGTCTCCTGGAGTAG 4 993
E14fr AAAAGCAGGCGGAGGGCAGGGAGTCG-----  5359
★ ★ ★ ★ ★
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Appendix, Section 4A
rnApd  CAT reporter construct and CAT plasmids
BamHI-EcoRI-
Stul-Xhol-






Figure. Plasmid map of pC4T-controlThe dotted square indicates the SV40 promoter, 
the open square shows the CAT  gene and the black square indicates the 









Sp6-> ^ T 7  <rT3
pC4T-basic
Figure. Plasmid map of pC^T-basicThe dotted square indicates the minimal SV40 
promoter,the open square shows the CAT  gene and the black square indicates the 
SV40polyA. The ampicillin resistance gene is indicated by the black arrow.
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BamHI-EcoRl-
Stul-Xhol-




Sp6 -> <rTl <rT3
 ►  ^
pApc-CAT
Figure. Plasmid map of yApc-CAT. The dotted square indicates the Ape promoter 
(-290 to +317bp), the open square shows the CAT gene and the black square 
indicates the SV40polyA. The ampicillin resistance gene is indicated by the 
black arrow.
Appendix, Section 4B 
frA pd  GFP reporter constructs
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frApcl deletion constructs- pCS2:GFPCMV 
Figure. Plasmid map of frApcl deletion constructs- pCS2:GFP'CMV. (A). Shows the
cloning of the frCdxl PCR products into pGEM-T. The dotted square indicates
the 4.0, 2.0 and 1.0 Kb frApcl PCR products. (B) Cloning of the frCdxl PCR
products into the pCS2:GFP^<v vector using the BamHI/ Xhol sites. The open
square shows the GFP gene and the black square indicates the SV40polyA. The
ampicillin resistance gene is indicated by the black arrow.
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Appendix, section 5A






Figure. Transient expression analysis of the frC dxl GFP constructs in to the zebrafish 
embryo at 80% epiboly. A. Lateral view of the Zcad expression at 50% epiboly. 
B,D and F. Expression map representing the GFP expression pattern shown for 
each frC dxl reporter construct. C,E and G. GFP expression of each construct in 
the zebrafish embryo at 80% epiboly (top view).
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Figure. Transient expression analysis of the frC dxl GFP constructs in to the zebrafish embryo at 1 somite stage. A. Lateral view of the Zcad 
expression at bud stage.B,E and H. Expression map representing the GFP expression pattern shown for each frC dxl reporter construct. C 
and D. GFP expression of the -1.0Kb frC dxl GFP construct. F and G. GFP expression of the -2.0Kb frC dxl GFP construct. I and J  GFP 
expression of the -4.0Kb frC dxl GFP construct in the zebrafish embryo at bud stage (lateral view). (A) anterior, (P) posterior.
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frCdxl GFP reporter construct, microinjection into the zebrafish, 14 somites stage
lkb
Figure. Transient expression analysis of the 1.0Kb frCdxl GFP construct in to the zebrafish embryo at 14 somites stage. A. Lateral view of the 
Zcad expression at 18 somite stage. B. Expression map representing the GFP expression pattern shown by the -1.0Kb frC dxl GFP 
construct. C- F. GFP expression in the tail bud and ventral mesenchyme region in the zebrafish embryo at 18 somite stage (lateral view). 
Embryos orientated (A) anterior to (P) posterior.
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frCdxl GFP reporter construct, microinjection into the zebrafish, 14 somites stage
2kb
Figure. Transient expression analysis of the 2.0Kb frC dxl GFP construct in to the zebrafish embryo at 14 somites stage. A. Lateral view of the 
Zcad expression at 18 somite stage. B. Expression map representing the GFP expression pattern shown by the -2.0Kb frC dxl GFP 
construct. C- F. GFP expression in the tail bud, ventral mesenchyme and spinal chord region in the zebrafish embryo at 18 somite stage 
(lateral view). Embryos orientated (A) anterior to (P) posterior.
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frCdxl GFP reporter construct, microinjection into the zebrafish, 14 somites stage
Figure. Transient expression analysis of the 4.0Kb frC dxl GFP construct in to the zebrafish embryo at 14 somites stage. A. Lateral view of the 
Zcad expression at 18 somite stage. B. Expression map representing the GFP expression pattern shown by the -4.0Kb frC dxl GFP 
construct. C- F. GFP expression in the tail bud and spinal chord region in the zebrafish embryo at 18 somite stage (lateral view). Embryos 
orientated (A) anterior to (P) posterior.
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Figure. Transient expression analysis of the frC dxl GFP constructs in to the zebrafish 
embryo at 25hpf. A. Lateral view of the Zcad expression at 25hpf. B and E. 
Expression map representing the GFP expression pattern shown for the -2.0Kb 
frC dxl GFP and -4.0Kb frC dxl GFP reporter constructs. C and D. GFP 
expression of the -2.0Kb frC dxl GFP construct in the spinal cord region. F, G 
and H. GFP expression of the -2.0Kb frC dxl GFP construct in the spinal cord 
and tail bud region in the zebrafish embryo at 25hpf (lateral view). Embryos 
orientated (A) anterior to (P) posterior.
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